virusspecif
cellmedi
immun
review
aspect
cell
effector
function
differ
anatom
site
context
natur
limit
immun
memori
recal
respons
particular
attent
given
recent
experi
use
revers
genet
technolog
explor
interact
respons
bmajorq
bminorq
epitop
rel
import
quantiti
versu
qualiti
respons
consid
togeth
characterist
immunodomin
hierarchi
factor
determin
natur
cell
receptor
tcr
repertoir
explor
use
approach
combin
singl
cell
pcr
mutat
structur
biolog
analysi
begin
understand
chemistri
tcrepitop
interact
way
hope
inform
fundament
insight
practic
consider
like
vaccin
design
molecular
divers
cell
respons
profil
also
discuss
prime
individu
mount
secondari
immun
respons
rapid
effect
primari
respons
also
maintain
absenc
boost
certain
level
effector
cell
antibodi
lifetim
aspect
immunolog
memori
distinct
cellular
basi
recal
respons
mediat
secondari
lymphoid
organ
central
memori
cell
memori
b
cell
immedi
protect
mediat
peripher
tissu
effector
memori
cell
antibodi
produc
longliv
plasma
cell
review
experiment
evid
support
bstem
cell
modelq
immunolog
memori
central
memori
cell
memori
b
cell
intermedi
progress
differenti
process
acquir
capac
prolifer
differenti
respons
polyclon
stimuli
cytokin
microbi
product
bystand
cell
help
self
renew
central
memori
cell
memori
b
cell
continu
spill
effector
cell
plasma
cell
thu
replenish
turn
describ
detail
mechan
sustain
serum
antibodi
level
follow
vaccin
discuss
implic
find
vaccin
design
find
central
nervou
system
cn
embodi
neurogenet
region
enrich
neural
stem
cell
nsc
spur
flurri
studi
basic
biolog
perspect
applic
therapi
mani
neurolog
disord
nsc
multipotenti
precursor
grow
selfrenew
extens
time
cultur
recent
argu
nsc
undergo
rapid
spontan
transform
would
repres
obstacl
use
therapeut
applic
neurolog
disord
well
basic
research
talk
shall
present
overview
state
art
field
discuss
recent
find
demonstr
extrem
function
stabil
nsc
particularli
human
origin
actual
capac
act
therapeut
entiti
damag
cn
involv
format
propag
malign
adult
human
brain
tumor
ie
glioblastoma
multiform
cnsreactiv
cell
clone
present
healthi
immun
repertoir
attack
target
tissu
upon
full
activ
invas
cn
inflammatori
cell
occur
two
wave
shortli
transfer
activ
cell
pass
intact
bbb
resid
cn
h
without
caus
diseas
second
much
larger
wave
cell
invad
cn
appar
precipit
neurolog
defect
loss
weight
trace
migratori
pathway
encephalitogen
cell
clinic
eae
lewi
rat
studi
retrovir
transduc
gfp
express
bgreenq
myelin
specif
cell
combin
serial
imag
realtim
assay
gene
transcript
protein
express
find
activ
encephalitogen
cell
radic
reprogram
gene
express
pattern
first
h
prodrom
period
sit
peripher
immun
organ
downregul
activ
marker
upregul
chemokin
receptor
h
larg
number
cell
invad
cn
via
bbb
twophoton
imag
reveal
mani
cell
rapidli
cruis
brain
parenchyma
other
seem
arrest
shall
present
evid
arrest
cell
recogn
local
present
autoantigen
intraparenchym
cell
activ
seem
underli
pathogen
inflammatori
respons
respons
clinic
eae
shortli
reactiv
green
cell
undergo
apoptot
cell
death
deplet
cn
coincid
termin
clinic
eae
episod
neural
immun
synapt
relat
inflamm
local
protect
respons
microbi
invas
injuri
must
finetun
regul
precis
defici
excess
inflammatori
respons
caus
morbid
shorten
life
span
discoveri
cholinerg
neuron
inhibit
acut
inflamm
qualit
expand
understand
nervou
system
modul
immun
respons
tracey
kj
natur
nervou
system
reflex
regul
inflammatori
respons
real
time
control
heart
rate
vital
function
vagu
nerv
transmit
antiinflammatori
cholinerg
signal
reticuloendotheli
system
inhibit
acut
cytokin
releas
respons
injuri
infect
select
revers
dhardwiredt
neural
system
critic
control
point
manipul
therapeut
advantag
anim
pattern
recognit
receptor
innat
immun
inflamm
mantovani
istituto
di
ricerch
farmacologich
mario
negri
milan
itali
pentraxin
group
protein
conserv
evolut
long
pentraxin
repres
discret
subfamili
prototyp
first
clone
member
addit
long
pentraxin
includ
neuron
pentraxin
neuron
pentraxin
well
np
receptor
prototyp
long
pentraxin
multifunct
pattern
recognit
receptor
produc
divers
cell
type
tissu
includ
central
peripher
nervou
system
respons
divers
signal
evid
suggest
play
non
redund
role
innat
immun
select
pathogen
femal
fertil
inflamm
repair
central
nervou
system
progress
definit
ligand
recogn
vitro
well
vivo
function
discuss
role
receptor
myeloid
cell
develop
function
colonna
depart
patholog
immunolog
washington
univers
school
medicin
st
loui
mo
usa
trigger
receptor
express
myeloid
cell
trem
belong
rapidli
expand
famili
receptor
activ
myeloid
cell
signal
adaptor
protein
trigger
phagocyt
secret
proinflammatori
chemokin
cytokin
activ
monocytederiv
dendrit
cell
remark
defici
lead
sever
diseas
character
dementia
bone
cyst
impli
homeostat
condit
may
also
regul
function
brain
microgli
cell
bone
osteoclast
address
function
vivo
gener
mice
compar
mice
result
demonstr
critic
function
develop
microglia
osteoclast
function
dendrit
cell
immun
respons
innat
immun
neuroprotect
neurodegener
rivest
chul
research
center
laval
univers
quebec
citi
quebec
canada
innat
immun
respons
initi
bind
pathogenassoci
molecular
pattern
pamp
cognat
tolllik
receptor
tlr
express
surfac
antigenpres
cell
apc
bloodbrain
barrier
bbb
restrict
access
immun
mediat
cell
blood
mechan
lead
proinflammatori
signal
brain
differ
system
organ
reason
term
bimmuneprivileg
organq
long
use
describ
reduc
exposur
brain
inflammatori
event
inabl
mount
immun
respons
process
antigen
contrari
notion
eleg
innat
immun
respons
take
place
well
organ
coordin
manner
central
nervou
system
cn
system
infect
cerebr
insult
like
system
apc
brain
microglia
react
pamp
tlrdepend
manner
emerg
evid
suggest
innat
immun
play
benefici
role
host
defens
recoveri
although
microgli
reactiv
becom
hallmark
neurodegen
process
lectur
present
site
stori
highlight
mechan
involv
control
inflammatori
respons
brain
either
protect
neuron
direct
caus
neurodegen
disord
activ
deactiv
regulatori
cell
function
e
shevach
laboratori
immunolog
nation
institut
allergi
infecti
diseas
nation
institut
health
bethesda
md
usa
natur
occur
regulatori
cell
serv
vital
function
cellular
attenu
immun
respons
instanc
suppress
domin
rais
import
question
natur
factor
control
mainten
activ
suppressor
cell
function
although
main
function
cell
suppress
product
cell
suppress
still
manifest
presenc
exogen
moreov
addit
complet
abrog
suppressor
function
thu
must
first
produc
respond
cell
prior
initi
suppressor
cell
function
nonactiv
regulatori
cell
constitut
express
gitr
tnfrfamili
member
whose
engag
thought
abrog
regulatori
cellmedi
suppress
howev
use
mice
capac
antigitr
abrog
suppress
could
shown
mediat
action
cell
mous
antigen
present
cell
constitut
express
gitrl
downregul
follow
tolllik
receptor
signal
thu
gitrl
provid
import
signal
cell
render
resist
mediat
regul
initi
immun
respons
downregul
gitrl
inflammatori
stimuli
may
enhanc
suscept
effector
cell
suppressor
activ
cours
infecti
insult
manipul
gitrgitrl
interact
may
prove
effect
way
manipul
regulatori
cell
function
vivo
regulatori
cell
privileg
target
treatment
autoimmun
diseas
l
chatenoud
hopit
necker
pari
franc
autoimmun
respons
control
regulatori
cell
depend
model
may
express
distinct
phenotyp
function
characterist
thymu
regulatori
cell
like
cell
shown
control
physiolog
organspecif
autoimmun
contrast
peripheri
cell
exhibit
regulatori
capac
antibodi
potent
immunosuppress
gener
appli
non
fcreceptor
fcr
bind
monoclon
data
laboratori
first
show
antibodi
could
revers
autoimmun
diabet
nod
mice
restor
selftoler
b
cell
antigen
led
clinic
trial
present
ongo
recent
onset
type
diabet
patient
use
non
fcreceptor
fcr
bind
monoclon
antibodi
concern
mechanist
aspect
antibodi
promot
immedi
clearanc
insul
follow
bresettingq
special
subset
immunoregulatori
cell
mediat
activ
toler
treat
mice
regulatori
cell
concentr
compart
share
marker
proport
increas
pancreat
mesenter
lymph
node
tgfbetadepend
vivo
vitro
antibodi
appear
thu
first
repres
novel
categori
immunotherapeut
agent
provid
cure
establish
autoimmun
capac
boost
immunoregulatori
cell
forese
proof
concept
autoimmun
diabet
could
extend
near
futur
autoimmun
diseas
vaccin
betaamyloid
alzheim
diseas
rm
nitsch
c
hock
divis
psychiatri
research
univers
zurich
zurich
switzerland
immun
betaamyloid
reduc
amyloid
plaqu
load
improv
impair
behavior
transgen
mice
determin
whether
antibodi
betaamyloid
also
effect
human
patient
alzheim
diseas
ad
particip
wyethelan
phase
clinic
trial
includ
patient
mild
moder
dementia
receiv
two
subsequ
dose
preaggreg
adjuv
random
placebocontrol
studi
design
observ
gener
antibodi
betaamyloid
patient
sera
found
antibodi
character
remark
specif
bona
fide
betaamyloid
plaqu
brain
tissu
absent
detect
crossreact
fulllength
app
monomer
form
abeta
therefor
develop
tissu
amyloid
plaqu
immunoreact
tapir
assay
quantifi
abil
antibodi
react
brain
betaamyloid
plaqu
brain
tissu
transgen
mice
express
adcaus
mutat
patient
gener
tapirposit
antibodi
period
show
significantli
slower
rate
declin
cognit
function
activ
daili
live
score
better
hippocampusdepend
memori
test
compar
patient
without
antibodi
benefici
clinic
effect
also
present
patient
experienc
transient
episod
immunizationrel
asept
meningoenceph
unwant
side
effect
immun
data
show
gener
antibodi
betaamyloid
respons
immun
slow
cognit
declin
patient
ad
provid
toler
improv
suggest
vaccin
betaamyloid
valuabl
option
treatment
ad
prospect
limit
genet
analysi
common
autoimmun
diseas
f
cucca
mg
marrosu
b
dipartimento
di
scienz
biomedich
e
biotecnologi
univers
cagliari
cagliari
itali
b
centro
sclerosi
multipla
dipartimento
di
neuroscienz
univers
cagliari
cagliari
itali
genet
analysi
multifactori
trait
multipl
sclerosi
type
diabet
complic
mani
factor
includ
interlocu
allel
heterogen
interact
differ
diseas
loci
interact
diseas
loci
environment
factor
complic
caus
low
penetr
may
compound
small
individu
genet
effect
diseas
loci
aforement
difficulti
could
allevi
concentr
research
isol
rel
homogen
popul
mediterranean
island
sardinia
popul
one
highest
incid
type
diabet
multipl
sclerosi
world
moreov
evid
coinherit
two
disord
sardinia
consist
suggest
highli
penetr
gene
present
central
role
gener
autoimmun
popul
sardinian
repres
ancient
genet
isol
accept
preneolith
origin
substanti
lack
popul
substructur
reduc
risk
artifact
due
popul
admixtur
presenttim
sardinian
popul
result
fixat
genet
variant
rare
absent
european
deriv
popul
particularli
use
pinpoint
etiolog
polymorph
result
obtain
popul
far
clearli
illustr
advantag
use
genet
isol
genet
analysi
multifactori
disord
rel
import
populationdemograph
chromosomeregion
specif
variabl
well
relev
interact
loci
genet
analysi
complex
trait
discuss
genet
analysi
multipl
sclerosi
linkag
associ
compston
depart
clinic
neurosci
cambridg
uk
use
linkag
associ
sever
candid
gene
show
reproduc
effect
suscept
resist
clinic
cours
phenotyp
resolut
neg
best
support
effect
suscept
hladrdq
tnfalpha
protect
may
provid
cours
may
influenc
polymorph
cntf
phenotyp
multipl
sclerosi
determin
mutat
mitochondri
dna
whole
genom
linkag
associ
screen
suggest
effect
may
encod
xp
eventu
six
main
categori
suscept
gene
predict
gene
determin
suscept
process
inflamm
across
rang
disordersth
autoimmun
gene
determin
specif
process
develop
multipl
sclerosisth
ubiquit
gene
relev
pathogenesi
isol
populationsth
domest
gene
determin
particular
phenotypesth
pleotrop
gene
determin
variat
clinic
courseth
modifi
gene
cluster
provid
specif
differ
heterogen
contribut
pathogenesisth
epistat
gene
major
part
futur
studi
resolv
question
diseas
heterogen
multipl
sclerosi
hla
complex
associ
larg
number
diseas
includ
multipl
sclerosi
case
ms
strong
associ
haplotyp
remain
uncertain
exactli
translat
risk
commonli
believ
notion
way
analog
ir
gene
experiment
anim
model
relat
differenti
present
mhc
molecul
cell
howev
signific
difficulti
interpret
least
equal
evid
linkag
non
dr
haplotyp
sibl
pair
report
comprehens
analysi
mac
class
type
thousand
famili
ms
cover
individu
locu
complex
characteris
ci
tran
effect
hierarch
suscept
interpret
term
known
genet
analysi
loci
anim
model
genet
tool
enlight
multipl
sclerosi
complex
r
holmdahl
medic
inflamm
research
lund
univers
lund
sweden
inbr
anim
use
studi
identif
gene
associ
complex
diseas
like
ms
mani
basic
diseas
pathway
lead
ms
like
share
autoimmun
chronic
inflammatori
diseas
like
rheumatoid
arthriti
ra
use
sever
differ
model
ms
ra
identifi
underli
gene
region
gene
contribut
diseas
princip
done
analysi
genet
segreg
cross
inbr
strain
vari
diseas
suscept
follow
linkag
genotyp
phenotyp
inform
method
other
isol
import
gene
region
bred
congen
strain
loci
studi
separ
contribut
gene
eventu
clone
congen
strain
shown
use
studi
mhc
region
gene
also
gene
outsid
mhc
region
exampl
report
mhc
class
ii
ab
gene
mous
gene
rat
protein
part
nadph
oxidas
complex
involv
gener
induc
oxid
burst
discoveri
polymorph
led
new
propos
pathway
oxygen
radic
modifi
antigen
present
result
activ
autoreact
cell
new
data
present
role
gene
model
ms
also
import
identifi
genet
environment
interact
identifi
gene
complex
diseas
like
ms
molecular
mechan
drive
transendotheli
migrat
leukocyt
across
bloodbrain
barrier
b
engelhardt
theodor
kocherinstitut
univers
bern
bern
switzerland
diapedesi
encephalitogen
lymphocyt
across
bloodbrain
barrier
uniqu
appli
intravit
fluoresc
microscopi
allow
us
visual
interact
circul
encephalitogen
lymphoblast
within
cn
microvasculatur
vivo
demonstr
encephalitogen
cell
blast
interact
spinal
cord
white
matter
microvasculatur
without
roll
mediat
gprotein
independ
captur
subsequ
gproteindepend
adhes
strengthen
cell
blast
microvascular
found
involv
transendotheli
migrat
cell
blast
across
spinal
cord
microvessel
vivo
endotheli
ligand
defin
exact
role
cell
extravas
use
mous
cell
brain
endothelioma
cell
brain
endothelioma
cell
support
transendotheli
migrat
cell
vitro
reexpress
differ
mutant
endothelioma
cell
demonstr
extracellular
domain
suffic
support
cell
adhes
presenc
cytoplasm
tail
strictli
requir
tem
rho
gtpase
activ
within
endotheli
cell
surprisingli
tyrosinephosphoryl
endotheli
necessari
tem
cell
rhogtpas
activ
cytoplasm
tail
endotheli
tyrosin
phosphorylationi
therefor
essenti
support
tem
lymphocyt
probabl
activ
rhosignal
endotheli
cell
gener
believ
signal
requir
open
endotheli
junction
cell
diapedesi
bloodbrain
barrier
endotheli
cell
interconnect
complex
tight
junction
serial
section
electron
microscopi
found
experiment
autoimmun
encephalomyel
mononuclear
cell
travers
cerebr
microvessel
transcellular
pathway
leav
endotheli
tight
junction
intact
wherea
morpholog
evid
involv
tight
junction
diapedesi
mononuclear
cell
across
inflam
bbb
could
obtain
case
uniqu
molecular
mechan
drive
transendotheli
migrat
leukocyt
across
bloodbrain
barrier
discuss
junjnk
axi
regul
neurodegener
neuroinflamm
herdegen
institut
pharmacolog
kiel
germani
cjun
ntermin
kinas
jnk
essenti
mediat
proinflammatori
action
peripher
immun
cell
strike
contrast
action
jnk
immun
cell
nervou
system
remain
elucid
demonstr
first
time
microglia
express
isoform
primari
brain
microgli
cultur
neonat
mice
rat
hid
et
al
biochem
pharm
present
data
activ
function
jnk
lipopolysaccharid
lp
tumor
necrosi
factor
alpha
tnfalpha
thrombin
induc
rapid
last
activ
jnk
activ
rest
microglia
stimul
lp
increas
total
amount
nuclear
jnk
wherea
pool
activ
jnk
rapidli
decreas
howev
phosphoryl
high
affin
substrat
transcript
factor
cjun
dramat
enhanc
analysi
nuclear
jnk
isoform
reveal
amount
declin
increas
vari
observ
suggest
mainli
respons
activ
transcript
factor
upstream
jnk
lp
induc
last
activ
constitut
present
interleukin
signal
pathway
role
autoimmun
inflamm
cn
cl
langrish
chen
dj
cua
dnax
research
inc
palo
alto
ca
usa
heterodimer
cytokin
compris
uniqu
subunit
common
subunit
share
signal
receptor
complex
consist
newli
discov
activ
jakstat
dnabind
complex
engag
receptor
complex
requir
expans
highli
encephalitogen
cell
popul
produc
tnf
ifngamma
thu
play
import
role
develop
expans
altern
cell
subsetdistinct
classic
respons
critic
pathogenesi
cn
autoimmun
inflamm
detriment
benefici
cytokin
signal
alzheim
diseas
mp
mattson
laboratori
neurosci
nation
institut
age
irp
baltimor
md
usa
alzheim
diseas
ad
progress
neurodegen
disord
synaps
becom
dysfunct
neurit
degener
neuron
die
result
memori
impair
psychiatr
problem
excess
product
accumul
cytotox
form
amyloid
beta
peptid
abeta
believ
pivot
abnorm
ad
deposit
abeta
associ
increas
level
proinflammatori
cytokin
activ
microgli
cell
astrocyt
abeta
induc
product
cytokin
cultur
microglia
astrocyt
mechan
respons
inflammatori
respons
involv
increas
oxid
stress
perturb
cellular
calcium
homeostasi
data
suggest
cytokin
may
either
promot
protect
neuron
degener
depend
upon
cell
type
signal
pathway
activ
exampl
tumor
necrosi
factor
tnf
activ
receptor
neuron
coupl
activ
transcript
factor
nfkb
activ
gene
encod
protein
prevent
neuron
death
hand
tnf
stimul
microglia
produc
damag
reactiv
oxygen
speci
nitric
oxid
excitotoxin
studi
transgen
mice
cultur
neural
cell
express
mutant
form
amyloid
precursor
protein
caus
inherit
form
ad
shown
mutat
result
enhanc
product
tnf
respons
immun
challeng
thu
activ
innat
immun
respons
may
contribut
demis
neuron
ad
drug
suppress
damag
cytokin
cascad
may
therapeut
benefit
hand
recent
studi
demonstr
strike
benefici
effect
immun
bad
miceq
abeta
suggest
may
possibl
prevent
ad
stimul
humor
immun
respons
abeta
develop
infectioninduc
molecular
mimicri
model
cn
autoimmun
diseas
induct
engin
nonpathogen
variant
theiler
viru
tmev
encod
peptid
encompass
immunodomin
myelin
epitop
epitop
mimic
sjl
mice
infect
tmev
encod
either
nativ
determin
molecular
mimic
h
influenza
proteas
iv
share
amino
acid
develop
earlyonset
demyelin
diseas
mediat
cell
autoimmun
natur
diseas
shown
fact
toler
either
nativ
mous
epitop
mimic
epitop
prevent
clinic
diseas
induct
associ
autoreact
respons
diseas
crossreact
respons
could
also
induc
infect
viru
engin
express
peptid
encompass
mimic
epitop
indic
mimic
peptid
natur
mimic
epitop
capabl
process
flank
residu
howev
mice
immun
multipl
time
core
core
peptid
complet
freund
adjuv
cfa
exhibit
clinic
diseas
symptom
due
failur
secret
high
level
ifngamma
respons
vitro
rechalleng
indic
import
virusinduc
innat
immun
signal
trigger
autoimmun
diseas
via
molecular
mimicri
viral
infect
autoimmunitya
doubleedg
sword
von
herrath
la
jolla
institut
allergi
immunolog
san
diego
usa
intuit
one
tend
associ
viral
infect
frequent
induc
profound
inflamm
multipl
organ
enhanc
autoimmun
process
diseas
type
diabet
multipl
sclerosi
substanti
evid
viral
infect
increas
incid
autoimmun
diseas
ie
nod
mous
coxsacki
infect
precipit
inflammatori
disord
autoimmun
compon
theiler
viru
occur
either
antigennonspecif
bystand
event
crossreact
viral
selfcompon
show
data
second
scenario
mimicri
illustr
molecular
mimicri
like
enhanc
alreadi
ongo
autoimmun
process
rather
precipit
diseas
de
novo
howev
recent
becom
increasingli
clear
opposit
situat
prevent
autoimmun
viral
infect
might
common
accumul
evid
virus
coxsacki
b
lcmv
prevent
diabet
viral
infect
good
us
show
recent
find
demonstr
chemokin
gradient
establish
viral
infect
lure
autoaggressor
away
site
organ
tissu
inflamm
revers
diseas
appear
case
perman
find
fit
recent
increas
trend
autoimmun
diseas
well
asthma
industri
nation
bhygien
hypothesisq
coronavirusinduc
immunopatholog
buchmeier
j
rempel
b
scripp
research
institut
la
jolla
ca
usa
b
univers
manitoba
winnipeg
canada
differ
diseas
outcom
highli
neurovirul
mhvjhm
mildli
neurovirul
attribut
variat
within
spike
glycoprotein
found
mhvjhm
neurovirul
mark
diminish
express
ifngamma
mrna
recruit
cell
cn
concomit
heighten
transcript
level
greater
macrophag
infiltr
rel
infect
abil
nonspik
gene
regul
immun
respons
evalu
use
chimer
virus
chimer
virus
made
variant
background
respect
contain
gene
mhvjhm
unexpectedli
gene
appear
modul
event
critic
viral
replic
surviv
unlik
unresolv
mhvjhm
infect
clearanc
infect
coincid
strong
ifngamma
transcript
increas
cell
infiltr
even
absenc
viral
replic
approxim
infect
mice
succumb
within
week
indic
enhanc
mortal
follow
infect
associ
viral
fit
rather
similar
mhvjhm
infect
reduc
surviv
follow
infect
observ
presenc
elev
mrna
accumul
enhanc
macrophag
number
within
infect
brain
observ
suggest
protein
mhvjhm
influenc
neurovirul
induct
driven
macrophag
immunopatholog
support
nih
grant
bherpesviru
character
distinct
neurotrop
implic
variou
neurolog
disord
includ
seizur
mening
enceph
multipl
sclerosi
previous
demonstr
cellular
receptor
ubiquit
complementregulatori
protein
prevent
cytolyt
attack
autolog
complement
also
serv
receptor
human
infecti
agent
evid
suggest
viral
use
mere
repres
cell
surfac
anchor
mechan
may
also
profound
implic
pathogenesi
develop
novel
vitro
experiment
model
investig
mechan
neuropatholog
longterm
cultur
primari
neural
stem
cell
deriv
human
fetal
brain
differenti
studi
suscept
infect
subsequ
complementmedi
damag
cultur
typic
consist
astrocyt
neuron
oligodendrocyt
product
infect
detect
b
determin
quantitativecalibr
realtim
pcr
associ
giant
multinucl
cell
format
express
antigen
observ
astrocyt
neuron
although
infect
associ
loss
typic
lineageassoci
marker
gfap
astrocyt
betatubulin
neuron
treatment
neural
cell
purifi
virion
antibodi
follow
exposur
human
complement
result
massiv
deposit
opson
fragment
detect
confoc
microscopi
widespread
cell
death
result
suggest
cytopath
effect
associ
replic
cn
may
amplifi
direct
engag
result
dramat
impair
complementregulatori
function
self
represent
thymu
extend
view
b
kyewski
german
cancer
research
center
heidelberg
germani
prevail
notion
toler
peripher
selfantigen
sole
cover
postthym
mechan
revis
recent
find
tissuespecif
antigen
express
thymic
stromal
cell
phenomenon
term
promiscu
gene
express
promiscu
express
tissueantigen
thymu
properti
thymic
epitheli
cell
rather
bone
marrowderiv
antigen
present
cell
impli
celltyp
specif
regul
thymic
medullari
epitheli
cell
express
uniqu
rang
tissu
antigen
mrna
level
compar
antigen
present
cell
epitheli
cell
tissu
set
gene
includ
mani
tissuespecif
antigen
clinic
relev
autoantigen
cancergerm
line
gene
without
share
appar
structur
function
common
antigen
express
restrict
cell
type
suffici
confer
specif
tcell
toler
attest
function
role
overal
contribut
promiscu
gene
express
central
toler
induct
infer
rang
level
selfantigen
express
manner
toler
state
antigen
analyz
individu
implic
result
regul
promiscu
gene
express
scope
central
toler
discuss
make
break
toler
myelin
basic
protein
j
goverman
cabbag
brabb
es
husebi
b
liggitt
univers
washington
seattl
wa
usa
b
nation
jewish
medic
centr
denver
co
usa
activ
immun
respons
myelin
antigen
believ
one
earli
step
pathogenesi
multipl
sclerosi
process
extens
studi
use
anim
model
experiment
allerg
encephalomyel
eae
induc
immun
myelin
antigen
complet
freund
adjuv
abil
trigger
myelinspecif
cell
peripheri
indic
cell
escap
immun
toler
mechan
normal
elimin
selfreact
cell
interest
focu
defin
role
toler
mechan
shape
repertoir
peripher
myelinspecif
cell
determin
breakdown
mechan
contribut
cn
autoimmun
pursu
studi
laboratori
gener
cell
receptor
transgen
model
cell
respons
differ
epitop
myelin
basic
protein
mbp
found
clonal
delet
thymu
import
toler
mechan
cell
undergo
high
avid
interact
mbp
epitop
antigenpres
cell
cell
undergo
low
avid
interact
mbp
epitop
escap
delet
result
also
show
regulatori
cell
prevent
autoimmun
mediat
high
low
avid
mbpspecif
cell
regulatori
cell
function
cn
peripheri
discuss
express
myelin
antigen
thymu
littl
goe
long
way
vk
kuchroo
z
ill
anderson
j
reddi
center
neurolog
diseas
brigham
women
hospit
harvard
medic
school
boston
usa
use
class
ii
plp
tetram
determin
frequenc
plp
reactiv
cell
narv
repertoir
sjl
mice
although
frequenc
vari
age
approxim
cell
peripher
repertoir
sjl
mice
bind
specif
tetram
eaeresist
mice
also
show
similar
frequenc
plp
reactiv
cell
peripher
repertoir
cell
expand
follow
specif
immun
find
tetram
reactiv
cell
narv
peripher
repertoir
sjl
mice
compart
vast
major
plp
tetram
reactiv
cell
resist
mice
gate
may
one
reason
plp
cell
expand
resist
mice
delet
cell
prior
immun
plp
result
expans
cell
induct
diseas
eaeresist
mice
preliminari
data
suggest
express
myelin
plp
vs
isoform
thymu
peripher
lymphoid
tissu
may
play
key
role
affect
suscept
resist
eae
affect
gener
regulatori
cell
antigen
recognit
pattern
autoreact
cell
multipl
sclerosi
r
martin
neuroimmunolog
branch
nind
nih
bethesda
md
usa
ms
consid
cellmedi
autoimmun
diseas
central
nervou
system
cn
inflamm
demyelin
vari
degre
axon
damag
effector
mechan
cn
damag
includ
antibodi
complement
cytokin
cell
lysi
other
well
factor
intrins
cn
tissu
eg
vulner
insult
evid
indic
cell
induc
perpetu
diseas
specif
spectrum
autoreact
cell
ms
selfand
foreign
antigen
complet
understood
number
myelin
antigen
among
target
recent
address
two
question
relat
biolog
role
autoreact
cell
ms
specif
function
high
avid
myelinspecif
cell
ms
differ
control
correl
specif
clinic
phenotyp
identifi
specif
csfinfiltr
cell
unbias
way
use
combinatori
peptid
chemistri
well
express
librari
employ
cdna
deriv
ms
brain
tissu
project
lead
numer
novel
observ
brief
high
avid
myelinspecif
cell
enrich
ms
patient
frequent
phenotyp
specif
myelin
peptid
clearli
relev
other
specif
phenotyp
myelinspecif
cell
relat
clinic
phenotyp
furthermor
unbias
approach
identifi
viral
antigen
trigger
csfinfiltr
clonal
expand
cell
csfinfiltr
cell
recogn
number
differ
self
antigen
among
brainspecif
well
ubiquit
autoantigen
oligodendrogenesi
neurogenesi
multipl
sclerosi
brain
chang
sm
staugaiti
bd
trapp
cleveland
clinic
foundat
cleveland
oh
usa
multipl
sclerosi
ms
inflammatori
diseas
cn
destroy
myelin
oligodendrocyt
axon
other
describ
gener
new
oligodendrocyt
chronic
demyelin
ms
lesion
present
evid
ms
brain
also
gener
new
neuron
immunohistochemistri
highlight
popul
cell
matur
neuron
morpholog
subcort
deep
white
matter
human
brain
cell
pyramid
fusiform
cell
bodi
one
three
major
process
branch
sever
time
cell
bodi
measur
mm
process
mm
long
neuron
seen
throughout
normal
white
matter
control
ms
cerebr
hemispher
cell
neuron
morpholog
also
psancamposit
white
matter
neuron
express
neuron
no
somatostatin
white
matter
neuron
neunposit
compar
normal
appear
white
matter
number
white
matter
neuron
significantli
decreas
within
ms
plaqu
neunposit
neuron
howev
increas
around
ms
plaqu
interestingli
bipolar
neun
psancamposit
cell
also
detect
subventricular
zone
svz
ms
lesion
svz
agedmatch
control
brain
identif
psancamneunposit
cell
immatur
morpholog
svz
increas
neunposit
cell
lesion
peripheri
rais
possibl
neurogenesi
within
demyelin
lesion
ms
numer
oligodendrocyt
precursor
cell
premyelin
oligodendrocyt
could
preserv
within
multipl
sclerosi
lesion
attest
diseas
myelin
repair
limit
deplet
oligodendrogli
cell
neurotroph
factor
could
therapeut
interest
ms
might
promot
either
oligodendrocyt
surviv
myelin
format
axon
protect
use
recent
develop
index
myelin
shown
synthet
neuroprotect
sigma
agonist
could
strongli
enhanc
myelin
analyz
whether
endogen
neurotroph
factor
could
also
stimul
myelin
format
found
cntfrelat
factor
activ
receptor
abl
stimul
myelin
via
activ
jak
stat
pathway
addit
cntfrelat
cytokin
also
abl
promot
oligodendrocyt
surviv
activ
distinct
signal
pathway
involv
kinas
akt
pathway
appear
crucial
regul
oligodendrocyt
death
surviv
factor
aim
protect
oligodendrogli
cell
apoptosi
either
neurotroph
factor
antioxyd
molecul
requir
direct
indirect
activ
analyz
oligodendrogli
express
two
gprotein
coupl
receptor
name
activ
respect
lysophosphatid
acid
receptor
specif
express
oligodendrocyt
postnat
brain
observ
activ
could
enhanc
surviv
matur
oligodendrocyt
activ
pathway
therefor
new
famili
receptor
might
also
therapeut
interest
ms
role
inflamm
creat
proremyelin
signal
cascad
mr
kotter
ww
li
f
molinaholgado
c
zhao
setzu
b
c
ffrenchconst
b
rj
franklin
cambridg
centr
brain
repair
depart
vetenirari
medicin
univers
cambridg
cambridg
uk
b
cambridg
centr
brain
repair
depart
vetenirari
patholog
univers
cambridg
cambridg
uk
remyelin
one
spontan
regen
process
adult
mammalian
cn
restor
saltatori
conduct
demyelin
axon
potenti
exert
axonprotect
effect
process
mediat
oligodendrocyt
precursor
cell
opc
recruit
area
demyelin
differenti
myelin
oligodendrocyt
environment
factor
orchestr
process
attract
much
recent
interest
pictur
emerg
complex
matrix
factor
chang
time
initi
promot
opc
recruit
induc
differenti
sever
studi
indic
inflammatori
respons
associ
demyelin
critic
trigger
sequenc
event
involv
crosstalk
inflammatori
cell
reactiv
astrocyt
lead
creation
proremyelin
environ
studi
mainli
use
toxinmodel
demyelin
inflamm
result
oligodendrocyt
injuri
primari
caus
exampl
slow
remyelin
occur
old
adult
anim
associ
delay
inflammatori
respons
intrins
chang
properti
age
microglia
furthermor
suppress
macrophag
respons
toxininduc
demyelin
monocyt
deplet
use
microglia
activ
inhibitor
minocyclin
lead
impair
opc
respons
impair
remyelin
convers
promot
inflammatori
respons
substanti
enhanc
myelin
opc
inject
adult
rat
retina
acut
experiment
autoimmun
enceph
eae
cellderiv
signal
may
downregul
immun
respons
also
induc
central
nervou
system
cn
repair
remyelin
initi
recruit
differenti
oligodendrocyt
precursor
cell
opc
demyelin
cn
lesion
data
show
cytokin
transform
growth
factor
tgf
beta
induc
microglia
secret
chemotact
factor
opc
identifi
hepatocyt
growth
factor
hgf
gene
microarray
analysi
function
studi
show
also
interferon
ifn
beta
cytokin
use
treat
multipl
sclerosi
ms
patient
induc
hgf
secret
microglia
ii
antibodi
hgf
receptor
cmet
abrog
opc
chemotaxi
induc
microglia
eae
hgf
express
seen
macrophag
microglia
recoveri
phase
eae
acut
stage
diseas
taken
collect
cytokin
tgfbeta
may
play
pivot
role
remyelin
induc
microglia
releas
hgf
chemotact
differenti
factor
opc
antibodi
neuromuscular
junctioneffect
gene
express
berrihaknin
cnr
umr
up
ipsc
hopit
mari
lannelongu
le
plessi
robinson
franc
myasthenia
gravi
mg
neuromuscular
disord
mediat
antibodi
direct
acetylcholin
receptor
achr
found
patient
spmg
remain
patient
either
autoantibodi
musk
yet
defin
antigen
snmg
analyz
molecular
mechan
involv
muscular
target
site
studi
express
select
gene
quantit
pcr
muscl
biopsi
mg
patient
found
level
achr
subunit
transcript
increas
sever
affect
mg
patient
independ
level
antiachr
antibodi
also
observ
upregul
utrophin
musk
rapsyn
mck
unchang
patient
interestingli
chang
similarli
observ
snmg
snpg
patient
complet
result
overview
event
occur
patient
muscl
compar
transcriptom
muscl
snmg
spmg
refer
normal
muscl
group
patient
subcategori
upregul
gene
essenti
involv
muscl
develop
chaperon
activ
regul
gene
extracellular
matrix
categori
altogeth
data
suggest
exist
compensatori
mechan
regul
express
sever
gene
involv
neuromuscular
junction
dysregul
gene
common
snmg
snpg
patient
suggest
common
mechan
autoimmun
attack
group
patient
autoantibodi
autonom
nervou
system
vernino
mayo
clinic
rochest
mn
usa
mani
case
acut
subacut
peripher
autonom
failur
associ
neurolog
autoimmun
antibodi
specif
ganglion
acetylcholin
receptor
nicotin
receptor
mediat
fast
synapt
transmiss
autonom
ganglia
found
patient
idiopath
autoimmun
autonom
neuropathi
seroposit
patient
characterist
clinic
profil
promin
parasympathet
failur
dri
eye
dri
mouth
impair
pupillari
respons
impair
bowel
bladder
motil
orthostat
hypotens
antibodi
level
correl
sever
clinic
symptom
sera
patient
inhibit
bind
agonist
ganglion
receptor
vitro
addit
clinic
respons
intraven
immunoglobulin
plasma
exchang
evid
experiment
anim
model
indic
ganglion
achr
antibodi
direct
caus
autonom
failur
case
autoimmun
autonom
failur
sever
gastrointestin
dysmotil
occur
associ
smallcel
lung
carcinoma
paraneoplast
autonom
neuropathi
patient
may
one
serum
autoantibodi
marker
includ
antihu
may
manifest
symptom
paraneoplast
neurolog
disord
paraneoplast
antibodiesnovel
target
j
dalmau
univers
pennsylvania
philadelphia
pa
usa
year
sinc
first
antibodi
neuron
antigen
identifi
serum
patient
paraneoplast
neurolog
disord
pnd
sinc
addit
antibodi
report
associ
pnd
current
consid
clinic
relev
marker
paraneoplasia
pndab
abil
test
marker
increas
awar
clinician
pnd
result
earli
recognit
manag
disord
preliminari
evid
impact
neurolog
outcom
basic
level
pndab
use
isol
target
antigen
often
play
critic
role
neuron
biolog
neurogenesi
overal
patient
pnd
cn
harbor
one
wellcharacter
pndab
among
patient
mani
show
sign
inflamm
cn
csf
suggest
immun
mechan
sever
strategi
appli
patient
lead
identif
novel
pndab
includ
singl
case
observ
ie
antibodi
identif
group
patient
similar
neurooncologicimmunolog
find
ie
antibodi
protein
group
patient
similar
syndrom
previous
consid
pndab
neg
latter
group
chang
tissu
process
probe
techniqu
ie
immunoprecipit
modifi
cdna
librari
screen
uncov
novel
immun
ident
target
antigen
discuss
antibodi
demyelin
diseas
c
linington
institut
medic
scienc
univers
aberdeen
aberdeen
uk
increas
evid
antibodydepend
mechan
involv
pathogenesi
demyelin
multipl
sclerosi
ident
antigen
target
pathogen
respons
remain
uncertain
studi
use
myelin
oligodendrocyt
glycoprotein
mog
model
antigen
reveal
antibodymedi
demyelin
must
view
epitop
rather
antigenspecif
phenomenon
demyelin
antibodi
respons
mog
select
target
discontinu
mog
epitop
whilst
respons
linear
mog
epitop
gener
benign
solut
crystal
structur
mog
complex
fab
fragment
demyelin
antibodi
demonstr
import
structur
constraint
determin
balanc
autoaggress
benign
autoimmun
influenc
genet
environment
factor
result
discuss
respect
relev
mog
target
antibodi
mediat
demyelin
human
diseas
use
anim
model
proteomicbioinformaticbas
methodolog
identifi
pathophysiolog
relev
autoantibodi
respons
novel
autoantigen
low
physic
abund
ms
gangliosid
autoantibodi
target
neuromuscular
junction
immunemedi
neuropathi
h
willison
univers
glasgow
glasgow
scotland
progress
understand
syndrom
greatli
acceler
identif
humor
respons
glycolipid
signific
proport
case
identif
molecular
mimicri
preced
infect
key
mechan
diseas
induct
use
vivo
ex
vivo
mous
neuromuscular
junction
prepar
model
system
test
effect
antiglycolipid
antibodi
nerv
termin
shown
complementdepend
alpha
latrotoxinlik
effect
compris
block
evok
ach
releas
destruct
termin
studi
synthas
synthas
nullmut
mice
lack
differ
gangliosid
provid
insight
role
gangliosid
composit
densiti
neuron
membran
predispos
injuri
termin
attack
complex
complement
form
membran
pore
allow
free
ionic
movement
critic
develop
structur
disorganis
nerv
termin
talk
review
current
understand
complex
field
address
new
approach
test
novel
treatment
debilit
diseas
molecular
mimicri
diseas
model
syndrom
n
yuki
depart
neurolog
dokkyo
univers
school
medicin
tochigi
osaka
japan
molecular
mimicri
microbi
self
compon
postul
mechan
account
antigen
tissu
specif
immun
respons
postinfecti
autoimmun
diseas
littl
direct
evid
exist
research
area
focus
princip
cellmedi
antipeptid
respons
rather
humor
respons
carbohydr
structur
syndrom
frequent
caus
acut
neuromuscular
paralysi
occur
week
variou
bacteri
viral
infect
particularli
campylobact
jejuni
enter
carbohydr
mimicri
bacteri
lipooligosaccharid
human
gangliosid
seen
relev
pathogenesi
syndrom
conclus
evid
report
sensit
c
jejuni
lipooligosaccharid
rabbit
develop
igg
antibodi
flaccid
limb
weak
paralyz
rabbit
patholog
chang
peripher
nerv
ident
present
syndrom
immun
mice
lipooligosaccharid
gener
monoclon
antibodi
react
bound
human
peripher
nerv
monoclon
antibodi
igg
patient
syndrom
block
muscl
action
potenti
musclespin
cord
cocultur
indic
antibodi
caus
muscl
weak
find
show
carbohydr
mimicri
import
caus
autoimmun
neuropathi
cytokin
tcell
immun
inflammatori
neuropathi
j
zhu
karolinska
institut
stockholm
sweden
acut
inflammatori
demyelin
polyneuropathi
syndrom
gb
anim
model
experiment
autoimmun
neuriti
ean
prototyp
cell
mediat
autoimmun
diseas
affect
peripher
nervou
system
pn
perivascular
accumul
lymphocyt
macrophag
pn
high
level
system
pn
myelin
antigenreact
cell
characterist
featur
diseas
therebi
suggest
pathogen
role
specif
cell
immunoregulatori
cytokin
apoptosi
autoreact
myelin
specif
cell
may
import
mechan
limit
immunoinflammatori
respons
abort
diseas
cytokin
differ
upregul
variou
clinic
phase
ean
gb
howev
role
cytokin
immun
regul
autoimmun
inflammatori
neuropathi
complex
simpl
dichotomi
would
suggest
new
treatment
may
search
augment
cell
apoptosi
inhibit
cell
respons
toward
peripher
myelin
counteract
complex
cytokin
imbal
treatment
antibodi
select
target
certain
proinflammatori
cytokin
well
immunomodulatori
prepar
promot
cytokin
benefici
influenc
diseas
cours
focu
futur
therapeut
trial
rockefel
univers
new
york
ny
usa
dendrit
cell
dc
distinct
lineag
hematopoiet
cell
control
sever
facet
immun
toler
feasibl
directli
studi
modifi
major
reservoir
dc
peripher
lymphoid
tissu
mice
antigen
incorpor
antibodi
select
target
dc
current
antibodi
endocyt
receptor
engin
antibodi
greatli
enhanc
present
vivo
mhc
class
ii
product
simultan
import
control
dc
matur
state
appropri
stimuli
differenti
dc
render
immunogen
wherea
steadi
state
dc
immatur
induc
peripher
toler
vivo
antigen
target
strategi
pursu
better
control
induct
toler
autoantigen
induct
immun
microbi
tumor
antigen
dc
function
also
studi
ex
vivo
approach
broadli
recogn
mechan
peripher
toler
induct
involv
regulatori
suppressor
cell
becom
appar
dc
induc
andor
expand
regul
includ
suppressor
cell
find
dc
serv
present
cell
expand
antigenspecif
suppressor
ex
vivo
expand
cell
effici
control
develop
diabet
nod
mice
although
field
begin
would
like
suggest
direct
consider
given
dc
design
therapi
autoimmun
diseas
traffic
antigen
present
cell
brain
newman
r
cararennadi
bernadessilva
r
weller
vh
perri
univers
southampton
southampton
uk
normal
healthi
rodent
brain
dendrit
cell
howev
follow
acut
brain
injuri
immun
mediat
lesion
small
number
dendrit
cell
appear
rat
brain
parenchyma
investig
origin
cell
rat
acut
excitotox
lesion
subject
number
differ
manipul
deplet
perivascular
macrophag
intracerebroventricular
inject
chlodron
liposom
prevent
appear
cell
parenchyma
bone
marrow
deplet
whole
bodi
irradi
abrog
appear
thu
cell
deriv
blood
transform
resid
cell
popul
investig
whether
potenti
antigen
present
cell
brain
parenchyma
perivascular
cell
traffic
brain
peripher
immun
system
fluoresc
microspher
approxim
size
viru
micrometr
bacterium
micrometr
microinject
distinct
brain
compart
inject
mening
ventricl
led
appear
fluoresc
microspher
cervic
lymph
node
liver
contrast
fluoresc
microspher
found
peripher
follow
inject
restrict
parenchyma
microspher
observ
within
perivascular
macrophag
local
inflammatori
respons
within
brain
result
dramat
alter
distribut
microspher
deliv
parenchyma
function
dendrit
cell
cn
diseas
suter
g
biollaz
gatto
l
bernasconi
c
cretton
herren
w
reith
b
fontana
univers
hospit
zurich
switzerland
b
univers
geneva
medic
school
geneva
switzerland
dendrit
cell
dc
uniqu
abil
prime
naiv
cell
initi
adapt
immun
recent
year
dc
identifi
inflam
central
nervou
system
cn
role
initi
regul
tissu
specif
immun
respons
unknown
report
dc
isol
mice
experiment
autoimmun
encephalomyel
eae
exhibit
matur
phenotyp
similar
immatur
bone
marrowderiv
dc
splenic
dc
character
intermedi
surfac
mhc
class
ii
low
express
costimulatori
molecul
howev
unabl
prime
naiv
cell
moreov
inhibit
cell
prolifer
stimul
matur
bone
marrowderiv
dc
tgfbeta
trail
found
significantli
contribut
cnsdcmediat
inhibit
cell
prolifer
thu
cnsdc
may
key
respons
maintain
immun
privileg
within
inflam
cn
molecular
basi
cellcel
interact
regul
function
activ
myeloid
lineag
cell
come
focu
foremost
activ
receptor
trem
famili
usual
associ
itamexpress
dnax
adapt
protein
dap
signal
cellular
activ
inhibitori
receptor
commonli
express
itim
trigger
cellular
inhibitori
pathway
broadli
express
igsuperfamili
molecul
includ
neuron
cn
short
cytoplam
tail
devoid
obviou
signal
domain
gene
target
result
enhanc
macrophag
microgli
activ
situ
suggest
may
ligand
normal
engag
inhibitori
receptor
myeloid
cell
receptor
clone
extens
character
shown
transduc
potent
inhibitori
activ
rang
myeloid
cell
vitro
vivo
despit
absenc
classic
itim
fresh
insight
role
regul
microgli
cell
function
describ
data
gene
express
profil
adult
microgli
cell
brain
macrophag
studi
reveal
number
molecul
especi
certain
activ
receptor
character
uniqu
molecular
fingerprint
microgli
cell
within
adult
cn
molecul
normal
regul
microgli
cell
situ
like
effect
gmcsf
microgli
cell
l
santambrogio
albert
einstein
colleg
medicin
new
york
ny
usa
microgli
cell
deriv
bone
marrow
precursor
colon
brain
parenchyma
import
function
cn
inflammatori
degen
traumat
condit
well
brain
homeostasi
contrast
organ
termin
differenti
dendrit
cell
macrophag
resid
popul
rather
undifferenti
state
microgli
cell
brain
could
contribut
bimmunoprivileg
stateq
global
gene
express
analysi
extent
consequ
gmcsf
mcsf
treatment
microgli
cell
reveal
substanti
express
reprogram
upon
cytokin
stimul
primari
murin
microgli
cell
stimul
mcsfinduc
transcript
gene
involv
tissu
organ
remodel
mainten
regul
brain
homeostasi
hand
gmcsf
stimul
induc
transcript
gene
import
antigen
process
cell
stimul
chemotaxi
innat
immun
immunosuppress
gmcsf
promot
microgli
particip
adapt
immun
respons
distinct
known
function
cell
prolifer
surviv
nonneuron
cell
al
neurodegener
mechan
therapi
jd
rothstein
john
hopkin
univers
depart
neurolog
baltimor
md
usa
amyotroph
later
sclerosi
adult
onset
neurodegen
diseas
character
clinic
muscl
wast
weak
tradit
diseas
character
loss
cortic
spinal
motor
neuron
howev
recent
studi
strongli
suggest
diseas
progress
death
motor
neuron
depend
upon
particip
nonneuron
cell
includ
focal
inflammatori
respons
dysfunct
astroglia
chimer
anim
studi
multipl
transgen
mous
studi
provid
evid
critic
particip
nonneuron
cell
ultim
degener
spinal
motor
neuron
addit
human
anim
model
studi
demonstr
multipl
abnorm
astrogli
function
al
abnorm
detect
even
astroglia
neuron
stem
cell
deriv
transgen
model
use
data
attempt
therapi
includ
use
neuron
astrogli
stem
cell
success
engraft
motor
neuron
stem
cell
well
astrogli
stem
cell
achiev
final
pharmacolog
mean
modul
cn
inflamm
eg
inhibit
astrogli
dysfunct
eg
glutam
transport
enhanc
present
anim
model
human
clinic
trial
activ
complement
central
nervou
system
role
neurodegener
neuroprotect
p
gasqu
depart
medic
biochemistri
brain
inflamm
immun
group
univers
wale
colleg
medicin
cardiff
uk
vertebr
brain
develop
innat
defenc
clearanc
system
pathogen
apoptot
cell
base
upon
activ
resid
glia
complement
inflammatori
cascad
essenti
compon
phylogenet
ancient
innat
immun
respons
crucial
natur
abil
ward
infect
instanc
complement
involv
host
defenc
trigger
gener
membranolyt
complex
surfac
pathogen
complement
fragment
name
opsonin
ie
interact
complement
cellsurfac
receptor
promot
phagocytosi
local
proinflammatori
respons
ultim
contribut
protect
heal
host
moreov
complement
biosynthesi
activ
also
occur
neurodegen
disord
alzheim
huntington
well
pick
diseas
cytolyt
cytotox
activ
complement
thought
contribut
neuron
loss
brain
tissu
damag
howev
recent
data
suggest
least
complement
compon
abil
contribut
neuroprotect
pathway
emerg
paradigm
complement
involv
clearanc
toxic
cell
debri
eg
amyloid
fibril
apoptot
cell
well
promot
tissu
repair
antiinflammatori
activ
knowledg
uniqu
molecular
cellular
innat
immunolog
interact
occur
develop
resolut
patholog
brain
facilit
design
effect
therapeut
strategi
protect
autoimmun
defens
mechan
destruct
selfcompound
role
regulatori
cell
prospect
therapeut
vaccin
schwartz
weizmann
institut
scienc
rehovot
israel
slowli
progress
neurodegen
diseas
central
nervou
system
cn
caus
numer
factor
addit
primari
trigger
potenti
benefit
neuroprotect
therapi
suggest
selfcompound
particip
progress
neurodegen
diseas
view
potenti
enemi
endogen
origin
caus
inappropri
activ
resid
microglia
eg
tnfalpha
found
adapt
arm
immun
respons
form
cell
direct
cn
selfantigen
resid
site
injuri
threaten
compound
shape
phenotyp
microglia
natur
occur
regulatori
cell
found
cell
restrict
spontan
abil
elicit
benefici
autoimmun
brainassoci
neuropeptidesneurotransmitt
shown
act
signal
molecul
inhibitori
activ
traffick
regulatori
cell
switch
boost
autoimmun
without
invok
autoimmun
diseas
achiev
weaken
activ
regulatori
cell
vaccin
weak
agonist
selfantigen
find
farreach
implic
riskfre
therapi
neurodegen
diseas
gener
particular
individu
suffer
one
disord
betaamyloid
vaccin
alzheim
diseas
tabira
nation
institut
longev
scienc
aichi
japan
alzheim
diseas
ad
disord
character
senil
plaqu
amyloid
deposit
primit
immun
respons
due
activ
microgliamacrophag
shown
immun
amyloid
precursor
protein
app
gene
transgen
mice
aggreg
amyloid
beta
protein
abeta
reduc
amyloid
burden
brain
clinic
trial
vaccin
therapi
ad
patient
halt
acut
meningoenceph
side
effect
thought
induc
cell
reactiv
abeta
howev
clinic
declin
found
much
less
patient
develop
antibodi
beta
amyloid
interest
know
autopsi
case
receiv
vaccin
suggest
disappear
senil
plaqu
thu
develop
better
vaccin
ad
warrant
develop
safe
vaccin
use
adenoassoci
viru
vector
carri
abeta
cdna
administr
vaccin
orogastr
tube
induc
antibodi
beta
amyloid
last
month
found
vaccin
quit
effect
safe
app
transgen
mice
might
explain
shift
gut
immun
system
neurotransmitt
glutam
dopamin
activ
specif
receptor
human
tcell
trigger
key
tcell
function
levit
ganor
weizmann
institut
scienc
rehovot
israel
tcell
express
specif
neurotransmitterreceptor
neurotransmitt
trigger
tcell
function
glutam
discov
first
time
normal
cancer
autoimmun
encephalitogen
tcell
alik
neuron
glia
cell
express
high
level
ionchannel
ionotrop
glutamatereceptor
evid
glutamateampa
receptor
human
tcell
includ
rtpcr
western
blot
immunostainingflowcytometri
sequenc
show
ident
tcell
brain
glutam
nm
potent
trigger
sever
tcell
function
among
integrinmediatedadhes
laminin
fibronectin
chemotacticmigr
toward
key
chemokin
dopamin
discov
first
time
normal
human
tcell
express
outer
membran
function
dopamin
receptor
subtyp
dopamin
nm
select
dopaminereceptor
agonist
trigger
variou
tcell
function
among
differenti
cytokinesecret
either
inflammatori
tnfalpha
antiinflammatori
cytokin
differ
robust
nonselect
cytokinesecret
btrigger
classicalq
tcractiv
integrinmedi
adhes
extracellular
glycoprotein
uniqu
denovo
geneexpress
abil
glutam
dopamin
trigger
tcell
function
geneexpress
could
substanti
scientif
clinic
import
numer
condit
health
diseas
among
transmigr
bgoodq
tcell
brain
differ
patrollingprotect
task
b
detriment
activ
mainten
bbadq
tcell
cn
eg
multiplesclerosi
present
self
thymu
network
novel
way
prevent
cure
autoimmun
diseas
v
geenen
lieg
univers
center
immunolog
liegesart
tilman
belgium
thymu
ensur
establish
selftoler
delet
selfreact
cell
gener
selfantigen
specif
regulatori
cell
repertoir
neuroendocrin
gene
transcrib
thymic
stromal
cell
thymic
neuroendocrin
precursor
engag
two
type
interact
pret
cell
either
ligand
bind
high
affin
neuroendocrin
receptor
express
thymocyt
process
selfantigen
present
thymic
mhc
machineri
thu
thymu
confront
occur
throughout
life
previous
emerg
neuroendocrin
famili
recent
evolv
system
character
stochast
gener
respons
divers
member
insulin
gene
famili
transcrib
thymu
tectnc
macrophag
jin
medullari
tec
andor
dendrit
cell
transcript
defect
thymu
diabetespron
bb
rat
sequenc
in
domin
hcell
autoantigen
present
mhcii
allel
confer
genet
suscept
type
diabet
homolog
sequenc
compet
in
bind
howev
compar
in
present
pbmc
purifi
adolesc
elicit
suppressiveregulatori
cytokin
profil
regard
prevent
administr
deriv
selfantigen
constitut
innov
approach
combin
antagon
bind
major
suscept
mhcii
allel
well
promot
specif
antigen
tolerogen
respons
receptor
mechan
sick
behavior
r
dantzer
nadjar
rm
p
parnet
jp
konsman
integr
neurobiolog
bordeaux
franc
signal
pathway
mediat
behavior
effect
acut
phase
reaction
yet
studi
behavior
effect
mediat
interact
cytokin
type
receptor
accessori
protein
demonstr
use
mice
gene
code
delet
immunoneutr
experi
antibodi
specif
confirm
role
receptor
receptor
express
low
abund
central
nervou
system
rat
mous
brain
immunohistochemistri
techniqu
reveal
predomin
express
level
bloodbrain
interfac
rat
brain
doubl
immunolabel
techniqu
show
express
restrict
endotheli
cell
venul
within
brain
parenchyma
circumventricular
organ
activ
receptor
associ
nuclear
factor
kappa
b
nfkappab
nuclear
transloc
robust
transcript
activ
inhibitor
kappa
b
alpha
ikappab
nfkappab
transloc
better
marker
activ
ikappab
prevent
nfkappab
activ
intracerebroventricular
administr
nemobind
domain
peptid
select
inhibit
ikkgammaikkbeta
interact
abrog
sick
behavior
induc
intraperiton
intracerebroventricular
inject
confirm
predomin
role
receptor
bloodbrain
interfac
neural
transduct
peripher
immun
messag
stressinduc
augment
skin
immun
f
dhabhar
health
scienc
center
ohio
state
univers
columbu
oh
usa
cellmedi
immun
cmi
respons
exert
import
immunoprotect
resist
infecti
agent
immunopatholog
allerg
autoimmun
hypersensit
effect
util
skin
cmi
respons
vivo
model
studi
neuroendocrineimmun
interact
initi
hypothes
acut
stress
respons
prepar
cardiovascular
musculoskelet
system
fight
flight
may
also
prepar
immun
system
challeng
may
impos
stressor
skin
cmi
model
enabl
us
examin
effect
stress
time
primari
secondari
exposur
antigen
studi
show
acut
h
stress
experienc
either
primari
innat
immun
respons
secondari
adapt
immun
respons
antigen
exposur
induc
larg
longlast
enhanc
skin
cmi
adrenalectomi
elimin
stressinduc
enhanc
cmi
acut
administr
physiolog
stress
concentr
corticosteron
andor
epinephrin
adrenalectom
anim
enhanc
skin
cmi
compar
control
cmi
site
acut
stress
anim
show
significantli
greater
erythema
indur
number
infiltr
leukocyt
level
cytokin
gene
protein
express
contrast
acut
stress
chronic
stress
immunosuppress
chronic
exposur
corticosteron
acut
exposur
dexamethason
significantli
suppress
skin
cmi
result
suggest
acut
stress
endogen
stress
hormon
enhanc
skin
immun
increas
leukocyt
traffick
cytokin
gene
express
site
antigen
entri
basic
mechanist
experi
well
clinic
studi
discuss
inflammatori
stress
gp
chrouso
preb
nichd
nih
univers
athen
athen
greec
like
stress
respons
inflammatori
reaction
individu
crucial
surviv
self
speci
also
like
stress
respons
inflamm
tailor
stimulu
timelimit
fulli
fledg
system
inflammatori
reaction
consist
activ
immun
immun
accessori
cell
result
stimul
four
major
program
acut
phase
reaction
sick
syndrom
pain
program
mediat
affer
sensori
autonom
system
stress
program
mediat
stress
system
ie
hypothalamicpituitaryadren
hpa
axi
locu
ceruleusnorepinephrin
sympathet
system
main
effector
substanc
system
inflammatori
respons
inflammatori
cytokin
tnfalpha
chemokin
mediat
inflamm
acut
phase
reactant
creactiv
protein
crp
cell
adhes
molecul
fibrinogen
plasminogen
activ
inhibitor
effector
sensori
affer
system
substanc
p
stress
system
name
hypothalam
crh
vasopressin
cortisol
norepinephrin
epinephrin
peripher
neuron
crh
sick
syndrom
consist
anorexianausea
fatigu
andor
depress
affect
somnol
hyperalgesia
sleep
disturb
elev
temperatur
increas
metabol
rate
manifest
suppress
glucocorticoid
yet
peripher
neuron
crh
activ
stress
inflammatori
reaction
substanc
p
activ
inflammatori
reaction
potenti
inflamm
recent
found
system
inflammatori
reaction
ard
sepsi
inadequ
activ
cortisol
secret
signific
cytokineinduc
glucocorticoid
resist
suggest
benefici
action
ad
glucocorticoid
corticotropinreleas
hormon
crh
immuneinflammatori
respons
lesson
knockout
mice
k
karali
divis
endocrinolog
children
hospit
harvard
medic
school
iibeaa
institut
biomed
research
academi
athen
athen
greec
crh
neuropeptid
isol
hypothalamu
main
mediat
stress
respons
mammal
crh
express
inflam
human
rodent
peripher
tissu
exert
potent
proinflammatori
effect
experiment
model
inflamm
use
mous
character
immunomodulatori
properti
crh
identifi
pathway
mediat
effect
mice
respond
inflammatori
stimuli
compromis
acth
respons
delay
although
final
similar
crh
mice
rise
corticosteron
respons
differ
crh
receptor
suggest
receptor
may
also
mediat
effect
crh
pituitari
follow
immun
stressor
highlight
immun
activ
stressor
induc
pituitaryadren
respons
mice
found
mice
reduc
inflammatori
respons
local
stimuli
carrageenin
confirm
proinflammatori
effect
crh
experi
reveal
proinflammatori
effect
epinephrin
unmask
crh
defici
suggest
coordin
action
epinephrin
crh
regul
acut
inflammatori
respons
system
inflammatori
respons
mice
also
significantli
reduc
magnitud
well
autoimmun
diseas
experiment
allerg
encephalomyel
pathway
mediat
proinflammatori
respons
crh
studi
demonstr
specif
crhmediat
induct
dna
bind
activ
immun
cell
interestingli
mice
profound
anorexia
weight
loss
despit
reduc
inflammatori
respons
latter
suggest
case
crh
defici
pathway
mediat
inflammationinduc
anorexia
depend
level
inflamm
identif
polymorph
gene
regul
inflammatori
diseas
may
unravel
crucial
pathogen
mechan
initi
step
map
gene
use
linkag
analysi
intercross
backcross
popul
howev
result
broad
quantit
trait
loci
qtl
contain
hundr
gene
present
studi
advanc
intercross
line
ail
combin
congen
strain
use
finemap
rat
chromosom
myelin
oligodendrocyt
glycoproteininduc
experiment
autoimmun
encephalomyel
mogea
mogea
chronic
relaps
diseas
close
mimic
key
featur
multipl
sclerosi
ms
congen
daaci
rat
strain
local
approxim
mb
larg
region
finemap
perform
ail
consist
intercross
result
two
adjac
eaeregul
qtl
design
two
qtl
span
mb
respect
contain
gene
includ
cluster
chemokin
gene
synten
human
chromosom
respect
display
linkag
ms
thu
consist
least
two
eaeregul
gene
provid
addit
evid
cluster
diseaseregul
gene
qtl
import
phenomenon
overlap
previous
identifi
qtl
human
mice
support
notion
suscept
allel
inflammatori
diseas
evolutionari
conserv
speci
cell
gene
express
profil
identifi
molecularli
clinic
distinct
subgroup
multipl
sclerosi
ji
satoh
nakanishi
h
onou
aranami
yamamura
nation
institut
neurosci
tokyo
japan
object
clarifi
molecular
background
underli
phenotyp
variabl
multipl
sclerosi
ms
method
use
cdna
microarray
comprehens
gene
express
profil
cell
ms
patient
rr
sp
variou
mri
lesion
distribut
ifnbeta
treatment
compar
ageand
sexmatch
healthi
subject
result
hierarch
cluster
analysi
gene
express
differenti
ifnuntr
ms
patient
control
discrimin
identifi
four
distinct
subgroup
ms
design
b
c
among
subgroup
show
express
pattern
similar
control
group
patient
present
lesion
distribut
restrict
cerebrum
cluster
subgroup
c
gene
categor
five
differ
class
number
subgroup
b
show
highest
upregul
class
gene
includ
nine
chemokin
associ
sever
clinic
activ
furthermor
ifnbeta
respond
cluster
subgroup
b
character
persist
induct
ifnrespons
gene
ifnbeta
treatment
conclus
result
indic
microarray
analysi
gene
express
profil
cell
could
classifi
heterogen
popul
ms
four
molecularli
distinct
subgroup
close
associ
diseas
activ
lesion
distribut
therapeut
respons
ifnbeta
clinicalgenet
studi
multipl
sclerosi
dutch
genet
isol
commun
r
hintzen
e
croe
c
van
duijn
hoppenbrouw
erasmu
mc
depart
neurolog
rotterdam
netherland
background
next
larg
genom
screen
studi
genet
isol
popul
altern
approach
order
identifi
genet
factor
involv
multipl
sclerosi
ms
object
identifi
ms
case
within
dutch
genet
isol
popul
attempt
link
common
ancestor
secondli
assess
famili
associ
type
diabet
mellitu
dm
autoimmun
thyroid
diseas
ms
thirdli
perform
genom
screen
method
ms
patient
trace
extens
famili
histori
taken
special
emphasi
paid
cooccurr
autoimmun
diseas
genealog
data
extend
gener
around
year
result
thirtyf
femal
male
ms
patient
identifi
mean
age
onset
symptom
year
diagnosi
year
forti
patient
relapsingremit
cours
primari
progress
cours
twenti
patient
could
link
common
ancestor
gener
clinic
characterist
patient
differ
link
famili
cooccurr
ms
observ
patient
thyroid
diseas
type
dm
found
significantli
often
ms
patient
control
conclus
famili
aggreg
ms
high
dutch
genet
isol
high
cooccurr
autoimmun
diseas
specif
link
ms
case
sever
studi
shown
multipl
sclerosi
ms
associ
hla
class
ii
specif
japan
associ
report
subpopul
conventionalm
patient
lack
oligoclon
band
ocb
csf
though
increas
risk
ocbposit
convent
ms
japan
risk
factor
ocbneg
ms
investig
whether
ocbneg
ocbposit
subpopul
ms
patient
sweden
show
hladr
frequenc
similar
seen
japan
patient
diagnos
accord
criteria
mcdonald
et
al
hladr
genotyp
determin
patient
control
resolut
correspond
serolog
type
ocb
detect
isoelectr
focus
iggspecif
immunofix
csf
protein
phenotyp
frequenc
compar
ocbneg
patient
ocbposit
patient
control
ocbneg
patient
significantli
less
common
significantli
common
ocbposit
patient
frequenc
significantli
higher
ocbposit
patient
control
differ
ocbneg
patient
control
frequenc
significantli
higher
ocbneg
patient
control
differ
ocbposit
patient
control
present
studi
perform
swedish
ms
patient
confirm
result
first
report
japan
thu
appear
ocbposit
ms
ocbneg
ms
may
distinct
diseas
subtyp
associ
particular
predisposit
hla
class
ii
specif
object
iron
misregul
oxid
stress
inflamm
play
interact
role
alzheim
diseas
ad
therefor
examin
polymorph
two
gene
iron
metabol
risk
ad
variant
transferrin
tf
gene
allel
haemochromatosi
hfe
gene
method
genotyp
elderli
control
ad
case
mild
cognit
impair
mci
optima
cohort
result
two
variant
associ
increas
risk
ad
presenc
carrier
variant
time
greater
risk
ad
compar
other
interact
signific
logist
regress
synergi
factor
analysi
carrier
two
allel
plu
apolipoprotein
except
high
risk
ad
conclus
suggest
combin
tf
hfe
may
lead
excess
redoxact
iron
induct
oxid
stress
neuron
exacerb
carrier
northern
european
carri
ironrel
variant
sinc
iron
overload
treatabl
condit
result
merit
replic
age
parent
season
immun
influenc
suscept
eae
e
blankenhorn
c
teuscher
b
j
bunn
b
p
fillmor
univers
illinoi
urbanachampaign
urbana
il
usa
b
univers
vermont
school
medicin
burlington
vermont
usa
experiment
allerg
encephalomyel
eae
princip
anim
model
multipl
sclerosi
ms
complex
trait
influenc
genet
environment
factor
examin
role
age
season
immun
sex
parentoforigin
poo
mice
logist
regress
analys
indic
odd
affect
increas
increas
week
age
greater
anim
inject
summer
compar
winter
spring
odd
also
differ
significantli
depend
poo
male
progeni
sjl
matern
granddam
patern
grandsir
twice
like
show
eae
male
reciproc
grandpar
surprisingli
cn
inflamm
male
mice
affect
poo
femal
progeni
influenc
poo
effect
linkag
analysi
use
cohort
mice
fail
detect
signific
linkag
chromosom
marker
loci
older
winterspr
popul
wherea
signific
linkag
detect
younger
summer
popul
result
provid
new
model
environment
effect
ms
may
help
explain
fact
although
linkag
hla
consist
find
ms
genet
studi
hlalink
ms
suscept
locu
may
influenc
effect
age
season
nonmendelian
genet
factor
background
sever
studi
demonstr
involv
myelin
oligodendrocyt
glycoprotein
mog
protein
multipl
sclerosi
ms
want
verifi
presenc
betiologicq
polymorph
mog
gene
sardinian
ms
patient
method
mog
gene
fulli
sequenc
healthi
sardinian
micro
snp
show
frequenc
sequenc
type
first
data
set
trio
famili
one
affect
parent
examin
transmiss
disequilibrium
test
tdt
mog
variant
significantli
associ
ms
snp
associ
use
control
test
second
set
famili
final
signific
valu
set
result
sequenc
mog
gene
reveal
novel
previous
found
snp
tdt
show
evid
associ
snp
tdt
whole
set
famili
confirm
associ
variant
allel
conclus
mog
gene
involv
suscept
ms
sardinian
extens
studi
larg
set
sporad
patient
confirm
data
ongo
mhc
class
ii
molecul
mhcii
present
antigen
cell
key
featur
adapt
immun
respons
previous
identifi
locu
rat
chromosom
major
influenc
nerv
injuryinduc
mhc
ii
express
microglia
gener
advanc
intercross
line
ail
use
genet
fine
map
reveal
linkag
mhcii
express
lod
score
mhc
ii
immunolabel
measur
spinal
cord
ventral
root
avuls
vra
microsatellitebas
haplotyp
map
panel
inbr
rat
strain
identifi
two
haplotyp
extend
mb
fragment
contain
gene
encod
ciita
known
regul
mhc
ii
express
sequenc
reveal
two
distinct
haplotyp
segreg
inbr
strain
high
low
mhc
ii
express
analysi
express
ciita
ciitainduc
invari
chain
spinal
cord
tissu
reveal
lower
level
transcript
rat
compar
da
normal
condit
vra
also
strong
correl
ciita
invari
chain
group
anim
stratifi
parent
allel
max
marker
locat
within
gene
result
identifi
genet
heterogen
gene
modul
inflammatori
process
nervou
system
identif
qtl
control
cortic
motor
evok
potenti
experiment
autoimmun
encephalomyel
correl
incid
onset
sever
diseas
mazon
vogler
u
strauss
b
p
wernhoff
rolf
b
ibrahim
institut
immunolog
univers
rostock
rostock
germani
b
depart
neurolog
univers
rostock
rostock
germani
experiment
autoimmun
encephalomyel
eae
polygen
chronic
inflammatori
demyelin
diseas
model
multipl
sclerosi
previou
studi
identifi
multipl
quantit
trait
loci
qtl
control
differ
aspect
diseas
pathogenesi
howev
direct
genet
control
motorevok
potenti
measur
demyelin
address
studi
examin
genet
control
differ
trait
eae
intercross
popul
gener
eae
suscept
sjlj
eae
resist
mous
strain
involv
anim
anim
genotyp
microsatellit
marker
interv
map
use
identifi
qtl
control
diseas
sever
onset
motor
evok
potenti
six
new
qtl
identifi
three
qtl
map
chromosom
control
sever
diseas
wherea
qtl
associ
latenc
corticomotor
evok
potenti
cmep
two
loci
influenc
sex
one
qtl
chr
cm
control
cmep
latenc
immun
correl
diseas
onset
suggest
possibl
role
myelin
pattern
structur
central
motor
pathway
suscept
eae
map
function
character
rat
r
nohra
jagod
olsson
karolinska
institut
stockholm
sweden
locu
regul
diseas
chronic
cytokin
product
experiment
autoimmun
encephalomyel
initi
map
daxbn
rat
congen
rat
strain
establish
phenotyp
effect
isol
locu
confirm
narrow
recombin
congen
strain
locu
current
map
region
eae
chronic
phenotyp
far
link
cytokin
product
phenotyp
mainli
measur
high
low
tnfalpha
product
cona
stimul
naiv
splenocyt
current
analyz
recombin
strain
suggest
ident
close
local
gene
regul
two
phenotyp
parallel
product
still
smaller
recombin
strain
highresolut
map
attempt
advanc
intercross
line
ail
furthermor
preliminari
immunolog
data
map
cytokin
product
phenotyp
cell
lineag
cell
monocytesmacrophag
nk
cell
thu
locu
effect
eae
possibl
also
inflammatori
condit
cytokin
dysbal
implic
posit
clone
ongo
highresolut
map
quantit
trait
loci
influenc
experiment
model
multipl
sclerosi
rat
marta
jagod
olsson
jc
lorentzen
karolinska
institutet
stockholm
sweden
inbr
rat
strain
show
vari
suscept
resist
myelin
oligodendrocyt
glicoprotein
mog
induc
encephalomyel
eae
close
mimic
multipl
sclerosi
human
previous
report
transfer
rat
chromosom
region
resist
rat
suscept
da
rat
affect
suscept
mogea
object
genet
dissect
influenc
mogea
method
gener
advanc
intercross
line
ail
da
mhc
ident
inject
mog
clinic
diseas
follow
individu
testcross
genotyp
use
microsatellit
marker
genotypephenotyp
analysi
perform
within
use
rqtl
detect
quantit
trait
loci
addit
subcongen
rat
cm
region
insert
da
background
compar
da
rat
mogea
suscept
result
ail
analysi
reveal
two
narrow
close
situat
qtl
smaller
interv
overlap
one
qtl
congen
rat
also
less
suscept
da
mogea
conclus
interv
harbor
least
two
gene
regul
mogea
one
gene
lie
within
interv
previous
report
regul
oilinduc
arthriti
qtl
design
gene
may
gener
regul
autoimmun
diseas
advanc
intercross
line
local
region
contain
k
becanov
jagod
jr
sheng
dahlman
e
wallstrfm
f
aboulenein
b
p
olofsson
c
r
holmdahl
c
h
lassmann
b
olsson
karolinska
institut
stockholm
sweden
b
univers
vienna
vienna
austria
c
lund
univers
lund
sweden
rat
origin
identifi
two
intercross
display
linkag
cn
inflamm
eae
sever
respect
region
overlap
also
identifi
cross
two
congen
strain
encompass
previous
describ
establish
da
allel
within
chromosom
fragment
confer
increas
diseas
suscept
well
increas
inflamm
demyelin
cn
compar
bn
allel
enabl
precis
finemap
eae
regulatori
gene
util
rat
advanc
intercross
line
ail
suscept
da
resist
strain
linkag
analysi
perform
advanc
intercross
line
consider
narrow
mogea
regulatori
locu
region
defin
number
candid
gene
demonstr
regulatori
effect
mogea
use
congen
strain
well
finemap
effect
region
contain
gene
report
effect
also
experiment
arthriti
studi
anim
model
ms
provid
import
insight
immunopathogenesi
diseas
genet
analys
model
overcom
certain
obstacl
encount
studi
human
patient
mogea
like
ms
complex
genet
diseas
contribut
major
histocompat
complex
mhc
gene
multipl
unknown
nonmhc
gene
linkag
analysi
use
map
eaelink
loci
rat
chromosom
cross
suscept
da
resist
aci
rat
region
diseas
regul
influenc
mogea
found
chromosom
present
studi
direct
examin
loci
undertaken
congen
strain
transfer
region
resist
aci
rat
suscept
da
background
phenotyp
compar
among
da
congen
subcongen
recombin
cm
show
congen
resist
mogea
low
level
antimog
antibodi
tendenc
sera
low
inflamm
demyelin
index
central
nervou
system
promis
keep
retain
phenotyp
differ
creat
congen
strain
collect
recombin
differ
congen
segment
permit
rapid
fine
map
within
centimorgan
thu
result
indic
region
harbor
eae
regul
gene
contribut
protect
eae
may
reflect
b
cell
arm
mog
autoimmun
conclus
studi
provid
approach
test
human
homolog
gene
ms
unveil
mechan
gene
regul
ms
like
diseas
novel
snp
code
region
multipl
sclerosi
patient
c
fenoglio
galimberti
r
clerici
ronzoni
de
riz
l
piccio
gatti
e
venturelli
l
berti
g
constantin
b
n
bresolin
e
scarpini
ospedal
maggior
milano
itali
b
univers
verona
verona
itali
lymphocyt
recruit
brain
critic
event
pathogenesi
multipl
sclerosi
ms
selectin
express
inflam
endothelium
particip
lymphocyt
adhes
brain
vessel
pselectin
glycoprotein
ligand
main
ligand
eand
pselectin
crucial
role
lymphocyt
recruit
genom
dna
isol
whole
blood
mutat
scan
carri
italian
patient
ms
well
agematch
control
detect
new
polymorph
frequenc
new
mutat
compar
patient
control
novel
singl
nucleotid
polymorph
snp
involv
gra
substitut
result
aminoacid
chang
posit
code
region
gene
determin
differ
frequenc
snp
ms
patient
compar
control
observ
stratifi
age
onset
gender
differ
allel
frequenc
observ
first
evid
presenc
caucasiansthi
snp
could
effect
function
locat
within
region
involv
bind
selectin
analysi
polymorph
tolllik
receptor
gene
patient
multipl
sclerosi
kroner
b
rosch
b
n
kruse
c
k
toyka
b
hemmer
b
p
rieckmann
univers
germani
b
heinrich
hein
univers
germani
c
univers
germani
multipl
sclerosi
diseas
deterior
often
occur
associ
bacteri
infect
particularli
lipopolysaccharid
lp
contain
gram
neg
bacteria
lp
known
activ
immun
cell
via
recent
describ
polymorph
gene
shown
caus
hyporespons
lp
therefor
investig
function
role
allel
distribut
polymorph
popul
mspatient
dna
obtain
patient
healthi
donor
polymorph
analys
allel
discrimin
ad
pcr
confirm
pcrrestrictionfragmentlengthpolymorph
rflp
automat
sequenc
pbmc
donor
differ
genotyp
stimul
lp
inactiv
gramneg
gramposit
bacteria
prolifer
product
tnfalpha
measur
genotyp
reveal
wildtyp
individu
patient
heterozyg
two
individu
homozyg
mutant
genotyp
associ
differ
genotyp
ms
suscept
subtyp
diseas
sever
could
found
significantli
lower
prolifer
rate
pbmc
deriv
heterozyg
individu
could
detect
stimul
lp
could
find
associ
genotyp
diseas
cours
multipl
sclerosi
ms
popul
howev
could
confirm
function
relev
polymorph
exposur
immun
cell
lp
multipl
sclerosi
autoimmun
diseas
risk
hladr
associ
northerneast
itali
p
gallo
laroni
calabres
p
perini
mp
albergoni
b
f
ranzato
l
battistin
multipl
sclerosi
center
depart
neurolog
scienc
univers
padova
padova
itali
b
blood
bank
univers
hospit
padova
itali
autoimmun
background
thought
character
famili
multipl
sclerosi
ms
patient
diseas
pattern
hladr
associ
seem
vari
consider
among
differ
ethnic
group
studi
occurr
autoimmun
diseas
ms
patient
agesexmatch
normal
control
nc
origin
live
northerneast
itali
almost
firstdegre
rel
subject
hladr
express
analys
ms
nc
risk
autoimmun
diseas
increas
ms
patient
compar
nc
ms
vs
nc
famili
multipl
autoimmun
patholog
autoimmun
famili
af
identifi
ms
group
nc
group
signific
excess
autoimmun
found
firstdegre
rel
ms
patient
associ
ms
type
diabet
mellitu
also
notic
express
ms
patient
af
significantli
higher
refer
ms
patient
nc
fifti
percent
ms
patient
express
allel
data
suggest
signific
risk
autoimmun
firstdegre
rel
ms
patient
role
autoimmun
predisposit
preferenti
associ
ms
least
southern
europ
c
promot
polymorph
associ
diseas
sever
multipl
sclerosi
patient
lutterotti
r
ehl
h
lassmann
b
f
deisenhamm
berger
reindl
clinic
depart
neurolog
innsbruck
medic
univers
innsbruck
austria
b
brain
research
institut
vienna
medic
univers
vienna
vienna
membran
receptor
express
cell
monocyt
lineag
known
essenti
mediat
innat
host
defens
phagocytosi
apoptot
cell
aim
studi
investig
possibl
associ
ct
promot
polymorph
gene
suscept
diseas
sever
patient
clinic
definit
multipl
sclerosi
ms
outcom
measur
diseas
sever
measur
progress
index
edssdiseas
durat
ms
sever
score
time
reach
hallmark
edss
well
annual
relaps
rate
establish
new
pcr
assay
sequencespecif
primer
analyz
genotyp
patient
furthermor
analyz
express
within
ms
lesion
patient
histopatholog
carrier
c
allel
sever
diseas
cours
progress
index
ms
sever
score
significantli
shorter
time
reach
hallmark
edss
found
associ
ct
polymorph
suscept
ms
upregul
ms
lesion
promin
acut
lesion
first
studi
describ
associ
ct
polymorph
within
promot
region
gene
receptor
innat
immun
system
longterm
diseas
sever
ms
patient
knowledgebas
interact
candid
gene
suscept
loci
portal
multipl
sclerosi
p
uk
zettl
b
p
wernhoff
hj
thiesen
koczan
sm
ibrahim
institut
immunolog
b
depart
neurolog
univers
rostock
rostock
germani
multipl
sclerosi
ms
polygen
diseas
mani
unknown
genet
factor
lead
set
clinic
phenotyp
differ
intens
period
scientif
commun
appli
varieti
approach
tissu
patient
anim
model
diseas
order
determin
candid
gene
phenotyp
manifest
genet
linkag
studi
transcriptom
proteom
experi
differ
tissu
wealth
inform
avail
sheer
number
public
gene
describ
interpret
result
novel
experi
labori
time
consum
task
help
set
new
hypothes
present
web
interfac
queri
databas
provid
new
evid
pathogenesi
ms
databas
includ
individu
gene
chromosom
loci
human
supplement
data
anim
model
diseas
link
public
resourc
interact
gene
loci
may
graphic
brows
databas
primarili
present
inform
rna
protein
express
data
ie
differenti
express
healthi
vs
diseas
tissu
includ
data
blood
urin
spinal
cord
brain
avail
regulatori
interact
repres
chromosom
suscept
loci
genet
linkag
analys
human
diseas
anim
model
interlink
gene
via
ensembl
genom
annot
intergenom
synteni
chromosom
loci
appli
characteris
gene
transfer
data
interact
loci
anim
model
diseas
experiment
autoimmun
encephalomyel
human
lymphocyt
recruit
brain
critic
event
pathogenesi
multipl
sclerosi
ms
control
adhes
molecul
involv
initi
contact
tether
roll
along
vessel
wall
mediat
selectin
integrin
chemoattractantinduc
integrin
activ
firm
arrest
diapedesi
eand
pselectin
requir
effici
tether
roll
neutrophil
mous
brain
vessel
distribut
polymorph
eselectin
gene
popul
patient
ms
agematch
control
studi
significantli
increas
frequenc
tt
genotyp
polymorph
ms
patient
observ
differ
distribut
patient
control
shown
patient
bear
wildtyp
allel
increas
probabl
develop
diseas
age
year
presenc
tt
genotyp
polymorph
seem
increas
suscept
develop
ms
possibl
regul
eselectin
transcript
rate
thu
facilit
recruit
activ
lymphocyt
brain
besid
polymorph
seem
suscept
factor
ms
although
presenc
could
influenc
age
onset
ifnbeta
exert
function
bind
subunit
receptor
aim
work
establish
genotyp
frequenc
snp
within
promot
region
gene
rel
start
transcript
polymorph
code
region
exon
exon
gene
evalu
impact
polymorph
respons
ifnbeta
assess
influenc
mrna
express
ms
patient
ifnbeta
therapi
control
evalu
snp
rflp
analysi
pcramplifi
fragment
measur
real
time
rtpcr
signific
differ
genotyp
distribut
patient
control
found
chi
analysi
seem
influenc
respons
ifnbeta
therapi
level
express
signific
differ
distribut
respond
non
respond
observ
stratifi
snp
whether
differ
distribut
genotyp
snp
code
region
control
patient
function
signific
need
studi
chromosom
multipl
sclerosi
bonetti
univers
helsinki
helsinki
finland
multipl
sclerosi
ms
demyelin
diseas
central
nervou
system
suspect
autoimmun
pathogenesi
genet
environment
factor
play
role
aetiolog
ms
consid
genet
heterogen
polygen
diseas
ms
evid
linkag
studi
allel
associ
studi
suggest
chromosom
would
harbour
predispos
gene
perform
twostag
studi
analys
associ
polymorph
chromosom
ms
marker
analys
finnish
ms
famili
observ
associ
test
ms
famili
find
previous
report
allel
haplotyp
associ
obtain
weak
signal
two
distinct
predispos
gene
one
proxim
distal
put
proxim
gene
associ
marker
famili
lack
distal
gene
associ
famili
highrisk
region
western
finland
base
cm
distanc
lack
linkag
disequilibrium
loci
conclud
two
associ
signal
independ
result
provid
preliminari
evid
two
distinct
ms
suscept
gene
outsid
background
evalu
correl
haplotyp
ageatonset
popul
multipl
sclerosi
ms
patient
sardinia
method
total
ms
patient
healthi
control
c
type
loci
individu
frequenc
hla
class
ii
genotyp
observ
patient
control
compar
estim
odd
ratio
determin
genotyp
frequenc
patient
earli
onset
year
vs
adult
onset
year
vs
control
level
signific
set
result
identifi
individu
earli
onset
risk
ms
increas
adult
onset
patient
carri
genotyp
compar
c
earli
onset
patient
compar
c
risk
increas
carrier
genotyp
comparison
adult
earli
onset
patient
show
risk
earli
onset
specif
associ
genotyp
genotyp
frequenc
earli
onset
adult
onset
patient
conclus
result
indic
sardinian
ms
patient
molecul
contribut
earli
onset
diseas
interestingli
risk
earli
onset
associ
autoimmun
diabet
highrisk
genotyp
background
analyz
distribut
men
women
cohort
sardinian
ms
patient
accord
haplotyp
examin
inherit
msassoci
allel
accord
parent
transmiss
method
studi
compris
men
women
ms
patient
healthi
sibl
type
perform
previous
describ
logist
model
use
test
parentoforigin
po
matern
genotyp
effect
allel
result
whole
cohort
patient
fm
ratio
rang
dri
subcategori
excess
patern
transmit
affect
healthi
offspr
found
po
effect
transmiss
father
evid
affect
women
men
effect
two
copi
matern
nontransmit
genotyp
found
femal
male
conclus
present
find
demonstr
sardinia
rel
risk
ms
due
locu
heterogen
one
etiolog
pathway
associ
possibl
involv
patern
matern
effect
diseas
risk
base
nationwid
seri
italian
twin
ms
collect
inform
famili
aggreg
perinat
earli
late
life
event
physiolog
medic
surgic
histori
item
may
repres
nonherit
risk
factor
data
twin
pair
prosecut
use
logist
regress
model
stepwis
forward
select
procedur
order
identifi
best
subset
covari
term
ms
predict
select
process
base
formal
likelihood
ratio
test
procedur
allow
identif
subset
covari
seem
signific
impact
rais
diseas
concord
twin
logist
approach
gener
ad
gaussian
random
effect
account
potenti
heterogen
among
twin
pair
depend
twin
pair
model
estim
use
gee
gener
estim
equat
maximum
likelihood
approach
analys
perform
stata
releas
colleg
station
tx
confirm
earli
life
infect
later
life
infect
breast
feed
mump
herp
viru
infect
red
measl
assumpt
milk
covari
signific
posit
neg
associ
diseas
role
herpesviru
entri
receptor
develop
ms
f
vogel
b
rosch
cepok
stei
b
v
grummel
kroner
c
c
p
rieckmann
c
n
sommer
b
b
hemmer
univers
germani
b
univers
marburg
marburg
germani
c
univers
germani
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
although
caus
ms
still
uncertain
well
accept
genet
environment
factor
import
develop
diseas
common
viral
infect
implic
environment
factor
influenc
onset
activ
diseas
studi
focus
gene
code
common
herp
viru
entri
receptor
gene
locat
region
previous
link
ms
genom
wide
linkag
studi
receptor
express
brain
immun
system
may
play
import
role
intercellular
adhes
entri
neurotrop
virus
brain
exon
gene
sequenc
ms
patient
healthi
control
identifi
number
new
confirm
previous
describ
polymorph
test
relev
ms
casecontrol
ms
patient
control
tdt
studi
ms
famili
far
none
polymorph
associ
ms
observ
complement
express
analys
receptor
peripher
mononuclear
cell
demonstr
differenti
express
ms
patient
control
summari
find
evid
herp
viru
receptor
gene
play
role
develop
ms
complement
activ
central
featur
inflammatori
process
previous
demonstr
rat
strain
differ
complement
express
lumbar
ventral
root
avuls
vra
model
nerv
injuryinduc
neurodegener
thu
situ
hybrid
label
mrna
vra
twice
high
da
rat
compar
pvg
furthermor
larg
scale
microarray
experi
mrna
level
significantli
differ
two
strain
baselin
naiv
rat
day
vra
extend
observ
genet
map
mrna
express
daxpvg
intercross
situ
hybrid
computerbas
imag
analysi
rat
genotyp
microsatellit
demonstr
suggest
linkag
lod
score
express
genet
locu
chromosom
regul
neurodegener
vra
paradigm
addit
mrna
express
pvg
da
rat
studi
brain
contus
model
one
week
unilater
brain
contus
level
mrna
measur
real
time
pcr
twice
high
da
rat
compar
pvg
result
demonstr
substanti
differ
regul
express
mechan
nerveinjuri
well
potenti
link
genet
determin
differ
nerv
cell
surviv
vra
paradigm
express
cytogenet
moleculargenet
marker
age
chang
lymphocyt
kuznetsova
institut
gerontolog
kiev
ukrain
object
studi
ychromosom
polymorph
three
ethnic
region
abkhasia
azerbaijan
high
ukrain
medium
longev
level
establish
ethnic
longev
variant
method
centenarian
abkhasia
azerbaijan
chromosom
polymorph
c
heterochromatin
chromosom
length
accord
yf
index
determin
result
longliv
abkhasia
azerbaijan
length
ychromosom
bigger
ukrain
yf
index
respect
middleag
popul
segment
ethnic
differ
mark
compar
centenarian
size
c
band
ychromosom
centenarian
three
studi
region
differ
significantli
abkhasia
azerbaijan
ukrain
howev
ethnic
differ
c
band
size
ychromosom
middleag
group
longest
c
band
regist
azerbaijan
nation
shorter
abkhasian
ukrainian
respect
conclus
absenc
mark
ethnic
differ
ychromosom
c
band
size
longliv
presenc
middleag
group
point
presenc
gener
ychromosom
polymorph
variant
longliv
three
region
size
ychromosom
c
band
individu
ethnic
longev
abkhasia
azerbaijan
similar
indic
longliv
fact
suggest
ychromosom
polymorph
variant
constitut
cytogenet
marker
individu
probabl
ethnic
longev
leber
hereditari
optic
neuropathi
lhon
associ
point
mutat
mitochondri
dna
character
bilater
usual
sequenti
optic
neuropathi
may
cooccur
multipl
sclerosi
ms
like
white
matter
lesion
despit
repeat
clinic
report
includ
magnet
reson
imag
well
histopatholog
examin
visual
system
pauciti
histopatholog
descript
lhon
associ
mslike
syndrom
present
case
femal
patient
mutat
present
bilater
optic
neuropathi
consecut
develop
hashimoto
thyreoid
well
widespread
demyelin
cn
lesion
outsid
visual
system
die
bronchopneumonia
age
immunohistochem
analysi
reveal
spectrum
neuropatholog
chang
includ
activ
inact
demyelin
plaqu
white
matter
optic
nerv
vacuol
cystic
necrosi
tcell
frontal
lobe
axon
damag
shadow
plaqu
massiv
tissu
destruct
cystic
necrosi
respect
associ
immunohistochem
detect
induc
nitric
oxid
synthas
ino
macrophag
microglia
variabl
phenotyp
extraopt
lhon
diseas
suggest
mtdna
mutat
may
affect
nervou
system
common
metabol
basi
occasion
may
aggrav
initi
autoimmun
patholog
syndrom
gb
postinfecti
polyradiculoneuropathi
character
inflammatori
demyelin
axon
degener
macrophag
gangliosidespecif
igg
implic
pathogenesi
gb
recent
demonstr
capac
antigangliosid
igg
induc
leukocyt
activ
via
crosslink
igg
receptor
fcgammar
suggest
inflammatori
potenti
autoantibodi
gb
three
fcgammar
famili
member
fcgammariia
fcgammariiia
fcgammariiib
display
function
biallel
polymorph
fcgammariia
vs
fcgammariiia
vs
fcgammariiib
vs
determin
efficaci
iggmedi
cellular
inflammatori
respons
bind
immun
complex
effici
wherea
display
increas
bind
capac
complex
therefor
fcgammar
polymorph
could
influenc
vigour
antibodyinduc
immun
respons
assess
relev
fcgammar
polymorph
suscept
sever
gb
determin
fcgammar
genotyp
distribut
dutch
british
patient
gb
dutch
british
control
allelespecif
pcr
genotyp
frequenc
increas
among
dutch
patient
sever
diseas
compar
patient
mild
diseas
metaanalysi
incorpor
previous
publish
data
encompass
total
gb
patient
control
confirm
associ
allel
sever
diseas
addit
show
enrich
genotyp
patient
mild
diseas
compar
patient
sever
diseas
fcgammariiia
fcgammariiib
genotyp
may
repres
diseasemodifi
factor
gb
associ
polymorph
myasthenia
gravi
mg
v
yilmaz
b
yg
parman
c
p
serdaroglu
c
f
deymeer
c
g
saruhandiresken
b
deta
depart
immunolog
b
deta
depart
physiolog
c
deta
depart
neurolog
istanbul
medic
faculti
istanbul
turkey
mg
character
autoantibodi
ab
acetylcholin
receptor
postsynapt
membran
neuromuscular
junction
product
ab
regul
cell
via
cytokin
interindividu
differ
cytokin
profil
appear
relat
allel
polymorph
gene
differ
distribut
polymorph
allel
may
implic
genet
suscept
mg
analyz
genet
suscept
mg
polymeras
chain
reactionrestrict
fragment
length
polymorph
pcrrflp
assay
appli
screen
singl
nucleotid
polymorph
ta
ca
posit
promot
ac
utr
gene
patient
healthi
control
hc
among
mg
group
seroposit
select
patient
antititin
ab
comparison
allel
haplotyp
genotyp
frequenc
polymorph
mg
hc
group
subgroup
mg
reveal
signific
differ
howev
associ
utr
c
allel
antititin
antibodi
posit
detect
result
implic
select
polymorph
contribut
genet
suscept
mg
studi
support
istanbul
univers
research
fond
myasthenia
gravi
mg
autoimmun
disord
mediat
autoantibodi
nicotin
acetylcholin
receptor
nachr
neuromuscular
junction
product
autoantinachr
antibodi
mg
depend
tcell
help
polymorph
cytotox
tlymphocyteassoci
gene
report
alter
cell
activ
confirm
genet
suscept
sever
autoimmun
diseas
includ
mg
determin
role
gene
polymorph
predisposit
mg
investig
patient
mg
ethnic
match
healthi
control
allel
determin
two
polymorph
site
gene
promot
region
first
exon
posit
msei
bsteii
restrict
enzym
digest
analys
correspondingli
allel
frequenc
gene
polymorph
patient
healthi
control
allel
c
found
correspondingli
frequenc
allel
polymorph
mg
group
compar
control
group
signific
differ
allel
frequenc
distribut
loci
patient
healthi
control
result
show
evid
associ
gene
polymorph
mg
myasthenia
gravi
mg
autoimmun
disord
antibodi
direct
human
nicotin
acetylcholin
receptor
neuromuscular
junction
associ
hla
class
ii
antigen
diseas
describ
countri
ethnic
mix
group
brazilian
mg
patient
associ
found
global
group
compar
casecontrol
studi
interestingli
split
hla
significantli
overrepres
male
mg
femal
patient
compar
sexmatch
control
sever
mg
associ
cooccur
homozigoz
appear
multipli
effect
risk
develop
mg
contrast
hla
appear
involv
protect
well
hla
common
protect
marker
male
mg
patient
nonthymomat
thymectomi
hand
strong
associ
hla
earlyonset
diseas
found
femal
mg
patient
summari
associ
hladr
class
ii
brazilian
mg
patient
contribut
understand
complex
diseas
hla
phenotyp
role
mg
pathogenesi
support
fapesp
agerel
chang
inflammatori
respons
cytokin
brain
campbel
dc
anthoni
univers
southampton
southampton
uk
adult
rat
brain
resist
action
proinflammatori
mediat
recruit
leukocyt
follow
injuri
resist
phenotyp
may
agedepend
studi
examin
whether
agerel
chang
inflammatori
respons
reflect
alter
respons
proinflammatori
cytokin
tumour
necrosi
factora
tnfa
respons
equival
brain
microinject
tnfa
juvenil
age
rat
display
increas
leukocyt
recruit
brain
loss
specif
leukocyt
recruit
profil
compar
respons
adult
rat
neutrophil
recruit
vessel
wall
associ
loss
tightjunct
protein
bloodbrain
barrier
breakdown
leukocyt
recruit
liver
surrog
marker
hepat
acutephas
respons
brain
injuri
also
elev
juvenil
age
rat
compar
adult
rat
studi
suggest
window
suscept
exist
rodent
brain
either
end
age
spectrum
guid
experiment
design
assess
antiinflammatori
strategi
agerel
neuropatholog
chemokin
modul
calcium
dynam
electrophysiolog
properti
cn
neuron
dl
gruol
kli
van
gassen
b
jg
netzeband
pne
de
graan
b
scripp
research
institut
la
jolla
ca
usa
b
rudolf
magnu
institut
neurosci
utrecht
netherland
one
number
chemokin
belong
cytokin
superfamili
involv
inflammatori
chemoattract
process
produc
high
level
central
nervou
system
cn
viral
infect
injuri
neuroinflamm
neurodegen
condit
cn
cell
includ
neuron
glia
express
receptor
cytokin
suggest
patholog
condit
commun
cn
cell
cytokin
signal
pathway
howev
understand
consequ
activ
cytokin
signal
system
cn
rel
limit
especi
cn
neuron
mani
cell
type
chemokin
signal
alter
intracellular
calcium
dynam
therefor
investig
potenti
involv
mechan
neuron
signal
activ
addit
examin
effect
neuron
excit
studi
focus
cerebellar
purkinj
neuron
identifi
cn
neuron
type
express
receptor
studi
carri
cultur
prepar
test
acut
bath
applic
high
concentr
nm
use
reflect
condit
diseas
state
result
show
increas
rest
calcium
level
enhanc
calcium
respons
evok
metabotrop
glutam
receptor
agonist
depress
excit
modulatori
effect
neuron
properti
like
contribut
alter
cn
function
associ
cn
diseas
injuri
support
microglia
infiltr
macrophag
involv
phagocytosi
apoptot
cell
myelin
debri
multipl
sclerosi
ms
lesion
central
nervou
system
cn
accumul
ingest
lipid
associ
foami
appear
cell
gener
assum
foami
macrophag
contribut
local
proinflammatori
environ
assumpt
base
surprisingli
scant
evid
sinc
mani
lipid
mediat
actual
known
mediat
immun
suppress
address
hypothesi
foami
macrophag
demonstr
antiinflammatori
phenotyp
situ
mimick
vitro
myelinlipid
prepar
demonstr
larg
major
foami
macrophag
postmortem
ms
brain
express
marker
characterist
antiinflammatori
altern
activ
macrophag
aamf
includ
produc
antiinflammatori
molecul
tgfbeta
express
pattern
vari
strongli
depend
locat
within
lesion
macrophag
perivascular
infiltr
express
proinflammatori
cytokin
tnfalpha
preliminari
vitro
data
suggest
myelinlipid
prepar
decreas
lpsinduc
tnf
product
induc
macrophag
thu
ms
foami
macrophag
within
cn
lesion
resembl
aamf
may
caus
lipid
mediat
sinc
myelinderiv
lipid
interfer
proinflammatori
mechan
macrophag
vitro
data
suggest
phagocyt
macrophag
may
display
regulatori
function
within
ms
lesion
surfac
unit
msrv
multipl
sclerosi
associ
retrovir
element
envelop
protein
induc
immun
bia
patient
ms
correl
diseas
activ
rolland
e
jouvinmarch
saresella
b
p
presenc
msrv
retrovir
element
defin
novel
famili
human
endogen
retrovirus
hervw
confirm
serum
cerebrospin
fluid
csf
patient
multipl
sclerosi
ms
correl
circul
msrv
virion
load
ms
evolut
demonstr
attempt
link
potenti
effect
msrv
ms
diseas
proinflammatori
properti
surfac
unit
msrv
envelop
protein
evalu
pbmc
ms
patient
compar
healthi
control
observ
diverg
reactiv
envsu
ms
control
pbmc
reflect
signific
increas
ifngamma
product
overal
ms
popul
compar
control
group
tnfalpha
similarli
stimul
interestingli
product
found
correl
expand
disabl
statu
scale
edss
patient
surfac
unit
msrv
envelop
protein
thu
affect
immun
system
patient
ms
immun
bia
thu
creat
appear
increas
diseas
evolut
proinflammatori
properti
envsu
could
compat
relationship
msrv
express
ms
immunopatholog
diseas
evolut
tradd
interact
influenc
ifngamma
signal
macrophagesmicroglia
en
benvenist
h
qin
n
kokorina
wesemann
univers
alabama
birmingham
birmingham
alabama
usa
inflammatori
event
central
nervou
system
cn
contribut
patholog
underli
diseas
multipl
sclerosi
alzheim
diseas
dementia
activ
macrophag
microglia
central
respons
macrophagesmicroglia
respond
cytokin
upon
engag
cell
surfac
receptor
activ
complex
intracellular
signal
pathway
ifngamma
tnfalpha
potent
activ
macrophag
microglia
aberrantli
express
cn
diseas
mention
tumor
necrosi
factor
associ
death
domain
protein
tradd
play
essenti
role
recruit
signal
molecul
tnfri
receptor
complex
ifngamma
util
signal
transduc
activ
alpha
signal
transduct
herein
demonstr
ifngamma
induc
format
nuclearloc
complex
ifngammamedi
phosphoryl
prolong
macrophag
reduc
tradd
express
moreov
increas
ifngammamedi
dna
bind
activ
nuclear
presenc
transcript
potenti
observ
tradd
bknockdownq
cell
data
indic
tradd
may
play
role
ifngamma
signal
form
complex
within
nucleu
regul
ifngammamedi
activ
thu
tradd
function
role
regul
respons
macrophagesmicroglia
ifngamma
impact
cellular
activ
subsequ
neuroinflammatori
respons
identif
complement
receptor
astrocyt
character
antiinflammatori
properti
v
gavrilyuk
kalinin
b
hilbush
b
middlecamp
b
mcguir
c
dl
feinstein
univers
illinoi
chicago
il
usa
b
digit
gene
technolog
san
diego
ca
usa
c
loyola
univers
chicago
il
usa
brain
inflamm
regul
endogen
substanc
includ
noradrenalin
na
increas
antiinflammatori
gene
identifi
naregul
antiinflammatori
gene
use
toga
total
gene
express
analysi
screen
astrocytederiv
rna
nainduc
cdna
clone
encod
form
complement
receptor
ident
rat
ident
human
variant
quantit
pcr
show
astrocyt
mrna
increas
na
wherea
vivo
deplet
na
reduc
level
western
blot
analysi
demonstr
basal
nainduc
express
primari
astrocyt
immunocytochem
stain
reveal
throughout
brain
coloc
neuron
astrocyt
astrocyt
induct
nitric
oxid
synthas
type
ilbeta
increas
treatment
antisens
oligonucleotid
reduc
cell
overexpress
level
human
lower
ms
ad
brain
versu
control
result
demonstr
isoform
express
glia
neuron
regul
na
exert
antiinflammatori
function
chang
level
brain
could
contribut
progress
inflammatori
damag
work
sponsor
grant
nih
activ
interferon
regulatori
implic
antivir
respons
human
primari
astrocyt
rivieccio
gr
john
b
hs
suh
x
song
sc
lee
cf
brosnan
albert
einstein
colleg
medicin
new
york
usa
b
mount
sinai
school
medicin
new
york
usa
cytokin
major
activ
astrocyt
lead
product
wide
rang
cytokin
chemokin
import
host
defens
pathogen
like
lp
signal
via
pathway
link
nfkappab
recent
studi
shown
ligand
lp
signal
independ
result
activ
interferon
regulatori
transcript
factor
requir
induct
primari
antivir
respons
gene
type
interferon
chemokin
consid
appar
similar
signal
hypothes
also
capabl
activ
human
primari
astrocyt
activ
would
result
express
type
interferon
necessari
innat
antivir
immun
use
qpcr
elisa
found
ifnbeta
astrocyt
also
observ
induc
nuclear
transloc
immunofluoresc
cell
fraction
follow
immunoblot
confirm
depend
type
interferon
express
activ
util
domin
neg
express
adenoviru
data
first
show
addit
tlr
stimul
human
primari
astrocyt
implic
cytokin
activ
gene
involv
innat
antivir
respons
downregul
abetainduc
cytokin
express
glial
cell
use
nfkappab
decoy
l
fisher
samuelsson
v
cort
toro
u
soomet
j
yang
langel
k
iverfeldt
depart
neurochemistri
neurotoxicolog
stockholm
univers
stockholm
sweden
alzheim
diseas
ad
progress
neurodegen
diseas
associ
impair
cognit
memori
betaamyloid
abeta
plaqu
seen
ad
surround
activ
astrocyt
microglia
believ
activ
glial
cell
contribut
neurotox
induct
oxid
damag
proinflammatori
cytokin
like
activ
glial
cell
believ
earli
event
develop
ad
detect
earli
ad
brain
suggest
cytokin
may
play
import
role
develop
ad
mani
inflammatori
event
includ
cytokin
induct
glial
cell
transcript
factor
nfkappab
play
key
role
suggest
therapeut
strategi
aim
control
develop
ad
could
includ
administr
drug
hinder
nfkappab
activ
studi
effect
mediat
abeta
abeta
peptid
nfkappab
bind
activ
cytokin
express
rat
primari
mix
glial
cell
cultur
examin
also
investig
possibl
block
action
nfkappab
use
doublestrand
oligonucleotid
contain
consensu
sequenc
nfkappab
bind
investig
effect
block
nfkappab
action
cytokin
express
cell
order
increas
cellular
uptak
nfkappab
decoy
use
cell
penetr
peptid
transportan
role
tnf
axon
lesioninduc
microgli
activ
vivo
c
fenger
n
drbjdahl
meldgaard
r
ladebi
k
lambertsen
b
finsen
univers
southern
denmark
odens
c
denmark
tnf
known
exert
strong
autoand
paracrin
effect
microglia
vitro
presum
vivo
investig
role
tnf
receptor
microgli
respons
wallerian
termin
synapt
degener
within
hippocampu
quantit
pcr
microdissect
perfor
pathdenerv
hippocampu
show
upregul
tnf
mrna
upregul
mrna
day
respect
presenc
tnf
confirm
western
blot
situ
hybrid
show
microgli
express
tnf
mrna
day
upregul
mrna
microgliallik
cell
start
day
microglia
underw
prolifer
lesion
induc
increas
microgli
number
wildtyp
mice
day
lesion
unles
comparison
microgli
number
wildtyp
tnfko
mice
point
toward
reduc
lesioninduc
increas
microgli
number
tnfand
tnfrko
mice
howev
statist
signific
twoway
anova
data
suggest
endogen
produc
tnf
may
redund
term
lesioninduc
expans
microgli
popul
vivo
product
interferongamma
microglia
j
kawanokuchi
mizuno
h
kato
h
takeuchi
j
wang
g
zhang
n
mitsuma
r
kuno
jin
suzumura
depart
neuroimmunolog
research
institut
environment
medicin
nagoya
univers
nagoya
japan
lack
major
histocompat
complex
mhc
antigen
express
neural
cell
consid
interact
immun
cell
specif
manner
interferongamma
ifngamma
enabl
interact
via
induct
mhc
antigen
express
neural
cell
ifngamma
also
induc
inflammatori
mediat
tnfalpha
nitric
oxid
glial
cell
thu
ifngamma
critic
cytokin
develop
cn
patholog
includ
neuron
degener
inflammatori
demyelin
howev
ifngamma
consid
produc
exclus
lymphoid
cell
show
murin
microglia
brain
macrophag
abl
produc
ifngamma
respons
mean
rtpcr
method
induct
ifngamma
mrna
western
blot
immunofluoresc
cytoplasm
express
ifngamma
microglia
murin
microgli
cell
line
cell
also
induc
produc
ifngamma
wherea
astrocyt
produc
ifngamma
stimuli
induct
ifngamma
result
induct
class
ii
mhc
antigen
express
microglia
sinc
produc
cn
glial
cell
cytokin
may
play
critic
role
initi
neural
cellsimmun
cell
interact
induc
autoimmun
process
cn
either
autocrin
paracrin
manner
biolog
role
two
new
haemopoiet
factor
brain
thymu
kikuchi
h
tomoyasu
b
yamamoto
c
kusakab
n
sakuragawa
e
kamo
e
nation
institut
neurosci
tokyo
japan
b
ohmori
red
cross
hospit
tokyo
japan
c
institut
medic
scienc
univers
tokyo
tokyo
japan
anb
tsukuba
institut
tsukuba
japan
e
school
medicin
toho
univers
sagamihara
japan
found
new
haemopoiet
factor
cone
rat
thymic
myoid
cell
mani
cell
produc
factor
detect
myasthen
hyperplast
thymi
normal
brain
suggest
biolog
role
monocyt
cell
growth
present
studi
aim
understand
potenti
biolog
role
brain
myasthen
thymu
new
born
rat
brain
rabbit
factor
igg
use
immunohistochem
studi
neural
cell
obtain
form
rat
cerebrum
cultur
kinas
assay
factor
detect
young
age
rat
brain
tissu
cultur
brain
cell
glial
cell
line
produc
two
factor
two
factor
purifi
cultur
stimul
growth
microgli
cell
two
antibodi
react
neural
cell
factor
support
neural
cell
growth
hyperplast
myasthen
thymi
factor
consist
detect
two
factor
also
support
growth
b
cell
result
suggest
two
new
haemopoiet
factor
play
import
physiolog
role
brain
regulatori
role
autoimmun
diseas
chemokin
secret
chemokin
receptor
express
brain
cell
aggreg
cultur
treat
interferongamma
fa
marqu
ia
romero
dk
male
aj
loughlin
open
univers
milton
keyn
uk
brain
cell
aggreg
cultur
system
approxim
brain
vivo
term
glial
neuron
develop
cellcel
interact
use
model
cn
parenchyma
vitro
cultur
establish
brain
tissu
gestat
spraguedawley
rat
embryo
untreat
aggreg
chemokin
receptor
detect
mrna
level
treatment
ifngamma
result
increas
express
detect
express
unstimul
aggreg
express
receptor
affect
ifngamma
treatment
protein
level
detect
immunocytochemistri
though
ifngamma
discern
effect
ifngamma
induc
secret
ligand
receptor
respect
timeand
dosedepend
manner
respons
ifngamma
observ
studi
modest
compar
observ
isol
glial
cell
popul
result
suggest
natur
extent
inflammatori
respons
cn
predict
studi
isol
cell
popul
critic
depend
interact
cell
complex
milieu
secret
mediat
approach
complement
exist
vivo
vitro
studi
allow
us
assess
effect
inflammatori
mediat
cell
within
complex
cn
environ
capsaicin
upregul
product
cytokin
dorsal
root
ganglion
drg
neuron
cultur
ne
saad
h
al
tannouri
elsabban
b
safiehgarabedian
sj
jabbur
american
univers
beirut
beirut
lebanon
background
aim
previou
work
laboratori
character
effect
endotoxin
et
treatment
secret
proinflammatori
cytokin
cultur
drg
neuron
aim
studi
investig
whether
challeng
drg
cell
capsaicin
alter
secret
tumor
necrosi
factor
tnf
alpha
interleukin
il
prostaglandin
method
primari
cultur
adult
rat
drg
neuron
treat
day
either
et
microg
ml
capsaicin
microg
ml
min
treatment
cell
wash
resuppli
fresh
media
supernat
sampl
h
concentr
mediat
determin
elisa
result
capsaicin
produc
signific
increas
level
reach
fold
initi
concentr
increas
compar
albeit
slightli
less
observ
et
challeng
optim
effect
obtain
concentr
capsaicin
conclus
capsaicin
challeng
drg
cultur
upregul
level
pro
antiinflammatori
mediat
result
provid
molecular
background
concept
neurogen
inflamm
support
grant
cdre
lncsr
effect
chronic
express
brain
cc
ferrari
depino
f
prada
podhajc
h
perri
b
anthoni
c
f
pitossi
gene
therapi
laboratori
institut
biochem
research
bueno
air
argentina
b
cn
inflamm
group
univers
southamptom
southampton
uk
c
molecular
neuropatholog
univers
southampton
southampton
uk
implic
patholog
sever
chronic
neurodegen
diseas
includ
multipl
sclerosi
alzheim
diseas
prion
diseas
howev
effect
longterm
express
brain
parenchyma
cn
integr
investig
use
recombin
adenoviru
produc
examin
effect
chronic
express
cn
parenchyma
express
detect
day
postinject
day
mark
restrict
recruit
neutrophil
vasodilat
breakdown
bloodbrain
barrier
bbb
ipsilater
inject
side
microglia
astrocyt
activ
evid
day
disorgan
nervou
tissu
vast
demyelin
observ
day
sign
neurodegener
observ
oligodendrocyt
neuron
evid
ultrastructur
alter
interestingli
day
nervou
tissu
complet
recov
appear
normal
sign
demyelin
infiltr
bbb
breakdown
summari
data
show
chronic
express
contrast
acut
deliveri
revers
damag
cn
integr
implic
cytokin
downstream
compon
major
mediat
demyelin
chronic
inflammatori
demyelin
diseas
hepat
cc
chemokin
control
magnitud
inflammatori
respons
within
injur
rodent
brain
sj
campbel
vh
perri
f
pitossi
b
ag
butchart
chertoff
b
water
dc
anthoni
univers
southampton
southampton
uk
b
univers
bueno
airesconicet
bueno
air
argentina
hepat
cxc
chemokin
behav
acut
phase
protein
regul
neutrophil
mobilis
recruit
follow
focal
inflamm
rat
brain
determin
whether
respons
specif
cxc
chemokin
whether
repres
generalis
respons
acut
brain
inflamm
examin
brain
liver
product
cc
chemokin
rat
microinject
tnfa
brain
earli
tnfa
challeng
mrna
protein
observ
liver
taqman
rtpcr
elisa
serum
level
also
elev
h
consist
maxim
mobilis
leukocyt
blood
monocyt
recruit
mark
liver
h
delay
brain
h
elev
hepat
serum
chemokin
implic
control
leukocytosi
leukocyt
recruit
brain
liver
sinc
dexamethason
pretreat
attenu
hepat
respons
modul
leukocyt
mobilis
reduc
monocyt
entri
brain
also
liver
thu
hepat
chemokin
product
control
amplifi
cn
respons
inflamm
control
rate
time
magnitud
composit
leukocyt
recruit
damag
brain
beta
contribut
earli
regul
inflamm
spinal
cord
injuri
tk
rice
jea
well
vw
yong
univers
calgari
calgari
canada
spinal
cord
injuri
sci
number
inflammatori
molecul
becom
rapidli
elev
role
neuroinflamm
sci
unclear
object
studi
examin
neuroinflamm
sci
determin
whether
particular
molecul
regul
process
sci
induc
mice
use
clip
compress
model
tempor
express
pattern
sever
cytokin
chemokin
matrix
metalloproteinas
mmp
determin
use
rnase
protect
assay
realtim
pcr
interleukin
il
beta
one
earli
inflammatori
molecul
upregul
sci
beta
transcript
increas
within
min
sci
transcript
level
sever
chemokin
mip
also
elev
min
sci
express
level
low
express
sever
mmp
becom
promin
later
determin
beta
involv
regul
express
inflammatori
molecul
wildtyp
mice
mice
genet
defici
beta
compar
differ
inflammatori
molecul
express
follow
sci
beta
defici
mice
show
reduc
level
sever
cytokin
alpha
chemokin
rant
mip
conclud
beta
upregul
earli
sci
may
key
regul
neuroinflamm
condit
granulocyt
macrophagecoloni
stimul
factor
gmcsf
triidothyronin
increas
oligodendrocyt
product
corpu
callosum
cc
follow
intracerebroventricular
icv
infus
duboi
weiss
univers
calgari
calgari
canada
found
gmcsf
produc
oligodendrocyt
embryon
neural
stem
cell
nsc
thu
hypothes
two
factor
would
also
increas
oligodendrocyt
product
adult
nsc
gmcsf
increas
percent
termin
differenti
oligodendrocyt
neurospher
deriv
adult
subventricular
zone
nsc
ask
whether
factor
might
regul
nsc
product
oligodendrocyt
vivo
infus
icv
solut
either
vehicl
control
gmcsf
later
ventricl
adult
mice
evalu
oligodendogli
develop
immunocytochem
method
gmcsf
increas
number
immatur
matur
oligodendrocyt
progenitor
well
termin
differenti
oligodendrocyt
cc
compar
control
infus
suggest
increas
oligodendrogli
product
stage
develop
gmcsf
also
decreas
number
tunelposit
cell
cc
suggest
reduc
cell
death
howev
gmcsf
increas
percent
brdu
cell
within
popul
matur
oligodendrocyt
suggest
gmcsf
enhanc
oligodendrocyt
surviv
wherea
princip
regul
differenti
studi
underway
investig
action
two
factor
follow
demyelin
lesion
aim
understand
whether
enhanc
surviv
differenti
newli
gener
oligodendrocyt
might
improv
remyelin
support
ms
scientif
research
foundat
canada
alphavir
express
transform
growth
factor
beta
inhibit
autoimmun
encephalomyel
mice
mjv
jc
holmlund
ae
hinkkanen
depart
biochemistri
pharmaci
akademi
univers
turku
finland
introduct
current
treatment
strategi
chronic
inflammatori
diseas
central
nervou
system
cn
almost
sole
base
downregul
immun
system
system
administ
drug
although
drug
may
show
efficaci
experiment
set
success
treatment
cn
disord
greatli
imped
limit
access
insuffici
quantiti
compound
site
inflamm
aim
assess
feasibl
live
neurotrop
viru
interfer
cn
inflamm
express
immunomodulatori
cytokin
method
gene
latent
constitut
activ
transform
growth
factor
tgf
beta
clone
replicationcompet
semliki
forest
viru
vector
describ
elsewher
et
al
studi
function
vivo
vector
administ
intraperiton
group
balbc
mice
induc
eae
result
tgf
beta
vector
shown
produc
biolog
activ
tgf
cell
cultur
administ
mice
eae
vector
abl
significantli
inhibit
develop
mean
sever
disord
compar
mice
receiv
salin
conclus
replicationcompet
avirul
alphavir
vector
may
serv
vehicl
noninvas
gene
deliveri
cn
antiinflammatori
immunomodul
viral
mediat
cytokin
express
offer
formid
treatment
strategi
inflammatori
cn
disord
therapi
convent
drug
administr
may
limit
potenti
role
autoimmun
impact
igiv
express
n
eller
inou
scott
food
drug
administr
bethesda
usa
fouralpha
helix
cytokin
share
receptor
subunit
usag
biolog
function
involv
gener
regul
normal
immun
respons
monocyt
activ
memori
cell
develop
immun
cell
monocytesmacrophag
microglia
dendrit
cell
among
cell
type
produc
may
membraneteth
associ
subunit
littl
secret
cell
make
protein
detect
difficult
associ
autoimmun
diseas
multipl
sclerosi
ms
rheumatoid
arthriti
unclear
whether
role
diseas
initi
marker
diseas
diseas
pathogenesi
develop
method
induc
detect
modul
surfac
human
mous
cell
cell
line
use
fac
analysi
method
use
correl
level
clinic
diseas
immun
globulin
intraven
igiv
shown
immunomodulatori
effect
use
treatment
ms
vari
result
use
mous
macrophag
cell
line
raw
shown
igiv
reduc
express
lesser
extent
tnfalpha
current
studi
assess
role
induct
persist
experiment
autoimmun
encephalomyel
eae
adopt
transfer
model
differenti
macrophag
express
upon
innat
immun
activ
defin
rat
experiment
autoimmun
encephalomyel
andersson
r
kokkola
j
wefer
h
erlandssonharri
ra
harri
karolinska
institutet
stockholm
sweden
aim
compar
analysi
activ
phenotyp
mq
deriv
autoimmunesuscept
autoimmuneresist
rat
strain
includ
investig
function
express
receptor
intracellular
signal
pathway
cytokin
solubl
mediat
releas
activ
cell
use
panel
stimuli
embrac
mani
activ
rout
method
realtim
pcr
elisa
western
blot
immunohistochemistri
result
major
differ
record
da
bn
pvg
rat
mq
follow
activ
cytokin
product
balanc
nosarginas
activ
result
phenotyp
repres
autoimmunesuscept
da
rat
mq
lower
tnf
product
associ
high
arginas
activ
high
express
convers
autoimmuneresist
bn
mq
phenotyp
higher
tnf
product
associ
low
arginas
activ
low
express
conclus
activ
mq
autoimmunesuscept
strain
associ
altern
macrophag
activ
indic
induct
arginas
activ
lower
product
classic
proinflammatori
mediat
high
express
mq
autoimmuneresist
strain
associ
higher
product
proinflammatori
mediat
classic
activ
phenotyp
preferenti
induct
mq
phenotyp
thu
reflect
dispar
genet
cellular
programm
defin
autoimmun
suscept
cytokin
express
peripher
nerv
injuri
lm
k
kimppa
b
ruohonen
tenhami
univers
turku
turku
finland
b
akademi
univers
turku
finland
aim
studi
enhanc
knowledg
gene
express
inflammatori
respons
peripher
nerv
transect
microarray
left
sciatic
nerv
male
sd
rat
transect
nerv
allow
regener
freeli
first
distal
section
besid
point
injuri
taken
h
h
day
transect
control
sampl
collect
nonoper
anim
sampl
four
rat
pool
time
point
total
rna
extract
sampl
hybrid
affymetrix
rat
genom
oligonucleotid
microarray
sampl
prepar
hybrid
perform
accord
affymetrix
recommend
sampl
compar
control
signal
log
ratio
slr
count
decid
valu
relev
express
consid
either
increas
decreas
express
mani
cytokin
cytokinerel
gene
detect
result
correl
well
previou
find
interest
find
signific
express
mrna
h
day
transect
also
increas
express
inflammatori
cytokin
beta
alpha
tgfbeta
note
first
day
transect
chemokin
alpha
beta
found
upregul
acut
inflammatori
demyelin
peripher
nervou
system
w
hu
hp
hartung
b
kieseier
heinrichhein
univers
germani
interleukin
il
newli
identifi
heterodimer
cytokin
compris
subunit
privat
subunit
mount
evid
suggest
rather
critic
involv
pathogenesi
variou
immunemedi
disord
present
studi
analyz
sequenti
mrna
express
pattern
sciatic
nerv
lewi
rat
myelininduc
experiment
autoimmun
neuriti
ean
classic
anim
model
syndrom
gb
use
semiquantit
revers
transcriptasepcr
mrna
found
upregul
prior
onset
clinic
symptom
day
postimmun
pi
peak
level
day
pi
preced
maximum
clinic
diseas
sever
declin
thereaft
sural
nerv
patient
gb
found
express
noninflammatori
control
macrophag
identifi
cellular
sourc
inflam
pn
immunohistochemistri
thu
present
data
suggest
primarili
express
macrophag
play
import
role
earli
phase
ean
therefor
appear
critic
involv
initi
rather
perpetu
immun
respons
immunemedi
inflamm
peripher
nerv
express
cytokin
silicon
tubetr
peripher
nerv
injuri
ruohonen
lm
k
kivi
b
pertovaara
hs
taskinen
univers
turku
turku
finland
b
leira
medic
compani
turku
finland
order
help
axon
reinnerv
loss
structur
continu
occur
silicon
tube
use
peripher
nerv
injuri
activ
differ
cytokin
occur
induc
inflamm
andor
help
axon
reinnerv
investig
express
cytokin
well
morpholog
chang
implant
silicon
tube
remov
piec
sciatic
nerv
clinic
improv
studi
pinprick
toespread
test
sampl
tube
distal
proxim
stump
taken
day
postop
follow
cytokin
studi
tnfa
ifng
tgfh
neurofila
antibodi
use
axon
reinnerv
sutur
use
fix
silicon
tube
induc
foreign
bodi
reaction
high
initi
express
studi
cytokin
express
somewhat
decreas
except
ifng
show
increas
express
five
day
day
three
express
tube
increas
day
except
ifng
declin
contralater
uninjur
nerv
show
express
earli
time
pointsth
present
studi
show
insert
silicon
tube
induc
chang
cytokin
express
suggest
involv
build
miss
part
peripher
nerv
object
character
product
monocyt
chemotact
protein
mcp
receptor
antagonist
cerebrospin
fluid
csf
patient
syndrom
gb
fisher
syndrom
fs
method
csf
sampl
gb
patient
mean
fs
patient
mean
collect
lumbar
punctur
lp
within
day
diseas
onset
case
repeat
lp
permit
csf
sampl
eight
patient
noninflammatori
neurolog
disord
ond
serv
control
quantit
sandwich
elisa
assay
r
employ
result
csf
level
gb
fs
patient
significantli
increas
compar
ond
howev
csf
level
significantli
increas
gb
strong
correl
csf
level
found
fs
r
gb
r
level
increas
clinic
peak
gb
level
decreas
prior
convalesc
conclus
may
play
import
role
gb
fs
contrari
upregul
fs
clear
differ
may
reflect
divers
pn
involv
area
differ
cytokin
milieu
gb
fs
gb
may
indic
recoveri
diseas
although
investig
need
decreas
synthesi
acut
phase
ischem
stroke
g
gromadzka
b
b
tarnacka
sarzynskadlugosz
czlonkowska
b
institut
psychiatri
neurolog
warsaw
poland
b
medic
univers
warsaw
poland
acut
phase
ischem
stroke
local
system
inflammatori
reaction
develop
inflamm
lead
increas
brain
damag
worsen
outcom
import
mediat
inhibit
inflammatori
process
antiinflammatori
cytokin
aim
studi
evalu
chang
mrna
express
peripher
blood
cell
pbc
serum
concentr
antiinflammatori
cytokin
acut
phase
first
day
materi
method
patient
healthi
control
subject
investig
materi
investig
edtablood
serum
mrna
express
pbc
investig
semiquantit
rtpcr
method
serum
concentr
investig
immunoenzymat
test
result
decreas
mrna
express
pbc
serum
concentr
notic
patient
lowest
synthesi
notic
patient
year
age
superfici
infarct
multipl
lesion
larg
lesion
area
lobe
notic
ct
scan
brain
perform
admiss
also
patient
die
hospit
conclus
acut
phase
ischem
stroke
synthesi
antiinflammatori
cytokin
diminish
decreas
synthesi
associ
wors
prognosi
interleukin
increas
sera
acut
ischaem
stroke
patient
correl
size
earli
brain
damag
j
losi
b
j
zaremba
univers
school
medicin
poznan
poland
b
institut
experiment
clinic
medicin
poznan
poland
proinflammatori
cytokin
releas
ischaemia
activ
brain
resid
peripher
blood
cell
import
mediat
inflammatori
respons
process
exacerb
cerebr
damag
interleukin
proinflammatori
cytokin
abl
induc
gene
express
synthesi
proinflammatori
cytokin
chemokin
adhes
molecul
hypothesi
particip
inflammatori
respons
ischaem
stroke
object
studi
determin
level
sera
ischaem
stroke
patient
compar
result
group
control
studi
relat
level
volum
hemispher
comput
tomographi
hypodens
area
repres
earli
ischaem
chang
blood
sampl
cranial
ct
perform
within
h
stroke
fifteen
tension
headach
patient
serv
control
group
level
significantli
higher
stroke
patient
comparison
control
moreov
level
correl
posit
volum
earli
ct
hypodens
area
result
suggest
involv
earli
inflammatori
respons
stroke
insulin
regul
overproduct
proinflammatori
cytokin
peripher
immun
cell
alzheim
diseas
sb
solert
taccani
e
locatelli
e
ferrari
fioravanti
depart
intern
medicin
geriatr
univers
pavia
pavia
itali
neuroinflamm
immun
dysregul
implic
neurodegen
processess
link
alzheim
diseas
ad
present
studi
undertaken
evalu
tnfalpha
product
seceret
supernat
lymphomononuclear
natur
killer
nk
cell
cellsml
subject
mild
moder
ad
cytokin
measur
incub
nk
cell
lp
agml
betaamyloid
fragment
abeta
agml
uml
insulin
amml
coincub
lp
abeta
signific
increas
spontan
modul
lp
abeta
releas
tnfalpha
nk
cell
demonstr
ad
subject
compar
match
healthi
subject
incub
nk
cell
insulin
alon
significantli
reduc
spontan
secret
cytokin
ad
subject
coincub
insulin
abeta
determin
dosedepend
normal
tnfalpha
releas
nk
cell
ad
subject
howev
insulin
action
complet
block
exposur
mitogenactiv
protein
kinas
mapk
inhibitor
present
studi
confirm
nk
immun
cell
regul
secret
inflammatori
neurotox
cytokin
ad
normal
effect
insulin
could
depend
mapk
modul
involv
insulin
intracellular
signal
pathway
immunemedi
ad
neuropatholog
gender
influenc
gene
express
model
parkinson
diseas
pd
ciesielska
joniec
b
przybylkowski
b
kurkowskajastrzebska
g
gromadzka
czlonkowska
czlonkowski
b
institut
psychiatri
neurolog
warsaw
poland
b
medic
univers
warsaw
poland
incid
pd
chang
gender
higher
preval
pd
men
may
suggest
link
estrogen
level
pd
inflamm
involv
etiopathogenesi
pd
suggest
play
role
regul
neuron
surviv
injur
nigrostriat
system
estrogen
could
modul
immun
reaction
regul
cytokin
express
examin
contribut
gender
differ
exist
pd
level
mrna
rtpcr
dopamin
da
hplc
assess
striatum
male
femal
mice
month
old
h
day
post
tetrahydropiridin
mptp
intox
male
femal
decreas
level
da
observ
within
day
follow
mptp
inject
achiev
minim
level
day
male
show
significantli
greater
reduct
striatal
da
mptp
caus
increas
mrna
striatum
male
femal
increas
significantli
higher
femal
femal
male
express
moder
increas
day
peak
day
post
mptp
intox
mptp
induc
smaller
neurotox
greater
gene
express
femal
male
mice
could
nt
exclud
sexual
dimorph
mrna
express
may
part
respons
protect
mptp
intox
femal
mice
multipl
anomali
patient
major
depress
alesci
p
martinez
kelkar
ilia
ar
ayala
j
licinio
b
gp
chrouso
pw
gold
nation
institut
health
bethesda
usa
b
univers
california
lo
angel
usa
addit
affect
cognit
neuroendocrin
abnorm
depress
patient
increas
risk
cardiovascular
diseas
bone
loss
major
induc
sick
behavior
potent
proinflammatori
prothrombot
agent
activ
osteoclastogenesi
healthi
individu
secret
increas
age
correl
adipos
show
characterist
circadian
pattern
purpos
studi
compar
secret
nine
depress
patient
nine
gender
ageand
bmimatch
control
attempt
link
chang
cytokin
manifest
major
depress
md
diagnosi
md
base
dsmiv
plasma
measur
highsensit
elisa
rhythmic
complex
secret
assess
cosinor
analys
approxim
entropi
apen
algorithm
respect
compar
healthi
subject
depress
patient
show
highli
signific
elev
mean
h
plasma
level
vs
pgml
meanfsem
higher
morn
valu
revers
circadian
rhythm
physiolog
complex
secret
reduc
depress
shown
lower
approxim
entropi
valu
vs
conclud
md
associ
multipl
abnorm
may
contribut
neuropsycholog
impair
comorbid
psychiatr
ill
cardiovascular
diseas
osteoporosi
cytokin
chemokin
subacut
scleros
panenceph
sspe
g
saruhandiresken
sp
yentur
v
demirbilek
b
g
yilmaz
b
e
onal
cokar
c
z
yapici
g
akmandemir
gokyigit
c
gurs
istanbul
univers
istanbul
turkey
b
cerrahpasa
medic
faculti
istanbul
turkey
c
haseki
hospit
istanbul
turkey
assess
role
cytokin
chemokin
sspe
cerebrospin
fluid
csf
serum
sampl
sspe
patient
patient
neurolog
infecti
inflammatori
diseas
patient
noninflammatori
neurolog
diseas
nin
examin
elisa
ifngamma
well
level
increas
respons
detect
sspe
median
csf
serum
level
pgml
higher
sspe
pgml
nin
pgml
group
csf
level
also
higher
sspe
nin
group
vs
pgml
wherea
ifngamma
level
differ
group
level
increas
csf
sspe
compar
nin
vs
pgml
howev
higher
detect
serum
sspe
pgml
compar
nin
group
pgml
respect
increas
system
intrathec
secret
without
accompani
ifngamma
induct
may
implic
initi
immun
activ
without
effect
cellular
respons
pathogenesi
sspe
select
intrathec
increas
point
differenti
attract
inflammatori
cell
nervou
system
accompani
local
regulatori
effect
studi
support
istanbul
univers
research
fund
numer
solubl
mediat
implic
yet
convincingli
document
multipl
sclerosi
ms
subject
sardinia
rel
homogen
ethnic
distant
compar
swede
popul
high
ms
incid
studi
cytokin
express
pattern
mononuclear
cell
mnc
femal
untreat
ms
patient
sassari
sardinia
stockholm
sweden
compar
sexand
agematch
healthi
control
area
mrna
express
measur
realtim
pcr
among
molecul
examin
significantli
increas
ms
compar
control
higher
express
mrna
confin
ms
sardinia
stockholm
compar
correspond
control
ms
patient
sardinia
also
express
higher
tnfalpha
compar
correspond
control
differ
tnfalpha
observ
ms
vs
control
stockholm
remark
higher
ms
compar
control
stockholm
compar
ms
control
sardinia
differ
observ
member
famili
ifngamma
ifngammar
signal
molecul
result
corrobor
proinflammatori
state
ms
gener
reflect
high
express
ie
induc
proinflammatori
cytokin
inflammatori
cytokin
tnfalpha
extent
express
tnfalpha
differ
ms
patient
differ
area
probabl
reflect
influenc
genet
environment
factor
object
studi
identifi
chang
complement
factor
concentr
degre
activ
serum
cerebrospin
fluid
csf
earli
multipl
sclerosi
ms
ie
time
diagnosi
diseas
mspatient
group
compar
control
group
neurolog
diseas
method
determin
protein
concentr
albumin
immunoturbidimetr
assay
total
serum
radial
immunodiffus
use
csf
elisa
perform
polyclon
antibodi
final
activ
serum
csf
elisa
perform
use
specif
monoclon
antibodi
signific
increas
mean
valu
activ
concentr
csf
ms
patient
control
group
observ
signific
increas
ms
patient
still
valid
upon
determin
fraction
activ
total
csf
activ
level
serum
significantli
differ
control
group
signific
chang
concentr
total
obtain
neither
csf
serum
conclus
complement
system
activ
csf
group
multipl
sclerosi
patient
earli
stage
diagnosi
aim
studi
evalu
whether
high
dose
methylprednisolon
mg
given
five
consecut
day
diseas
exacerb
impact
immun
paramet
detect
peripher
blood
ms
patient
follow
cell
phenotyp
determin
use
twocolour
flow
cytometri
steroid
day
start
therapi
cell
b
cell
h
cell
tsc
cell
nk
cell
cell
b
cell
monocyt
granulocyt
produc
well
studi
patient
women
men
mean
age
improv
disabl
found
therapi
mean
edss
therapi
signific
increas
b
cell
decreas
cell
nk
cell
observ
treatment
trend
decreas
cell
secret
signific
decreas
monocyt
secret
also
note
known
might
one
cytokin
respons
bloodbrain
barrier
disrupt
migrat
immun
cell
central
nervou
system
post
mortem
studi
ms
patient
brain
increas
expres
receptor
detect
aspect
result
might
import
explain
gs
effect
ms
exacerb
upregul
stat
interferonstimul
gene
simian
immunodefici
viru
enceph
via
interferongamma
e
robert
zandonatti
c
flynn
k
roinick
h
fox
scripp
research
institut
la
jolla
ca
usa
previous
report
upregul
stat
along
interferon
ifn
stimul
gene
isg
frontal
lobe
simian
immunodefici
virusinfect
monkey
enceph
sive
immunohistochemistri
ihc
reveal
astrocyt
endotheli
cell
microgliamacrophag
larg
neuron
upregul
may
confer
antivir
antiapoptot
properti
astrocyt
microglia
howev
increas
neuron
link
dendrit
retract
factor
may
impact
neuropatholog
human
h
ive
hivassoci
dementia
examin
pathway
involv
stat
isg
express
use
frontal
lobe
tissu
found
increas
ifngamma
mrna
ifnalpha
beta
interestingli
mrna
isg
also
upregul
acut
infect
week
post
inocul
monkey
howev
ihc
show
perivascular
cell
endothelium
limit
number
astrocyt
although
upregul
cn
acut
infect
ifn
result
suggest
alon
abl
induc
statisg
astrocyt
neuron
thu
increas
statisg
express
enceph
could
due
action
ifngamma
interestingli
mani
isg
found
sive
case
previous
describ
upregul
increas
ifnalphabeta
may
scenario
case
pivot
role
ifngamma
axi
control
tissu
parasit
inflamm
central
nervou
system
trypanosoma
cruzi
infect
j
lannesvieira
v
michailowski
b
r
gazzinelli
b
depart
immunologyioc
oswaldo
cruz
foundat
rio
de
janeiro
brazil
b
laboratori
immunopatolog
cpqr
oswaldo
cruz
foundat
belo
horizont
brazil
cytokin
propos
play
pivot
role
control
tissu
parasit
pathogenesi
experiment
chaga
diseas
infect
caus
intracellular
protozoan
trypanosoma
cruzi
symptomat
meningoenceph
rare
occur
frequent
found
children
year
age
immunosuppress
transplant
hivinfect
patient
central
nervou
system
cn
alter
enlarg
perivascular
space
inflammatori
infiltr
observ
acut
infect
mice
cruzi
mice
less
suscept
silva
et
al
et
al
herein
investig
role
cytokin
ifngamma
establish
cruzielicit
meningoenceph
ifngamma
knockout
ko
mice
background
highli
suscept
cruziinduc
meningoenceph
character
increas
number
parasit
nest
inflammatori
infiltr
neurolog
signal
mortal
interestingli
inflammatori
infiltr
detect
cn
cruziinfect
mice
mostli
devoid
cell
infect
anim
treat
suboptim
dose
benznidazol
antiparasit
drug
cn
heart
main
site
reactiv
parasit
inflamm
ifngammako
mice
respect
thu
result
suggest
level
ifngamma
defici
major
determin
site
reactiv
cruzi
infect
immunocompromis
host
human
adult
microglia
express
function
tolllik
receptor
cs
jack
vc
montgrain
n
arbour
jp
antel
montreal
neurolog
institut
mcgill
univers
montreal
canada
classic
tolllik
receptor
tlr
signal
activ
antigen
present
cell
apc
induc
proinflammatori
cytokin
secret
altern
pathway
induc
ligand
lead
product
interferon
ifn
beta
current
therapi
ms
aim
studi
assess
express
tlr
adult
human
microglia
resid
apc
cn
determin
whether
signal
stimul
product
ifnbeta
interferoninduc
protein
tlr
express
microglia
isol
surgic
specimen
assess
rtand
qrtpcr
flow
cytometri
function
signal
assay
elisa
cytokin
qrtpcr
ifnbeta
microglia
maintain
basal
cultur
condit
mrna
consist
detect
surfac
express
low
undetect
contrast
although
mark
variat
amongst
individu
protein
strongli
express
cell
surfac
vitro
ligat
respect
ligand
doubl
strand
ds
rna
lp
consist
induc
express
ifnbeta
secret
microglia
notabl
ligat
result
significantli
stronger
ifnbeta
respons
ligat
signal
via
tlr
also
induc
tnfalpha
local
product
ifnbeta
within
cn
may
modul
complex
proinflammatori
respons
characterist
ms
microglia
resid
semiprofession
phagocyt
cn
microgli
activ
common
mani
neurolog
condit
includ
viru
infect
prion
diseas
alzheim
diseas
innat
immun
system
recognis
conserv
molecular
pattern
microorgan
set
pattern
recognit
receptor
tolllik
receptor
tlr
member
multitud
tlr
clone
though
exact
function
tissu
distribut
yet
characteris
microglia
shown
express
receptor
investig
express
profil
tlr
microglia
cn
cell
type
viral
enceph
group
balbc
nunu
mice
infect
sfv
tissu
sampl
multipl
time
point
gene
express
analysi
undertaken
use
quantit
rtpcr
tissu
section
studi
immunocytochemistri
rest
mous
brain
extens
express
tlr
microglia
level
tlr
differenti
modul
sfv
infect
nunu
mice
demonstr
posit
correl
level
viral
ifnalpha
transcript
stimul
cultur
microglia
lipopolysaccharid
result
differ
pattern
tlr
express
observ
viru
infect
potenti
dual
role
astrocyt
innat
autoimmun
cn
respons
induc
theiler
viru
infect
p
carpenti
miller
northwestern
univers
feinberg
school
medicin
chicago
il
usa
theiler
murin
encephalomyel
viru
tmev
establish
persist
central
nervou
system
cn
infect
glial
cell
suscept
mice
lead
develop
autoimmun
demyelin
diseas
autoimmun
natur
promin
infiltr
cell
phagocyt
central
nervou
system
tmevinduc
demyelin
diseas
tmevidd
consid
highli
relev
anim
model
multipl
sclerosi
previous
shown
innat
immun
stimul
astrocyt
tolllik
receptor
ligand
result
product
innat
immun
effector
molecul
induct
antigen
present
cell
apc
function
infect
astrocyt
tmev
induc
express
proinflammatori
cytokin
chemokin
adhes
molecul
type
ifn
mechan
astrocyt
recogn
viral
infect
investig
preliminari
data
indic
depend
replic
viru
later
cours
tmevidd
cell
macrophagesmicroglia
produc
larg
amount
ifngamma
tnfalpha
contrast
viral
infect
cytokin
stimul
apc
function
astrocyt
therefor
propos
model
astrocyt
import
earli
cn
inflamm
recruit
peripher
immun
cell
cn
tmev
infect
capabl
contribut
cell
activ
late
autoimmun
phase
diseas
acut
cn
infect
neurotrop
coronaviru
jhmv
control
lymphocyt
howev
viru
persist
glia
associ
sustain
inflamm
ongo
myelin
loss
acut
infect
perforin
mediat
cytolysi
control
viru
replic
macrophag
microglia
astrocyt
contrast
infect
ifngamma
defici
mice
suggest
ifngamma
perforin
control
viru
replic
oligodendrocyt
specif
implic
antivir
role
ifngammamedi
signal
oligodendrocyt
novel
transgen
mice
express
domin
neg
ifngamma
receptor
chain
control
proteolipid
protein
promot
deriv
express
transgen
readili
detect
elev
level
chain
surfac
oligodendroglia
transgen
compar
wild
type
wt
mice
increas
express
associ
enhanc
chain
express
peripher
immun
respons
affect
follow
cn
infect
clinic
score
inflamm
demyelin
similar
group
howev
viru
still
recov
cn
transgen
mice
day
wt
mice
control
infect
day
histolog
analysi
reveal
inabl
clear
viru
oligodendrocyt
transgen
mice
find
indic
ifngamma
mediat
antivir
mechan
depend
signal
oligodendrocyt
demyelin
depend
upon
viral
persist
oligodendrocyt
infect
interferongamma
necessari
borna
diseas
virusinduc
immunopatholog
requir
antivir
defenc
cell
j
hausmann
kr
engelhardt
k
baur
hj
rziha
b
p
staeh
univers
freiburg
freiburg
germani
b
feder
research
centr
viru
diseas
anim
germani
mouseadapt
variant
highli
neurotrop
noncytolyt
borna
diseas
viru
bdv
caus
meningoenceph
fatal
neurolog
diseas
mrl
mice
diseas
mediat
cell
recogn
immunodomin
epitop
teleissi
n
protein
bdv
nspecif
immun
prime
wildtyp
mice
primeboost
protocol
confer
celldepend
protect
bdv
infect
diseas
interestingli
immun
prime
effici
protect
perforindefici
mice
infect
bdv
wherea
protect
seen
interferongammadefici
gko
mice
moreov
adult
gko
mice
highli
suscept
bdv
infect
wherea
adult
wildtyp
mice
resist
kinet
analysi
adult
mice
show
bdv
abl
establish
initi
infect
subsequ
clear
wildtyp
gko
mice
observ
brain
infect
gko
wildtyp
mice
show
celldepend
sever
neuron
damag
hippocampu
suggest
neuroprotect
role
interferon
gamma
bdvinduc
meningoenceph
conclus
bdvspecif
cell
requir
interferongamma
mediat
antivir
defenc
induc
neurolog
diseas
suggest
two
distinct
effector
mechan
work
moreov
interferon
gamma
appear
neuroprotect
bdvinduc
central
nervou
system
immunopatholog
tumor
necrosi
factoralpha
requir
host
defens
mous
model
staphylococcu
aureusinduc
experiment
brain
abscess
kielian
ed
bearden
ac
baldwin
n
esen
univers
arkansa
medic
scienc
littl
rock
ar
usa
brain
abscess
repres
signific
medic
problem
despit
recent
advanc
made
detect
therapi
use
staphylococcu
aureusinduc
brain
abscess
model
establish
laboratori
sought
defin
function
import
tnfalpha
host
antibacteri
immun
respons
use
cytokin
gene
knockout
ko
mice
result
demonstr
although
share
mani
redund
activ
tnfalpha
import
contain
bacteri
infect
evolv
brain
abscess
evid
increas
mortal
bacteri
burden
tnfalpha
ko
mice
compar
wild
type
wt
anim
contrast
found
major
contributor
host
antibacteri
immun
respons
microarray
analysi
use
evalu
downstream
consequ
origin
lack
subsequ
proinflammatori
mediat
express
brain
abscess
ko
wt
anim
although
numer
gene
significantli
induc
follow
aureu
infect
beta
two
chemokin
macrophag
inflammatori
gamma
b
lymphocyt
chemoattractantblc
differenti
regul
ko
versu
wt
anim
result
indic
tnfalpha
play
pivot
role
acut
stage
brain
abscess
develop
regul
ensu
antibacteri
inflammatori
respons
intermedi
filament
gfap
import
control
experiment
murin
staphylococcu
aureusinduc
brain
abscess
toxoplasma
enceph
w
stenzel
deckert
soltek
b
schlqter
b
univers
cologn
cologn
germani
b
univers
heidelberg
heidelberg
germani
cn
infect
control
effect
cell
immun
system
organ
specif
cell
astrocyt
play
import
part
host
respons
well
function
role
astrocyt
exert
via
intermedi
protein
glial
fibrillari
acid
protein
gfap
cn
infect
studi
murin
staphylococcu
aureusinduc
brain
abscess
compar
wild
type
wt
mice
mice
develop
larger
poorli
demarc
inflammatori
lesion
parallel
significantli
increas
intracerebr
bacteri
load
diffus
leukocyt
infiltr
even
contralater
hemispher
purul
ventricul
vascul
sever
brain
edema
observ
correl
lack
border
function
activ
astrocyt
strongli
upregul
gfap
express
abscess
surround
wt
mice
clinic
import
lack
restrict
inflamm
markedli
aggrav
cours
diseas
manifest
seizur
sever
weight
loss
mice
data
parallel
observ
model
toxoplasma
enceph
te
intracerebr
parasit
load
significantli
increas
tachyzoiteinduc
tissu
necrosi
brain
mice
chronic
te
collect
find
delin
host
defens
function
astrocyt
via
restrict
pathogen
spread
multipl
within
cn
therebi
contribut
protect
highli
vulner
brain
parenchyma
neurotrop
coronaviru
infect
mice
result
acut
demyelin
encephalomyel
follow
nonproduct
viral
persist
acut
replic
resolv
cell
within
week
post
infect
pi
wherea
viral
persist
control
neutral
antibodi
kinet
cn
b
cell
recruit
differenti
investig
viru
specif
antibodi
secret
cell
asc
within
cn
increas
promin
day
pi
maintain
high
frequenc
persist
contrast
low
frequenc
detect
bone
marrow
alter
antibodi
specif
within
cn
asc
persist
provid
evid
ongo
dynam
regul
wherea
spike
nucleocapsid
protein
specif
asc
account
viru
specif
asc
day
pi
gradual
declin
thereaft
furthermor
mani
asc
unknown
specif
associ
persist
flow
cytometr
analysi
infiltr
isol
infect
cn
indic
gradual
increas
b
cell
day
pi
delay
plasmablast
recruit
reflect
emerg
syndecan
posit
cell
day
pi
rel
percentag
syndecan
posit
cell
remain
constant
day
ongo
differenti
suggest
increas
loss
class
ii
surfac
express
thu
alter
specif
phenotyp
support
dynam
process
within
b
cell
compart
cn
viral
persist
contrast
appar
senesc
cell
reactiv
persist
inhibit
increas
cn
immun
activ
siv
replic
acut
siv
infect
j
mankowski
queen
p
tarwat
rj
adam
mc
zink
je
clement
john
hopkin
univers
baltimor
md
usa
acut
infect
product
viral
replic
present
brain
siv
simian
immunodefici
viru
infect
macaqu
although
enceph
develop
time
earli
viral
replic
brain
accompani
cn
immun
activ
includ
endotheli
cell
express
elev
microgli
express
mhc
class
ii
upregul
cox
cyclooxygenas
express
subsequ
product
arachadon
metabolit
brain
may
key
pathway
regul
cn
immun
respons
acut
infect
determin
whether
inhibit
acut
siv
infect
alter
cn
immun
activ
therebi
modul
viral
replic
cn
six
pigtail
macaqu
treat
rofecoxib
select
inhibitor
initi
day
siv
infect
cn
immun
activ
cn
viral
burden
measur
compar
group
sivinfect
untreat
anim
endotheli
express
parenchym
microgli
activ
measur
imag
analysi
immunostain
tissu
section
elev
rofecoxibtr
sivinfect
anim
day
postinocul
compar
untreat
infect
anim
demonstr
arachadon
acid
metabolit
prostaglandin
may
downregul
cn
immun
respons
parallel
increas
cn
immun
activ
cn
viral
replic
measur
real
time
rtpcr
significantli
elev
basal
ganglia
rofecoxibtr
anim
versu
untreat
infect
anim
find
demonstr
complex
immunomodul
cn
pathway
product
play
divers
role
psycholog
stress
profound
effect
pathogenesi
multipl
sclerosi
ms
effect
mediat
interact
endocrin
immun
nervou
system
laboratori
investig
impact
stress
suscept
theiler
virusinduc
demyelin
tvid
mous
model
multipl
sclerosi
genet
suscept
strain
mice
tvid
restraint
stress
activ
hypothalam
pituitaryadren
axi
autonom
nervou
system
result
immunosuppress
mainli
increas
product
glucocorticoid
stress
mice
decreas
nk
cell
activ
decreas
chemokin
express
ltn
rant
brain
spleen
reduc
chemokin
express
may
account
decreas
inflamm
cn
result
increas
viral
replic
dissemin
higher
viral
load
subsequ
lead
earlier
diseas
onset
sever
clinic
histolog
sign
demyelin
diseas
result
import
implic
understand
pathogenesi
ms
suggest
stress
event
earli
infect
agent
capabl
induc
demyelin
may
result
immunosuppress
failur
elimin
pathogen
turn
may
lead
develop
ms
fund
grant
cjrw
mwm
nation
multipl
sclerosi
societi
rg
nih
nind
microgli
dynam
wnv
enceph
gett
matsumoto
njc
king
univers
sydney
sydney
australia
fatal
case
west
nile
viru
wnv
enceph
show
microgli
activ
nodul
format
leukocyt
infiltr
pivot
import
interferongamma
ifngamma
microgli
activ
viru
erad
investig
role
ifngamma
microgli
respons
leukocyt
infiltr
wnv
enceph
eightweekold
wt
ifngamma
knockout
ifngko
mice
inocul
intranas
wnv
flow
cytometr
immunohistochem
analysi
perform
characteris
infiltr
constitut
cell
popul
microgli
activ
clear
strain
day
concurr
detect
neuron
wnv
infect
nodul
format
around
infect
neuron
evid
day
concurr
leukocyt
infiltr
nodul
significantli
greater
wt
day
correl
increas
macrophag
number
region
high
nodul
format
correl
high
neuron
infect
nodul
format
strain
maxim
day
reduct
day
maxim
viral
leukocyt
load
seen
number
mhcii
microglia
remain
similar
wt
significantli
reduc
ifngko
day
compar
mhcii
macrophag
increas
wt
day
microgli
activ
ifngamma
independ
possibl
induc
signal
infect
neuron
contrast
microgli
nodul
format
correl
tempor
numer
differenti
leukocyt
infiltr
strain
enhanc
ifngamma
differenti
mhcii
cell
number
strain
correl
presenc
ifngamma
may
function
implic
west
nile
viru
enceph
cell
function
ifngammadefici
mice
rana
n
king
univers
sydney
sydney
australia
west
nile
viru
wnv
emerg
neurotrop
flaviviru
murin
model
wnv
enceph
wildtyp
wt
administ
subleth
dose
pfu
intraperiton
wnv
sarafend
show
mortal
howev
mortal
observ
ifngamma
knockout
mice
ko
sinc
ifngamma
import
antivir
cytokin
modul
lymphocyt
function
activ
examin
brain
spleen
cnsdrain
cervic
lymph
node
cln
infect
mice
examin
chemokin
mrna
cellular
popul
effector
ctl
activ
differenti
upregul
chemokin
rant
mrna
found
surprisingli
greater
express
ko
compar
wt
brain
infiltr
inflammatori
leukocyt
evid
day
postinfect
pi
still
maintain
day
pi
beyond
period
detect
viru
differ
found
two
strain
howev
use
sensit
fluorolysi
ctl
assay
found
day
pi
peak
cn
infect
deep
cln
cn
derivedleukocyt
ko
mice
reduc
capac
specif
lyse
wnvinfect
target
cell
find
wt
ko
splenocyt
equal
abl
lyse
target
throughout
cours
infect
suggest
fewer
wnvspecif
cell
possibl
deep
cln
traffick
ko
cn
altern
may
direct
role
play
ifngamma
mediat
cytotox
activ
wnvinfect
cell
herp
simplex
viru
induc
central
nervou
system
cn
demyelin
lf
kastrukoff
cm
jone
b
fr
carbon
b
univers
british
columbia
vancouv
canada
b
univers
melbourn
melbourn
australia
induc
recurr
multifoc
cn
demyelin
specif
strain
mice
follow
mucos
inocul
viru
three
stage
demyelin
occur
first
result
immun
respons
direct
infecti
viru
investig
immun
mechan
mediat
develop
stage
demyelin
male
nunu
bgbg
mice
lip
inocul
lab
strain
mice
pretreat
mab
along
gammadelta
tcelldefici
bcelldefici
mice
also
studi
spread
viru
cn
along
develop
cn
demyelinaton
determin
viru
spread
cn
nunu
bgbg
mice
mice
treat
either
mab
gammadelta
tcelldefici
bcelldefici
mice
cn
demyelin
develop
bgbg
mice
taken
togeth
result
suggest
local
replic
viru
spread
peripher
nervou
system
pn
affect
innat
adapt
immun
system
contrast
natur
killer
nk
cell
tcell
play
role
spread
viru
cn
develop
first
stage
demyelin
herp
simplex
viru
hsv
common
neurotrop
viru
infect
epitheli
cell
subsequ
trigemin
ganglia
tg
brain
tissu
studi
focus
immunomodul
roquinimex
linomid
affect
cours
corneal
hsv
infect
balbc
mice
address
question
immunomodul
affect
local
well
system
immun
respons
whether
roquinimex
could
facilit
spread
hsv
central
nervou
system
cn
viral
cultur
use
detect
replic
hsv
cytokin
respons
brain
tg
studi
quantit
rapid
realtim
rtpcr
method
stimul
splenocyt
eia
increas
mortal
hsvinfect
seen
acut
infect
enhanc
express
mrna
decreas
brain
roquinimextr
infect
mice
also
express
ifngamma
mrna
decreas
time
express
increas
signific
chang
seen
mrna
express
system
immun
respons
roquinimex
treatment
suppress
product
ifngamma
also
product
conclus
downregul
respons
mice
lead
increas
mortal
corneal
infect
mice
result
import
regard
safeti
immunomodul
treatment
viral
infect
diffusiontensor
imag
tempor
lobe
acut
herpessimplexviru
enceph
j
sellner
c
herweh
heiland
hartmann
u
ruprechtkarlsunivers
heidelberg
heidelberg
germani
herpessimplexviru
enceph
hsve
still
carri
signific
morbid
seriou
sequela
survivor
despit
advanc
treatment
critic
care
magnet
reson
imag
mri
especi
diffusionweight
mri
improv
diagnost
sensit
contain
inform
prognost
valu
furthermor
diffusiontensor
imag
dti
enabl
vivo
character
structur
function
integr
brain
could
diagnost
therapeut
valu
hsve
clinic
impair
cranial
mri
chang
studi
five
patient
acut
pcrproven
hsve
studi
fraction
anisotropi
fa
mean
diffus
md
primarili
affect
tempor
lobe
comparison
valu
five
healthi
control
data
aquir
place
region
interest
whole
tempor
lobe
perform
dse
noncolinear
gradient
fa
patient
hsve
healthi
control
furthermor
md
smm
hsve
smm
healthi
control
despit
sever
clinic
impair
could
find
signific
differ
fa
md
studi
tempor
lobe
seri
five
patient
hsve
diffus
chang
small
region
might
display
data
aquisit
whole
tempor
lobe
roi
analysi
correl
mrchang
clinic
impair
may
provid
accur
inform
investig
cytokin
respons
intranas
herp
simplex
viru
type
infect
trigemin
ganglia
tg
brain
balbc
mice
fourto
mice
infect
f
sampl
taken
five
timepoint
day
uninfect
day
day
day
day
post
infect
viru
detect
rapid
cultur
hsvpcr
sampl
analyz
cytokin
interleukin
il
ifngamma
realtim
pcr
method
use
lightcycl
alfatif
express
also
analyz
lightcycl
system
replic
viru
observ
tg
day
whereaft
amount
decreas
hsvdna
detect
brain
day
tg
found
significantli
elev
express
mrna
ifngamma
acut
hsv
infect
day
day
compar
uninfect
mice
express
significantli
downregul
tg
day
day
respect
express
decreas
brain
day
day
day
brain
cytokin
respons
intranas
infect
differ
extent
ocular
infect
broberg
et
al
journal
interferon
cytokin
research
vol
dynam
neurotroph
factor
express
experiment
herpessimplex
viru
enceph
j
sellner
lenhard
j
haa
r
von
einsiedel
b
u
ruprechtkarlsunivers
heidelberg
heidelberg
germani
b
klinikum
magdeburg
magdeburg
germani
herpessimplex
viru
common
caus
nonepidem
focal
enceph
hsve
still
associ
high
morbid
mortal
neurotroph
factor
play
import
role
neuron
surviv
recoveri
acut
injuri
central
nervou
system
cn
studi
mrnaexpress
glial
cell
linederiv
neurotroph
factor
gdnf
brainderiv
neuroptroph
factor
bdnf
establish
model
murin
herpessimplexviru
enceph
regul
neurotroph
factor
determin
acut
phase
diseas
eg
day
post
inocul
recoveri
month
post
inocul
result
demonstr
sequenti
modul
mrna
express
acut
phase
gndf
persist
overexpress
mrna
even
month
acut
enceph
furthermor
administr
acyclovir
well
adjunct
methylprednisolon
acyclovir
promot
significantli
increas
express
gdnf
acut
enceph
downregul
bdnf
result
indic
differenti
express
pattern
neurotroph
factor
acut
viral
enceph
may
impact
neuron
surviv
regener
promot
neurotroph
factor
acut
viral
enceph
may
repres
addit
therapeut
target
treatment
highli
disabl
diseas
human
effect
antigenspecif
toler
tcell
viral
infect
central
nervou
system
teagu
miller
northwestern
univers
chicago
illinoi
usa
antigenspecif
toler
tcell
induc
inject
antigen
coupl
ecdifix
cell
recipi
mice
procedur
pursu
possibl
therapi
autoimmun
diseas
prevent
andor
amelior
sever
tcell
mediat
diseas
mice
begun
analyz
use
method
toler
tcell
found
effector
function
specif
tcell
fact
effect
inhibit
encount
ecdifix
cell
bear
specif
antigen
infect
sjlj
mice
theiler
murin
encephalomyel
viru
tmev
lead
demyelin
diseas
similar
multipl
sclerosi
human
mice
howev
clear
viru
thu
resist
diseas
role
tcell
diseas
controversi
thu
far
shown
mice
induct
toler
tcell
specif
immunodomin
tmev
tcell
epitop
follow
tmev
infect
render
mice
suscept
viral
persist
motor
dysfunct
also
shown
modest
effect
viral
persist
diseas
suscept
sjlj
mice
thu
method
use
assess
role
specif
tcell
diseas
scenario
addit
coupl
cell
toler
tcell
attract
potenti
therapi
diseas
tcell
pathogen
role
nfkappab
theiler
virusinduc
cytokinechemokin
gene
activ
demyelin
diseas
bs
kim
jp
palma
ac
fuller
h
kang
min
northwestern
univers
medic
school
chicago
usa
theiler
murin
encephalomyel
viru
tmev
infect
cn
induc
demyelin
diseas
similar
human
multipl
sclerosi
delin
earli
event
viral
induc
demyelin
diseas
chemokin
cytokin
gene
activ
upon
viral
infect
glial
cell
examin
infect
sjlj
primari
astrocyt
cultur
induc
select
proinflammatori
cytokin
chemokin
gene
addit
proinflammatori
cytokin
function
synergist
virusinduc
chemokin
gene
express
cellular
gene
activ
tmev
depend
nfkappab
pathway
result
demonstr
infect
astrocyt
glial
cell
tmev
induc
earli
nfkappabmedi
cytokinechemokin
gene
activ
involv
cn
inflammatori
respons
lead
demyelin
interestingli
mice
defici
nfkappab
subunit
permit
viral
persist
cn
clinic
manifest
signific
decreas
cell
infiltr
cn
increas
cell
macrophag
infiltr
found
knock
mice
compar
control
mice
howev
fewer
cnsinfiltr
cell
specif
tmev
clear
studi
nfkappab
subunit
import
resolut
cn
infect
resist
mice
studi
undertaken
address
role
nfkappab
subunit
upstream
signal
involv
cellular
activ
pathogenesi
tmevinduc
demyelin
diseas
zincbind
motif
leader
protein
theiler
murin
encephalomyel
viru
critic
viral
persist
demyelin
k
asakura
h
murayama
b
himeda
ohara
kanazawa
medic
univers
ishikawa
japan
b
sendai
citi
hospit
sendai
japan
da
strain
member
subgroup
strain
theiler
murin
encephalomyel
viru
caus
biphas
diseas
character
acut
selflimit
gray
matter
inflamm
follow
chronic
inflammatori
demyelin
spinal
cord
suscept
strain
mice
second
phase
serv
experiment
model
multipl
sclerosi
da
subgroup
synthes
l
protein
altern
initi
codon
function
l
fulli
understood
l
consid
play
key
role
viral
persist
though
controversi
demyelin
previous
demonstr
l
express
exclus
neuron
vivo
acut
phase
infect
central
nervou
system
cn
gener
mutant
viru
express
epitopetag
l
k
asakura
et
al
j
virol
howev
studi
mutant
viru
fail
grow
though
grew
fail
persist
cn
explor
basi
failur
gener
panel
new
mutant
virus
express
epitopetag
l
two
new
mutant
virus
success
caus
persist
infect
demyelin
spinal
cord
enabl
us
identifi
l
immunohistochem
demyelin
lesion
mutant
viru
studi
reveal
spare
zincbind
motif
leader
protein
tmev
crucial
effect
persist
infect
cn
well
establish
earli
life
stress
induc
longlast
chang
behavior
neuroendocrin
reactiv
stress
howev
littl
known
longterm
consequ
neonat
stress
suscept
infecti
autoimmun
diseas
present
studi
investig
effect
neonat
stress
suscept
viral
mediat
anim
model
multipl
sclerosi
theiler
murin
encephalomyel
viru
tmev
infect
tmev
induc
biphas
infect
cn
poliolik
symptom
observ
acut
infect
follow
autoimmunemedi
demyelin
late
diseas
experi
balbcj
pup
expos
daili
one
three
condit
first
week
life
neonat
matern
separ
nm
nm
undisturb
adulthood
mice
inocul
intracrani
theiler
viru
sacrif
day
postinfect
prolong
nm
decreas
viral
clearanc
spinal
cord
male
femal
mice
day
pi
wherea
brief
nm
increas
viral
clearanc
nm
mice
exhibit
blunt
corticosteron
respons
tmev
infect
increas
adren
lymph
node
weight
chang
accompani
alter
histolog
sign
mening
microgliosi
spinal
cord
alter
motor
function
find
suggest
matern
separ
longterm
effect
neuroimmun
neuroendocrin
behavior
respons
tmev
infect
present
studi
examin
effect
social
stress
anim
model
multipl
sclerosi
theiler
murin
encephalomyel
infect
tmev
tmev
induc
biphas
infect
cn
poliolik
symptom
observ
acut
infect
follow
neuroinflammatori
demyelin
late
diseas
previous
shown
effect
social
disrupt
sdr
acut
theiler
viru
infect
depend
upon
time
sdr
applic
relat
infect
sdr
appli
prior
infect
presdr
led
glucocorticoid
gc
resist
mice
develop
sever
diseas
cours
increas
inflamm
contrast
sdr
appli
concurr
infect
consdr
gc
resist
fail
develop
diseas
cours
less
sever
inflamm
moder
current
studi
extend
line
work
examin
impact
sdr
cours
chronic
phase
diseas
three
group
infect
balbcj
mice
receiv
sdr
either
immedi
prior
concurr
infect
nonstress
addit
replic
pattern
acut
behavior
impair
found
presdr
group
develop
earlier
sever
hind
limb
impair
impair
rotarod
inclin
plane
perform
reduc
sensit
von
frey
stimul
reduc
spontan
locomotor
activ
converg
line
evid
demonstr
social
stress
exacerb
acut
chronic
phase
theiler
viru
infect
treatment
option
sspe
experi
beta
interferon
b
anlar
guven
b
aydin
c
hacettep
univers
ankara
turkey
b
social
hospit
ankara
turkey
c
hospit
ankara
turkey
aim
effici
treatment
method
lack
subacut
scleros
panenceph
sspe
compar
result
obtain
two
form
hifn
sspe
method
two
form
agweek
im
name
ag
sc
name
given
nonrandom
fashion
patient
diagnos
sspe
receiv
oral
inosiplex
mgkg
receiv
treatment
month
least
year
followup
evalu
result
treatment
group
similar
term
age
sex
durat
diseas
stage
diagnosi
differ
stage
patient
wksc
group
mean
followup
month
patient
group
stabil
improv
surviv
durat
treatment
significantli
shorter
im
group
fatal
rate
month
frequenc
side
effect
differ
group
conclus
despit
differ
stage
patient
proport
tient
satisfactori
outcom
higher
overal
progress
similar
group
random
studi
difficult
realiz
sspe
clinic
variabl
diseas
open
studi
give
although
limit
evid
treatment
suggest
hifn
high
dose
combin
inosiplex
might
constitut
applic
option
investig
antigenspecif
cell
respons
sspe
analyz
prolifer
cytokin
secret
sspe
patient
healthi
control
hc
specif
antigen
measl
vaccin
mv
pbmc
sspe
hc
group
stimul
mbp
mog
alphabcrystallin
mv
ppd
prolifer
measur
stimul
indic
si
ifngamma
product
determin
cultur
supernat
elisa
median
si
valu
mbp
mog
alphabcrystallin
differ
group
trend
toward
decreas
product
respons
mbp
sspe
patient
hc
vs
pgml
respect
prolifer
vs
well
ifngamma
product
respons
ppd
impair
sspe
patient
vs
vs
pgdml
vs
pgml
respect
prolif
respons
mv
differ
among
group
howev
vitro
secret
sspe
patient
mv
lower
hc
vs
pgml
result
demonstr
bystand
cellular
respons
myelin
antigen
implic
central
nervou
system
primari
target
autoimmun
respons
sspe
previous
report
lower
respons
measl
viru
seem
persist
sspe
role
neuroimmunophilin
ligand
lipopolysaccharid
lp
induc
peripher
central
hyperalgesia
singh
sk
kulkarni
institut
uip
panjab
univers
chandigarh
india
exposur
tissu
endotoxin
lipopolysaccharid
lp
lead
induct
induc
nitric
oxid
synthas
ino
immunosuppress
report
suppress
lpsinduc
ino
nitrit
level
macrophag
tissu
present
studi
aim
assess
modulatori
effect
lipopolysaccharid
induc
central
well
peripher
hyperalgesia
possibl
ino
inhibit
lp
induc
signific
hyperalgesia
measur
central
well
peripher
method
dose
mgkg
ip
analges
activ
dose
depend
significantli
revers
peripher
well
central
hyperalgesia
aminoguanidin
specif
ino
inhibitor
dose
depend
mgkg
ip
significantli
revers
lpsinduc
hyperalgesia
potentati
lower
subeffect
dose
dose
depend
significantli
revers
elev
nitrit
level
brain
paw
lpstreat
mice
rat
respect
elev
mpo
myeloperoxid
level
lp
treat
paw
rat
also
significantli
revers
treatment
aminoguanidin
revers
lpsinduc
elev
myloperoxid
mpo
nitrit
level
also
potentait
effect
lower
dose
possibl
ino
inhibit
revers
lpsmediat
alter
pain
hyperalgesia
restor
elev
mpo
nitrit
level
lp
treat
anim
thu
may
screen
possibl
adjuv
treatment
system
hyperalgesia
novel
role
olfactori
ensheath
cell
neuroimmunolog
defenc
rodent
olfactori
system
vincent
west
mi
chuah
univers
tasmania
hobart
australia
dendrit
olfactori
receptor
cell
expos
extern
environ
whilst
axon
project
directli
olfactori
bulb
cn
provid
rout
pathogen
brain
bypass
bloodbrain
barrier
yet
infect
via
rout
appear
limit
local
defenc
within
olfactori
system
given
close
apposit
olfactori
ensheath
cell
oec
olfactori
receptor
axon
along
entir
project
glial
cell
could
constitut
import
compon
olfactori
immun
defenc
recent
detect
enrich
transcript
sever
immun
factor
cultur
neonat
oec
microarray
analysi
includ
lysozym
lyz
chemokin
growthregul
oncogen
gro
monocyt
chemoattract
protein
interleukin
transcript
factor
ccaatenhanc
bind
protein
beta
cebpb
lyz
gro
express
confirm
realtim
rtpcr
detect
gene
product
immunostain
cultur
oec
detect
signific
level
either
chemokin
oec
normal
adult
olfactori
system
lyz
mrna
induc
cultur
oec
presenc
staphylococcu
aureu
escherichea
coli
e
coli
lipopolysaccharid
lp
agml
convers
gro
strongli
induc
e
coli
lp
current
test
function
immun
factor
oec
cultur
olfactori
system
mengo
viru
encephalomyel
prevent
polyanion
coam
interferonindepend
chemokin
induct
enhanc
phagocytosi
starckx
billiau
j
van
damm
g
opdenakk
univers
leuven
leuven
belgium
polyanion
compound
coam
chloriteoxid
oxyamylos
protect
mice
lethal
encephalomyel
caus
intraperiton
ip
mengo
viru
infect
vivo
protect
effect
associ
multipl
biolog
activ
coam
reduct
plasma
viru
titer
found
ip
inject
mg
coam
induc
dramat
increas
periton
leukocyt
count
explain
select
infiltr
polymorphonuclear
leukocyt
pmn
pmn
migrat
peritoneum
respons
gradient
granulocyt
chemotact
presenc
subsequ
migrat
pmn
coincid
releas
gelatinas
b
periton
caviti
although
phagocyt
activ
periton
macrophag
two
murin
macrophag
cell
line
significantli
affect
coam
increas
number
pmn
peritoneum
respons
enhanc
phagocyt
effici
accumul
proteolyt
enzym
antivir
activ
coam
mediat
induct
interferon
sinc
coam
contrast
polyi
c
protect
mous
fibroblast
cytopathogen
effect
mengo
viru
vitro
addit
observ
effect
reli
mechan
altogeth
experiment
result
indic
vivo
antivir
activ
coam
origin
retent
viru
within
periton
caviti
due
increas
phagocytosi
kill
viru
immun
system
play
key
role
dissemin
prion
infect
peripheri
central
nervou
system
cn
follicular
dendrit
cell
critic
prion
replic
lymphoid
tissu
subsequ
neuroinvas
wherea
myeloid
dendrit
cell
dc
indic
candid
vector
prion
propag
cn
sinc
noth
known
abil
dc
migrat
cn
prion
diseas
investig
immunohistochem
local
dc
brain
mice
intraperiton
infect
mouseadapt
kfu
strain
syndrom
human
genet
prion
disord
normal
brain
cell
present
mening
choroid
plexu
wherea
major
mice
sacrif
day
postinfect
dpi
scatter
dendritiform
cell
also
detect
cerebr
cortex
subcort
white
matter
thalamu
cerebellum
sometim
perivascular
locat
brain
mice
late
stage
infect
show
sever
spongiform
degener
medulla
oblongata
thalam
nuclei
sever
white
matter
area
accumul
prpsc
observ
predominantli
thalam
level
dpi
becam
diffus
termin
stage
diseas
find
demonstr
myeloid
dc
enter
cn
prion
infect
mice
suggest
possibl
role
cell
pathogenesi
prion
disord
cerebr
malaria
cm
seriou
complic
due
infect
plasmodium
falciparum
patient
often
present
neurolog
symptom
progress
death
pathogenesi
cm
well
understood
although
believ
larg
hostmedi
event
cytokin
play
promin
role
role
chemokin
less
clear
although
recent
work
suggest
express
chemokin
receptor
leukocyt
sequest
within
brain
may
crucial
develop
murin
cm
express
known
chemokin
chemokin
receptor
examin
compar
mous
model
malaria
mice
infect
plasmodium
berghei
anka
develop
neurolog
symptom
similar
human
cm
die
day
postinocul
pi
wherea
mice
infect
p
berghei
present
cerebr
manifest
die
day
pi
overwhelm
parasitaemia
anaemia
rtpcr
use
determin
rel
express
chemokin
gene
brain
mice
sever
chemokin
receptor
includ
found
upregul
mice
present
cm
compar
mice
without
cerebr
symptom
laser
captur
microdissect
techniqu
also
employ
order
determin
cellular
sourc
chemokin
vessel
separ
parenchyma
cell
mrna
level
candid
chemokin
chemokin
receptor
gene
assess
use
rtpcr
chang
express
chemokin
may
play
import
role
pathogenesi
cm
parasit
glycoconjugatesrol
neurocysticercosi
pathogenesi
ji
alvarez
jm
teal
univers
texa
health
scienc
center
san
antonio
san
antonio
tx
usa
neurocysticercosi
ncc
infect
central
nervou
system
larva
helminth
taenia
solium
symptom
sever
associ
intens
immun
respons
first
long
asymptomat
period
host
immun
seem
incap
resolv
infect
helminth
tegument
dynam
respons
advers
environ
rapidli
shed
ncc
patient
exhibit
humor
respons
least
carbohydr
antigen
glycoconjugatesgc
analyz
express
differ
gc
ncc
infect
specimen
determin
gc
present
parasit
tegument
use
fluorochrom
label
lectin
specif
differ
carbohydr
lectin
util
label
tegument
interestingli
gc
bound
wheat
germ
agglutinin
concavalina
also
found
taken
macrophagesmicroglia
peanut
lectin
bind
gc
hand
remain
parasit
throughout
infect
detect
host
cell
confirm
lectinbind
gc
stain
cell
parasit
origin
develop
antibodi
glycoprotein
solium
antibodi
lectin
coloc
macrophagesmicroglia
indic
parasit
origin
thu
constant
releas
gc
may
help
parasit
persist
advers
host
environ
massiv
antigen
uptak
immun
cell
could
interfer
normal
immun
function
addit
molecul
like
provid
sourc
persist
antigen
respons
lifelong
sequela
mani
ncc
patient
gram
neg
lipopolysaccharid
indirectli
induc
baxon
stunningq
rat
g
ifergan
bersudski
dori
wirguin
soroka
univers
medic
center
bengurion
univers
negev
beersheva
israel
tissu
dysfunct
sepsi
common
cell
death
heart
kidney
liver
lung
rel
minor
suggest
sepsi
activ
defens
mechan
caus
cellular
process
reduc
basic
bhousekeepingq
role
examin
whether
similar
process
induc
peripher
nerv
bloodnerv
barrier
bnb
breach
system
inject
lewi
rat
presensit
klh
campylobact
jejuni
cj
e
coli
lipopolysaccharid
lp
exposur
caus
transient
conduct
block
within
h
accompani
simultan
minor
neural
insult
intraneur
inject
salin
associ
morpholog
abnorm
inject
lp
result
conduct
abnorm
second
set
experi
incub
lewi
rat
splenocyt
cj
e
colilp
h
splenocyt
lp
reactiv
medium
slrm
inject
lewi
rat
sciatic
nerv
caus
transient
conduct
block
appear
h
inject
result
suggest
gramneg
lp
induc
acut
immunolog
respons
mediat
solubl
factor
capabl
penetr
bnb
caus
transient
baxon
stunningq
function
affect
neural
conduct
pathophysiolog
process
could
involv
pathogenesi
critic
ill
neuropathi
septic
patient
multisystem
failur
bbb
dysfunct
hive
accompani
disrupt
tight
junction
tj
brain
microvascular
endotheli
cell
bmvec
tj
protein
occludin
downregul
parallel
mo
egress
cn
small
gprotein
rho
play
role
bmvec
tj
assembl
hypothes
loss
tj
integr
associ
rho
activ
trigger
mo
brain
migrat
investig
util
artifici
bbb
system
explor
relationship
tj
rhorho
kinas
rhok
activ
transendotheli
mo
migrat
mo
passag
across
bbb
respons
macrophag
chemotact
protein
increas
hive
evalu
inhibitor
rho
c
botulinum
transferas
rhok
infect
mo
migrat
effici
uninfect
mo
respons
mobmvec
cocultur
led
rho
activ
occludin
phosphoryl
block
passag
infect
uninfect
mo
rhok
inhibitor
prevent
bbb
leakag
occludin
phosphoryl
associ
mo
migrat
bmvec
transfect
domin
neg
mutant
result
occludin
upregul
tj
domin
activ
darhok
transfect
led
disloc
occludin
membran
loss
bmvec
contact
dnrhok
transfect
bmvec
use
bbb
construct
mo
passag
across
bbb
reduc
observ
suggest
pharmacolog
manipul
rhorhok
may
prevent
mo
egress
across
bbb
hive
although
hiv
present
brain
infect
individu
individu
develop
neurolog
diseas
indic
viral
host
characterist
act
togeth
develop
neurolog
diseas
identifi
character
salient
genom
function
featur
allow
viral
strain
induc
neuroaid
use
rhesu
macaqu
model
neuroaid
serial
passag
microgliaassoci
siv
brain
rhesu
macaqu
isol
viru
final
passag
gener
nine
uniqu
brainadapt
siv
clone
brain
two
macaqu
neurolog
diseas
sequenc
analys
brainadapt
clone
show
remark
high
level
similar
nef
ltr
region
genom
sequenc
distinct
neurovirul
strain
siv
function
character
repres
brainadapt
clone
show
robust
vitro
infect
cell
primari
macrophag
primari
microglia
also
demonstr
infecti
phenotyp
distinct
clone
character
earli
peak
level
follow
slow
declin
uniqu
infect
phenotyp
may
result
abil
initi
infect
much
larger
percentag
cultur
cell
posit
vivo
select
brainadapt
strain
siv
result
nearhomogen
strain
viru
distinct
properti
may
give
clue
viral
basi
neuroaid
cognit
motor
disord
occur
hivinfect
individu
result
signific
morbid
mortal
remain
seriou
problem
even
era
highli
activ
antivir
therapi
although
numer
potenti
neurotox
molecul
identifi
natur
cn
disord
remain
elus
use
sivinfect
rhesu
monkey
carri
function
patholog
molecular
analys
differ
stage
neurolog
diseas
distinct
well
overlap
set
gene
differenti
regul
acut
infect
chronic
asymptomat
infect
aid
cn
diseas
neuroaid
greatest
number
differ
found
neuroaid
transcript
profil
reveal
known
gene
significantli
upregul
function
approxim
half
gene
character
anoth
upregul
transcript
also
identifi
yet
genet
classifi
protein
encod
novel
gene
intrigu
predict
properti
includ
transcript
regul
alter
rna
secondari
structur
control
protein
subcellular
local
viralhost
interact
occur
cn
environ
profound
effect
cellular
process
elucid
effect
enabl
understand
hiv
infect
lead
cn
dysfunct
schwann
cell
sc
primarili
respons
format
myelin
within
pn
might
involv
local
immun
respons
pn
sever
line
evid
indic
sc
display
immunerel
function
express
mhc
class
ii
antigen
suggest
sc
acquir
role
facult
antigen
present
cell
tolllik
receptor
tlr
emerg
key
receptor
respons
recogn
specif
conserv
compon
microb
lipopolysaccharid
lp
implic
play
critic
role
variou
inflammatori
disord
lp
may
relev
antigen
caus
immunemedi
demyelin
pn
studi
express
tlr
pn
resid
cell
sc
rat
variou
tlr
detect
vitro
found
regul
substrat
interferonalpha
phorbol
pma
timeand
dosedepend
fashion
measur
rnalevel
rtpcr
well
protein
level
immunofluoresc
stimul
lp
secret
variou
inflammatori
mediat
induc
determin
qualit
protein
array
quantit
elisa
mediat
includ
chemokin
growth
factor
proteas
inhibitor
induct
effect
block
specif
antibodi
well
inhibitor
nuclear
factorkappa
b
thu
data
indic
sc
might
act
link
innat
acquir
immun
via
tlr
inflam
pn
skelet
muscl
immunolog
microenviron
site
mani
desir
undesir
immun
reaction
tolllik
receptor
tlr
crucial
player
innat
immun
system
sens
invas
microorgan
induc
antimicrobi
respons
elucid
mechan
innat
immun
respons
human
muscl
investig
express
mrna
cultur
human
myoblast
rhabdomyosarcoma
cell
use
qrtpcr
muscl
cell
show
constitut
express
mrna
upregul
ligand
poli
c
synthet
analog
dsrna
ifngamma
ligand
lipopolysaccharid
lp
tnfalpha
protein
locat
mainli
intracellular
assess
flow
cytometri
western
blot
analysi
poli
c
induc
nfkappab
activ
secret
muscl
cell
vivo
muscl
fiber
noninflam
muscl
inflammatori
myopathi
express
analys
immunhistochemistri
qrtpcr
importantli
mrna
highli
upregul
hivmyopathi
corrobor
vitro
observ
taken
togeth
find
may
contribut
understand
muscular
respons
microbi
stimuli
infect
pathogenesi
autoimmun
inflammatori
disord
syndrom
gb
acut
autoimmun
polyradiculoneuropathi
clinic
present
flaccid
paralysi
areflexia
variabl
sensori
disturb
elev
cerebrospin
fluid
protein
without
pleocytosi
although
gb
previous
view
unitari
disord
variat
current
view
group
syndrom
sever
distinct
subtyp
fifteeen
patient
gb
develop
syndrom
infect
gramneg
bacterium
campylobact
jejuni
c
jejuni
lead
caus
acut
gastroenter
human
strong
tendenc
appear
antibodi
bind
gangliosid
particularli
measur
serum
patient
gb
particularli
axon
variant
type
associ
c
jejuni
infect
investig
local
c
jejuni
nervou
tissu
use
immunoelectron
microsopi
confoc
laser
microscopi
exclus
local
central
peripher
nerv
myelin
observ
central
nerv
axon
peripher
nerv
axon
could
find
c
jejuni
immunoelectron
microscopi
studi
taken
clarifi
role
anteced
infect
c
jejuni
role
antigangliosid
antibodi
respons
lentivir
express
system
demonstr
l
protein
theiler
viru
antiapoptot
effect
macrophag
cell
line
ohara
himeda
k
asakura
kontani
kanazawa
medic
univers
kahokugun
ishikawa
japan
da
subgroup
strain
theiler
viru
tv
persist
cn
infect
mice
induc
demyelin
demyelin
diseas
serv
experiment
model
multipl
sclerosi
mechan
viru
persist
demyelin
remain
unknown
da
subgroup
strain
synthes
protein
call
l
initi
site
outoffram
polyprotein
previou
studi
use
mutant
viru
dal
l
aug
substitut
acg
show
l
antiapoptot
effect
macrophag
cell
line
order
confirm
better
character
antiapoptot
effect
l
use
lentivir
vector
gener
constitut
express
l
l
cell
express
l
confirm
western
blot
antil
antibodi
dna
ladder
seen
control
cell
hour
pi
contrast
ladder
detect
follow
infect
dal
l
cell
activ
cell
l
cell
time
cours
case
dna
ladder
data
suggest
l
antiapoptot
activ
macrophag
function
ci
tran
antiapoptot
activ
l
may
play
import
role
tv
pathogenesi
identif
novel
marker
encephalitogen
effector
cell
eae
u
boehlmann
b
becher
univers
hospit
zurich
neuroimmunolog
center
zurich
switzerland
lymphocyt
thought
play
central
role
initi
potenti
propag
multipl
sclerosi
anim
model
experiment
autoimmun
encephalomyel
eae
recent
shown
paradigm
use
reliabl
marker
encephalitogen
identifi
two
mutant
mous
strain
autoaggress
cell
virtual
indistinguish
virtu
express
known
suspect
gene
yet
one
strain
eae
hypersuscept
resist
sinc
activ
statu
cell
correl
express
specif
gene
use
highdens
gene
express
array
discov
potenti
encephalitogen
gene
induc
identifi
sever
gene
could
potenti
pathogen
function
current
involv
encephalitogen
target
gene
verifi
vivo
use
rnai
knockdown
transgen
overexpress
target
gene
gene
deliveri
vivo
use
recombin
lentivir
vector
infect
mous
embryo
gener
transgen
mice
constitut
express
sirna
target
gene
infect
mogreact
cell
line
prior
adopt
transfer
naiv
recipi
mice
preliminari
data
clearli
show
sever
newli
identifi
gene
confer
encephalitogen
potenti
critic
develop
eae
taken
togeth
approach
allow
us
reliabl
unmask
potenti
encephalitogen
gene
vivo
silenc
tbet
prevent
autoimmun
demyelin
diseas
e
lovettrack
ae
rocchini
j
choy
sc
northrop
rz
hussain
mk
rack
ut
southwestern
medic
center
dalla
tx
usa
tbet
transcript
factor
regul
ifngamma
product
cell
nk
cell
develop
antisens
oligonucleotid
astbet
small
interf
rna
sirnatbet
specif
tbet
tool
determin
role
tbet
differenti
encephalitogen
cell
transfect
naiv
mbpspecif
cell
astbet
sirnatbet
prior
differenti
result
decreas
ifngamma
product
dramat
reduct
abil
cell
transfer
experiment
autoimmun
encephalomyel
eae
naiv
recipi
mice
addit
vivo
administr
astbet
sirnatbet
mice
time
immun
myelin
antigen
prevent
eaetbet
ifngamma
express
suppress
lymph
node
spleen
mice
studi
suggest
tbet
may
viabl
target
therapi
diseas
multipl
sclerosi
role
immunemodul
neural
protect
eae
chitni
j
imitola
w
elyaman
p
chawla
sharuk
sj
khouri
brigham
women
hospit
harvard
medic
school
boston
usa
background
pathway
may
play
import
role
regul
immun
respons
peripheri
well
cn
designmethod
eae
induc
mice
wt
immun
peptid
myelin
oligodendrocyt
glycoprotein
molecul
trillium
therapeut
administ
iv
postimmun
neuron
cortic
cultur
prepar
wld
wt
embryo
expos
lpsactiv
microglia
vitro
without
block
antibodi
trillium
therapeut
result
signal
suppress
clinic
diseas
administ
prime
effector
stage
eae
axon
loss
demyelin
reduc
cn
mice
receiv
treat
anim
increas
product
prime
splenocyt
vitro
restimul
mog
peptid
previous
found
significantli
higher
express
wld
neuron
wildtyp
neuron
neuron
cultur
wld
mice
protect
addit
lpsactiv
microglia
contrast
wt
neuron
addit
ab
wld
cultur
abrog
protect
suggest
neuron
protect
wld
relat
express
conclus
signal
associ
protect
eae
increas
cytokin
product
neuron
overexpress
confer
protect
microglialinduc
injuri
macrophag
stimul
protein
msp
modul
innat
immun
tyrosin
kinas
receptor
ron
extent
ron
msp
express
central
nervou
system
cn
influenc
neuroinflamm
unknown
investig
effect
ron
msp
multipl
sclerosi
ms
establish
mous
model
ms
experiment
allerg
encephalomyel
eae
ron
mrna
protein
abund
cn
diminish
eae
ms
rel
control
msp
level
unchang
msp
inhibit
tnfalpha
express
monocytoid
cell
eae
ron
heterozygot
null
anim
show
augment
tnfalpha
diminish
level
spinal
cord
compar
wild
type
litterm
control
moreov
neurolog
diseas
heterozygot
null
anim
exhibit
rapid
onset
overal
worsen
sever
term
neurobehavior
deficit
togeth
accentu
demyelin
axon
injuri
neuroinflamm
rel
wild
type
control
thu
mspron
axi
repres
distinct
pathway
cn
neuroinflamm
pathogen
effect
regul
experiment
autoimmun
encephalomyel
histidin
decarboxylasedefici
mice
r
pedotti
musio
scabeni
b
gallo
l
poliani
h
ohtsu
b
r
mantegazza
nation
neurolog
institut
c
besta
milan
itali
b
tohoku
univers
sendai
japan
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
gener
perceiv
helper
mediat
diseas
howev
recent
observ
suggest
allerg
autoimmun
mechan
involv
develop
eae
pharmacolog
blockad
histamin
one
main
mediat
allerg
respons
mice
human
might
prevent
eae
order
studi
contribut
endogen
histamin
express
eae
induc
eae
histidin
decarboxylas
hdc
defici
mice
express
histamineproduc
activ
lack
histamin
upon
immun
myelin
oligodendrocyt
glycoprotein
mog
mice
develop
eae
incid
somehow
lower
compar
wild
type
mice
onset
eae
delay
compar
hdc
mice
mice
develop
diseas
present
sever
cours
compar
wild
type
mice
higher
eaerel
mortal
hyper
acut
cours
case
cell
prolifer
mog
similar
mice
cell
mice
producegreat
amount
interferongamma
furthermor
mice
produc
higher
level
igg
antibodi
mog
compar
mice
result
suggest
endogen
histamin
importantli
modul
eae
histamin
ubiquit
regul
divers
physiolog
process
includ
inflamm
neurotransmiss
four
subtyp
histamin
receptor
current
recogn
genet
pharmacolog
studi
shown
histamin
receptor
express
tcell
antigen
present
cell
play
import
role
regul
teffector
cell
function
lead
autoimmun
inflammatori
respons
within
cn
histamin
receptor
express
hematopoiet
cell
predominantli
presynapt
serv
import
autoregulatori
function
associ
releas
histamin
neurotransmitt
show
despit
ident
tcell
effector
respons
mice
disrupt
histamin
receptor
immun
induct
experiment
allerg
encephalomyel
develop
earlier
sever
clinic
sign
acut
phase
diseas
compar
wildtyp
control
enhanc
clinic
diseas
mice
also
associ
earlier
disrupt
bloodbrain
barrier
significantli
greater
histopatholog
diseas
failur
mice
limit
acut
phase
autoimmun
inflammatori
respons
clinic
diseas
consist
inhibit
neg
regul
presynapt
autoregulatori
function
maintain
tissu
barrier
permeabl
addit
genet
complement
studi
indic
structur
polymorph
within
third
intracellular
loop
may
underli
previous
identifi
qtl
control
sever
clinic
sign
weight
loss
phenotyp
known
regul
central
activ
macrophag
migrat
inhibitori
factor
mif
recent
shown
regul
cell
activ
cell
divis
macrophag
cytokin
product
importantli
increas
level
mif
found
cerebrospin
fluid
multipl
sclerosi
ms
patient
antibodi
block
mif
shown
blunt
acut
eae
mice
interf
home
cell
cn
explor
role
mif
relapsingremit
eae
wild
type
wt
mice
immun
myelin
oligodendrocyt
glycoprotein
mog
peptid
mice
acut
eae
similar
wt
mice
mice
show
dramat
decreas
number
sever
diseas
relaps
compar
wt
mice
proinflammatori
cytokin
level
tnfalpha
ifngamma
sharpli
decreas
mice
rel
wt
control
time
point
secret
cell
significantli
increas
mice
corticosteron
level
markedli
elev
mice
acut
diseas
recoveri
period
result
show
mif
exert
profound
effect
diseas
relaps
mediat
part
regulatori
effect
glucocorticoid
hormon
cytokin
product
support
nih
grant
nation
ms
societi
grant
autoreact
cell
persist
rat
protect
eae
activ
innat
immun
sb
conant
na
wolf
rh
swanborg
wayn
state
univers
detroit
usa
lewi
rat
render
unrespons
experiment
autoimmun
encephalomyel
eae
immun
myelin
basic
protein
mbp
domin
encephalitogen
epitop
incomplet
freund
adjuv
howev
protect
rat
harbor
inact
encephalitogen
cell
investig
whether
cell
could
activ
vitro
although
respond
poorli
prolifer
vigor
secret
ifngamma
cocultur
plu
suggest
anerg
could
also
activ
cell
prolifer
secret
peptid
plu
cpg
oligonucleotid
control
oligonucleotid
thu
product
innat
immun
activ
anerg
autoreact
cell
ab
releas
unrespons
cell
anerg
state
presenc
alon
ie
without
cpg
wherea
inhibit
prolifer
plu
cpgactiv
cell
cell
isol
use
magnet
bead
prolifer
vigor
cpg
plu
wherea
cell
prolifer
poorli
tgfbeta
implic
regulatori
cell
treg
activ
sinc
treg
cell
frequent
express
phenotyp
result
consist
hypothesi
treg
cell
maintain
autoreact
cell
anerg
state
releas
anergi
product
innat
immun
system
eg
cpg
overrid
regulatori
mechan
maintain
immun
homeostasi
support
nih
nation
ms
societi
failur
interferon
gamma
receptor
null
mice
recov
eae
due
absenc
nitric
oxid
sa
fordham
staykova
willenborg
australian
nation
univers
medic
school
canberra
australia
ifngamma
gamma
mice
develop
sever
usual
fatal
eae
immunis
mog
peptid
wherea
wild
type
mice
develop
milder
diseas
furthermor
passiv
transfer
diseas
specif
lymphoid
cell
ifngamma
mice
produc
knockout
ifngamma
mice
sever
eae
recipi
fail
recov
ident
cell
produc
equal
sever
diseas
ifn
gamma
r
mice
recipi
recov
result
provid
evid
ifngamma
essenti
eae
develop
play
import
role
downregul
diseas
hypothesis
ifngamma
stimul
product
limit
diseas
hypothesi
incorrect
transfer
encephalitogen
cell
immunis
gamma
mice
induc
nitric
oxid
synthas
knockout
mice
respond
ifngamma
make
result
sever
eae
yet
anim
recov
also
show
eae
differ
strain
mice
lack
ifngamma
r
immunis
three
differ
encephalitogen
develop
sever
usual
fatal
eae
ident
pathologyextens
neutrophil
infiltr
conclud
inabl
ifngamma
mice
recov
eae
due
inabl
shut
effector
cell
fact
absenc
ifngamma
respons
result
malign
neutrophil
inflammatori
respons
rather
rel
benign
mononuclear
respons
presenc
inhibit
reduc
interact
two
free
radic
may
regul
immun
respons
intens
autoimmun
studi
eae
ident
sourc
spleen
unknown
use
cell
separ
show
spleen
cell
prime
mice
respons
regul
cell
prolifer
mhcunrestrict
manner
demonstr
presenc
activ
spleen
cell
narv
mice
produc
furthermor
nonadher
cell
major
sourc
product
fac
analysi
indic
cell
hi
neg
neg
iaie
neg
lo
possibl
repres
immatur
myeloid
cell
purifi
cell
contain
differ
stage
granulocyt
matur
tuberculosi
cfa
respons
cell
increas
spleen
follow
immun
start
earli
day
pi
continu
least
week
pi
studi
provid
novel
way
innat
immun
cell
regul
adapt
immun
antibodi
respons
glial
progenitor
cell
proteoglycan
exacerb
experiment
autoimmun
encephalomyel
eae
e
mathey
schubart
b
k
william
j
trotter
c
c
linington
univers
aberdeen
aberdeen
scotland
uk
b
harvard
medic
school
boston
usa
c
johann
mainz
germani
remyelin
adult
central
nervou
system
carri
popul
glial
progenitor
cell
posit
migrat
lesion
site
repair
injuri
howev
multipl
sclerosi
ms
endogen
repair
mechan
ineffici
ultim
fail
diseas
progress
reason
failur
remyelin
chronic
ms
lesion
poorli
understood
howev
presenc
autoantibodi
cerebrospin
fluid
ms
patient
may
indic
autoimmun
respons
cell
respons
remyelin
use
dna
vaccin
strategi
rat
gener
specif
autoantibodi
respons
first
two
ln
domain
protein
antibodi
respons
assay
western
blot
elisa
flow
cytometri
dna
vaccin
strategi
allow
us
assess
effect
antibodi
respons
modul
diseas
sever
adopt
transfer
eae
remyelin
mog
induc
eae
find
indic
selftoler
protein
disrupt
rat
consequ
autoantibodi
respons
enhanc
clinic
histolog
sever
eae
lysophosphatid
acid
lpa
receptor
express
nervou
system
includ
neuron
cell
white
matter
tract
neuron
cell
white
matter
tract
immun
system
lymphocyt
express
unstimul
helper
cell
express
whilst
macrophag
express
experiment
autoimmun
encephalomyel
eae
autoimmun
diseas
patholog
featur
equival
multipl
sclerosi
ms
rna
prepar
spinal
cord
control
eae
rat
profil
lpa
receptor
express
use
taqman
analysi
averag
mrna
level
receptor
decreas
respect
eae
sampl
comparison
control
howev
mrna
receptor
increas
comparison
control
receptor
mrna
express
detect
control
group
induc
eae
group
signific
increas
receptor
reflect
huge
infiltr
lymphocyt
eae
model
suggest
target
receptor
may
influenc
progress
eae
potenti
ms
multifunct
cytokin
oncostatin
osm
involv
progress
resolut
inflammatori
process
hurst
et
al
exact
function
role
cytokin
neuroinflamm
current
unknown
sever
studi
document
elev
level
osm
brain
patient
progress
relapsingremit
neurolog
inflammatori
diseas
multipl
sclerosi
ms
osm
may
play
import
role
progress
neuroinflamm
virtu
spatial
tempor
express
role
leukocyt
recruit
studi
evalu
spatial
tempor
express
osm
neuroinflamm
use
chronic
relaps
biozzi
mous
model
ms
brain
spinal
cord
tissu
collect
mice
differ
stage
diseas
process
semiquantit
pcr
use
determin
presenc
osm
mrna
evid
present
indic
tissu
level
osm
mrna
associ
sever
symptom
phase
diseas
cell
adhes
molecul
fundament
import
autoimmun
diseas
multipl
sclerosi
ms
anim
model
ms
experiment
autoimmun
encephalomyel
eae
affect
interact
target
effector
cell
defin
role
cell
adhes
molecul
term
interact
neuron
activ
microglia
cell
peripher
nerv
regener
molecul
upregul
promot
nerv
outgrowth
show
express
regul
cytokin
locat
interfac
injur
axon
activ
microglia
homophil
bind
neuron
microglia
effici
block
oligopeptid
moreov
identifi
injur
axon
glial
cell
eae
therefor
suggest
implic
patholog
eae
wherebi
cytokin
regul
adhes
glial
cell
injur
axon
role
central
dopamin
deplet
regul
experiment
autoimmun
encephalomyel
mice
e
balkowieciskra
kurkowskajastrzebska
b
joniec
czlonkowska
b
czlonkowski
medic
univers
warsaw
poland
b
institut
psychiatri
neurolog
warsaw
poland
circumstanti
evid
suggest
involv
central
dopaminerg
system
regul
immun
respons
aim
studi
investig
influenc
central
dopamin
deplet
experiment
autoimmun
encephalomyel
eae
progress
dopamin
deplet
obtain
treatment
mptp
mgkg
eae
elicit
day
mptp
intox
immun
mog
ag
mice
injur
dopaminerg
system
onset
symptom
observ
day
earlier
day
vs
day
mice
treat
mptp
mptpeae
group
two
attack
note
longer
total
time
compar
eae
group
one
short
attack
observ
similarli
remiss
symptom
eae
group
appear
earlier
mptpeae
group
howev
diseas
index
differ
group
histolog
analysi
reveal
stronger
infiltr
inflammatori
cell
mening
perivascular
space
white
matter
lumbar
spinal
cord
mptpeae
mice
previou
studi
mptp
shown
direct
action
immun
cell
herein
demonstr
eae
induct
progress
may
depend
central
dopamin
action
suggest
indirect
mechan
involv
report
result
murin
eae
establish
multipl
sclerosi
ms
model
gener
laboratori
induc
autoimmun
peptid
amino
acid
myelin
oligodendrocyt
glycoprotein
mog
use
singl
inject
protocol
two
differ
mous
strain
gener
diseas
resembl
relapsingremit
rr
ms
nodlt
mice
primari
progress
pp
ms
mice
current
evid
axonglia
gliaglia
commun
lead
us
undertak
time
cours
studi
astrocyt
respons
eae
type
report
signific
find
two
ms
type
differ
astrocyt
respons
pattern
preclin
period
consider
astrocyt
hypertrophi
occur
rreae
wherea
ppeae
show
much
smaller
increas
progress
astrocyt
hypertrophi
occur
throughout
white
matter
grey
matter
without
parenchym
inflamm
remiss
rreae
astrocyt
hypertrophi
remain
astrocyt
process
rreae
intercal
separ
inflammatori
cell
small
group
wherea
inflammatori
foci
ppeae
free
astrocyt
process
rreae
astrocyt
respons
relat
diseas
stage
clinic
score
ppeae
observ
suggest
astrocyt
respons
consider
less
activ
ppeae
give
rise
hypothesi
genet
context
respons
may
influenc
particular
form
ms
express
introduct
signal
molecul
sonic
hedgehog
shh
involv
sever
process
cn
develop
recent
protein
concentr
shh
shown
upregul
activ
diseas
spontan
demyelin
mous
model
decreas
multipl
sclerosi
ms
white
matter
specif
object
studi
investig
express
pattern
shhdure
lesion
evolut
myelinoligodendrocyteglycoprotein
mog
induc
experiment
autoimmun
encephalomyel
eae
model
strongli
mimick
ms
method
mogea
activ
induc
da
rat
histolog
evalu
perform
paraffinembed
cn
section
day
activ
immun
result
activ
demyelin
inact
lesion
immunoreact
shh
present
macrophag
astrocyt
endotheli
cell
addit
astrocyt
lesion
surround
show
stain
shh
earli
remyelin
remyelin
lesion
express
shh
found
astrocyt
macrophag
endotheli
cell
axon
show
sign
acut
injuri
highest
densiti
shh
express
axon
found
earli
remyelin
lesion
conclus
provid
first
immunohistochem
analysi
express
pattern
shh
autoimmun
encephalomyel
studi
demonstr
shh
play
role
repair
mechan
adult
cn
local
shh
injur
axon
earli
remyelin
might
indic
role
shh
axon
surviv
factor
alter
neurotroph
factor
cours
experiment
autoimmun
encephalomyel
j
ahsu
vw
yong
univers
calgari
calgari
canada
neurotroph
factor
confer
neuroprotect
regener
immunomodul
diseas
central
nervou
system
includ
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
elev
certain
neurotroph
factor
observ
eae
ms
studi
sought
determin
express
profil
neurotroph
factor
relat
stage
diseas
progress
remiss
eae
order
gain
insight
possibl
function
relapsingremit
eae
induc
femal
mice
use
myelin
oligodendrocyt
glycoprotein
immunogen
mice
sacrif
day
postimmun
first
sign
diseas
peak
diseas
remiss
lumbarsacr
spinal
cord
extract
analys
use
real
timepolymeras
chain
reaction
multipl
neurotroph
factor
elev
eae
includ
ciliari
neurotroph
factor
insulinlik
growth
promin
junctur
upregul
sever
neurotroph
factor
peak
diseas
resolut
remiss
current
experi
seek
evalu
cellular
sourc
function
neurotroph
factor
eae
particularli
regard
immunomodul
multipl
sclerosi
ms
caus
combin
genet
predisposit
environment
factor
result
cell
infiltr
cn
mani
environment
factor
implic
diseas
although
result
studi
perform
date
remain
inconclus
possibl
geneticbiochem
factor
implic
ms
dysregul
matrix
metalloproteinas
mmp
famili
zinc
contain
proteas
mani
physiolog
function
mani
diseas
proteas
upregul
acquir
harm
function
specif
implic
detriment
experiment
autoimmun
enceph
eae
anim
model
ms
ms
studi
examin
activ
heavi
metal
found
hg
exert
biphas
respons
importantli
nm
hg
increas
activ
twofold
combin
hg
increas
level
interferongamma
human
mous
cell
cultur
compar
requir
demonstr
inabl
hg
increas
interferongamma
level
cell
null
mice
recoveri
cytokin
level
follow
exogen
addit
hgtreat
null
cell
ongo
experi
address
facilit
eae
hgtreat
wildtyp
mice
postul
dysregul
hg
exposur
lead
alter
cell
reactiv
may
underli
progress
case
ms
murin
eae
well
establish
model
recapitul
mani
clinic
physiopatholog
aspect
ms
close
examin
earliest
chang
gene
express
even
preced
inflamm
report
yet
collect
serum
cn
tissu
nod
mice
immun
mog
timepoint
encompass
first
clinic
attack
day
postimmun
microarraybas
gene
express
profil
perform
spinal
cord
four
mice
timepoint
array
total
three
anim
use
histopatholog
stain
time
interv
supervis
unsupervis
machin
learn
algorithm
use
identifi
express
signatur
correl
diseas
stage
histolog
profil
remark
earliest
express
chang
cn
observ
histolog
evid
inflamm
addit
mass
spectrometrybas
proteom
profil
obtain
sera
anim
correl
gene
express
pattern
search
earli
marker
neuroinflamm
high
frequenc
express
data
enabl
formul
precis
model
diseas
pathogenesi
studi
demonstr
util
combin
genom
proteom
approach
toward
unravel
molecular
pathway
lead
clinic
diseas
recoveri
eae
eventu
ms
chemokin
receptor
chronic
relaps
experiment
autoimmun
encephalomyel
ar
glabinski
b
bielecki
k
selmaj
medic
univers
lodz
poland
chemokin
small
molecul
direct
migrat
inflammatori
cell
toward
tissu
site
inflamm
abil
chemokin
involv
pathogenesi
inflammatori
diseas
central
nervou
system
cn
present
studi
analyz
express
three
late
describ
chemokin
receptor
cn
peripher
tissu
chronicrelaps
experiment
autoimmun
encephalomyel
chreae
anim
model
multipl
sclerosi
ms
method
femal
swrxsjlj
mice
immun
encephalitogen
peptid
chemokin
receptor
express
analyz
use
quantit
rnase
protect
assay
rpa
analysi
perform
first
attack
remiss
second
attack
chreae
anim
without
chreae
use
control
result
observ
upregul
three
analyz
chemokin
receptor
spinal
cord
first
second
chreae
attack
brain
upregul
less
promin
express
spinal
cord
correl
well
diseas
sever
spleen
express
three
chemokin
receptor
compar
phase
chreae
blood
express
lower
chreae
control
normal
anim
conclus
result
suggest
chemokin
receptor
involv
pathogenesi
chreae
may
potenti
target
treatment
cn
autoimmun
disord
tweak
tnfrelat
weak
induc
apoptosi
receptor
experiment
autoimmun
encephalomyel
eae
x
kleiter
g
giegerich
steinbrech
univers
regensburg
regensburg
germani
tweak
member
tnf
superfamili
mediat
prominflammatori
effect
receptor
examin
consequ
tweakand
chronic
relaps
experiment
autoimmun
encephalomyel
eae
induc
neutral
antibodi
respons
tweak
respect
found
signific
amelior
clinic
cours
moginduc
eae
rat
plp
induc
eae
sjl
mice
accompani
signific
decreas
spinal
cord
infiltr
addit
perform
dnavaccin
eukaryot
express
plasmid
encod
tweak
result
sever
diseas
cours
compar
control
vaccin
anim
vitro
ex
vivo
studi
suggest
blockad
signal
interfer
recruit
immun
effector
cell
cn
express
adrenomedullin
adm
receptor
central
nervou
system
lewi
rat
acut
experiment
allerg
encephalomyel
eae
c
paul
c
bolton
b
univers
west
england
bristol
uk
b
william
harvey
research
institut
london
uk
loss
normal
bloodbrain
barrier
bbb
function
integr
featur
neuroinflammatori
process
multipl
sclerosi
ms
previous
demonstr
restor
bbb
function
associ
improv
clinic
outcom
model
ms
vitro
studi
shown
adm
capabl
regul
bbb
characterist
includ
transendotheli
electr
resist
permeabl
pglycoprotein
pump
activ
therefor
admmedi
control
bbb
function
may
viabl
therapeut
target
control
cours
ms
clearli
essenti
determin
whether
receptor
pathway
intact
neuroimmun
challeng
occur
eae
model
ms
use
immunohistochemistri
assess
express
adm
receptor
receptoractivitymodifi
protein
ramp
confer
calcitonin
receptorlik
receptor
specif
adm
cn
anim
acut
eae
preliminari
studi
indic
normal
spinal
cord
express
strongli
associ
morpholog
identifi
capillari
structur
exhibit
low
vascular
presenc
eae
cn
tissu
express
maintain
immedi
heightofdiseas
express
similarli
preserv
henc
receptor
pathway
respect
express
appear
intact
cerebrovasculatur
eae
therefor
potenti
exist
employ
adm
relat
agonist
restor
bbb
function
neuroinflamm
experiment
autoimmun
encephalomyel
eae
wellcharacteris
autoimmun
disord
central
nervou
system
cn
investig
enzym
control
complex
alter
extracellular
matrix
ecm
environ
may
lead
greater
understand
role
cn
inflamm
adamt
enzym
metalloproteinas
degrad
versican
aggrecan
brevican
phosphacan
neurocan
found
within
cn
promot
cell
adhes
migrat
influenc
neurit
outgrowth
investig
potenti
role
adamtss
white
matter
spinal
cord
rat
prediseas
peak
recoveri
stage
acut
eae
naiv
control
assess
express
natur
inhibitor
well
ecm
compon
phosphacan
neurocan
mrna
protein
level
phosphacan
downregul
cn
peak
diseas
compar
narv
control
wherea
neurocan
upregul
prediseas
anim
compar
narv
control
provid
first
report
adamt
express
eae
work
fund
wellcom
trust
previou
work
found
highli
express
spinal
cord
mice
afflict
eae
anim
model
ms
current
investig
whether
interact
opn
function
eae
progress
vitro
found
timedepend
cleav
opn
major
product
inhibit
metalloproteinas
inhibitor
eae
produc
week
old
femal
mice
via
immun
myelin
oligodendrocyt
glycoprotein
anim
sacrif
either
initi
diseas
ascend
phase
diseas
peak
diseas
score
stabil
spinal
cord
examin
mrna
protein
express
level
opn
western
blot
analys
show
diseas
onset
opn
cleavag
product
first
appear
reach
maximum
express
ascend
phase
diseas
mrna
express
opn
show
similar
trend
current
experi
seek
identifi
cleavag
product
opn
role
diseas
postul
interact
opn
may
import
role
eae
onset
progress
experiment
autoimmun
encephalomyel
eae
induc
recombin
myelin
oligodendrocyt
glycoprotein
rmog
rat
accur
model
multipl
sclerosi
ms
immunopatholog
grow
bodi
experiment
evid
point
critic
involv
matrix
metalloproteinas
mmp
critic
checkpoint
immunopathogenesi
diseas
howev
knowledg
new
mmp
famili
member
express
profil
inflammatori
demyelin
limit
present
studi
analyz
express
pattern
known
rat
mmp
rmogea
model
da
rat
clinic
cours
use
real
time
rtpcr
central
nervou
system
infiltr
tcell
detect
immunohistochemistri
cryostat
section
rna
extract
area
consecut
section
mmp
mrna
level
measur
variat
relat
earli
stage
nonsymptomat
anim
mrna
found
strikingli
upregul
remain
highli
express
even
recoveri
phase
diseas
membranebound
recent
describ
among
upregul
enzym
hand
reveal
persist
downregul
cours
diseas
result
demonstr
highli
differenti
regul
mmp
mrna
express
inflammatori
infiltr
rmogea
rat
model
studi
specif
express
pattern
select
mmp
might
help
broaden
understand
specif
role
mmp
inflammatori
demyelin
induc
nitric
oxid
synthas
ino
mediat
axon
injuri
experiment
autoimmun
encephalomyel
f
aboulenein
p
weiser
bradl
h
lassmann
brain
research
institut
vienna
univers
vienna
austria
multipl
sclerosi
ms
tcell
mediat
inflammatori
diseas
central
nervou
system
cn
suppos
autoimmun
natur
sinc
hallmark
ms
patholog
demyelin
plaqu
associ
rel
preserv
axon
despit
complet
destruct
myelin
sheath
axon
injuri
interpret
secondari
consequ
primari
demyelin
axon
degener
recogn
import
caus
neurolog
deficit
howev
pathogenet
mechan
underli
axon
injuri
within
inflammatori
diseas
cn
remain
still
larg
undefin
littl
evid
direct
immun
attack
free
radic
oxygen
andor
nitrogen
speci
may
crucial
axon
patholog
purpos
induc
acut
monophas
eae
lewi
rat
passiv
transfer
encephalitogen
mbpspecif
tcell
wild
type
plp
overexpress
transgen
lewi
rat
presenc
absenc
demyelin
antimog
antibodi
perform
immunohistochemistri
found
experi
express
induc
nitric
oxid
synthas
ino
key
enzym
free
radic
product
exclus
confin
perivascular
macrophag
microglia
acut
axon
injuri
identifi
accumul
amyloid
precursor
protein
correl
strictli
number
inosposit
macrophagesmicroglia
antimog
antibodi
mediat
demyelin
result
augment
axon
injuri
ino
express
find
may
major
implic
therapi
inflammatori
cn
diseas
bn
rat
report
resist
induct
type
experiment
autoimmun
encephalomyel
eae
number
mechan
suggest
provid
evid
high
product
nitric
oxid
peripheri
result
resist
spleen
cell
bn
rat
make
time
stimul
ifn
gamma
cell
pvg
lewi
rat
bn
rat
make
substanti
either
eae
suscept
strain
follow
immunis
cfa
carbonyl
iron
use
adjuv
increas
level
bn
rat
render
highli
suscept
eae
cfa
given
simultan
neuroantigen
carbonyl
iron
drive
level
resist
restor
eae
produc
use
carbonyl
iron
characteris
extens
presenc
macrophagemicroglia
central
nervou
system
cn
lesion
cytokin
profil
lymph
node
cn
differ
one
eae
lewi
rat
express
ino
tmevidd
ng
carlson
ke
hill
watt
jw
rose
vaslchc
univers
utah
salt
lake
citi
ut
usa
object
recent
report
ino
express
chronicact
plaqu
ms
patient
propos
enzym
contribut
enhanc
glutamatemedi
excitotox
oligodendrocyt
neuron
confoc
microscopi
ino
express
theiler
murin
encephalomyel
viru
tmev
induc
demyelin
diseas
tmevidd
examin
assess
whether
express
preced
onset
neuropatholog
clinic
diseas
method
mice
given
ic
inject
tmev
assess
clinic
symptom
demyelin
inflamm
interv
week
post
inject
express
ino
examin
use
immunofluoresc
confoc
microscopi
combin
cellspecif
marker
cnpase
oligodendrocyt
gfap
astrocyt
result
ino
detect
isol
region
brain
earli
week
postinject
purkinj
cell
cerebellum
express
inosino
also
observ
region
hippocampu
week
prior
onset
symptom
moder
amount
ino
observ
spinal
cord
region
near
oligodendrocyt
also
observ
associ
ino
nearbi
within
oligodendrocyt
conclus
express
observ
oligodendrocyt
may
import
consequ
respect
vulner
cell
glutamatemedi
excitotox
analog
neuron
excitotox
express
may
render
oligodendrocyt
vulner
glutamatemedi
excitotox
death
oxid
modif
alter
autoantigen
myelin
oligodendrocyt
glycoproteinimpl
induct
diseas
toler
mice
men
j
bergquist
b
r
harri
karolinska
institutet
stockholm
sweden
b
uppsala
univers
uppsala
sweden
myelin
antigen
may
becom
autoantigen
modif
structur
concept
receiv
littl
attent
date
understand
effect
chemic
modif
myelin
antigen
mimick
vitro
process
like
occur
inflammatori
reaction
vivo
may
provid
clue
antigen
natur
protein
underli
ms
develop
studi
modif
myelin
oligodendrocyt
glycoprotein
mog
malondialdehyd
mda
physiolog
gener
lipidperoxid
use
ief
fplc
fticr
mass
spectrometr
analys
demonstr
mda
modif
lead
chang
protein
weight
charg
mice
immunis
mdamog
develop
sever
form
eae
antigenspecif
recal
respons
elev
mdamog
compar
normal
mog
formul
mogalum
vaccin
mdamog
improv
protect
efficaci
final
csf
ms
patient
higher
titr
antimog
igg
mdamog
control
mog
believ
oxid
modif
mog
lead
enhanc
autoantigen
promot
induct
diseas
induct
induct
protect
diagnosi
human
ms
develop
therapeut
strategi
use
singl
amino
acid
substitut
mog
plp
first
select
alanin
lysin
amino
acid
substitut
induc
eae
mice
vitro
induc
strong
cell
respons
mani
substitut
peptid
encephalitogen
suggest
residu
critic
ether
bind
mhc
activ
cell
other
induc
either
diseas
prolifer
addit
sever
peptid
nonencephalitogen
immunogen
vitro
suggest
peptid
may
induc
regulatori
respons
two
alanin
substitut
mog
mog
mog
select
basi
induc
eae
high
tcell
respons
vitro
administ
toler
regimen
remiss
attempt
inhibit
chronic
relaps
eae
conclus
nonencephalitogen
singl
amino
acid
substitut
mog
plp
inhibit
relaps
diseas
mice
immunis
mog
therapi
significantli
effect
wildtyp
peptid
use
object
intraven
inject
pertussi
toxin
pt
greatli
facilit
induct
sever
experiment
autoimmun
diseas
mochizuki
includ
experiment
autoimmun
encephalomyel
eae
investig
whether
enhanc
autoimmun
pt
relat
differ
express
apoptot
protein
caspas
autoreact
cell
method
sjl
mice
immun
proteolipid
protein
plp
cfa
one
experiment
group
mice
receiv
addit
intraven
inject
ng
pertussi
toxin
mice
examin
eae
diseas
score
histolog
sign
eae
singl
cell
suspens
prepar
drain
lymph
node
analyz
flow
cytometri
stain
mhc
class
ii
tetram
specif
antibodi
caspas
result
pt
requir
immun
mice
develop
clinic
histolog
sign
eae
administr
pt
increas
absolut
number
autoreact
cell
drain
lymph
node
day
immun
express
caspas
autoreact
helper
cell
reduc
mice
receiv
pt
conclus
demonstr
induct
autoimmun
pt
associ
inhibit
apoptosi
autoreact
helper
cell
high
threshold
autoantigenspecif
stimul
induct
experiment
autoimmun
encephalomyel
cellspecif
mice
b
nuclear
factor
nf
kb
famili
transcript
factor
play
pivot
role
cell
activ
surviv
adapt
immun
respons
ikb
kinas
part
ikk
complex
central
compon
intracellular
signal
pathway
lead
canon
nfkb
activ
use
mice
lack
specif
cell
investig
role
autoantigenspecif
cell
activ
induct
autoimmun
diseas
found
highli
impair
myelinoligodendrocyteglycoprotein
mog
cell
activ
vitro
complet
resist
mog
eae
cellspecif
mice
contrast
cellspecif
mice
transgen
pathogen
cell
receptor
tcr
suscept
eae
therefor
ineffici
prime
andor
expans
cell
seem
respons
resist
cellspecif
mice
induct
eae
pharmacolog
inhibit
ikk
vitro
reduc
specif
prolifer
cytokin
product
transgen
cell
data
suggest
threshold
autoantigenspecif
cell
activ
underscor
potenti
valu
ikk
inhibit
therapi
autoimmun
diseas
immun
sjl
mice
encephalitogen
peptid
induc
eae
antigen
resuspend
ifa
supplement
mgml
mt
studi
effect
presenc
mt
immun
two
tcr
repertoir
specif
frequenc
usag
polar
repertoir
affect
presenc
mt
promot
effect
adjuv
appear
due
recruit
toward
wider
spectrum
tcr
repertoir
rather
robust
expans
repertoir
cell
appear
ln
day
immun
day
spleen
cn
onset
first
episod
eae
disappear
cn
remiss
detect
plateau
phase
first
relaps
diseas
investig
influenc
mhc
gene
manifest
central
nervou
system
cn
autoimmun
diseas
studi
myelin
oligodendrocyt
glycoprotein
mog
induc
eae
congen
mice
found
clinic
sign
patholog
differ
dramat
accord
mhc
haplotyp
moginduc
eae
mice
sever
clinic
character
propriocept
defect
spastic
reflex
pronounc
parenchym
inflammatori
infiltr
observ
brain
compris
cell
b
cell
macrophag
neutrophil
cell
preferenti
local
brain
cell
subset
predomin
spinal
cord
contrast
mice
develop
mild
chronic
eae
character
ascend
paralysi
littl
inflamm
observ
brain
mice
strain
spinal
cord
sever
target
larg
lesion
compos
predominantli
neutrophil
extent
lesion
correl
antibodi
deposit
mogspecif
cell
respons
mice
encompass
sever
mog
epitop
differ
singl
mog
epitop
target
mice
role
immun
cell
subset
cell
specif
antibodi
respons
determin
pathogenesi
diseas
discuss
model
elucid
immunolog
paramet
influenc
clinic
diseas
may
provid
insight
complex
heterogen
pathogenesi
multipl
sclerosi
hypothesi
astrocyt
particip
maintain
immun
privileg
central
nervou
system
cn
mainli
base
vitro
data
show
inhibit
mitogen
antigendriven
lymphocyt
prolifer
previous
shown
rat
cell
preincub
astrocyt
complet
inhibit
prolif
respons
narv
lymphocyt
mitogen
stimuli
cocultiv
ratio
respect
studi
demonstr
isol
mononuclear
cell
spinal
cord
scmnc
da
rat
differ
phase
experiment
autoimmun
encephalomyel
eae
unrespons
mitogen
stimuli
acut
phase
relaps
eae
furthermor
cocultiv
scmnc
obtain
rat
peak
eae
narv
lymphocyt
inhibit
prolifer
cona
latter
cell
popul
inhibitori
effect
restrict
scmnc
cell
obtain
lymph
node
anim
influenc
mitogeninduc
prolifer
respond
cell
interestingli
scmnc
isol
anim
recoveri
phase
eae
unabl
inhibit
prolifer
narv
cell
studi
observ
phenomena
would
contribut
understand
mechan
involv
spontan
recoveri
inflammatori
diseas
cn
although
mani
way
inhibit
autoimmun
demyelin
diseas
rodent
model
poor
translat
multipl
sclerosi
ms
progress
diseas
continu
despit
immunotherapi
inhibit
bloodbrain
barrier
dysfunct
relaps
rate
prophylact
autoimmun
toler
induc
varieti
differ
mean
yet
therapeut
toler
establish
diseas
provid
difficult
goal
robust
relaps
biozzi
abh
mous
model
ms
use
combin
transientdelet
prime
autoreact
cell
antibodi
follow
week
later
intraven
myelinantigen
administr
antigencoupledsplenocyt
establish
relaps
diseas
experiment
autoimmun
encephalomyel
effect
silenc
follow
diseas
induct
unfortun
treatment
initi
late
chronicrelaps
diseas
three
paralyt
attack
despit
inhibit
relaps
mice
demonstr
evid
secondari
progress
includ
increas
spastic
deterior
mobil
suggest
autoimmun
therapi
ms
begin
earli
possibl
optimum
chanc
success
indic
suffici
deficit
accumul
target
relaps
immunolog
compon
diseas
alon
unlik
suffici
control
progress
base
clinic
outcom
therefor
appear
correl
observ
human
found
rodent
model
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
experiment
autoimmun
encephalomyel
eae
anim
model
use
studi
ms
mediat
encephalitogen
cell
tbox
express
cell
tbet
transcript
factor
believ
play
key
role
regul
ifngamma
gene
differenti
pathogen
autoimmun
cell
determin
role
tbet
play
differenti
encephalitogen
cell
investig
effect
silenc
tbet
express
pathway
achiev
tbet
suppress
design
antisens
oligonucleotid
small
interf
rna
specif
tbet
tbet
suppress
result
reduc
protein
level
affect
pathway
addit
tbet
found
bind
ifngamma
promot
via
chromatin
immunoprecipit
assay
therefor
tbet
appear
regul
differenti
encephalitogen
cell
pathway
may
potenti
target
therapeut
diseas
ms
motorevok
potenti
mep
transcrani
electr
stimul
studi
vivo
method
assess
corticospin
system
chang
chronic
experiment
autoimmun
encephalomyel
eae
obtain
immun
mice
parallel
neuropatholog
cortic
mep
record
eae
mice
day
postimmunis
dpi
absent
mice
dpi
respect
dpi
record
mep
major
eae
mice
mice
preserv
mep
latenc
significantli
increas
peak
dpi
slight
revoveri
afterward
latest
timepoint
mep
amplitud
significantli
decreas
suggest
chronic
axon
loss
consid
overal
mep
issu
method
sensit
almost
approach
eae
neuropatholog
demonstr
inflammatori
infiltr
sinc
dpi
peak
either
inflamm
demyelin
dpi
tend
fade
later
axon
loss
firstli
detect
dpi
reach
maximum
dpi
thu
smallsiz
slow
even
absent
mep
observ
latest
eae
stage
keep
neuropatholog
find
suggest
acut
axon
damag
chronic
axon
loss
character
featur
eae
mice
perhap
consequ
earli
inflammatorydemyelin
event
occur
first
dpi
therefor
mep
contribut
gain
insight
eae
pathophysiolog
also
quantit
assess
experiment
neuroprotect
therapi
cn
demyelin
diseas
estim
eae
sever
use
videobas
motion
analysi
tail
motil
schmitz
tomov
w
neiss
angelov
institut
anatomi
univers
cologn
cologn
germani
avoid
bias
clinic
score
eae
rat
develop
method
object
evalu
onset
sever
diseas
sinc
tail
atoni
earliest
consist
symptom
eae
videotap
tail
movement
appear
paraparesi
day
postinduct
dpi
peak
paraparesi
dpi
use
motu
peak
perform
technolog
analys
common
motor
perform
tail
muscl
evalu
angl
tail
bodi
normal
condit
tail
lie
loos
inspect
tabl
upon
lift
anim
tail
acquir
horizont
posit
due
reflex
contract
musculatur
measur
deviat
tail
longitudin
axi
anim
bodi
sagitt
plane
therebi
dorsal
flexion
estim
neg
ventral
flexionin
posit
degre
intact
anim
dorsal
flexion
ventral
show
tail
movement
intact
rat
occur
gener
neg
region
dpi
dorsal
flexion
ventral
flexion
atd
dpi
dorsal
flexion
increas
dramat
ventral
flexion
videobas
motion
analysi
tail
motiliy
valuabl
tool
estim
onset
clinic
progress
result
eaetreat
although
multipl
sclerosi
ms
consid
autoimmun
diseas
central
nervou
system
cn
immun
respons
take
place
cn
lymphoid
organ
remain
elucid
success
induc
variou
subtyp
eae
rat
carri
lewi
background
gene
immun
recombin
rat
mog
variou
solut
adjuv
purpos
present
studi
analyz
detail
clinic
immunopatholog
featur
moginduc
eae
rat
immun
high
dose
solubl
mog
pertussi
toxin
pt
induc
acut
frequent
fatal
eae
wherea
medium
dose
partial
aggreg
mog
without
pt
produc
relaps
remit
rr
eae
secondari
progress
sp
eae
induc
rat
immun
immun
protocol
intermedi
natur
two
optic
nerv
approxim
immun
rat
spinal
cord
frequent
involv
detect
clinic
patholog
histolog
examin
reveal
despit
varieti
clinic
subtyp
progress
patholog
process
strikingli
uniform
ie
initi
inflamm
minim
demyelin
follow
predomin
demyelin
minim
lymphocyt
infiltr
find
suggest
lesion
later
stage
maintain
humor
factor
taken
togeth
experiment
system
serv
model
neuromyel
optica
nmo
analysi
provid
use
inform
elucid
pathogenesi
develop
immunotherapi
nmo
ms
adult
mous
neural
precursor
cell
anpc
vitro
label
increas
concentr
fe
use
three
differ
super
paramagnet
iron
oxid
spio
contrast
media
endoremr
resovistr
sineremr
iron
uptak
cell
viabil
prolifer
differenti
vitro
test
h
day
vitro
label
prepar
agaros
phantom
contain
dispers
unlabel
label
cell
free
spio
measur
surfac
coil
signal
chang
routin
use
sequenc
relax
increas
dose
spio
use
mgml
fe
uptak
spio
much
higher
anpc
incub
vitro
polylisinel
iron
nanoparticl
mild
cell
toxic
measur
cell
incub
mgml
fe
relax
paramet
parallel
increas
cell
concentr
iron
particl
contrast
media
test
endoremr
show
highest
signal
decreas
anpc
success
label
vitro
novel
spio
contrast
media
method
might
allow
vivo
anpc
track
express
endotheli
selectin
document
ms
multipl
sclerosi
eae
alpha
fucosyltrasferas
fuct
catalyz
glycosyl
pselectin
glycoprotein
ligand
endotheli
eand
pselectin
goal
studi
determin
role
fuct
induct
eae
method
fuctdefici
mice
fuctiv
fuctvii
doubl
defici
mice
fuctiv
vii
gener
genet
background
intravit
microscopi
studi
perform
inflam
brain
vessel
eae
induc
use
peptid
result
cell
effici
roll
arrest
inflam
brain
venul
antieand
pselectin
antibodi
block
tether
roll
lymphocyt
brain
venul
lymphocyt
produc
mice
effici
tether
roll
brain
venul
compar
cell
wt
mice
contrast
primari
adhes
lymphocyt
obtain
fuctvii
mice
drastic
reduc
onset
activelyinduc
eae
mice
significantli
delay
diseas
significantli
inhibit
fuctvii
mice
compar
wt
mice
cell
obtain
fuctvii
mice
display
roll
eand
pselectin
physiolog
flow
conclus
data
unveil
critic
role
fuctvii
recruit
activ
lymphocyt
inflam
brain
venul
suggest
fuct
play
role
pathogenesi
autoimmun
inflammatori
diseas
brain
method
magnet
columnenrich
deplet
subpopul
adult
rat
hematopoiet
bone
marrow
cell
bmc
transplant
alon
chicken
ovalbuminspecif
rat
cell
sever
combin
immunodefici
scid
mice
recipi
scid
mice
assess
locat
phenotyp
transplant
bmcderiv
cell
suscept
cn
inflamm
induc
subsequ
transfer
myelinspecif
cell
result
bmc
express
low
undetect
level
alpha
integrin
associ
high
potenti
cellenhanc
migrat
cn
highest
diseaseinduc
activ
compar
bmc
express
high
level
alpha
integrin
bmc
express
low
undetect
alpha
integrin
also
associ
enhanc
traffick
cn
sever
diseas
compar
bmc
express
high
alpha
integrin
conclus
cn
apc
develop
bmc
express
low
undetect
development
pathway
enhanc
nonmyelinspecif
cell
acut
prepathogen
time
frame
may
respons
modul
suscept
sever
cn
inflamm
diseas
multipl
sclerosi
mani
tnfalphaassoci
neuropatholog
includ
ms
cerebr
malaria
vascular
dementia
hiv
enceph
contribut
made
high
level
cerebr
tnfalpha
express
pathogenesi
outcom
condit
remain
unresolv
found
tnfalpha
brain
give
rise
endothelinmedi
reduct
region
cerebr
blood
volum
rcbv
accompani
delay
bloodbrain
barrier
breakdown
compromis
tissu
energi
metabol
investig
role
platelet
event
microinject
proinflammatori
cytokin
tnfalpha
brain
parenchyma
discov
tnfalpha
induc
accumul
gpiibiiia
posit
platelet
within
intact
cerebrovasculatur
follow
adher
posit
mononuclear
cell
fashion
reminisc
cerebr
malaria
patholog
platelet
accumul
restrict
microvasculatur
venul
also
present
arteriol
next
investig
adenoviralmedi
chronic
tnfalpha
express
might
affect
platelet
accumul
found
platelet
remain
within
cerebr
vasculatur
cbv
chronic
reduc
chronic
adenovir
mediat
express
tnfalpha
also
associ
neuron
cell
death
monocyt
recruit
administr
antiselectin
antibodi
success
reduc
platelet
cell
accumul
find
indic
target
pathway
tnfinduc
platelet
accumul
may
repres
use
target
neuropatholog
associ
elev
tnfalpha
reduc
cbv
infiltr
leukocyt
cn
key
event
develop
multipl
sclerosi
ms
molecul
involv
interact
leukocyt
endotheli
cell
therefor
candid
target
therapi
member
tetraspanin
familiy
small
surfac
protein
implic
cellular
adhes
motil
prolifer
also
regul
activ
two
major
adhes
receptor
leukocyt
therefor
set
determin
function
leukocyt
transmigr
time
laps
videomicroscopi
assay
use
monitor
transmigr
rat
monocyt
cell
across
confluent
monolay
immortalis
rat
cerebrovascular
endotheli
cell
monoclon
antibodi
mab
rat
consist
result
inhibit
monocyt
transmigr
compar
control
receiv
mab
isotyp
control
endotheli
cell
prestimul
mixtur
ifngamma
h
inhibit
mab
increas
around
similar
effect
mab
conclud
import
transendotheli
migrat
monocyt
furthermor
result
provid
strong
support
explor
therapeut
target
ms
understand
mechan
immun
cell
migrat
ms
lesion
offer
great
therapeut
potenti
studi
focus
chemokin
classifi
homeostat
essenti
b
cell
migrat
lymph
follicl
may
also
affect
cell
sinc
receptor
upregul
cell
activ
report
overexpress
msbrain
lesion
detect
quantit
pcr
within
ms
lesion
immunoloc
cell
macrophagelik
appear
perivascular
area
parenchyma
csf
ms
patient
elev
correl
intrathec
ig
product
presenc
b
cell
plasma
cellsplasma
blast
cell
monocyt
cell
almost
b
cell
csf
express
strong
correl
cell
b
cell
migrat
brain
ms
might
qualifi
chemokin
futur
therapeut
target
ms
mononuclear
inflammatori
infiltr
common
characterist
infect
inflammatori
cn
disord
consist
tcell
monocyt
activ
microglia
chemokin
chemokin
receptor
play
key
role
recruit
inflammatori
cell
site
inflamm
cc
receptor
express
tcell
monocyt
blood
interact
anim
model
disrupt
interact
use
neutralis
agent
knockout
anim
lead
decreas
inflammatori
infiltr
clinic
diseas
studi
identifi
pattern
express
inflammatori
infiltr
number
cn
disord
includ
multipl
sclerosi
ms
west
nile
encephalomyel
wne
use
immunohistochemistri
bind
assay
cn
major
tcell
express
wherea
activ
monocyt
spars
express
antibodi
inhibit
bind
frozen
ms
section
csf
small
percentag
tcell
major
activ
monocyt
express
express
mononuclear
cell
close
contact
activ
microglia
wne
express
differenti
regul
tcell
compar
monocyt
cn
express
either
upregul
tcell
upon
transmigr
across
bloodbrain
barrier
immunoreact
tcell
preferenti
recruit
cn
may
potenti
therapeut
target
cn
inflammatori
disord
role
substanc
p
receptor
cn
inflammatori
diseas
e
reink
macvilay
z
fabri
univers
wisconsinmadison
madison
wi
usa
substanc
p
neuropeptid
shown
affect
immun
system
nervou
system
vasculatur
shown
import
role
inflamm
act
increas
activ
proinflammatori
leukocyt
increas
edema
vasodil
adhes
molecul
express
vascular
endotheli
cell
involv
detect
pain
sensori
neuron
investig
role
substanc
p
receptor
central
nervou
system
cn
autoimmun
use
model
diseas
experiment
autoimmun
encephalomyel
eae
receptor
knock
mice
treat
subcutan
inject
cn
selfpeptid
myelin
oligodendrogli
protein
mog
data
show
receptor
express
brain
microvessel
endotheli
cell
mice
lack
receptor
experi
less
sever
diseas
chronic
state
character
lower
clinic
score
less
demyelin
infiltr
spinal
cord
result
indic
substanc
p
receptor
contribut
cn
inflammatori
diseas
open
new
direct
possibl
treatment
diseas
multipl
sclerosi
perivascular
accumul
monocytederiv
macrophag
lymphocyt
characterist
featur
multipl
sclerosi
patholog
order
enter
brain
parenchyma
immun
cell
need
cross
bloodbrain
barrier
bbb
barrier
mainli
compos
special
brain
endotheli
cell
pericyt
perivascular
macrophag
endotheli
cell
pericyt
line
vascular
astrogli
basement
membran
bm
respect
studi
molecular
composit
bm
wellcharacter
ms
lesion
use
panel
antibodi
direct
sever
bm
protein
laminin
chain
present
endotheli
bm
wherea
antilaminin
antibodi
specif
decor
astrogli
membran
laminin
antibodi
immunostain
bm
similarli
fibronectin
heparan
sulfat
proteoglycan
hspg
glycosaminoglycan
gag
local
bm
interestingli
observ
laminin
chainposit
structur
within
perivascular
cuff
pattern
also
immunoposit
extracellular
matrix
ecm
compon
includ
fibronectin
hspg
gag
alreadi
shown
hspg
gag
bind
chemokin
small
protein
control
cellular
migrat
therefor
hypothes
deposit
ecmbm
compon
perivascular
space
may
act
conduit
network
chemokin
therebi
contribut
recruit
inflammatori
cell
futur
research
warrant
studi
function
role
ecmbm
molecul
multipl
sclerosi
pathogenesi
beta
chemokin
enhanc
adhes
monocyt
human
brain
microvessel
endotheli
cell
vitro
k
liu
r
prameya
b
r
shahidi
b
v
wu
b
k
dorovinizi
univers
british
columbia
vancouv
canada
b
vancouv
hospit
health
scienc
centr
vancouv
canada
chemokin
implic
recruit
leukocyt
brain
cn
inflamm
factor
regul
traffick
monocyt
across
bloodbrain
barrier
bbb
remain
poorli
understood
investig
effect
beta
chemokin
monocyt
adhes
human
brain
microvessel
endotheli
cell
hbmec
vitro
model
bbb
primari
cultur
grown
confluenc
collagen
membran
doubl
chamber
chemotaxi
system
place
lower
chamber
establish
concentr
gradient
hbmec
monolay
use
untreat
treat
tnfalpha
ifngamma
h
mimic
inflammatori
condit
peripher
blood
monocyt
place
hbmec
incub
min
radiolabel
diffus
across
collagen
membran
cytokinetr
hbmec
monolay
timedepend
manner
bound
subendotheli
matrix
basal
cell
surfac
chemokin
diffus
minim
across
untreat
hbmec
cytokin
treatment
increas
adhes
monocyt
hbmec
approxim
concentr
gradient
increas
adhes
monocyt
untreat
cytokinetr
hbmec
find
suggest
potenti
role
recruit
monocyt
across
bbb
site
inflamm
cn
experiment
autoimmun
encephalomyel
eae
inflammatori
demyelin
diseas
central
nervou
system
cn
wide
studi
anim
model
multipl
sclerosi
ms
eae
model
characteris
disturb
balanc
coordin
caus
mice
roll
axial
rotatori
motion
inflammatori
demyelin
lesion
found
primarili
brainstem
cerebellum
lesser
extent
spinal
cord
inflammatori
infiltr
contain
lymphocyt
monocyt
macrophag
also
polymorphonuclear
cell
pmn
make
model
patholog
similar
acut
variant
ms
marburg
diseas
cytokin
chemokin
play
role
promot
immun
respons
determin
lesion
composit
eae
ms
therefor
examin
cytokin
chemokin
chemokin
receptor
express
eae
model
determin
factor
involv
leukocyt
infiltr
cn
result
indic
potent
chemotact
agent
pmn
receptor
highli
express
within
cn
addit
rant
chemotact
agent
monocytesmacrophag
eosinophil
basophil
receptor
well
proinflammatori
cytokin
ifngamma
tnfalpha
also
express
within
cn
model
relev
data
implic
futur
research
discuss
promot
secret
human
astrocyt
brain
endotheli
cell
ea
subileau
h
davi
f
colyer
j
greenwood
b
male
romero
open
univers
milton
keyn
uk
b
univers
colleg
london
london
uk
high
level
chemokin
receptor
report
multipl
sclerosi
ms
lesion
play
import
role
activ
lymphocyt
monocyt
diapedesi
toward
inflam
site
howev
littl
known
effect
cell
bloodbrain
barrier
bbb
use
transmiss
electron
microscopi
immunogold
stain
postmortem
ms
brain
tissu
reveal
presenc
hbec
surround
astrocyt
normal
appear
white
matter
white
matter
lesion
demonstr
express
primari
human
brain
endotheli
cell
hbec
immunocytochemistri
vitro
addit
cultur
medium
effect
permeabl
hbec
monolay
dextranfitc
kda
kda
vitro
bbb
model
express
adhes
molecul
modifi
hbec
howev
led
increas
level
supernat
stimul
hbec
astrocyt
addit
induc
phosphoryl
astrocyt
either
mek
inhibitor
inhibitor
fail
block
releas
suggest
signal
pathway
may
involv
process
result
suggest
could
play
role
infiltr
process
amplifi
network
chemokin
signal
act
leukocyt
migrat
chemokin
receptor
implic
leukocyt
ingress
brain
central
nervou
system
cn
inflamm
observ
multipl
sclerosi
express
sever
chemokin
receptor
lymphocyt
particularli
differ
greatli
depend
locat
blood
cerebr
spinal
fluid
brain
tissu
suggest
receptor
may
modul
traffick
may
requir
migrat
address
receptor
modul
mononuclear
cell
diapedesi
cn
parenchyma
use
static
invitro
model
bloodbrain
barrier
bbb
recapitul
bbb
properti
use
model
perform
transmigr
assay
peripher
blood
mononuclear
cell
character
receptor
express
profil
leukocyt
cell
memori
cell
transmigr
enrich
transmigr
cell
compar
input
nonmigr
cell
studi
use
popul
show
surfac
marker
cell
capac
cross
bbb
play
essenti
role
extravas
extend
experiment
approach
addit
chemokin
receptor
cell
popul
bbb
transmigr
assay
provid
use
inform
promot
understand
biolog
signific
differenti
chemokin
receptor
express
blood
compar
parenchym
cn
lesion
model
monocytemacrophag
migrat
revers
transmigr
brain
scripp
research
institut
la
jolla
ca
usa
cell
monocytemacrophag
lineag
shown
princip
target
product
replic
within
central
nervou
system
addit
dementia
shown
correl
macrophag
abund
brain
accumul
macrophag
neuroaid
like
initi
increas
entri
monocyt
brain
mechan
prevent
macrophag
egress
brain
mean
prevent
macrophag
death
may
also
contribut
accumul
develop
novel
transendotheli
migrat
model
allow
us
test
abil
chemokin
alter
monocytemacrophag
traffick
migrat
accumul
peripher
blood
mononuclear
cell
ablumen
ie
tissu
side
vitro
endotheli
monolay
investig
migrat
cell
highli
enrich
monocyt
includ
monocyt
also
investig
revers
transmigr
monocyt
ablumen
lumen
side
ie
circul
hypothes
within
hivinfect
brain
molecul
express
decreas
revers
transmigr
macrophag
lead
increas
number
tissu
macrophag
base
microarray
analys
show
osteopontin
potent
chemoattract
protein
upregul
brain
simian
immunodefici
viru
enceph
case
current
examin
role
osteopontin
comparison
chemokin
includ
fractalkin
transendotheli
migrat
model
hypothesi
osteopontin
involv
decreas
revers
transmigr
lipoic
acid
prevent
monocyt
migrat
across
bloodbrain
barrier
migrat
monocyt
across
bloodbrain
barrier
bbb
critic
step
develop
inflammatori
lesion
multipl
sclerosi
ms
transendotheli
migrat
monocyt
requir
activ
particip
brain
endotheli
cell
bec
need
rearrang
cytoskeleton
tight
junction
previous
show
reactiv
oxygen
speci
ro
essenti
monocyt
migrat
superoxid
pertin
ro
affect
integr
endotheli
cell
layer
investig
whether
antioxid
lipoic
acid
la
could
inhibit
monocyt
migrat
across
bbb
vitro
la
decreas
migrat
monocyt
across
monolay
bec
use
life
cell
imag
techniqu
quantit
assess
ro
produc
within
minut
upon
interact
monocyt
endothelium
induc
chang
cytoskeleton
could
prevent
la
vivo
la
dosedepend
prevent
develop
clinic
sign
monocyt
infiltr
cn
acut
experiment
allerg
encephalomyel
eae
togeth
result
indic
oxygen
radic
essenti
monocyt
migrat
vitro
well
vivo
rosscaveng
like
la
may
tool
prevent
monocyt
migrat
across
bbb
may
therefor
potenti
candid
treatment
ms
develop
microglia
mous
embryon
stem
cell
migrat
brain
parenchyma
tsuchiya
kc
park
toyonaga
yamada
h
nakabayashi
e
nakai
n
ikawa
k
shimizu
depart
neurosurgeri
kochi
medic
school
kohasu
nankokushi
kochi
japan
microglia
similar
peripher
macrophag
exist
central
nervou
system
cn
microglia
function
antigen
present
cell
sever
cn
diseas
detail
mechan
remain
obscur
yet
microgli
progenitor
precursor
cell
identifi
deriv
microglia
mous
embryon
stem
cell
es
cell
high
densiti
cell
induc
stimul
gmcsf
follow
neuron
differenti
mous
es
cell
use
fivestep
method
express
high
low
induc
cell
microglia
express
mhc
class
ii
molecul
express
enhanc
lp
hand
detect
mhc
class
molecul
neglig
deriv
microglia
irrespect
lp
stimul
intraven
transfer
gfp
microglia
deriv
gfp
es
cell
caus
select
accumul
brain
peripher
tissu
spleen
lymph
node
gfp
cell
detect
mainli
corpu
callosum
hippocampu
rare
cerebr
cortex
anoth
marker
microglia
primarili
express
furthermor
gfp
cell
exhibit
ramifi
morpholog
characterist
matur
microglia
thu
suggest
matur
microglia
induc
protocol
may
function
brainspecif
deliveri
medicin
bioactiv
materi
protein
gene
integr
part
bloodbrain
barrier
astrocyt
play
import
role
regul
home
differ
leukocyt
subset
inflam
central
nervou
system
cn
aim
studi
investig
whether
astrocyt
produc
chemokin
facilit
dendrit
cell
dc
migrat
use
rnase
protect
assay
andor
elisa
found
human
astrocyt
stimul
vitro
beta
tumor
necrosi
factor
produc
act
immatur
myeloid
dc
attract
matur
myeloid
dc
supernat
cytokinestimul
astrocyt
cultur
effect
control
cellfre
medium
supernat
unstimul
astrocyt
induc
migrat
monocytederiv
immatur
dc
find
immatur
dc
migrat
toward
desensit
correspond
receptor
reduc
dc
migrat
respons
astrocyt
supernat
indic
astrocyt
produc
biolog
relev
amount
chemokin
immunohistochem
studi
show
unaffect
human
brain
express
neuron
cerebrovascular
endothelia
brain
tissu
multipl
sclerosi
ms
patient
immunoposit
also
detect
reactiv
astrocyt
within
chronic
lesion
express
ms
lesion
investig
find
suggest
astrocyt
may
activ
contribut
dc
recruit
cn
autoimmun
diseas
bonemarrow
stem
cell
migrat
across
bloodbrain
barrier
differenti
microglia
normal
neurodegen
mous
model
ar
simard
rivest
laval
univers
quebec
citi
canada
stem
cell
capabl
differenti
multipl
cell
type
order
develop
regener
differ
tissu
howev
still
unclear
whether
bone
marrowderiv
stem
cell
migrat
across
bloodbrain
barrier
bbb
mani
region
central
nervou
system
cn
cell
differenti
microglia
thu
studi
differenti
bone
marrow
stem
cell
upon
immigr
cn
system
transplant
stem
cell
express
greenfluoresc
protein
gfp
lethal
irradi
mice
show
circul
stem
cell
migrat
across
bbb
differenti
microglia
throughout
cn
normal
mice
cell
also
indic
may
potent
apc
compar
residenti
microglia
also
test
whether
stem
cell
immigr
cn
would
increas
neurodegen
model
thu
inject
brain
sodium
nitroprussid
chemic
caus
extens
neurodegener
found
gfpposit
cell
migrat
differenti
microglia
significantli
preval
region
afflict
neuron
death
taken
togeth
data
show
microglia
blood
origin
cross
bbb
preferenti
recruit
damag
area
brain
could
potenti
activ
cell
adapt
immun
system
result
may
great
clinic
relev
immunederiv
neuron
disord
cancer
patient
undergo
allogen
hematopoiet
stemcel
transplant
character
macrophag
brain
cell
popul
experiment
cerebr
malaria
tf
pai
chatterje
instituto
gulbenkian
de
oira
portug
brain
macrophag
compris
heterogen
popul
cell
parenchym
microgli
cell
perivascular
macrophag
mening
choroid
plexu
macrophag
rel
contribut
popul
infect
cn
alway
clearli
determin
studi
address
activ
brain
macrophag
context
cerebr
malaria
cm
plasmodium
falciparum
infecti
agent
cm
human
sever
cerebr
complic
character
revers
encephalopathi
kinet
activ
brain
macrophag
investig
brain
slice
infect
anim
stain
tomato
lectin
obviou
morphologyc
chang
increas
stain
brain
macrophag
observ
day
mice
start
die
character
leukocyt
perform
flowcytometr
analysi
sever
marker
cell
monocyt
macrophag
activ
macrophag
increas
percentag
cell
express
high
level
slightli
observ
moribund
mice
popul
mainli
deriv
donor
cell
bone
marrow
chimer
mice
express
tcr
alphabeta
alpha
consider
level
myeloid
marker
slight
increas
also
observ
percentag
high
posit
cell
howev
detect
brain
macrophag
increas
express
classic
marker
macrophag
activ
mhc
class
ii
suggest
cerebr
malaria
activ
brain
macrophag
display
differ
activ
phenotyp
lymphomononuclear
infiltr
cn
mice
acut
gvhd
allogen
bone
marrow
transplant
p
sostak
c
padovan
gerbitz
straub
ludwigmaximilinansunivers
munich
germani
graftversushost
diseas
gvhd
system
complic
allogen
bone
marrow
transplant
bmt
often
affect
skin
liver
seldom
may
caus
peripher
neuromuscular
disord
far
involv
cn
deni
autopsi
studi
recent
clinic
experiment
find
suggest
gvhd
might
also
manifest
cn
anim
model
chronic
gvhd
could
alreadi
detect
cerebr
lymphomononuclear
infiltr
microgli
activ
upregul
adhes
molecul
studi
acut
cerebr
gvhd
perform
less
systemat
therefor
investig
brain
mice
experiment
acut
gvhd
condit
total
bodi
irradi
mous
strain
cba
receiv
bone
marrow
mice
induct
acut
gvhd
syngen
transplant
anim
mice
irradi
transplant
serv
control
mice
brain
investig
week
transplant
immunohistochemistri
allogen
anim
found
lymphomononuclear
infiltr
often
associ
leptomening
plexu
rare
within
brain
parenchyma
infiltr
nearli
absent
syngen
irradi
control
compar
earlier
find
extend
lymphomononuclear
infiltr
lower
acut
gvhd
chronic
gvhd
data
provid
evid
involv
cn
occur
acut
chronic
gvhd
differ
underli
pathophysiolog
mechan
need
clarif
essenti
role
pathway
establish
trypanosoma
cruzielicit
meningoenceph
j
lannesvieira
e
silva
ap
marino
depart
immunologyioc
oswaldo
cruz
foundat
rio
de
janeiro
brazil
central
nervou
system
cn
damag
occur
trypanosoma
cruzi
infect
especi
immunosuppress
patient
enhanc
suscept
mice
acut
meningoenceph
associ
higher
upregul
vascular
cell
adhes
cn
vascular
endothelia
less
suscept
vitro
adhes
activ
peripher
blood
cell
cn
blood
vessel
abrog
antibodi
also
inhibit
cell
migrat
cn
cruziinfect
mice
lastli
reactiv
meningoenceph
immunosuppress
chronic
infect
mice
associ
upregul
therefor
hypothes
play
pivot
role
establish
cruzielicit
enceph
osteopontin
opn
found
one
major
upregul
gene
inflammatori
neuropatholog
ms
theiler
viru
infect
eae
siv
enceph
role
opn
chemoattract
inflammatori
cell
studi
vivo
use
rodent
air
pouch
model
ap
opn
inject
subcutan
ap
balbc
mice
cell
harvest
caviti
period
predominantli
mononuclear
cell
accumul
gradual
earli
time
point
reach
peak
h
follow
decreas
histopatholog
ap
adjac
skin
show
adher
opnelicit
cell
cell
exhud
h
opn
inject
ap
phenotyp
character
compar
chemoattract
opn
power
induc
higher
number
cell
ap
furthermor
opn
cell
exhibit
distinct
characterist
opninduc
macrophag
express
higher
level
opn
receptor
involv
migrat
cell
brain
parenchyma
lower
level
relat
respons
cell
differ
express
observ
overal
induc
immatur
macrophag
opn
attract
stimul
cell
characterist
migrat
macrophag
similar
found
inflam
cn
work
support
nih
endoneuri
macrophag
respons
experiment
slow
progress
neuropathi
mainli
intrins
origin
k
wacker
eb
ringelstein
r
kiefer
univers
germani
macrophag
major
impact
pathogenesi
peripher
neuropathi
increas
peripher
neuropathi
addit
recent
demonstr
import
proport
endoneuri
macrophag
respons
traumat
inflammatori
neuropathi
gener
resid
macrophag
invad
hematogen
macrophag
prove
hypothesi
resid
macrophag
capabl
gener
macrophag
respons
slow
progress
neuropathi
use
chimer
mice
carri
green
fluoresc
protein
posit
bonemarrow
mice
allow
differenti
resid
hematogen
macrophag
administr
acrylamid
mice
develop
progress
neuropathi
fluoresc
microscopi
immunohistochemistri
use
quantifi
resid
gfp
hematogen
macrophag
addit
basic
macrophag
properti
examin
found
acrylamid
induc
neuropathi
endoreuri
macrophag
becom
activ
prolifer
phagocytos
increas
number
ratio
gfp
macrophag
chang
slightli
toward
increas
macrophag
addit
quantit
analysi
macrophag
shape
reveal
gfp
endoneuri
macrophag
activ
macrophag
taken
togeth
result
point
toward
intrins
gener
macrophag
respons
slow
progress
lengthdepend
neuropathi
macrophag
share
basic
macrophag
properti
like
phagocytosi
mhcii
express
differ
macrophag
shape
gfp
macrophag
could
interpret
differ
function
state
long
term
resid
hematogen
macrophag
regulatori
substrat
gelatinas
neuroinflamm
pe
van
den
steen
nelissen
starckx
p
proost
j
van
damm
g
opdenakk
laboratori
immunobiolog
rega
institut
univers
leuven
leuven
belgium
gelatinas
upregul
neuroinflammatori
diseas
shown
degrad
myelin
basic
protein
mbp
therebi
caus
demyelin
eg
multipl
sclerosi
addit
gelatinas
b
particip
degrad
bloodbrain
barrier
cleav
junction
protein
show
gelatinas
b
cleav
sever
immunoregulatori
molecul
particular
gelatinas
b
cleav
cxcchemokin
neutrophilattract
chemokin
counterpart
mous
cleav
aminotermin
increas
activ
posit
feedback
loop
consequ
first
potenti
aminotermin
truncat
subsequ
degrad
addit
cleavag
activ
neutrophilattract
cxcchemokin
either
unaffect
human
downregul
ctapiii
groalpha
contrast
neutrophilattract
chemokin
ligand
mig
attract
activ
tcell
cleav
carboxytermin
region
gelatinas
b
cleavag
expect
downregul
activ
anoth
exampl
immunoregulatori
substrat
gelatinas
b
interferonbeta
ifnbeta
approv
therpeut
agent
multipl
sclerosi
ifnbeta
cleav
inactiv
gelatinas
b
particular
aglycosylform
ifnbeta
sensit
cleavag
glycosyl
variant
indic
role
sugar
proteas
resist
furthermor
gelatinas
b
degrad
heatshock
protein
alphabcrystallin
result
gener
immunogen
remnant
epitop
find
import
implic
understand
treatment
neuroinflammatori
diseas
phenotyp
infiltr
cell
brain
lupuspron
mice
x
b
sakic
sle
autoimmun
disord
affect
morpholog
function
cn
studi
lupuspron
mrl
mice
elucid
behavior
dysfunct
induc
lupuslik
diseas
previou
studi
shown
leukocyt
infiltr
brain
mrllpr
mice
coincid
neurotox
csf
intrathec
synthesi
igg
propos
destruct
periventricular
neuron
predict
antibodyproduc
cell
present
mrl
mice
brain
becom
inflam
infiltr
leukocyt
character
mab
antigen
cell
mostli
locat
ventricl
macrophag
blymphocyt
plasma
cell
less
frequent
detect
almost
infiltr
cell
comparison
agematch
mrllpr
mice
brain
old
mrl
control
show
cell
infiltr
predomin
lymphocyt
presenc
cell
suggest
cell
macrophag
play
role
cytokineinduc
brain
damag
presenc
b
plasma
cell
provid
support
hypothesi
toxic
igg
synthes
intrathec
cytokin
express
cell
phenotyp
present
examin
report
meet
work
support
fund
nih
b
sakic
recipi
fsorc
career
develop
award
signal
deliv
cannabinoid
receptor
block
recruit
encephalitogen
lymphocyt
brain
venul
pkadepend
mechan
b
rossi
bach
fusco
b
f
fachinetti
b
leon
b
g
constantin
univers
verona
verona
itali
b
research
innov
padova
itali
known
cannabinoid
treatment
prevent
develop
experiment
autoimmun
encephalomyel
mechan
action
well
elucid
goal
studi
determin
potenti
role
cannabinoid
receptor
recruit
lymphocyt
brain
venul
critic
event
initi
autoimmun
inflamm
method
plp
autoreact
lymphocyt
produc
sjl
immun
mice
intravit
microscopi
studi
perform
inflam
brain
vessel
express
adhes
molecul
apoptosi
studi
flow
cytometri
releas
intracellular
calcium
store
determin
use
result
select
cannabinoid
receptor
antagonist
cannabinoid
receptor
antagonist
use
compound
effect
intracellular
calcium
releas
alter
express
adhes
molecul
apoptosi
encephalitogen
lymphocyt
intravit
microscopi
studi
perform
inflam
brain
vessel
show
effect
roll
consist
inhibit
lymphocyt
arrest
brain
microcircul
signific
effect
lymphocyt
recruit
vivo
pka
protein
kinas
inhibitor
abl
prevent
inhibit
lymphocyt
stick
brain
vessel
conclus
data
help
understand
antiinflammatori
effect
exert
cannabinoid
suggest
signal
transduct
gener
interfer
recruit
lymphocyt
inflam
brain
venul
involv
cell
activ
cell
adhes
process
furthermor
exert
uniqu
enzymat
specif
cleav
dipeptid
chemokin
ligand
neuropeptid
neuropeptid
substanc
p
although
function
suggest
function
role
autoimmun
conflict
result
regard
possibl
clinic
applic
well
underli
mechan
report
two
substrain
mutant
fischer
rat
lack
endogen
dpiv
enzymat
activ
show
reduc
suscept
acut
activelyinduc
eae
mbp
cfa
pertussi
signific
delay
onset
observ
male
rat
femal
mutant
substrain
also
sever
diseas
markedli
suppress
suppress
like
effect
neg
rat
associ
time
depend
subsetspecif
modul
blood
leukocyt
number
spinal
chord
infiltr
leukocyt
reduct
circul
b
cell
day
postimmun
pi
number
nkt
cell
day
pi
peak
clinic
score
blood
increas
number
nk
nkt
cell
well
reduc
number
granulocyt
cell
spinal
cord
day
pi
result
indic
protectivelik
effect
reduc
expressionenzymat
activ
eae
emphasis
cell
migrationadhes
contribut
mechan
rat
grow
evid
indic
cell
may
play
major
role
pathogenesi
multipl
sclerosi
ms
experiment
autoimmun
encephalomyel
eae
mechan
control
recruit
cell
inflam
brain
venul
yet
understood
object
studi
propos
compar
behavior
autoreact
versu
cell
inflam
brain
venul
method
cell
produc
bind
eand
pselectin
chimera
determin
flow
cytomeri
intravit
microscopi
perform
inflam
brain
venul
mice
result
stimul
cell
display
increas
express
compar
stimul
moreov
cell
display
increas
bind
pselectinigg
chimera
vitro
situ
analys
reveal
autoreact
cell
increas
capabl
tether
roll
inflam
brain
venul
compar
cell
importantli
tether
roll
cell
complet
block
antibodi
pselectin
conclus
find
show
inflam
brain
endothelium
express
pselectin
preferenti
recruit
autoreact
cell
versu
cell
suggest
cell
may
role
earli
inflamm
autoimmun
process
effect
antibodi
chronic
experiment
allerg
encephalomyel
eae
mice
j
rundl
v
gauden
r
mead
christi
celltech
r
ltd
cambridg
uk
lewi
rat
guinea
pig
eae
model
treatment
antibodi
small
molecul
inhibitor
reduc
clinic
sever
yednock
et
al
kent
et
al
piraino
et
al
leon
et
al
howev
chronic
relaps
eae
model
sjl
mous
inhibit
may
either
diminish
exacerb
diseas
depend
time
treatment
theien
et
al
theien
et
al
present
studi
investig
effect
antibodi
chronic
eae
model
mous
eae
induc
adult
femal
mice
subcutan
sc
inject
complet
freund
adjuv
contain
mgml
mycobacterium
mg
myelin
oligodendrocyt
glycoprotein
mog
peptid
flank
ml
day
pertussi
toxin
administ
intraperiton
ngmous
day
mice
treat
mous
chimer
antibodi
isotyp
control
mgkg
sc
twice
weekli
either
prophylact
day
therapeut
incid
prophylact
treatment
caus
reduct
maximum
cumul
clinic
score
respect
mannwhitney
u
reduc
incid
fischer
exact
test
therapeut
treatment
caus
reduct
maximum
clinic
score
mannwhitney
u
conclus
effect
chronic
murin
eae
model
suggest
mechan
drive
initi
mainten
diseas
express
cutan
lymphocyt
antigen
cla
activ
lymphocyt
critic
effici
tether
roll
inflam
brain
venul
b
rossi
l
piccio
b
l
colantonio
c
e
scarpini
b
dambrosio
c
g
constantin
univers
verona
verona
itali
b
univers
milan
milan
itali
c
bioxel
milan
itali
previous
shown
endotheli
selectin
express
inflam
brain
endothelium
eae
experiment
model
subacut
inflamm
cla
repres
fucosyltransferaseviiinduc
carbohydr
modif
pselectin
glycoprotein
respons
interact
endotheli
selectin
object
goal
studi
determin
role
cla
epitop
lymphocyt
recruit
brain
method
lymphocyt
gener
intravit
microscopi
perform
subacut
inflam
brain
microcircul
result
human
murin
cell
effici
tether
roll
brain
venul
contrast
lymphocyt
abl
roll
firmli
adher
inflam
brain
endothelium
anticla
antibodi
almost
complet
abolish
recruit
lymphocyt
brain
importantli
observ
dramat
increas
captur
roll
subsequ
arrest
lymphocyt
express
cla
compar
cell
moreov
compar
adhes
interact
cell
cla
observ
express
cla
determin
signific
increas
tether
roll
conclus
data
unveil
cla
epitop
critic
recruit
inflam
brain
venul
may
repres
attract
pharmaceut
target
explor
autoimmun
diseas
brain
infiltr
cn
cell
preced
onset
relaps
experiment
autoimmun
encephalomyel
eae
report
mice
sever
relapsingremit
diseas
extens
infiltr
cell
compar
mice
develop
mild
lowrelaps
diseas
respons
myelin
oligodendrocyt
peptid
observ
led
us
search
mechan
specif
regul
traffick
cell
relaps
mice
found
cell
chemoattract
cytokin
import
role
regul
relaps
eae
found
product
within
cn
mice
eae
correl
well
extent
cell
b
cell
infiltr
acut
relaps
diseas
cn
produc
infiltr
cell
cell
b
cell
treatment
neutral
antibodi
success
revers
paralysi
amelior
relaps
diseas
treat
mice
diminish
infiltr
cell
lesser
demyelin
spare
axon
observ
show
import
role
regul
relaps
eae
describ
novel
therapeut
approach
specif
imped
cell
chemoattract
eae
neutral
find
high
relev
develop
new
therapi
relaps
eae
potenti
ms
role
hemehem
oxygenas
system
multipl
sclerosi
patholog
j
van
horssen
fa
wagen
b
de
vri
vumc
amsterdam
netherland
b
umc
nijmegen
nijmegen
netherland
multipl
sclerosi
ms
character
infiltr
monocytederiv
macrophag
activ
monocyt
secret
inflammatori
mediat
like
reactiv
oxygen
speci
ro
contribut
axon
damag
demyelin
induc
heme
oxygenas
ho
gene
respond
chang
cellular
redox
potenti
provok
ro
previous
demonstr
increas
mrna
level
quantit
pcr
microarray
analysi
experiment
autoimmun
encephalomyel
eae
rat
brain
valid
model
ms
ho
break
heme
free
iron
carbon
monoxid
co
biliverdin
convert
biliverdin
reductas
bvr
antioxid
bilirubin
iron
directli
sequest
inactiv
coinduc
ferritin
hememedi
ro
format
inflammatori
process
may
contribut
tissu
damag
eaem
brain
aim
studi
identifi
cellular
sourc
bvr
ferritin
eae
rat
brain
well
human
ms
lesion
find
demonstr
well
bvr
ferritin
markedli
upregul
infiltr
macrophag
ferritin
also
express
astrocyt
activ
lesion
therefor
hypothes
hemehem
oxygenas
system
may
involv
transendotheli
migrat
monocyt
futur
studi
effect
heme
ho
activ
co
bilirubin
monocyt
migrat
addit
research
need
elucid
role
hemeho
system
pathogenesi
ms
express
defin
subset
regulatori
effectormemori
cell
kleinewietfeld
f
puent
g
borsellino
b
l
battistini
b
k
falk
molecular
medicin
mdc
berlin
germani
b
institut
neuroimmunolog
ircc
santa
lucia
rome
itali
regulatori
cell
central
element
peripher
toler
littl
known
howev
phenotyp
function
characterist
regulatori
cell
regard
memori
studi
show
chemokin
receptor
express
distinct
subset
regulatori
cell
similar
counterpart
cell
exhibit
marker
activ
expans
memori
indic
effectormemori
function
although
regulatori
cell
compris
cell
subset
naiv
mice
cell
outnumb
respect
popul
cell
ratio
true
memori
cell
gener
vivo
narv
cell
encount
antigen
contrast
activ
marker
induct
immedi
evid
sever
round
prolifer
cell
enrich
peripher
blood
accumul
cn
induct
eae
counteract
infiltr
effectormemori
cell
thu
cell
seem
repres
popul
bregulatori
effectormemoryq
cell
destin
control
destruct
immun
respons
directli
inflam
tissu
report
pharmacolog
deplet
fibrin
revers
relaps
paralysi
establish
polyphas
model
remittingrelaps
experiment
autoimmun
encephalomyel
eae
induc
proteolipid
protein
sjlj
mice
investig
therapeut
effect
fibrin
deplet
pharmacolog
deplet
mice
fibrin
develop
first
paralyt
incid
untreat
mice
relaps
day
immun
contrast
fibrindeplet
mice
recov
faster
untreat
mice
never
relaps
rotarod
behavior
test
demonstr
fibrindeplet
mice
increas
motor
skill
compar
untreat
group
current
research
cellular
molecular
mechan
fibrin
eae
present
overal
experi
identifi
fibrin
potenti
target
therapeut
intervent
ms
support
nmss
wadsworth
foundat
grant
ka
previou
studi
demonstr
oligomer
recombin
tcr
ligand
rtl
treat
clinic
sign
experiment
autoimmun
encephalomyel
eae
induc
longterm
cell
toler
encephalitogen
peptid
produc
monomer
peptid
construct
suitabl
use
sjlj
mice
develop
relaps
diseas
inject
peptid
cfa
given
iv
sc
empti
free
peptid
prevent
relaps
significantli
reduc
clinic
sever
eae
induc
peptid
sjlj
mice
inhibit
eae
induc
differ
encephalitogen
peptid
rtl
treatment
eae
caus
stabl
enhanc
cell
prolifer
secret
peripheri
reduc
secret
inflammatori
factor
central
nervou
system
cn
modest
reduct
inflammatori
cell
reduc
express
inflammatori
factor
enhanc
express
factor
result
suggest
monomer
rtl
therapi
induc
cytokin
switch
curb
encephalitogen
potenti
cell
without
fulli
prevent
entri
cn
wherein
reduc
sever
inflamm
result
strongli
support
clinic
applic
novel
class
peptidemhc
class
ii
construct
patient
multipl
sclerosi
focus
cell
respons
known
encephalitogen
myelin
peptid
multipl
sclerosi
character
invas
central
nervou
system
cn
inflammatori
cell
migrat
monocyt
across
bloodbrain
barrier
crucial
diseas
onset
sever
activ
monocytederiv
macrophag
secret
inflammatori
mediat
oxygen
radic
contribut
axon
demyelin
damag
result
neurolog
deficit
flavonoid
natur
occur
food
compound
antiinflammatori
properti
scaveng
oxygen
radic
impli
might
suppress
clinic
symptom
multipl
sclerosi
investig
issu
treat
rat
sensit
experiment
allerg
encephalomyel
eae
flavonoid
demonstr
flavonoid
luteolin
potent
quercetin
suppress
clinic
symptom
eae
lewi
rat
prevent
leukocyt
infiltr
cn
therapeut
potenti
luteolin
assess
chronic
relapsingremit
eae
model
darkagouti
rat
demonstr
luteolin
substanti
suppress
clinic
symptom
administ
either
diseas
onset
luteolin
treatment
result
reduc
inflamm
axon
damag
cn
prevent
monocyt
migrat
across
brain
endothelium
modul
activ
rho
gtpase
signal
transduc
involv
transendotheli
migrat
oral
administr
luteolin
also
significantli
reduc
clinic
symptom
result
indic
therapeut
potenti
dietari
adapt
multipl
sclerosi
phosphat
receptor
agonist
evalu
oral
monotherapi
multipl
sclerosi
act
redistribut
lymphocyt
blood
spleen
peripher
lymph
node
ln
evalu
experiment
autoimmun
encephalomyel
eae
focus
total
myelin
basic
protein
mbp
specif
serum
immunoglobulin
ig
indic
helper
type
driven
immun
respons
twoweek
oral
therapi
mgkg
prevent
eae
onset
lew
rat
efficaci
accompani
decreas
circul
lymphocyt
reduct
splenic
cell
downregul
transferrin
receptor
ln
b
cell
peak
diseas
vehicl
group
week
postimmun
correl
increas
titer
mbpspecif
igg
lower
almost
undetect
cyclosporin
csa
treat
rat
compound
suppress
symptom
treatment
yet
ig
profil
vastli
differ
compar
vehicl
total
igg
level
lower
csa
unexpectedli
almost
higher
treatment
contrast
csa
ratio
markedli
reduc
rat
primarili
due
upregul
total
mbpspecif
protect
effect
may
base
ln
retent
autoreact
effector
cell
also
quantit
chang
polyclon
antibodi
respons
possibl
involv
deviat
similarli
combin
atorvastatin
ga
suboptim
dose
associ
enhanc
lymphocyt
secret
tgfbeta
decreas
secret
ifngamma
histopatholog
examin
show
decreas
infiltr
blood
leukocyt
cn
tissu
anim
treat
combin
therapi
conclus
combin
therapi
atorvastatin
ga
effect
amelior
clinic
symptom
eae
result
extrem
promis
provid
rational
test
combin
atorvastatin
ga
ms
intraven
iv
intrathec
inject
mice
affect
experiment
autoimmun
encephalomyel
eae
syngen
adult
neural
precursor
cell
anpc
promot
multifoc
remyelin
function
recoveri
select
home
within
inflam
central
nervou
system
cn
area
explor
immun
mechan
sustain
phenomenon
sjl
mice
found
select
anpc
home
capabl
mainli
mediat
membran
express
cell
adhes
molecul
cam
chemokin
undifferenti
anpc
constitut
express
high
affin
state
mice
chemokin
rant
stromalderiv
factor
sdf
modul
dosedepend
manner
anpc
chemoattract
vitro
intravit
microscopi
show
vivo
anpc
arrest
inflam
brain
venul
inject
carotid
arteri
final
vivo
blockag
significantli
reduc
cn
home
anpc
result
indic
anpc
home
specif
inflam
brain
area
eae
iv
inject
owe
constitut
express
cell
adhes
molecul
cam
chemokin
receptor
use
enchephalitogen
lymphocyt
enter
cn
despit
mani
claim
neuroprotect
experiment
allerg
encephalomyel
eae
data
often
indic
major
neuroprotect
effect
occur
secondari
inhibit
leukocyt
cn
entri
result
reduct
clinic
diseas
reduc
cascad
trigger
neurodegener
therefor
agent
act
immunomodul
rather
direct
neuroprotect
howev
failur
inhibit
progress
multipl
sclerosi
ms
despit
inhibit
lesion
format
relaps
highlight
import
neurodegener
ms
experiment
autoimmun
encephalomyel
eae
instruct
model
humandemyelin
diseas
multipl
sclerosi
lewi
lew
rat
immun
myelinbas
protein
mbp
suffer
eae
character
singl
episod
paralysi
recov
spontan
becom
refractori
reinduct
diseas
lf
novel
molecul
inhibit
differenti
autoantigenspecif
cell
effector
pathogen
lymphocyt
potent
immunosuppress
effect
sever
patholog
manifest
includ
eae
present
studi
demonstr
lew
rat
protect
eae
lf
treatment
benefit
long
last
toler
reimmun
mbp
cfa
week
treatment
withdraw
fail
induc
eae
long
last
toler
transfer
lymph
node
cell
protect
rat
syngen
recipi
mediat
antigenspecif
regulatori
cell
prevent
activ
eae
regulatori
cell
also
gener
thymectom
anim
function
depend
presenc
tgf
beta
togeth
data
demonstr
shortterm
treatment
lf
prevent
eae
lew
rat
also
permit
develop
antigenspecif
toler
mediat
regulatori
cell
effect
ngf
antingf
antibodi
bstem
cellsq
inflammatori
respons
brain
eae
rat
v
triaca
l
alo
nation
research
council
cnr
rome
itali
use
experiment
allerg
encephalomyel
eae
rat
investig
effect
nerv
growth
factor
ngf
antinerv
growth
factor
antibodi
antingf
brain
rat
ngf
neurotrophin
crucial
neuron
growth
differenti
mainten
develop
adulthood
cn
injuri
eae
shown
caus
mark
circul
brain
synthesi
ngf
higher
respons
brain
cell
ngf
show
radiolabel
ngf
inject
ventricl
control
rat
mainli
local
svz
cell
coexpress
ngfreceptor
trka
h
treatment
h
radioact
virtual
absent
svz
almost
exclus
detect
cell
parenchyma
adjac
svz
cell
also
posit
marker
matur
neuron
oligodendrocyt
astrocyt
earli
neuron
marker
neurofila
nestin
premin
express
svz
cell
eae
brain
follow
ngf
inject
investig
effect
ngf
antingf
svz
cell
prolifer
found
eae
per
se
stimul
ngf
enhanc
brdu
incorpor
svz
antingf
reduc
number
brdu
incorpor
cell
compar
eae
rat
result
suggest
ngf
protect
action
eae
brain
probabl
act
damag
brain
cell
immun
cell
explor
protect
role
adult
neural
precursor
cell
anpc
mice
experiment
autoimmun
encephalomyel
eae
intraven
iv
inject
syngen
anpc
mice
relapsingremit
form
diseas
sjl
mice
immun
subcutan
proteolipid
protein
plp
iv
inject
million
syngen
anpc
onset
diseas
first
relaps
anpc
enter
brain
spinal
cord
select
reach
inflam
cn
area
show
abl
surviv
day
transplant
three
month
immun
mice
transplant
diseas
onset
first
relaps
show
signific
decreas
diseas
score
cumul
score
number
relaps
signific
decreas
extent
demyelin
axon
loss
also
found
interestingli
major
transplant
anpc
maintain
time
undifferenti
phenotyp
within
host
cn
accumul
mainli
around
brain
venul
gliogen
neurogen
factor
eg
possibl
maintain
anpc
quiescent
statewer
coloc
data
indic
anpcsonc
iv
transplantedmay
surviv
within
cn
long
period
time
protect
relapsingremit
eae
owe
capabl
select
reach
perivenular
inflam
area
stem
cell
surviv
factor
express
background
although
neural
precursor
cell
remyelin
focal
lesion
mechan
benefici
effect
clinic
relev
model
multipl
sclerosi
ms
unclear
therefor
examin
clinic
neuropatholog
immunolog
effect
neural
sphere
transplant
chronic
eae
method
multipotenti
neural
sphere
newborn
gfptransgen
mice
transplant
intraventricularli
chronic
eae
mice
shamand
spheretranspl
anim
score
clinic
sacrif
day
postinduct
histopatholog
analysi
demyelin
axon
patholog
assess
kluverbarrera
stain
amyloid
precursor
protein
immunohistochemistri
bielschowski
stain
inflamm
quantifi
count
perivascular
infiltratesand
imag
analysi
immunohistochemistri
brain
cell
identifi
immunofluoresc
lymphocyt
prolifer
examin
vitro
incorpor
cytokin
product
examin
real
time
pcr
elisa
result
eaeattract
transplant
cell
migrat
white
matter
tract
neural
sphere
transplant
attenu
clinic
cours
chronic
eae
reduc
demyelin
axon
patholog
neural
sphere
transplant
inhibit
inflammatori
brain
process
paramet
increas
brain
regulatori
tcell
transplant
decreas
inflammatori
infiltrateassoci
axon
damag
addit
neural
sphere
eaederiv
lymphocyt
vitro
inhibit
prolif
respons
cona
mog
peptid
reduc
moginduc
product
interferongamma
conclus
neural
sphere
transplant
attenu
clinic
patholog
featur
chronic
eae
graft
effect
mediat
modul
autoimmuneinflammatori
process
toler
induct
bone
marrow
transplant
multipl
sclerosi
model
mm
herrmann
gaertner
r
weissert
herti
institut
clinic
brain
research
univers
germani
bone
marrow
transplant
bmt
experiment
treatment
approach
multipl
sclerosi
ms
ms
chronic
autoimmun
diseas
cell
macrophag
autoantibodi
depend
pathogenesi
myelinoligodendrocyteglycoprotein
mog
induc
experiment
autoimmun
encephalomyel
eae
rat
reproduc
patholog
featur
therefor
use
model
ms
spars
knowledg
impact
genet
factor
time
tissu
repopul
immuneregulatori
mechan
bmt
ms
use
mhc
rat
ident
eae
suscept
da
resist
aci
rat
perform
bmt
studi
diseas
induct
peak
diseas
remiss
eae
da
rat
da
aci
bone
marrow
whole
bodi
irradi
gy
contrast
control
bmt
result
strong
diseas
protect
appli
cn
lesion
clinic
symptom
evolv
subsequ
autoantigeninduc
relaps
cn
lesion
protect
effect
associ
chang
rel
size
b
cell
compart
shift
cell
recognit
differ
mog
epitop
signific
reduct
mogspecif
autoantibodi
data
indic
protect
effect
bmt
relev
anim
model
ms
mainli
due
tolerogen
effect
autoantigenspecif
b
cell
subsequ
reduct
autoantibodi
titer
astrocyt
abl
induc
regulatori
cell
complet
abolish
prolif
respons
cell
vitro
aim
studi
test
inhibitori
capac
astrocyteinduc
regulatori
cell
vivo
use
eae
model
da
rat
rat
spinal
cord
homogenateimmun
anim
receiv
day
pi
lymph
node
cell
lnc
previous
incub
astrocyt
astrolnc
group
medium
alon
control
group
sever
clinic
sign
markedli
reduc
astrolnc
group
judg
mean
clinic
score
cumul
diseas
index
allevi
eae
symptom
correl
result
pathohistolog
analysi
astrolnc
also
abl
interfer
transfer
eae
mbpimmun
rat
treat
day
pi
astrolnc
control
lnc
day
later
drain
lnc
collect
restimul
vitro
inject
narv
recipi
control
anim
develop
eae
none
six
anim
receiv
cell
astrolnc
group
show
sign
diseas
interestingli
protect
effect
observ
astrolnc
administ
naiv
anim
simultan
encephalitogen
cell
result
suggest
import
role
astrocyteinduc
regulatori
cell
regul
cn
inflamm
experiment
autoimmun
encephalomyel
eae
anim
model
human
demyelin
diseas
multipl
sclerosi
ms
character
cell
mediat
inflammatori
respons
central
nervou
system
cn
autoantigen
interact
encephalitogen
cell
apc
cn
crucial
step
diseas
initi
astrocyt
suggest
play
essenti
role
initi
maintain
cn
autoimmun
elev
ifngamma
observ
ms
eae
deleteri
mspatient
address
effect
astrocyt
unrespons
ifngamma
eae
studi
transgen
tg
mice
express
dominantneg
ifngamma
receptor
control
gfappromot
gfapdifngr
mice
comparison
age
match
wild
type
wt
syngen
mice
differ
peripher
immun
respons
assess
cell
prolifer
cytokin
secret
seen
tgand
wtmice
eae
induc
immun
peptidecfa
anim
score
daili
clinic
symptom
tgmice
suscept
eae
wtcontrol
averag
day
diseas
onset
day
howev
gfapdifngr
mice
exhibit
significantli
sever
clinic
symptom
peak
diseas
score
vs
cumul
score
vs
higher
mortal
vs
wtmice
histopatholog
evalu
spinal
cord
section
reveal
slight
increas
extent
cellular
infiltr
sever
demyelin
tganim
compar
wtcontrol
find
support
import
role
ifngamma
mediat
astrocyt
signal
amelior
cn
autoimmun
diseas
multipl
sclerosi
ms
demyelin
diseas
cn
myelin
axon
lost
multipl
foci
call
plaqu
sporad
repair
occur
give
appear
dshadow
plaquest
area
thin
remyelin
howev
process
often
incomplet
well
establish
inhibit
alpha
beta
integrin
block
immun
cell
influx
cn
provid
benefit
patient
anim
model
system
util
mechan
examin
whether
presenc
inflammatori
cell
suppress
spontan
myelin
repair
experiment
autoimmun
encephalomyel
eae
eae
induc
hartley
guinea
pig
anim
chosen
treatment
base
two
criteria
anim
chronic
stage
diseas
nday
post
immun
anim
hind
limb
paresi
clinic
score
anim
receiv
either
salin
day
tissu
examin
light
electron
microscopi
evid
remyelin
found
plaqu
show
evid
remyelin
day
treatment
myelin
repair
occur
half
total
lesion
area
half
anim
regain
motor
function
signific
repair
gain
motor
function
vehicl
treat
anim
therefor
prolong
inhibit
cn
inflamm
absenc
target
myelin
repair
facilit
mechan
spontan
remyelin
establish
cytokinedeliveri
system
within
central
nervou
system
cn
use
helperdepend
adenovir
vector
hdad
engin
gene
green
fluoresc
protein
gfp
report
gene
hdad
vector
inject
cisterna
magna
ic
mice
diffus
ventricular
subarachnoid
space
infect
ependym
leptomening
cell
surround
area
inject
mice
affect
myelinoligodendrocyteglycoprotein
mog
experiment
autoimmun
encephalomyel
eae
day
clinic
onset
mice
display
progress
clinic
recoveri
day
immun
averag
eae
score
vs
control
mice
treat
empti
vector
motorevok
potenti
mep
record
control
mice
one
mice
central
conduct
time
signific
decreas
vs
control
mice
recoveri
associ
significantli
increas
number
cnsinfiltr
regulatori
cell
conclud
gene
therapi
use
hdad
vector
determin
recruit
cell
suppress
function
abl
induc
clinic
function
recoveri
murin
model
multipl
sclerosi
prevent
eae
treatment
neurotrop
alphaviru
vector
express
tissu
inhibitor
p
furu
grfnberg
j
hinkkanen
akademi
univers
turku
finland
object
experiment
autoimmun
encephalomyel
eae
enhanc
activ
matrix
metalloproteinas
mmp
implic
diseas
pathogenesi
prompt
recent
observ
increas
simultan
downregul
mrna
cn
mice
sever
eae
use
semliki
forest
viru
sfv
transfer
express
recombin
murin
gene
cn
eae
mice
result
express
confirm
cultur
cell
cn
infect
anim
follow
intraperiton
infect
pfu
sfvtimp
focal
timp
protein
express
achiev
throughout
brain
although
alreadi
treatment
empti
vector
inhibit
develop
eae
extent
express
viru
significantli
enhanc
inhibit
administ
mice
also
lower
diseas
grade
inhibit
statist
signific
contrast
effect
similar
coinfect
found
express
also
noninfect
cn
resid
cell
surround
viru
posit
area
suggest
bystand
induct
conclus
data
strengthen
view
mmp
involv
pathogenesi
eae
provid
clear
evid
virusmedi
deliveri
protein
inhibitor
effect
prevent
clinic
diseas
timp
might
candid
novel
treatment
regimen
cn
autoimmun
disord
multipl
sclerosi
background
immunoglobulin
intraven
administr
ivig
possess
multipl
immunomodulatori
properti
repres
way
interf
patholog
process
multipl
sclerosi
ms
experiment
autoimmun
encephalomyel
eae
infus
ivig
shown
significantli
amelior
diseas
howev
present
known
whether
ivig
enter
cn
suffici
amount
influenc
local
immun
respons
treatment
effect
due
peripher
action
ivig
object
purpos
present
studi
evalu
ivig
enter
cn
pass
bloodbrain
barrier
acut
cours
eae
assess
ivig
accumul
inflammatori
foci
method
eae
induc
suscept
rat
anim
treat
ivig
infus
acut
attack
diseas
immunoglobulin
radiolabel
vivo
administr
localis
visualis
cn
tissu
section
mean
autoradiographi
studi
evalu
biodistribut
plasma
halflif
also
perform
result
observ
signific
increas
bind
ivig
cn
tissu
rat
eae
correl
degre
inflamm
assess
histolog
evalu
furthermor
autoradiographi
radiolabel
ivig
localis
region
brain
inflammatori
infiltr
area
demyelin
also
found
lack
apolipoprotein
e
apo
exacerb
experiment
autoimmun
encephalomyel
nakanishi
ji
satoh
b
aranami
b
g
hiros
yamamura
b
kanazawamed
univers
ishikawa
japan
b
ncnp
tokyo
japan
recent
studi
shown
ms
patient
allel
exhibit
rapid
progress
sever
disabl
allel
studi
immunoregulatori
role
apo
develop
eae
immunemedi
demyelin
diseas
use
apoeknockout
ko
mice
model
system
eae
induc
femal
apoeko
mice
wild
type
wt
mice
immun
myelin
oligodendrocyt
glycoprotein
mog
clinic
score
antigenspecif
prolifer
respons
cytokin
product
region
lymph
node
ln
cell
igg
antibodi
titer
histopatholog
spinal
cord
studi
cannabinoid
may
allevi
symptom
multipl
sclerosi
furthermor
cannabinoid
might
also
modul
neuroinflamm
saw
dthc
ineffect
passiv
varieti
experiment
autoimmun
encephalomyel
eae
lewi
rat
howev
r
win
synthet
cannabinoid
significantli
syppress
clinic
sign
cannabinoid
may
exert
either
proor
antiapoptot
effect
depend
cell
type
investig
possibl
chang
cell
apoptosi
relat
protect
cannabinoid
mean
flow
cytometri
found
r
win
induc
profound
increas
apoptosi
encephalitogen
cell
line
time
dose
depend
ascertain
type
cannabinoid
receptor
involv
cell
line
cultur
receptor
antagonist
respect
win
inact
isom
wherea
effect
win
prevent
induct
apoptosi
dosedepend
way
indic
involv
receptor
howev
concentr
r
win
requir
moder
effect
win
strongli
suggest
observ
effect
might
part
cannabinoid
receptor
independ
r
win
affin
receptor
dthc
find
may
help
explain
observ
discrep
protect
eae
immunoregul
model
multipl
sclerosi
use
synthet
cannabinoid
r
jl
croxford
yamamura
nation
institut
neurosci
tokyo
japan
multipl
sclerosi
ms
human
autoimmun
demyelin
diseas
central
nervou
system
wherebi
immun
system
attack
myelin
symptom
includ
spastic
tremor
bladder
dysfunct
pain
current
therapi
betainterferon
copaxon
decreas
mriles
load
relaps
rate
howev
diseas
progress
larg
unaffect
therefor
novel
therapeut
agent
requir
ms
treatment
anecdot
evid
clinic
survey
suggest
mani
ms
patient
deriv
subject
improv
spastic
chronic
pain
spasm
smoke
marijuana
cannabinoid
agonist
mediat
effect
cannabinoid
receptor
cb
mainli
express
cn
neuron
involv
regul
neurotransmiss
contrast
express
peripher
thought
immunomodulatori
function
experiment
autoimmun
encephalomyel
eae
anim
model
ms
mediat
myelinspecif
cell
therefor
investig
use
synthet
cannabinoid
agonist
r
treat
ongo
eae
diseas
demonstr
treatment
r
onset
clinic
symptom
significantli
inhibit
diseas
sever
progress
associ
inhibit
myelin
specif
cell
prolifer
differenti
phenotyp
autoimmun
humor
respons
furthermor
therapeut
effect
absent
ifngammadefici
mice
conclus
cannabinoid
potent
therapeut
agent
may
benefici
ms
symptomat
treatment
spastic
immunosuppress
agent
rational
phospholipas
hydrolyz
phosphatidylcholin
lysophosphatidylcholin
arachidon
acid
aa
caus
myelin
breakdown
induc
inflamm
respect
two
major
form
cytosol
secret
thought
major
form
contribut
aa
releas
therefor
studi
role
pathogenesi
eae
anim
model
multipl
sclerosi
method
eae
gener
mice
natur
occur
null
mutat
major
form
sjlj
mice
contain
form
block
use
arachidonyl
trifluromethyl
keton
select
inhibitor
assess
role
onset
progress
diseas
inhibit
enzym
time
eae
induct
first
paralyt
attack
result
mice
sjlj
mice
treat
inhibitor
time
eae
induct
show
remark
decreas
incid
diseas
delay
treatment
peak
first
paralyt
episod
mice
also
result
signific
reduct
inflammatori
burden
recoveri
relapsingremit
diseas
conclus
find
suggest
inhibit
may
play
import
role
onset
progress
eae
estrogen
treatment
shown
exert
protect
effect
experiment
autoimmun
encephalomyel
eae
clinic
trial
multipl
sclerosi
ms
whilst
commonli
assum
estrogen
exert
effect
modul
immun
function
show
treatment
inhibit
mous
eae
without
affect
autoantigenspecif
cell
respons
cytokin
product
use
mutant
mice
estrogen
receptor
alpha
eralpha
unambigu
inactiv
found
eralpha
respons
inhibit
eae
next
gener
irradi
bone
marrow
chimera
eralpha
express
select
impair
inflammatori
lymphocyt
limit
radiosensit
hematopoiet
compart
data
show
protect
effect
clinic
eae
cnsinflamm
depend
eralphasign
inflammatori
cell
likewis
eae
develop
prevent
chimer
mice
select
express
eralpha
system
immun
compart
conclus
data
demonstr
benefici
effect
autoimmun
diseas
involv
eralphasign
bloodderiv
inflammatori
cell
indic
eralpha
express
tissu
cnsresid
microglia
endotheli
cell
mediat
effect
nacetylcystein
nac
wellknown
antioxid
act
scaveng
reactiv
oxygen
speci
precursor
reduc
glutathion
gsh
recent
report
nac
exert
also
immunomodulatori
activ
induct
polar
cell
respons
inhibit
b
cell
dendrit
cell
function
downregul
costimulatori
molecul
therefor
test
whether
nac
capabl
prevent
experiment
autoimmun
encephalomyel
eae
establish
model
multipl
sclerosi
nac
administr
oral
daili
dosag
mgml
drink
water
start
day
immun
significantli
prevent
eae
progress
compar
control
mice
associ
reduct
cn
infiltr
cell
macrophag
well
decreas
demyelin
test
nac
therapeut
protocol
diseas
progress
inhibit
compar
vehicletr
control
found
nac
inhibit
stimul
encephalitogen
cell
plu
mab
probabl
due
immmunosuppress
effect
nac
apc
level
also
show
nac
inhibit
cell
migrat
toward
chemokin
involv
cell
home
cn
data
indic
nac
effect
interfer
autoimmun
reaction
associ
eae
attempt
exploit
power
immunoregulatori
properti
transform
growth
factorbeta
tgfbeta
autoimmun
diseas
therapi
compromis
stimulatori
effect
fibrogenesi
extracellular
matrix
gener
tgfbetafunct
local
regul
activ
latent
tgfbeta
subsequ
intracellular
signal
via
smad
protein
block
tgfbetasignal
upregul
tgfbeta
proinflammatori
cytokin
hypothes
inhibit
enhanc
tgfbetasignal
site
local
inflamm
central
nervou
system
cn
administr
vivo
amelior
clinic
sign
activ
adopt
transfer
experiment
autoimmun
encephalomyel
diminish
cn
inflamm
result
increas
extracellular
matrix
format
autoreact
cell
expos
antigen
prime
secondari
activ
show
consider
reduc
encephalitogen
conclus
inhibit
repres
novel
system
treatment
strategi
target
autoimmun
inflamm
augment
tgfbetasignal
site
tgfbetaactiv
without
tgfbetaassoci
toxic
cell
activ
critic
step
develop
autoimmun
attack
brain
methyl
emerg
novel
posttransduct
mechan
involv
regul
cell
signal
found
previous
mta
inhibitor
methyl
reaction
prevent
macrophag
activ
murin
sepsi
model
method
experiment
autoimmun
encephalomyel
eae
induc
lewi
rat
immun
myelin
basic
protein
mbp
anim
treat
mta
microm
intraperiton
ip
daili
placebo
immun
clinic
histolog
score
compar
group
result
found
anim
treat
mta
milder
diseas
mean
clinic
score
mta
group
placebo
group
delay
onset
diseas
addit
mtatreat
anim
less
inflammatori
infiltr
demyelin
area
compar
placebo
anim
conclus
mta
potent
inhibitor
methyl
reaction
prevent
develop
full
autoimmun
respons
eae
model
therapeut
efficaci
novel
immunosuppress
antiinflammatori
agent
cellmedi
autoimmun
diseas
test
influenc
myelin
basic
protein
mbp
induc
experiment
autoimmun
encephalomyel
eae
anim
model
multipl
sclerosi
assess
onset
symptom
eae
lewi
rat
could
suppress
intraperiton
administr
induct
phase
diseas
diseas
suppress
associ
mark
suppress
mbpspecif
cell
reactiv
vitro
without
evid
gener
impair
cell
activ
collect
data
suggest
may
provid
novel
therapeut
option
cellmedi
autoimmun
diseas
anim
model
possibl
man
aim
present
studi
evalu
effect
murin
interferonbeta
mifnbeta
dexamethason
dex
myelin
oligodendrocyt
glycoprotein
mog
induc
experiment
autoimmun
encephalomyel
eae
femal
mice
murin
model
human
diseas
multipl
sclerosi
ms
eae
induc
subcutan
inject
mog
peptid
incomplet
freund
adjuv
mix
mycobacterium
tuberculosi
follow
intraperiton
inject
pertussi
toxin
mice
treat
subcutan
inject
mifnbeta
dose
unitsmous
dex
dose
mgkg
bodi
weight
treatment
start
day
eaeinduct
administr
everi
second
day
day
cours
diseas
follow
day
result
demonstr
signific
reduct
individu
averag
maximum
clinic
score
mice
treat
mgkg
dex
treatment
dex
also
effect
reduc
inflamm
demyelin
mice
eae
howev
effect
mifnbeta
signific
reduct
individu
maximum
clinic
score
mice
receiv
unit
mifnbeta
effect
ampa
antagonist
transient
focal
cerebr
ischemia
multipl
sclerosi
rat
k
ricz
g
gigler
albert
matucz
goston
benedek
j
czi
lg
g
g
egi
pharmaceut
ltd
budapest
hungari
role
ampa
receptor
pathogenesi
neurodegen
disord
well
establish
neg
alloster
modul
ampa
receptor
good
anticonvuls
neuroprotect
effect
anim
model
global
perman
focal
cerebr
ischemia
present
studi
compar
neuroprotect
effect
gyki
structur
analogu
compound
transient
focal
cerebr
ischemia
experiment
autoimmun
encephalomyel
eae
test
middl
cerebr
arteri
occlud
intralumin
min
use
monofila
effect
two
compound
administ
min
occlus
mgkg
ip
evalu
reperfus
gyki
reduc
core
respect
total
brain
infarct
respect
male
lewi
rat
treat
guinea
pig
myelin
basic
protein
induct
eae
compound
administ
mgkg
ip
twice
daili
day
start
day
immun
reduc
cumul
neurolog
score
partial
revers
histopatholog
damag
effect
gyki
signific
favour
neuroprotect
effect
indic
good
perspect
develop
treatment
stroke
multipl
sclerosi
object
studi
studi
undertaken
enlighten
influenc
major
effector
stress
responseendocrin
catecholamin
ca
neuron
releas
noradrenalin
develop
eae
method
adult
da
rat
treat
either
salin
propranolol
chlorid
g
day
pt
sc
day
begin
treatment
immun
guinea
pig
spinal
cord
homogen
complet
freund
adjuv
b
pertussi
vaccin
clinic
sing
diseas
maximum
express
thymocyt
thymocyt
prolif
apoptot
index
express
peripher
blood
lymphocyt
pbl
analyz
fca
result
pt
decreas
morbid
mortal
rate
diseas
propranololtr
rat
maxim
sign
diseas
well
durat
reduc
pt
affect
thymocyt
yield
alter
thymocyt
phenotyp
profil
percentag
cell
cell
rel
proport
subset
thymocyt
express
tcralphabeta
except
decreas
percentag
cell
increas
rel
number
pbl
decreas
cell
remain
unaffect
although
percentag
pbl
reduc
propranololtr
rat
multipl
sclerosi
ms
inflammatori
demyelin
diseas
central
nervou
system
wide
accept
autoimmun
play
signific
role
anim
model
equival
ms
experiment
autoimmun
encephalomyel
eae
implic
autoimmun
cell
respons
initi
factor
substanti
evid
compon
immun
system
recruit
ms
eae
caus
myelin
damag
neuronalaxon
injuri
complement
c
system
implic
myelinolyt
agent
man
experiment
anim
fluidphas
fragment
chemotact
phagocyt
cell
activ
mani
cell
type
describ
studi
effect
blockad
use
acf
opdchawr
welldocu
lewi
rat
model
eae
antibodymedi
demyelin
form
eae
adea
diseas
monitor
clinic
use
multipl
patholog
paramet
acf
opdchawr
treatment
effect
clinic
cours
patholog
outcom
either
primarili
inflammatori
eae
model
profoundli
demyelin
adea
model
heterodimer
cytokin
play
import
role
drive
differenti
helper
type
cell
cell
consid
key
factor
initi
autoimmun
inflammatori
demyelin
experiment
autoimmun
encephalomyel
eae
howev
recent
evid
show
dispens
pathogenesi
sever
eae
develop
absenc
respons
data
rais
possibl
immunomodulatori
action
diseas
model
object
studi
test
abil
exogen
modul
chronic
eae
induc
mous
use
tcell
prolifer
assay
elisa
flow
cytometri
realtim
pcr
histopatholog
character
autoimmun
respons
control
mice
found
suppress
eae
clinic
patholog
administ
earli
induct
phase
diseas
suppress
eae
accompani
induct
ifngamma
tnfalpha
inhibit
moginduc
cell
prolifer
treat
mice
ifngammadefici
mice
resist
diseas
suppress
also
inhibit
mrna
express
proinflammatori
cytokin
conclud
exogen
inhibit
eae
prematur
induct
autoreact
effector
cell
increas
ifngamma
inhibitori
effect
cell
addit
antiinflammatori
effect
may
mediat
inhibit
disrupt
tgfbetasign
pathway
macrophag
compart
impact
immunemedi
diseas
u
malipiero
f
ackermann
karlsson
b
k
buerki
u
koedel
c
fontana
univers
hospit
zurich
zurich
switzerland
b
lund
univers
lund
sweden
c
ludwigmaximilliansunivers
munich
germani
tgfbeta
famili
protein
secret
molecul
potent
immunoregulatori
properti
control
mani
activ
macrophag
express
mhcii
chemotaxi
product
cytokin
receptor
product
reactiv
oxygen
speci
nitric
oxid
activ
infiltr
macrophag
seen
variou
diseas
model
includ
experiment
allerg
encephalomyel
eae
bacteri
mening
latter
block
tgfbeta
current
studi
investig
role
tgfbeta
macrophag
compart
inflammatori
autoimmun
diseas
model
order
interrupt
tgfbetasign
pathway
macrophag
delet
trii
breed
flox
trii
mice
mice
express
cre
recombinas
macrophagespecif
mous
lysozymem
promot
cultur
bone
marrow
cell
mice
devoid
trii
macrophagemonocyt
lineag
cell
show
delet
exon
trii
gene
lpsinduc
product
tnfalpha
inhibit
tgfbeta
creexpress
macrophag
macrophag
wildtyp
anim
show
reduct
tnfalpha
secret
presenc
tgfbeta
result
show
disrupt
tgfbetasign
pathway
macrophag
tgfbeta
macrophag
receptor
knockout
mice
current
test
eae
bacteri
mening
analyz
diseas
progress
disturb
tgfbetasign
macrophag
compart
bechtold
et
al
ann
neurol
press
led
us
question
whether
agent
might
affect
cell
activ
vitro
rat
lymph
node
cell
stimul
phytohemagglutinin
presenc
flecainid
lamotrigin
phenytoin
agml
exhibit
reduct
proport
icam
cell
cultur
condit
lamotrigin
also
caus
decreas
cell
prolifer
decreas
observ
flecainid
phenytoin
effect
flecainid
cell
activ
also
examin
follow
subcutan
inject
anim
eae
induc
immunis
spinal
cord
homogen
administr
flecainid
mgkgday
day
postimmunis
alter
percentag
cell
posit
result
reduct
proport
icam
cell
summari
result
show
sodium
channel
block
agent
affect
cell
function
vitro
vivo
myelinspecif
cell
receptor
transgen
cell
vaccin
dna
encod
myelin
oligodendrocyt
glycoprotein
mog
peptid
suppress
experiment
autoimmun
encephalomyel
eae
induc
peptid
eae
anim
model
multipl
sclerosi
ms
activ
induc
immun
myelin
protein
peptid
cpg
dna
content
plasmid
dna
backbon
necessari
effici
dna
vaccin
eae
recent
demonstr
suppress
mechan
involv
induct
interferonbeta
data
great
interest
sinc
interferonbeta
use
mstherapi
human
studi
transcript
gene
use
cdna
microarray
spleen
dna
vaccin
rat
rel
control
rat
peak
diseas
plasmacytoid
dendrit
cell
pdc
associ
gene
defin
mice
human
pdc
differenti
express
dnavaccin
rat
compar
control
contrast
human
system
lupu
erythematosu
sle
pdc
suggest
involv
pathogenesisour
data
may
indic
pdc
mediat
protect
eae
possibl
via
endogen
product
interferonbeta
activ
crucial
eae
ms
develop
membran
molecul
express
earli
lymphocyt
activ
therapi
inhibit
antigenrespons
studi
role
therapeut
potenti
mab
eae
ms
use
mab
character
celltyp
specif
ms
lesion
mab
effect
eae
mice
immun
peptid
studi
compar
clinic
sign
brain
immunohistochemistri
lymphocyt
prolifer
cytokin
level
mabtreat
untreat
anim
tcell
domin
celltyp
acut
chronic
ms
lesion
day
mabpretr
eae
mice
lower
mean
clinic
score
sem
compar
eae
control
suggest
mab
inhibit
eae
develop
addit
mab
halt
clinic
progress
establish
eae
day
mabtreat
mice
score
compar
control
clinic
improv
typic
accompani
reduc
mononuclear
cell
infiltr
eae
lesion
mabtreat
compar
untreat
mice
mab
effect
immunologicallyselect
treat
mice
lower
splenocyt
ifngamma
express
reduc
tcell
prolifer
compar
control
pilot
data
suggest
involv
pathogenesi
eae
possibl
ms
mab
potenti
ms
therapi
select
immunomodulatori
effect
phenotyp
kinet
csf
b
cell
inflammatori
cn
diseas
cepok
f
vogel
v
grummel
hofmann
b
hemmer
clinic
neuroimmunolog
group
depart
neurolog
philipp
univers
marburg
germani
b
cell
frequent
found
cerebrospin
fluid
csf
patient
neuroinflammatori
diseas
like
multipl
sclerosi
ms
variou
infecti
cn
diseas
object
present
studi
character
phenotyp
kinet
b
cell
subpopul
csf
blood
patient
ms
infecti
diseas
order
dissect
differ
chronic
acut
inflammatori
cn
diseas
purpos
perform
serial
analys
csf
blood
cell
flowcytometri
patient
ms
acut
infecti
diseas
lyme
meningoradicul
viral
mening
plasma
cell
b
cell
detect
patient
ms
acut
infecti
diseas
cn
contrast
peripher
blood
b
cell
csf
show
memori
phenotyp
express
csf
b
cell
also
downregul
sever
b
cell
marker
like
plasma
cell
upregul
compar
peripher
plasmacel
interestingli
determin
serial
analysi
differenti
kinet
pattern
ms
patient
observ
compar
acut
infecti
diseas
ms
patient
cell
plasma
cell
remain
stabl
year
accompani
stabl
igg
synthesi
contrast
infecti
diseas
plasmacel
drop
immedi
within
week
pathogen
remov
data
demonstr
ms
perman
stabl
activ
humor
immun
system
occur
multipl
sclerosi
ms
character
increas
intrathec
synthesi
immunoglobulin
unknown
specif
presenc
bcell
clonal
expans
central
nervou
system
cn
ectop
lymphoid
tissu
develop
site
chronic
inflamm
thought
sustain
local
immun
process
investig
whether
abnorm
bcell
follicl
could
identifi
cn
ms
patient
section
postmortem
ms
brain
spinal
cord
examin
immunohistochemistri
presenc
b
cell
plasma
cell
cell
follicular
dendrit
cell
express
lymphoid
chemokin
lymphoid
folliclelik
structur
contain
b
cell
cell
plasma
cell
follicular
dendrit
cell
produc
observ
cerebr
mening
two
three
patient
secondari
progress
ms
relapsingremit
primari
progress
ms
prolifer
b
cell
detect
intramening
follicl
find
suggest
germin
center
format
despit
accumul
numer
b
cell
plasma
cell
around
blood
vessel
folliclelik
structur
identifi
white
matter
lesion
format
ectop
lymphoid
follicl
mening
patient
ms
could
play
role
maintain
humor
auto
immun
diseas
progress
full
matur
process
b
cell
csf
suggest
exist
intrathec
lymphoidlik
compart
subject
ms
inflammatori
disord
cn
uccelli
casazza
e
ferretti
b
giunti
e
zappia
pistorio
b
c
gambini
c
gl
mancardi
v
pistoia
c
neuroimmunolog
unit
depart
neurosci
ophthalmolog
genet
genoa
itali
b
laboratori
oncolog
g
gaslini
institut
genoa
itali
c
laboratori
patholog
g
gaslini
institut
genoa
itali
clonal
expand
popul
hypermut
b
cell
detect
cn
ms
subject
suggest
process
b
cell
affin
matur
may
occur
insid
cn
character
flow
cytometri
b
cell
subset
identifi
within
csf
ms
patient
individu
inflammatori
neurolog
disord
oind
centroblast
subset
exclus
repres
within
lymphoid
organ
detect
csf
peripher
blood
pb
patient
group
memori
b
cell
repres
hypermut
b
cell
significantli
increas
csf
vs
pb
group
memori
b
cell
express
high
level
costimulatori
molecul
upregul
suggest
activ
state
lymphotoxinalpha
key
player
lymphoid
neogenesi
present
csf
ms
oind
patient
express
ms
brain
tissu
provid
favour
microenviron
b
cell
matur
studi
suggest
compartiment
b
cell
respons
occur
within
cn
ongo
inflammatori
reaction
evolv
stage
b
cell
differenti
observ
secondari
lymphoid
organ
baff
product
human
brain
astrocyt
brain
multipl
sclerosi
ms
provid
longterm
surviv
nich
b
cell
plasma
cell
give
rise
persist
oligoclon
ig
b
cell
activ
factor
tnf
famili
baff
play
crucial
role
b
cell
surviv
report
baff
express
normal
human
brain
produc
astrocyt
vitro
baff
transcript
found
gray
white
matter
amount
lymphat
tissu
tonsil
adenoid
splice
variant
deltabaff
express
lower
level
fulllength
variant
brain
lymphat
tissu
baff
regular
compon
normal
spinal
fluid
demonstr
brain
astrocyt
doublefluoresc
microscopi
cultur
human
astrocyt
secret
high
amount
baff
stimul
ifngamma
tnfalpha
mediat
furinlik
proteas
quantiti
baff
secret
per
astrocyt
manifold
higher
monocyt
macrophag
ms
lesion
express
baff
elev
seen
quantit
pcr
baff
local
astrocyt
baff
receptor
baffr
found
infiltr
immun
cell
studi
establish
believ
first
time
nonimmun
cell
type
produc
substanti
amount
baff
baff
product
cn
might
contribut
long
term
surviv
b
cell
ms
brain
panel
novel
candid
antigen
multipl
sclerosi
reveal
phage
cdna
display
v
somer
c
govart
j
rau
p
stinissen
biomedisch
onderzoeksinstituut
biom
limburg
universitair
centrum
univers
limburg
diepenbeek
belgium
cerebrospin
fluid
csf
patient
clinic
definit
multipl
sclerosi
ms
character
presenc
oligoclon
antibodi
use
diagnost
test
howev
despit
intens
research
antibodi
specif
remain
unknown
identifi
immunogen
target
recogn
humor
immun
respons
ms
focu
novel
method
call
bserolog
antigen
select
sa
q
base
phage
display
first
construct
cdna
display
librari
clone
normal
cdna
librari
prepar
activ
chronic
ms
plaqu
vari
degre
demyelin
inflammatori
activ
soar
et
al
express
fusion
protein
filament
phage
minor
coat
protein
pvi
cdna
display
librari
enrich
pool
csf
relapsingremit
ms
patient
identifi
panel
nine
differ
clone
reactiv
csf
pool
detail
serolog
analysi
nine
differ
antigen
larg
panel
individu
patient
control
csf
show
exclus
reactiv
ms
patient
csf
eight
differ
antigen
sequenc
analysi
reveal
clone
never
associ
ms
conclus
find
demonstr
novel
molecular
approach
use
identifi
novel
candid
antigen
ms
use
diseas
marker
use
studi
humor
immun
respons
ms
approach
identif
target
autoantibodi
multipl
sclerosi
et
littleton
j
palac
vincent
oxford
univers
oxford
uk
find
multipl
sclerosi
ms
patient
oligoclon
igg
band
upon
isoelectr
focus
cerebrospin
fluid
partial
clinic
respons
immunosuppress
drug
support
theori
role
antibodi
diseas
howev
previous
employ
candid
antigenbas
approach
usual
involv
elisa
assay
fail
identifi
patholog
relev
antibodi
antigen
hypothesis
antigen
target
relev
antibodi
would
locat
cell
membran
neuron
oligodendrogli
cell
develop
approach
use
identifi
target
antigen
first
appli
demonstr
musclespecif
kinas
musk
muscl
cell
target
myasthenia
gravi
appli
context
ms
use
immunocytochemistri
flow
cytometri
show
myasthenia
gravi
patient
sera
contain
antibodi
musk
bind
muskexpress
te
rhabdomyosarcoma
cell
musk
immunoprecipit
te
cell
extract
sera
identifi
western
blot
appli
approach
found
relapsingremit
secondari
progress
ms
patient
sera
contain
igg
antibodi
bound
sknsh
neuroblastoma
cell
use
neuron
antibodycontain
ms
sera
immunoprecipit
antigen
biotinlabel
sknsh
cell
extract
isol
antigen
western
blot
immunoprecipit
immunoprecipit
antigen
identifi
protein
sequenc
syndrom
gb
post
infecti
polyradiculoneuropathi
character
demyelin
axon
degener
peripher
nerv
phagocyt
glycolipid
gangliosid
specif
antibodi
thought
involv
pathogenesi
recent
document
inflammatori
capac
gbsassoci
igg
measur
leukocyt
degranul
phagocytosi
addit
experi
show
sera
contain
induc
leukocyt
activ
measur
degranul
respect
patient
sera
investig
leukocyt
activ
iggreceptor
fcgammar
depend
shown
block
studi
use
fcgammarspecif
antibodi
addit
pool
gammaglobulin
ivig
use
treatment
gb
reduc
gangliosidespecif
igginduc
leukocyt
activ
dosedepend
way
result
indic
gangliosidespecif
igg
contain
proinflammatori
activ
ivig
may
reduc
function
new
genesnew
target
therapi
myasthenia
gravi
souroujon
feferman
b
revit
b
p
maiti
b
berrihaknin
c
fuch
b
open
univers
israel
tel
aviv
israel
b
weizmann
institut
scienc
rehovot
israel
c
centr
nation
de
la
recherch
scientifiqu
ipsc
hopit
mari
lannelongu
le
plessi
robinson
franc
new
gene
involv
pathogenesi
experiment
autoimmun
myasthenia
gravi
eamg
identifi
dna
microarray
technolog
differenti
express
gene
associ
myasthenia
focus
gene
code
phosphodiesteras
pde
chemokineswhich
respect
involv
lymphocyt
activ
differenti
migrat
target
tissu
microarray
analysi
support
real
time
rtpcr
reveal
signific
increas
mrna
level
specif
pde
subtyp
lymph
node
cell
muscl
myasthen
rat
pentoxifyllin
ptx
gener
pde
inhibitor
suppress
ongo
eamg
led
downregul
pde
subtyp
tnfalpha
effect
ifngamma
tgfbeta
result
suggest
ptx
may
futur
serv
potenti
drug
immunotherapi
myasthenia
gravi
human
mrna
level
chemokin
mig
receptor
upregul
myasthen
rat
reduc
eamg
suppress
signific
increas
mrna
level
also
observ
thymus
muscl
myasthen
patient
result
suggest
signal
potenti
target
immunotherapi
myasthenia
gravi
delet
fcreceptorgamma
abrog
encephalitogen
effector
cell
eae
e
urich
b
becher
depart
neurolog
neuroimmunolog
unit
univers
zurich
zurich
switzerland
role
blymphocyt
autoantibodi
experiment
autoimmun
encephalomyel
eae
remain
heavili
debat
report
b
cell
irrelev
develop
eae
use
b
celldefici
mice
other
shown
antibodi
central
requir
furthermor
mice
defici
fcreceptor
fcr
shown
resist
develop
eae
fcr
recogn
immunoglobulin
thu
requir
fcr
develop
eae
appar
conflict
find
obtain
use
b
celldefici
mice
determin
underpin
paradox
use
b
celland
fcrgammadefici
mice
establish
function
role
molecul
induct
eae
confirm
b
cell
defici
mice
fulli
suscept
develop
moginduc
eae
regardless
whether
peptid
recombin
mog
use
immun
contrast
find
mice
defici
fcrgamma
shown
eaeresist
preliminari
data
indic
combin
mutat
fcrgamma
phenotyp
domin
bcellfcrgamma
defici
mice
eaeresist
data
show
fcrgamma
chain
recruit
tcr
complex
effector
cell
ablat
fcrgamma
lesion
cell
compart
rather
fcreceptor
bear
cell
taken
togeth
data
dismiss
involv
humor
immun
moginduc
eae
demonstr
fcrgammadelet
affect
lymphocyt
rather
fcrbear
accessori
cell
induct
effector
phase
experiment
allerg
encephalomyel
independ
fc
gamma
chain
e
breij
heijnen
r
vloet
j
van
immunoglobulin
igg
receptor
fcgammar
implic
induct
experiment
allerg
encephalomyel
eae
address
role
fcgammar
effector
phase
eae
use
induct
protocol
abl
reproduc
induc
chronic
eae
fcr
mice
lack
stimulatori
fcgammar
fcgammari
fcgammariii
diseas
incid
sever
similar
eae
wild
type
wt
mice
howev
diseas
onset
significantli
delay
suggest
role
fcr
gammachain
signal
earli
immunolog
event
result
eae
model
use
bcell
independ
therefor
interact
myelinspecif
antibodi
fcgammar
unlik
contribut
diseas
induct
fcr
gammachain
involv
number
antibodyindepend
signal
pathway
propos
delay
onset
eae
fcr
mice
result
disturb
one
pathway
rather
defici
antibodyfcgammar
interact
subsequ
investig
role
fcgammr
antibodyenhanc
eae
monoclon
antimog
antibodi
mab
previous
shown
enhanc
clinic
eae
eae
induc
wt
fcr
mice
group
inject
mg
mab
diseas
onset
wt
fcrg
mice
mab
sever
enhanc
eae
reveal
clinic
score
immunocytochem
analysi
cn
result
demonstr
antimyelin
antibodi
enhanc
clinic
eae
absenc
stimulatori
fcgammar
discrimin
pattern
igg
self
reactiv
brain
antigen
describ
multipl
sclerosi
ms
patient
highlight
possibl
b
cell
involv
defin
sequenc
humor
event
involv
selfreact
igg
repertoir
sequenti
compar
experiment
autoimmun
encephalomyel
eae
mice
control
mice
eae
induc
immun
sjlj
mice
proteolipid
protein
control
group
compris
either
mice
receiv
complet
freund
adjuv
cfa
pertussi
toxin
healthi
mice
sera
collect
weekli
test
immunoblot
assay
use
healthi
mice
brain
homogen
statist
procedur
linear
discrimin
analysi
indic
selfreact
igg
repertoir
significantli
differ
group
mice
day
day
character
discrimin
antigen
involv
might
provid
new
tool
understand
mechan
underli
initi
progress
eae
ms
intracerebr
express
baff
format
bfolliclelik
structur
mening
mice
experiment
autoimmun
encephalomyel
columbacabeza
r
magliozzi
b
serafini
f
aloisi
depart
cell
biolog
neurosci
istituto
superior
di
rome
itali
given
abnorm
bcell
activ
occur
central
nervou
system
cn
multipl
sclerosi
patient
investig
whether
autoimmun
trigger
cn
express
molecul
regul
develop
function
organ
lymphoid
follicl
site
bcell
respons
initi
found
gene
express
chemokin
facilit
bcell
recruit
follicl
baff
regul
bcell
surviv
markedli
upregul
cn
sjl
mice
plp
relapsingremit
experiment
autoimmun
encephalomyel
eae
use
immunohistochemistri
folliclelik
structur
contain
b
cell
reticulum
follicular
dendrit
cell
identifi
brain
stem
mening
proport
relaps
mice
prolifer
b
cell
also
detect
inflam
mening
intracistern
inject
lymphotoxinbeta
receptorig
fusion
protein
block
action
lymphotoxin
alphabeta
key
cytokin
lymphoid
organ
develop
either
delay
complet
suppress
eae
relaps
reduc
bcell
prolifer
cn
line
recent
observ
ms
find
indic
less
immun
privileg
mening
compart
might
promot
autoreact
bcell
respons
also
suggest
local
target
molecul
involv
bcell
immun
lymphoid
tissu
develop
consid
possibl
therapeut
strategi
control
cn
autoimmun
diseas
background
mast
cell
element
allerg
immun
respons
particip
regul
immun
respons
associ
pathogenesi
eae
shown
previou
studi
pattern
selfigg
reactiv
could
model
patholog
process
underli
variou
form
multipl
sclerosi
sequenc
event
involv
eae
work
evalu
incid
antiallerg
drug
igg
reactiv
brain
homogen
method
eae
induc
immun
sjlj
mice
one
group
mice
treat
daili
immun
pyrilamin
histamin
receptor
antagonist
group
mice
platelet
activ
factor
receptor
pafr
antagonist
control
eae
group
receiv
pb
sera
collect
weekli
sequenti
igg
immunoreact
profil
perform
western
blot
brain
homogen
analyz
statist
procedur
result
expect
clinic
sign
eae
delay
reduc
mice
treat
pyrilamin
analysi
antibodi
pattern
show
evolv
distinctli
three
group
mice
moreov
discrimin
analysi
indic
selfreact
antibodi
repertoir
differ
significantli
group
mice
conclus
pyrilamin
reduc
significantli
clinic
sign
eae
data
show
analysi
immun
profil
could
indic
marker
evalu
diseas
progress
diseas
resolut
autoimmun
disord
eae
studi
natur
oligoclon
igg
singlecel
rtpcr
use
character
ig
repertoir
blymphocyt
plasma
cell
ms
csf
sequenc
analysi
amplifi
heavyand
lightchain
variabl
v
region
identifi
rearrang
germlin
segment
extent
somat
mutat
clonal
relationship
within
cell
popul
expand
blymphocyt
plasma
cell
clone
detect
csf
includ
csf
examin
clinic
isol
syndrom
comparison
repertoir
csf
show
repertoir
restrict
contain
larger
number
clone
share
littl
sequenc
overlap
correspond
repertoir
identifi
put
antigen
target
ms
oligoclon
igg
develop
transient
mammalian
express
system
produc
recombin
antibodi
util
rearrang
vregion
sequenc
plasma
cell
clone
recombin
igg
use
variou
immunoassay
includ
screen
cdna
express
librari
random
peptid
librari
identifi
potenti
target
ms
oligoclon
igg
antibodi
nativ
myelinoligodendrocyteglycoprotein
multipl
sclerosi
patient
gaertner
kl
de
graaf
r
weissert
herti
institut
clinic
brain
research
germani
best
character
autoantigen
autoantibodi
mediat
myelin
destruct
multipl
sclerosi
ms
myelinoligodendrocyteglycoprotein
mog
mog
glycoprotein
aa
immunoglobulin
superfamili
express
surfac
myelin
sheath
nativ
mog
purifi
mogtransfect
cell
affin
purif
igm
igg
mogspecif
antibodi
sera
ms
patient
control
determin
elisa
igm
antibodi
nativ
mog
elev
patient
first
demyelin
event
compar
control
detect
high
antimog
igg
respons
patient
acut
diseas
exacerb
secondari
chronic
progress
diseas
compar
control
contrast
patient
remiss
elev
igg
antibodi
titer
thess
data
underscor
relev
conform
glycosyl
mog
recognit
full
repertoir
mogspecif
ig
ms
patient
propos
antibodi
nativ
mog
may
potenti
diagnost
test
ms
possibl
surrog
marker
therapi
determin
threedimension
structur
extracellular
domain
mog
mogex
mogex
complex
antigen
bind
fragment
fab
use
xray
crystallographi
demyelin
monoclon
mous
antibodi
recognis
pure
conformationdepend
epitop
vast
major
demyelin
mogspecif
antibodi
complex
structur
first
structur
classic
hidden
autoantigen
complex
antibodi
reveal
highli
discontinu
epitop
membranedist
side
mog
homologu
mog
express
outsid
central
nervou
system
abl
induc
bcell
toler
interestingli
residu
bound
least
conserv
mog
rel
despit
epitop
discontinu
one
loop
mog
domin
interact
conform
amino
acid
form
loop
howev
strain
maintain
surround
loop
structur
provid
simpl
explan
failur
detect
region
peptid
map
linear
peptid
wide
accept
autoimmun
respons
myelin
compon
play
import
role
pathogenesi
multipl
sclerosi
ms
aim
current
project
find
new
myelin
antigen
immunogen
ms
purifi
human
myelin
glycoprotein
sucros
gradient
centrifug
subsequ
lentillectin
affin
chromatographi
sera
ms
patient
control
screen
elisa
western
blot
wb
addit
immunoadsorpt
eluat
ms
control
patient
use
screen
western
blot
elisa
experi
found
increas
reactiv
human
myelin
glycoprotein
ms
patient
versu
control
patient
wb
seri
protein
differ
molecular
weight
recogn
ms
patient
control
wb
protein
spot
recogn
immunoadsorpt
eluat
ms
patient
ident
protein
spot
could
identifi
mass
spectrometri
thu
use
proteom
approach
could
identifi
novel
candid
autoantigen
humor
immun
respons
ms
ongo
studi
recombin
protein
clarifi
protein
predomin
target
immun
respons
ms
multipl
sclerosi
ms
chronic
inflammatori
diseas
central
nervou
cn
system
increas
evid
studi
experiment
autoimmun
encephalomyel
eae
ms
suggest
involv
autoreact
antibodi
immunopathogenesi
cn
demyelin
understand
involv
cnsreactiv
autoantibodi
studi
immunoglobulin
gene
rearrang
respect
antigen
specif
individu
band
plasma
cell
ms
lesion
immunoglobulin
heavi
h
light
l
chain
gene
individu
microdissect
cell
amplifi
rtpcr
rearrang
h
l
chain
gene
clone
vector
system
suitabl
express
recombin
antibodi
screen
antigen
specif
order
identifi
conformationdepend
epitop
current
establish
eukaryot
express
librari
human
brain
tissu
use
highli
purifi
mrna
differ
cn
region
gener
cdna
librari
contain
independ
clone
high
proport
fulllength
cdna
insert
rang
kb
cdnalibrari
clone
viral
vector
system
surfac
express
cn
antigen
mammalian
cell
provid
correct
fold
glycosyl
eukaryot
express
librari
provid
essenti
tool
screen
identif
novel
target
autoantigen
multipl
sclerosi
understand
role
autoantibodi
pathogenesi
ms
structurebas
design
glycopeptid
glc
abl
recogn
specif
autoab
sera
import
subgroup
ms
patient
autoimmun
condit
autoab
detect
use
glycosyl
antigen
ag
recogn
conform
epitop
glycopeptid
librari
base
aminoacid
structur
divers
screen
competit
elisa
ms
patient
sera
control
demonstr
relev
epitop
contain
asn
glc
moieti
expos
tip
betahairpin
structur
moreov
aminoacid
sequenc
import
correct
epitop
access
isol
glc
ab
recogn
myelin
oligodendrocyt
ag
instrument
isol
correspond
nativ
ag
proteom
approach
base
highresolut
mass
spectrometri
lead
characteris
molecular
level
valu
glc
appear
longitudin
studi
untreat
ms
patient
report
preliminari
data
ongo
trial
rituximab
relaps
multipl
sclerosi
ms
patient
suboptim
respons
standard
therapi
rituximab
chimer
monoclon
antibodi
deplet
circul
b
cell
object
assess
safeti
effect
b
cell
antibodi
ms
patient
number
enhanc
lesion
mri
primari
endpoint
still
blind
present
result
patient
treat
two
discontinu
drug
one
due
fever
one
short
breath
nine
patient
treat
four
dose
mgm
without
seriou
side
effect
week
posttreat
chang
cerebrospin
fluid
csf
oligoclon
band
number
igg
concentr
serum
antibodi
myelin
oligodendrocyt
glycoprotein
myelin
basic
protein
seen
proport
b
cell
csf
reduc
six
eight
patient
csf
igg
synthet
rate
decreas
five
eight
two
patient
detect
neutral
antibodi
beta
interferon
titer
decreas
one
baselin
becam
posit
one
treatment
eight
patient
reach
week
time
walk
improv
four
stabl
three
wors
one
conclus
rituximab
appear
safe
ms
patient
deplet
circul
b
cell
less
robust
effect
csf
b
cell
igg
synthesi
support
nmss
usa
genentech
turner
syndrom
associ
syndrom
complex
autoimmun
serolog
profil
case
report
losi
b
lori
r
salti
stagi
ospedal
pediatrico
meyer
florenc
itali
b
azienda
ospedaliera
di
careggi
florenc
itali
turner
syndrom
ts
associ
autoimmun
disord
thyroid
celiac
diseas
inflammatori
bowel
diseas
juvenil
rheumatoid
arthriti
type
diabet
mellitu
celiac
diseas
turn
associ
sever
autoimmun
disord
neurolog
diseas
particular
peripher
neuropathi
cerebellar
ataxia
report
young
femal
patient
diagnos
ts
karyotyp
subsequ
laboratori
examin
reveal
presenc
serum
antibodi
gliadin
endomisium
tissu
transglutaminas
nucleu
smooth
muscl
microsom
thyroglobulin
hla
analysi
reveal
presenc
februari
duoden
biopsi
show
increas
intraepitheli
lymphocyt
potenti
celiac
diseas
diagnos
normal
thyroid
function
august
admit
hospit
histori
increas
weak
four
limb
basi
laboratori
electrophysiolog
examin
diagnos
acut
motor
axon
neuropathi
aman
pure
motor
axon
variant
syndrom
treat
intraven
immunoglobulin
high
titer
anti
sulfatid
phosphatidylinositol
antibodi
serolog
evid
recent
coxsacki
b
viru
infect
first
descript
associ
ts
aman
patient
complex
serolog
profil
autoimmun
acetylcholinesteras
use
screen
drug
treat
patient
human
brain
prove
anion
subsit
acetylcholinesteras
ach
torpedo
construct
part
conform
epitop
direct
mcab
enzym
paper
cross
immunoact
mcab
ach
bovin
erythrocyt
ach
human
erythrocyt
ach
human
brain
ach
detect
enzymelink
immunosorb
assay
dotblot
immunoassay
result
show
ach
react
well
antibodi
mcab
react
ach
except
torpedo
ach
suggest
anion
subsit
ach
bovin
erythrocyt
human
brain
erythrocyt
differ
torpedo
ach
although
ester
subsit
contain
activ
serin
thu
recommend
ach
human
brain
use
mark
enzym
appli
select
drug
treat
patient
alzheim
diseas
organophosph
poison
order
get
effect
drug
man
natur
autoantibodi
neurofila
protein
alphainternexin
human
sera
k
teesalu
rajasalu
pa
janmey
b
r
uibo
univers
tartu
tartu
estonia
b
univers
pennsylvania
philadelphia
usa
serum
autoantibodi
aab
pituitari
antigen
associ
autoimmun
hypophys
idiopath
hypopituitar
autoimmun
endocrinopathi
aim
present
studi
character
main
aab
reactiv
pituitari
antigen
patient
idiopath
hypopituitar
type
diabet
use
immunoblot
method
sera
six
patient
idiopath
hypopituitar
patient
type
diabet
healthi
control
studi
frequent
patient
serum
igg
reactiv
observ
human
pituitari
antigen
crossreact
kda
protein
rat
brain
identifi
alphainternexin
alphainx
proteom
method
use
alphainx
contain
cytoskelet
extract
aab
screen
igg
igm
aab
neuronspecif
type
iv
intermedi
filament
protein
found
patient
sera
well
healthi
subject
signific
differ
frequenc
group
level
igm
alphainx
aab
higher
patient
hypopituitar
compar
healthi
control
mannwhitney
utest
addit
first
demonstr
common
occurr
alphainx
aab
human
sera
aab
also
frequent
found
neurofila
heavi
subunit
nfh
known
target
natur
aab
rel
rare
neuron
protein
conclud
alphainx
aab
belong
natur
aab
repertoir
physiolog
function
need
elucid
mechan
immun
respons
myasthen
thymu
kamo
h
tomoyasu
b
yamamoto
c
kusakab
kikuchi
e
school
medicin
toho
univ
sagamihara
japan
b
ohmori
red
cross
hospit
ohmori
japan
c
institut
medic
scienc
univ
tokyo
tokyo
japan
anb
tsukuba
institut
tsukuba
japan
e
nation
institut
neurosci
tokyo
japan
mg
autoimmun
diseas
induc
autoantibodi
selfachr
thymectomi
result
clinic
effect
suggest
thymu
play
central
role
antibodi
product
howev
immunopatholog
mechan
effect
elucid
aim
understand
mechan
mg
thymi
use
immunohisthochem
stain
bcell
marker
ifngamma
haemopoiet
factor
nude
mous
splenocyt
vitro
immun
respons
srbc
hyperplast
mg
thymi
commonli
contain
mani
produc
cell
bcell
essenti
lack
infgamma
produc
cell
mg
thymi
also
contain
mani
myoid
lineag
cell
produc
haemopoiet
factor
thu
mg
thymi
new
cytokin
network
develop
design
vitro
immun
respons
system
consist
nude
mous
splenocyt
solubl
factor
mimic
microenviron
hyperplast
mg
thymu
alon
induc
small
number
antisrbcantibodi
produc
cell
howev
myoid
cell
haemopoiet
factor
ad
togeth
mani
antisrbc
produc
bcell
detect
igg
subclass
also
induc
secondari
respons
result
suggest
hyperplast
mg
thymu
gener
new
bcell
stimulatori
mechan
found
peripheri
antimog
autoantibodi
sera
patient
myasthenia
gravi
thymoma
c
cappelletti
p
cristaldini
p
bernasconi
f
andreetta
simoncini
f
baggi
f
cornelio
r
mantegazza
nation
neurolog
institut
bcarlo
bestaq
milan
itali
thymoma
neoplasm
thymic
epitheli
origin
commonli
associ
myasthenia
gravi
mg
mg
patient
thymoma
antibodi
postsynapt
nicotin
acetylcholin
receptor
antititin
antiryanodin
receptor
antibodi
posit
predict
valu
thymoma
detect
respect
seem
autoantibodi
produc
within
thymoma
nevertheless
antibodi
differ
antigen
associ
thymoma
test
antihuman
recombin
mog
antibodyspecif
elisa
mg
sera
posit
antiachr
antibodi
thymic
hyperplasia
thymoma
seroneg
ten
patient
posit
antimog
antibodi
posit
one
stratifi
accord
thymu
histolog
six
patient
posit
thymoma
analyz
mogspecif
transcript
express
mg
thymu
specimen
posit
signal
found
differ
patholog
thymic
alter
hyperplasia
involut
thymoma
variabl
intens
differ
data
previous
report
eur
j
immunol
mog
express
observ
nonpatholog
young
thymus
result
suggest
thymomaassoci
immun
dysregul
underli
gener
antibodi
toward
differ
self
antigen
whose
pathogenet
role
remain
defin
measur
autoantibodi
muscl
specif
tyrosin
kinas
receptor
musk
may
use
assess
manag
patient
acetylcholin
receptor
antibodi
achrab
neg
myasthenia
gravi
mg
develop
new
conveni
assay
muskab
measur
base
purifi
recombin
musk
addit
use
rat
human
recombin
musk
assay
assess
assay
serum
sampl
al
incub
al
rat
human
immun
complex
form
precipit
antihuman
igg
microlitr
muskab
detect
rang
nmoll
musk
bound
sera
achrabneg
mg
patient
studi
contrast
muskab
detect
achrabposit
mg
patient
sera
furthermor
lamberteaton
myasthen
syndrom
sera
nonmg
neuromuscular
diseas
sera
control
autoimmun
diseas
sera
healthi
blood
donor
sera
contain
detect
muskab
interassay
coeffici
variat
cv
sampl
muskab
nmoll
respect
intraassay
cv
sampl
muskab
nmoll
respect
similar
result
obtain
rat
human
musk
overal
immunoprecipit
assay
develop
provid
simpl
specif
precis
procedur
detect
muskab
continu
attempt
antigenspecif
suppress
immun
system
urbatsch
il
sterz
rkm
peper
k
trommer
eur
j
immunol
fusion
protein
compos
amino
acid
extracellular
domain
human
acetylcholin
receptor
human
muscl
plant
toxin
gelonin
express
e
coli
gelonin
potent
singl
chain
type
ribosomeinactiv
protein
due
lack
b
chain
type
ii
toxin
activ
intact
cell
recombin
gelonin
glycosyl
twice
activ
vitro
translat
assay
nativ
toxin
fusion
protein
form
inclus
bodi
could
solubil
presenc
guanidinium
chlorid
exhibit
nativ
structur
shown
antibodi
recogn
conform
epitop
half
maxim
inhibit
translat
achiev
ngml
compar
ngml
nativ
gelonin
recombin
product
use
therapeut
agent
treatment
myasthenia
gravi
current
investig
myasthen
rat
autoimmun
agrypnia
due
autoantibodi
gabab
receptor
g
frisullo
g
della
marca
mirabella
caggiula
g
mennuni
p
tonali
ap
batocchi
institut
neurolog
cathol
univers
rome
itali
describ
clinic
featur
woman
sever
relapsingremit
episod
agrypnia
continu
hz
activ
pattern
eeg
record
dysautonom
symptom
nocturn
respiratori
failur
plasma
exchang
highdos
corticosteroid
treatment
induc
remiss
clinic
symptom
recoveri
rem
nrem
sleep
immunohistochemistri
show
incub
patient
serum
csf
intens
immunoreact
brainstem
hippocampu
cerebellum
granular
layer
use
western
blot
patient
igg
recogn
kda
protein
mous
cerebellum
cortex
brainstem
immunohistochem
analysi
patient
purifi
igg
show
bind
gabaerg
synapserich
neuron
cell
preincub
mous
cerebellum
section
patient
igg
complet
abolish
stain
obtain
antibodi
use
antigad
antibodi
evalu
pathogen
patient
antibodi
purifi
igg
differ
concentr
inject
cisterna
magna
mice
preimplant
two
eeg
electrod
observ
h
inject
sever
respiratori
failur
follow
death
mice
inject
high
dose
sever
ataxia
follow
breath
depress
mice
inject
middl
dose
progress
truncal
ataxia
mice
inject
low
dose
symptom
disappear
complet
h
eeg
show
strong
reduct
delta
eeg
activ
start
h
igg
inject
persist
along
h
mice
inject
igg
healthi
subject
show
neurolog
symptom
studi
demonstr
antibodi
caus
autoimmun
agrypnia
antibodi
glutam
acid
decarboxylas
gad
describ
number
autoimmun
neurolog
diseas
eg
stiffperson
syndrom
ataxia
observ
sera
patient
stiffperson
syndrom
studi
circul
antigliadin
antibodi
led
us
investig
relationship
antigad
antibodi
gluten
sensit
use
elisa
investig
preval
level
antigad
antibodi
patient
gluten
ataxia
common
neurolog
manifest
gluten
sensit
patient
coeliac
diseas
comparison
control
effect
glutenfre
diet
also
investig
preval
antigad
antibodi
patient
gluten
ataxia
patient
coeliac
diseas
glutenfre
diet
respect
higher
healthi
control
antibodi
level
group
significantli
reduc
introduct
glutenfre
diet
confirm
elisa
result
achiev
use
western
blot
gad
import
antigen
gluten
sensitivityrel
diseas
may
provid
link
gluten
sensit
neurolog
dysfunct
elimin
antigad
antibodi
glutenfre
diet
may
import
therapeut
implic
antigadassoci
autoimmun
diseas
gluten
ataxia
common
neurolog
manifest
gluten
sensit
common
form
gluten
sensit
gluten
ataxia
believ
immunemedi
pathogenesi
patient
possess
circul
antigliadin
antibodi
igg
andor
iga
signific
proport
also
possess
antibodi
direct
tissu
transglutaminas
andor
glutam
acid
decarboxylas
gad
addit
previous
report
presenc
circul
antipurkinj
cell
antibodi
patient
identif
protein
target
antibodi
may
facilit
understand
pathogenesi
condit
aim
current
studi
investig
avid
cerebellar
target
antibodi
use
sodium
thiocyan
elut
assay
gel
electrophoresi
western
blot
mass
spectrometri
comparison
patient
coeliac
diseas
appropri
control
group
preliminari
result
suggest
appar
differ
avid
either
antigliadin
antigad
antibodi
group
sera
patient
gluten
ataxia
appear
react
frequent
protein
within
certain
molecular
weight
rang
kda
kda
sera
group
analysi
protein
malditof
allow
identif
use
glycochip
r
microarray
technolog
identif
anti
glc
alpha
glc
alpha
serum
antibodi
specif
biomark
multipl
sclerosi
schwarz
l
spector
gortler
l
glassmarmor
b
karni
c
n
dotan
miller
b
glycomind
ltd
lod
israel
b
carmel
medic
center
haifa
israel
c
sorarski
medic
center
tel
aviv
israel
unmeet
need
develop
specif
biomark
multipl
sclerosi
ms
improv
manag
patient
monitor
effect
treatment
object
identifi
anti
glycan
antibodi
serv
biomark
screen
serum
patient
relapsingremit
ms
rrm
librari
glycan
glycan
chip
found
significantli
higher
level
igm
antiglc
alpha
glc
alpha
antibodi
antibodi
control
patient
suffer
neurolog
diseas
autoimmun
diseas
higher
level
patient
primari
progress
ms
ppm
suggest
level
antibodi
specif
biomark
rrm
potenti
clinic
util
ms
prognosi
diseas
manag
background
sever
recent
report
identifi
high
titr
antiglutam
acid
decarboxylas
autoantibodi
gadab
associ
cerebellar
ataxia
aetiolog
link
remain
unclear
well
frequenc
level
gadab
unselect
atax
popul
explor
signific
populationbas
idiopath
loca
iloca
patient
south
wale
provid
phenotyp
method
materi
sera
patient
mean
diseas
durat
year
rang
analys
antigad
ab
use
commerci
radioimmunoassay
result
interpol
standard
curv
construct
use
dilut
standard
control
healthi
sera
result
three
patient
show
highli
elev
ab
titr
background
histori
type
diabet
mellitu
dm
type
ii
dm
respect
three
iloca
patient
comorbid
dm
type
ii
show
normal
ab
titr
clinic
patient
show
rel
pure
cerebellar
syndrom
extracerebellar
neurolog
manifest
signific
phenotyp
differ
observ
iloca
patient
discuss
amongst
populationbas
iloca
patient
posit
gadab
data
emphasis
need
routin
screen
gadab
patient
iloca
improv
diagnost
accuraci
iloca
case
well
creat
opportun
therapeut
intervent
circul
specif
cell
respons
unknown
autoimmun
diseas
central
nervou
system
cn
involv
twentyf
patient
relapsingremit
ms
clinic
isol
syndrom
ci
high
risk
ms
neurolupu
sle
without
cn
involv
healthi
volunt
label
blood
pehlaa
tetram
load
myelin
specif
peptid
accord
previous
publish
tcell
respons
human
myelin
proteinderiv
peptid
itag
beckman
coulter
europ
slsrfswga
flygallla
vlfssdfri
along
antibodi
analys
flow
cytomet
tcell
specif
myelin
epitop
expand
patient
ms
ci
patient
clinic
activ
neurolupu
two
ci
one
ms
patient
specif
mbp
respect
cell
one
ms
mbp
plp
one
ci
mbp
mag
one
ms
neurolupu
mbp
respect
plp
mag
none
healthi
volunt
sle
patient
devoid
neurolupu
seem
main
peptid
target
class
irestrict
cellular
respons
myelin
specif
determin
earli
event
develop
ms
lesion
format
cellular
infiltr
consist
monocytederiv
macrophag
lymphocyt
sequenc
cdna
ms
brain
lesion
control
brain
reveal
osteopontin
opn
abund
cytokineencod
transcript
uniqu
ms
plaqu
opn
induc
chemotaxi
immun
cell
promot
induct
cytokin
inhibit
releas
cytokin
previou
studi
demonstr
imbal
type
cytokin
mrna
level
pbmc
rr
ms
patient
preced
occurr
increas
diseas
activ
determin
whether
opn
may
contribut
phenomenon
relat
opn
serum
level
diseas
activ
investig
longitudin
studi
sixteen
rr
ms
patient
undergo
monthli
clinic
mri
examin
trend
observ
opn
serum
level
relat
clinic
exacerb
elev
level
month
prior
occurr
relaps
moreov
opn
protein
level
significantli
elev
month
prior
increas
lesion
number
median
increas
compar
baselin
level
wherea
relat
observ
opn
level
increas
gadolinium
gd
enhanc
lesion
volum
data
indic
opn
play
role
increas
diseas
activ
rr
ms
patient
system
vs
central
nervou
system
cellular
immun
relev
relapsingremit
multipl
sclerosi
matsui
araya
hy
wang
k
ozawa
saida
utano
nation
hospit
kyoto
japan
clarifi
disturb
cellmedi
immun
blood
central
nervou
system
cn
associ
activ
phase
multipl
sclerosi
ms
pair
peripher
blood
cerebrospin
fluid
csf
sampl
obtain
patient
relapsingremit
ms
rrm
examin
percentag
lymphocyt
subset
level
solubl
immun
mediat
activ
rrm
patient
character
increas
cell
blood
invers
correl
plasma
level
increas
cell
decreas
cell
found
csf
patient
csf
cell
show
posit
correl
leukocyt
count
well
albumin
level
addit
csf
high
cell
show
neg
correl
csf
cell
count
posit
correl
csf
level
also
studi
clinic
relev
cellular
immun
paramet
determin
percentag
anoth
group
nontreat
inact
rrm
patient
found
increas
csf
cell
predict
exacerb
ms
within
month
find
suggest
flow
cytometr
analysi
csf
cell
provid
good
measur
ongo
inflamm
cn
well
indic
aberr
immun
lead
ms
relaps
near
futur
probe
specif
recombin
antibodi
gener
multipl
sclerosi
cerebrospin
fluid
random
peptid
librari
x
yu
g
owen
burgoon
ritchi
k
keay
gilden
univers
colorado
health
scienc
center
denver
usa
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
common
laboratori
abnorm
associ
ms
intrathec
synthesi
oligoclon
immunoglobulin
ig
g
brain
cerebrospin
fluid
csf
specif
oligoclon
igg
ms
unknown
determin
specif
singl
cell
rtpcr
use
amplif
igg
heavyand
lightchain
vregion
vh
vl
plasma
cell
ms
csf
pair
vh
vl
region
overrepres
igg
sequenc
select
gener
recombin
antibodi
rab
specif
rab
probe
pan
phagedisplay
random
peptid
librari
peptid
three
round
pan
affinityselect
peptid
identifi
elisa
confirm
bind
specif
ms
rab
sequenc
align
swissprot
databas
reveal
plethora
put
target
includ
peptid
highli
homolog
protein
pathogen
refin
mani
potenti
antigen
studi
alanin
scan
use
identifi
amino
acid
peptid
import
antibodi
bind
phagedisplay
random
peptid
librari
potenti
identifi
continu
epitop
mimotop
ms
antigen
reliabl
easi
measur
immunolog
marker
abl
denot
diseas
characterist
multipl
sclerosi
ms
patient
still
lack
appli
multivari
statist
analysi
result
obtain
measuringbi
realtim
rtpcrmrna
level
immunolog
relev
molecul
eg
cytokin
chemokin
chemokin
receptor
peripher
blood
mononuclear
cell
pbmc
ms
patient
combin
measur
mrna
level
tnfalpha
tgfbeta
abl
distinguish
ms
patient
healthi
individu
ms
pattern
combin
mrna
level
identifi
primari
progress
ms
patient
ppm
pattern
tnfalpha
differenti
relaps
ms
patient
rrm
pattern
final
signific
correl
found
mrna
level
tnfalpha
measur
pbmc
mononuclear
cell
obtain
cerebrospin
fluid
hand
find
correl
immunolog
marker
gadoliniumenhanc
magnet
reson
imag
mri
detect
lesion
mri
lesion
load
result
indic
multiparametr
analysi
mrna
level
immunolog
relev
molecul
pbmc
may
repres
success
strategi
identif
put
peripher
marker
diseas
state
diseas
activ
ms
patient
frequenc
gangliosid
antibodi
neuropathi
neurolog
inflammatori
diseas
vari
consider
larg
depend
techniqu
use
studi
extend
valid
standard
elisa
develop
european
inflammatori
neuropathi
caus
treatment
incat
group
igg
igm
antibodi
determin
incatelisa
larg
group
patient
control
correl
varianc
cv
calcul
determin
standard
deviat
divid
mean
optic
densiti
well
one
serum
sampl
use
posit
control
sampl
cv
igg
igm
variat
could
attribut
variat
well
plate
day
technician
antibodi
found
patient
syndrom
gb
chronic
demyelin
inflammatori
polyneuropathi
multifoc
motor
neuropathi
inflammatori
polyneuropathi
ipnp
noninflammatori
polyneuropathi
nipnp
motor
neuron
diseas
none
multipl
sclerosi
form
autoimmun
diseas
healthi
control
igg
antibodi
found
patient
gb
ipnp
nipnp
conclus
incatelisa
good
reproduc
presenc
igg
antibodi
almost
specif
inflammatori
neuropathi
object
correl
lymphocyt
network
peripher
blood
neurolog
statu
edss
mri
activ
newli
diagnos
untreat
ms
patient
method
twenti
patient
present
first
cn
inflammatori
event
suggest
ms
enrol
studi
everi
day
year
underw
clinic
mri
evalu
flow
cytometri
analysi
broadspectrum
lymphocyt
subset
result
twelv
patient
show
mri
activ
throughout
followup
patient
signific
reduct
blood
alphabeta
cell
compar
refer
subject
concomit
mri
activ
observ
decreas
frequenc
follow
lymphocyt
subset
alphabeta
cell
cell
nkt
cell
nklike
cell
nk
cell
subgroup
patient
observ
increas
gammadelta
cell
alphabeta
cell
begin
mri
activ
conclus
newli
diagnos
ms
patient
display
concomitantli
mri
activ
increas
termin
differenti
alphabeta
cell
presenc
reduct
defin
regulatori
cell
subset
preliminari
data
indic
assess
peripher
immunophenotyp
trait
consist
pattern
lymphocyt
subset
may
use
clinic
manag
ms
patient
understand
mechan
sustain
effect
diseas
modifi
drug
ms
may
help
refin
current
therapi
knowledg
diseas
pathogenesi
investig
gene
express
microarray
peripher
blood
mononuclear
cell
pbmc
ms
patient
baselin
month
interferonbeta
rebif
mcg
blood
sampl
gadoliniumenhanc
mri
obtain
h
last
inject
influenc
ifnbeta
gene
express
pronounc
one
month
therapi
involv
gene
immunolog
signific
other
relat
energi
metabol
cell
cycl
cytoskeleton
dynam
gene
valid
rtpcr
includ
filaminb
increas
decreas
repres
novel
find
investig
given
role
modul
classii
antigen
present
accord
previou
report
reduc
express
hladr
pbmc
ms
autoimmun
diseas
rtpcr
show
decreas
untreat
ms
patient
compar
healthi
control
includ
three
diseas
discord
monozygot
twin
set
global
impact
ifnbeta
treatment
gene
express
tend
decreas
first
month
therapi
decreas
express
may
contribut
downregul
mhc
class
ii
one
known
immunomodulatori
action
ifnbeta
vivo
cell
imag
magnet
reson
mr
may
power
tool
reveal
pathogen
event
cell
migratori
process
multipl
sclerosi
purpos
cell
isol
label
ex
vivo
mr
contrast
agent
reintroduc
bodi
studi
aim
develop
effici
method
label
primari
monocyt
suitabl
contrast
agent
use
two
differ
size
ultra
small
particl
iron
oxid
uspio
sinerem
endorem
benefici
effect
preincub
transfect
agent
ta
polyl
fugen
superfect
evalu
label
effici
determin
time
mri
perl
stain
iron
cell
viabil
function
constantli
monitor
incub
monocyt
endorem
result
label
effici
higher
time
decreas
superfect
ta
increas
uptak
endorem
conclus
endorem
preincub
superfect
effici
label
primari
monocyt
current
plan
experi
track
primari
monocyt
anim
model
multipl
sclerosi
multipl
sclerosi
ms
demyelin
diseas
character
inflamm
brain
spinal
cord
wide
variabl
symptom
diseas
cours
progress
rate
area
cn
involv
base
autoimmun
natur
ms
migrat
immun
cell
brain
reason
imprint
diseas
would
present
peripher
blood
pb
cell
order
identifi
molecular
differ
relapsingremit
rr
ms
patient
healthi
control
hc
rrm
patient
differ
phase
diseas
investig
geneexpress
profil
whole
blood
hc
rrm
patient
use
cdna
micro
array
complex
cdna
total
gene
differ
significantli
express
rrm
patient
hc
differenti
express
gene
repres
sever
distinct
function
categori
interestingli
larg
number
gene
reflect
differ
activ
g
protein
signal
ms
patient
hc
preliminari
data
reveal
indic
import
molecular
biolog
variat
rrm
patient
hc
rrm
patient
differ
phase
diseas
provid
lead
relev
biolog
pathway
could
ultim
lead
identif
novel
criteria
sub
classif
immunemedi
mechan
play
crucial
role
patogenesi
multipl
sclerosi
ms
though
neurodegener
axon
loss
earli
event
ms
therapeut
approach
remain
restrict
antiinflammatori
drug
responsiv
patient
avail
drug
limit
detect
respons
gener
shift
cytokin
product
studi
group
ms
patient
monthli
puls
methylprednisolon
mp
cyclophosphamid
cpa
therapi
patient
method
progress
ms
patient
femal
male
age
yr
durat
ms
yr
divid
two
group
accord
clinic
respons
good
respond
stabl
patient
versu
nonrespond
peripher
blood
taken
day
g
mp
g
cpa
administr
peripher
blood
ageand
sexmatch
healthi
control
use
compar
cytokin
product
result
discuss
cytokin
product
differ
significantli
treatment
respond
versu
nonrespond
surprisingli
significantli
higher
express
lymphocyt
respond
may
explain
theori
immunosuppress
effect
inflamm
still
activ
strikingli
signific
differ
detect
product
ifn
gamma
tnf
alpha
ms
patient
healthi
control
suggest
immun
hyperactiv
present
diseas
even
second
decad
durat
despit
aggress
treatment
aim
investig
interact
immunolog
chang
vertebr
syndrom
multipl
sclerosi
ms
patient
method
patient
definit
ms
examin
mean
age
fsigma
year
kurtzk
expand
disabl
statu
scale
edss
score
result
chronic
back
neck
pain
present
patient
mean
age
onset
vertebr
pain
year
mean
durat
pain
year
impair
vertic
spinal
balanc
scoliosi
kyphosi
diagnos
patient
correl
follow
vertebr
sign
immunolog
indic
high
tonu
paravertebr
muscl
high
level
circul
immun
complex
cic
tlymphocyt
presens
muscl
trigger
point
thorac
girdl
high
level
cic
antindna
antibodi
cd
hladr
pronounc
spondyloarthrosi
level
cic
relationship
may
explain
immun
aggress
muscl
cartilagin
cell
correl
level
antindna
antibodi
confirm
fact
polyclon
activ
plaqu
cervic
part
spinal
cord
visualis
magnet
reson
imag
patient
vertebr
sign
neck
pain
scoliosi
high
tonu
paravertebr
muscl
trigger
muscl
point
level
pronounc
group
versu
patient
without
cervic
lesion
conclus
immunolog
chang
cervic
plaqu
influenc
develop
vertebr
syndrom
multipl
sclerosi
csf
chang
ifn
betatr
ms
patient
k
yokoyama
juntendo
univers
tokyo
japan
object
interferon
ifn
beta
pleiotroph
molecul
complex
immunoregulatori
activ
commonli
use
world
wide
howev
valid
definit
therapeut
respons
need
individu
treatment
decis
collect
csf
sampl
ms
neurolog
diseas
control
assess
clinic
respons
mechan
ifn
beta
multipl
sclerosi
ms
patient
csf
analysi
method
csf
relapsingremit
ms
patient
neurolog
diseas
ond
collect
inform
consent
nitric
oxid
metabolit
amino
acid
measur
hplc
igg
index
also
calcul
patient
chang
measur
relat
clinic
diseas
sever
expand
disabl
statu
score
edss
evalu
could
measur
compar
csf
chang
ifn
beta
treatment
two
patient
summari
relaps
ms
patient
sever
edss
worsen
show
increas
amino
acid
level
metabolit
chang
drastic
acut
phase
diseas
ifn
beta
treatment
decreas
concentr
well
igg
index
conclus
ifn
beta
treatment
might
influenc
igg
synthesi
csf
ms
patient
serial
measur
igg
index
might
use
surrog
marker
effect
ifn
beta
treatment
neuroinflammatori
diseas
cn
immun
cell
infiltr
cn
parenchyma
cerebrospin
fluid
although
two
popul
may
distinct
regard
phenotyp
function
current
assum
csf
cell
resembl
close
parenchymainfiltr
cell
blood
counterpart
thu
far
cn
biopsi
remain
invas
procedur
analyz
csf
immun
cell
repres
uniqu
tool
understand
pathophysiolog
neuroimmun
diseas
develop
techniqu
allow
gene
array
analysi
small
amount
rna
prompt
us
evalu
feasibl
analyz
gene
profil
csf
cell
result
indic
ng
mrna
extract
ml
csf
obtain
ms
patient
theoret
allow
perform
rtpcr
one
csf
sampl
howev
rna
qualiti
assess
analyz
ratio
ribosom
band
depend
primarili
time
elaps
csf
sampl
csf
process
inde
csf
cell
immedi
treat
rna
extract
display
unalt
rna
profil
moreov
good
qualiti
sampl
select
amplif
step
requir
order
perform
assay
analysi
studi
elisa
cerebrospin
fluid
csf
serum
level
classic
solubl
hlai
shlai
nonclass
solubl
hlag
shlag
molecul
relapsingremit
rr
secondari
progress
sp
primari
progress
pp
multipl
sclerosi
ms
patient
group
accord
clinic
magnet
reson
imag
mri
evid
diseas
activ
patient
inflammatori
neurolog
disord
oind
noninflammatori
neurolog
disord
nind
intrathec
product
shlai
shlag
frequent
ms
oind
nind
consist
valu
clinic
mri
activ
clinic
mri
inact
ms
shlai
respect
clinic
mri
stabl
clinic
mri
activ
ms
shlag
respect
decreas
shlai
increas
shlag
level
detect
serum
clinic
activ
ms
mri
activ
ms
show
high
low
csf
level
shlai
shlag
respect
result
seem
indic
csf
serum
shlai
shlag
balanc
could
modul
ms
activ
opposit
direct
cell
immunoglobulinand
mucindomaincontain
molecul
tim
compris
recent
describ
famili
molecul
express
cell
shown
express
murin
thelper
th
cell
clone
implic
pathogenesi
experiment
autoimmun
encephalomyel
contrast
associ
polymorph
airway
hyperreact
suggest
mice
tim
molecul
investig
human
diseas
use
realtim
taqman
rtpcr
show
human
line
express
higher
mrna
level
line
demonstr
higher
express
analysi
cerebrospin
fluid
mononuclear
cell
csfmc
obtain
patient
multipl
sclerosi
ms
reveal
significantli
higher
mrna
express
compar
control
moreov
higher
express
associ
clinic
remiss
low
express
ifngamma
mrna
csfmc
contrast
express
correl
well
high
express
ifngamma
tnfalpha
data
impli
differenti
express
human
tim
molecul
cell
may
suggest
differenti
involv
differ
phase
human
autoimmun
diseas
cerebrospin
fluid
tau
protein
multipl
sclerosi
e
pal
multipl
sclerosi
immunemedi
demyelin
diseas
central
nervou
system
howev
myelin
axonalneuron
damag
also
develop
advanc
stage
earli
stage
well
may
final
respons
irrevers
disabl
solubl
marker
microtubuleassoci
protein
tau
suitabl
detect
axon
damag
evalu
neurodegener
vivo
csf
tau
level
determin
enzymelink
immunosorb
assay
elisa
ms
viral
enceph
control
patient
tau
level
elev
ms
enceph
case
compar
control
ms
group
tau
level
correl
diseas
durat
sever
therefor
conclud
csf
tau
would
probabl
marker
detect
axon
loss
effect
use
neuroimmunolog
test
diagnost
research
purpos
requir
standard
method
extern
qualiti
control
scheme
two
requir
guarante
accuraci
reliabl
diagnost
routin
data
reproduc
research
set
aini
promot
unpreced
consensusbas
program
procedur
method
standard
neuroimmunolog
twentysix
italian
centr
join
program
four
area
identifi
approxim
total
number
examsyear
bracket
cerebrospin
fluid
examin
diagnost
paraneoplast
neurolog
syndrom
diagnost
peripher
disimmun
neuropathi
diagnost
myasthenia
gravi
questionnairebas
survey
prepar
expertisebas
select
centr
reveal
interlaboratori
variabl
procedur
assay
methodolog
attempt
uniform
procedur
method
made
internet
contact
two
aini
workshop
contemporarili
qualiti
assur
scheme
futur
promot
result
program
summar
four
internetavail
document
http
wwwainiit
document
yearli
updat
report
test
indic
limit
agre
common
protocol
instruct
result
interpret
essenti
refer
improv
diagnost
perform
repres
premis
clinic
guidelin
neuroimmunolog
howev
lack
data
concern
ocb
diseasemodifi
drug
dmd
therapi
chang
pattern
report
literatur
aim
assess
ocb
csf
patient
relapsingremit
multipl
sclerosi
rrm
treat
dmd
patient
method
set
rrm
patient
consist
femal
age
year
averag
age
male
age
year
averag
age
csf
sampl
taken
averag
month
averag
month
initi
dmd
interferon
beta
glatiram
acet
therapi
number
alkalin
ocb
csf
assess
method
isoelectr
focus
pair
sampl
test
appli
assess
statist
signific
result
patient
reduct
number
ocb
averag
observ
patient
number
ocb
increas
averag
chang
ocb
number
present
also
patient
result
differ
statist
significantli
conclus
result
document
immunomodul
effect
dmd
decreas
intrathec
synthesi
igg
character
immunorelev
human
brain
antigen
multipl
sclerosi
patient
twodimension
electrophoresi
z
adwan
swaida
neuroimmunolog
institut
swaida
syria
object
identifi
character
new
immunorelev
antigen
associ
multipl
sclerosi
background
current
none
myelinassoci
antigen
target
conclus
discrimin
immun
respons
observ
multipl
sclerosi
ms
patient
healthi
subject
recent
studi
laboratori
found
analysi
global
igg
immun
profil
whole
brain
selfantigen
discrimin
ms
subject
healthi
subject
could
also
differenti
three
clinic
form
diseas
inde
respect
brain
antigen
defin
accord
molecular
weight
describ
support
discrimin
immun
respons
designmethod
protein
identif
discrimin
band
perform
onedimension
twodimension
immunoblot
use
ms
patient
sera
follow
mass
spectrometri
analysi
databas
search
result
approach
total
differ
immunorelev
antigen
band
detect
band
broken
spot
select
mass
spectrometr
analysi
annot
conclus
serolog
proteom
analysi
serpa
may
constitut
new
tool
identif
new
msassoci
antigen
leptin
level
subgroup
patient
multipl
sclerosi
kurn
arsava
bi
ikrikci
r
karabudak
hacettep
univers
medic
faculthi
ankara
turkey
introduct
leptin
primarili
synthes
adipos
tissu
respons
control
appetit
energi
metabol
apart
effect
metabol
leptin
shown
play
import
role
inflammatori
condit
object
measur
serum
leptin
level
among
differ
subgroup
patient
multipl
sclerosi
predominantli
mediat
inflammatori
condit
method
fourteen
recent
diagnos
relapsingremit
multipl
sclerosi
rrm
patient
ten
rrm
patient
immunomodulatori
drug
therapi
thirteen
primari
progress
multipl
sclerosi
patient
agematch
nine
control
subject
includ
studi
bodi
mass
index
bmi
calcul
patient
serum
leptin
level
measur
elisa
result
mean
leptin
level
ngml
control
newli
diagnos
rrm
rrm
immunomodulatori
treatment
primari
progress
ms
patient
respect
statist
signific
differ
among
studi
group
adjust
height
weight
bmi
valu
conclus
leptin
peptid
influenc
immun
system
modul
crucial
role
trigger
acut
inflamm
suffici
data
role
central
nervou
system
inflamm
demyelin
studi
differ
detect
serum
leptin
level
neither
control
ms
patient
among
ms
subgroup
disruptiom
bloodbrain
barrier
compos
endotheli
cell
accompani
infiltr
macrophag
lymphocyt
implic
pathogenesi
multipl
sclerosi
ms
vascularendotheli
cadherin
vecadherin
major
protein
compon
interendotheli
adheren
junction
import
barrier
function
regul
leukocyt
transendotheli
migrat
determin
serum
level
vecadherin
investig
signific
vecadherin
format
ms
lesion
subject
patient
relapsingremit
ms
healthi
control
serum
concentr
vecadherin
measur
elisa
method
measur
plasma
activ
von
willebrand
factor
vwf
serum
level
solubl
thrombomodulin
stm
marker
endotheli
injuri
plasma
level
hepatocyt
growth
factor
hgf
marker
endotheli
repair
patient
ms
serum
vecadherin
level
tend
higher
ms
patient
exacerb
agematch
control
ms
patient
remiss
significantli
differ
among
group
serum
vecadherin
level
tendenc
associ
plasma
hgf
level
ms
patient
serum
vecadherin
level
significantli
associ
plasma
vwf
activ
serum
stm
level
ms
patient
find
suggest
serum
concentr
vecadherin
may
increas
reflect
endotheli
repair
adheren
junction
format
bloodbrain
barrier
patient
ms
object
evalu
gene
express
profil
pbmc
newli
diagnos
untreat
ms
patient
compar
healthi
subject
method
twenti
patient
first
event
ms
underw
clinic
mri
evalu
pbmc
collect
everi
day
year
rna
extract
pbmc
nine
ms
patient
mri
activ
ten
sex
agematch
healthi
subject
fluoresc
cdna
probe
prepar
revers
transcript
hybridis
cdna
array
human
gene
prepar
use
lucidea
microarray
spotter
amershampharmacia
biotech
array
includ
gene
involv
apoptosi
cell
prolifer
inflamm
cdna
refer
consist
mrna
pool
human
cell
line
normalis
sampletorefer
log
ratio
calcul
spot
signal
background
least
sampl
group
consid
statist
analysi
result
follow
rna
integr
test
probe
prepar
chip
hybridis
highqual
fluoresc
spot
obtain
ten
percent
evalu
gene
show
differenti
express
upon
comparison
ms
control
conclus
although
statist
analysi
still
progress
preliminari
observ
support
use
cdna
microarray
technolog
detect
alter
gene
express
profil
peripheri
ms
patient
activ
diseas
multipl
sclerosi
wide
believ
autoimmun
diseas
driven
rel
domin
cell
regulatori
cell
sought
identifi
lineag
activ
marker
human
th
subtyp
might
serv
biomark
diseas
activ
diagnost
aid
guid
therapeut
efficaci
test
murin
cell
subset
marker
deriv
sage
librari
human
system
polaris
pbmc
cultur
produc
vitro
defin
cytokin
cocktail
valid
elisa
real
time
pcr
put
marker
gene
sage
includ
gangliosid
activ
protein
integrin
e
beta
regulatori
cell
differenti
express
gene
two
protein
four
transmembran
domain
relat
famili
gata
use
marker
cell
found
express
cell
induc
pma
stimul
subset
mark
specif
express
activ
cell
four
transmembran
protein
previous
identifi
chandra
current
test
express
molecul
marker
diseas
activ
multipl
sclerosi
object
correl
mxa
product
respons
treatment
dose
ifnbeta
nab
occurr
method
month
mcg
treatment
patient
persist
diseas
activ
random
either
continu
mcg
dose
receiv
increas
dose
mcg
mxa
determin
immunochemiluminesc
whole
blood
sampl
elisa
pbmc
supernat
nab
mxainduct
assay
result
present
preliminari
data
concern
patient
mxa
product
peak
month
treatment
greater
increas
patient
respond
well
also
peak
month
remain
higher
baselin
respond
increas
ifnbeta
dose
associ
renew
mxa
increas
nab
occur
four
patient
nab
posit
associ
decreas
mxa
chang
product
conclus
mxa
level
correl
well
treatment
respons
ifnbeta
dose
laser
microdissect
singlecel
rtpcr
analysi
igg
repertoir
sspe
brain
burgoon
k
keay
gp
owen
ritchi
xl
yu
dh
gilden
univers
colorado
health
scienc
center
denver
co
usa
promin
immunolog
featur
subacut
scleros
panenceph
sspe
chronic
fatal
measl
viru
enceph
presenc
increas
igg
oligoclon
band
ogb
brain
csf
oligoclon
igg
antibodi
direct
measl
viru
determin
fine
specif
individu
immun
cell
sspe
brain
develop
techniqu
analyz
igg
repertoir
chronic
inflammatori
cn
diseas
microdissect
individu
plasma
cell
sspe
brain
identifi
specif
igg
sequenc
express
cell
plasma
cell
identifi
frozen
section
postmortem
sspe
brain
immunostain
individu
cell
microdissect
nondestruct
infrar
laser
cdna
synthes
sequenc
specif
igg
heavylight
chain
pair
express
plasma
cell
determin
nest
rtpcr
amplif
repertoir
plasma
cell
singl
sspe
brain
reveal
featur
antigendriven
select
affin
matur
includ
clonal
expans
somat
hypermut
variabl
region
sequenc
insert
express
vector
produc
larg
quantiti
function
recombin
igg
rigg
studi
specif
rigg
reactiv
potenti
identifi
antigen
chronic
inflammatori
cn
diseas
unknown
caus
multipl
sclerosi
behcet
diseas
neurobehcet
diseas
nbd
chronic
inflammatori
diseas
central
nervou
system
cn
although
exact
etiolog
nbd
unknown
gener
accept
autoimmun
involv
auto
antigen
probabl
resid
cn
target
immun
respons
current
studi
argu
protein
especi
heat
shock
protein
hsp
initi
enhanc
factor
behcet
diseas
regard
level
tnfalpha
one
import
cytokin
neuroimmun
disord
cerebrospin
fluid
csf
nbd
patient
examin
csf
collect
nbd
patient
acut
chronic
state
st
marianna
univers
hospit
tnfalpha
analyz
messag
protein
level
rtpcr
elisa
relationship
tnfalpha
acut
chronic
state
csf
obtain
nbd
patient
thu
result
indic
may
one
initi
enhanc
factor
nbd
unexplain
case
cn
disord
evid
chlamydia
pneumonia
dna
c
contini
seraceni
r
cultrera
castellazzi
e
fainardi
b
marchetti
c
e
granieri
univers
ferrara
ferrara
itali
b
anna
hospit
ferrara
itali
c
bellaria
hospit
bologna
itali
chlamydia
c
pneumonia
link
number
cn
chronic
diseas
includ
ms
individu
describ
case
neurolog
disord
enceph
meningoenceph
syndrom
lumbosacr
meningoradicul
method
cerebr
spinal
fluid
csf
serum
specimen
collect
patient
undefin
mening
meningoenceph
without
respiratori
symptom
neurolog
magnet
reson
imag
abnorm
retrospect
analys
npcr
btouchdownq
specif
primer
c
pneumonia
momp
hsp
gene
specif
iggiga
antibodi
respons
evalu
elisa
result
patient
posit
c
pneumonia
pcr
either
csf
serum
momp
gene
rna
antichlamydi
igg
antibodi
respons
found
two
patient
serolog
test
bacteria
viru
neg
c
pneumonia
infect
includ
differenti
diagnosi
meningoenceph
even
associ
respiratori
symptom
interest
high
quot
pcr
posit
gene
primari
immunogen
elicit
inflammatori
respons
chlamydi
diseas
patient
previous
demonstr
ms
diseas
contini
et
al
multipl
sclerosi
press
may
interpret
part
stress
respons
trigger
autoimmun
reactiv
studi
quantit
rel
transcript
level
endogen
vasoact
neuropeptid
act
hormon
neurotransmitt
immun
modul
neurotroph
action
readili
catalys
small
peptid
fragment
bind
site
immunogen
known
associ
rang
autoimmun
condit
theoret
paper
describ
biolog
plausibl
mechan
chronic
fatigu
syndrom
sudden
infant
death
syndrom
utilis
antigliadin
antibodi
ab
use
method
patient
consid
gluten
sensit
gluten
ataxia
lead
dietari
treatment
regim
explor
signific
amongst
iloca
patient
populationbas
studi
use
elisa
altern
immunoassay
method
materi
sera
patient
mean
diseas
durat
year
rang
analys
use
western
blot
wb
antigliadin
igaigg
ab
follow
quantit
use
densitomet
result
assay
compar
group
sexand
agematch
elderli
inpati
nonneurolog
control
group
well
posit
control
result
initi
wb
step
iloca
elderli
cd
sera
show
probabl
immunoreact
gliadin
valid
find
quantit
densitomet
reveal
cd
iloca
none
amongst
elderli
control
signific
immunoreact
discuss
data
suggest
antigliadin
ab
detect
may
depend
assay
employ
wbdensitomet
approach
iloca
patient
show
signific
level
antigliadin
igaigg
ab
may
gluten
ataxia
contrari
previou
report
suggest
level
elisa
studi
serum
autoantibodi
postinfecti
acut
cerebellar
ataxia
uchibori
sakuta
kusunoki
b
chiba
kyorin
univers
tokyo
japan
b
kinki
univers
osaka
japan
acut
cerebellar
ataxia
aca
characteris
acut
onset
selflimit
ataxia
follow
system
viral
infect
autoimmun
process
suggest
antineuron
antibodi
report
aca
antigen
molecul
identifi
search
serum
antibodi
patient
aca
western
blot
wb
use
total
protein
fraction
extract
cerebellar
tissu
sd
antigen
found
igm
antibodi
strongli
react
protein
approxim
kda
cerebellar
cortex
show
strongest
antigen
among
variou
nervou
nonnerv
tissu
base
amount
protein
strongest
reaction
detect
cytoplasm
fraction
antigen
protein
separ
subject
ntermin
amino
acid
sequenc
sequenc
amino
acid
residu
shown
ident
ntermin
sequenc
trios
phosphat
isomeras
tpi
serum
sampl
patient
aca
band
mobil
detect
wb
antitpi
igm
antibodi
titer
measur
quantit
use
elisa
patient
show
significantli
high
antibodi
titer
mean
healthi
control
decreas
time
patient
check
time
cours
evalu
find
suggest
antitpi
igm
antibodi
may
relat
aca
pediatr
autoimmun
neuropsychiatr
disord
associ
streptococcu
panda
refer
propos
subgroup
childhood
onset
obsess
compuls
disord
ocd
andor
tourett
syndrom
onset
exacerb
ill
trigger
group
streptococc
pharyng
children
present
sudden
dramat
symptom
ocd
episod
sawtooth
cours
ill
often
show
subtl
neurolog
sign
tic
choreiform
movement
sudden
clumsi
worsen
handwrit
present
updat
current
research
compar
gener
immun
function
cellular
marker
autoantibodi
children
present
ocdtic
exacerb
children
healthi
correl
immun
find
panda
subtyp
made
children
ocdtic
without
panda
subtyp
increas
concentr
sever
inflammatori
cytokin
observ
brain
tissu
cerebrospin
fluid
csf
sever
neurodegen
diseas
includ
alzheim
diseas
syndrom
epilepsi
parkinson
diseas
multipl
sclerosi
whether
inflammatori
molecul
causal
neurodegen
process
secondari
role
neuron
surviv
damag
still
known
one
distinct
featur
immun
molecul
act
cascad
stimul
inhibit
one
anoth
product
action
crucial
question
concern
initi
stimuli
trigger
product
differ
cytokin
simultan
present
neurodegen
condit
measur
highli
sensit
sandwich
enzym
immunoassay
detect
serum
control
pd
patient
concentr
serum
patient
pd
higher
control
patient
result
agre
previou
report
cytokin
level
elev
striatal
dopaminerg
region
brain
patient
pd
cytokin
play
import
role
mitogen
neurotroph
factor
brain
increas
cytokin
compensatori
respons
may
occur
brain
patient
pd
progress
neurodegener
increas
cytokin
may
contribut
compensatori
respons
primari
initi
trigger
neurodegener
acut
brain
ischemia
inflamm
outcom
studi
sotgiu
b
marchetti
b
ml
foi
g
arru
b
zanda
pirisi
sanna
g
rosati
istituto
di
clinica
neurologica
univers
sassari
sassari
itali
b
dipartimento
di
neurofarmacologia
oasi
ircc
troina
itali
although
numer
exampl
fail
surrog
marker
provid
literatur
metalloproteinas
adhes
molecul
serum
level
seem
predict
neurolog
deterior
patient
ischem
stroke
accumul
evid
suggest
howev
inflamm
includ
detriment
protect
compon
thu
contribut
neurotox
neuroprotect
central
nervou
system
aim
investig
issu
evalu
seri
consecut
patient
acut
ischem
stroke
within
h
stroke
onset
serum
concentr
panel
differ
biomark
previous
report
associ
stroke
tnfalpha
bdnf
neurolog
impair
score
use
gc
go
nih
scale
stroke
onset
three
month
followup
tnfalpha
bdnf
particularli
associ
clinic
sever
ischem
stroke
show
linear
correl
initi
final
nih
scale
contrari
contrast
previou
report
show
signific
invers
correl
upregul
patient
develop
milder
sever
score
three
month
suggest
may
neuroprotect
action
patient
ischem
brain
injuri
context
complex
cascad
proinflammatori
respons
impli
inappropri
haemostasi
contribut
ischem
damag
number
issu
known
risk
factor
develop
vascular
dementia
differ
found
stroke
vascular
dementia
vad
prevent
type
dementia
determin
risk
factor
vad
extrem
import
evalu
role
humor
paramet
genesi
vad
elderli
patient
investig
group
patient
vad
compar
result
cerebrovascular
nondement
patient
vand
healthi
control
subject
without
cerebr
ischem
episod
signific
increas
hci
fg
crp
slcami
svcami
ilib
observ
vad
patient
compar
found
cerebrovascular
ischem
patient
control
respect
mmoll
mgdl
mgl
mgl
mgl
pgml
pgml
pgml
vs
mmoll
mgdl
mgl
mgl
mgl
pgml
pgml
pgml
vs
mmoll
mg
dl
mgl
mgl
mgl
pgml
pgml
pgml
respect
mann
whitney
utest
find
demonstr
hci
humor
inflammatori
factor
elev
individu
suffer
vad
ischem
stroke
studi
confirm
increas
system
level
proinflammatori
immunoregul
cytokin
may
found
patient
vad
prognost
signific
antibodi
acetylcholin
receptor
achr
myasthenia
gravi
mg
g
galassi
p
faglioni
ariatti
object
evalu
signific
antibodi
achr
mg
method
retrospect
studi
conduct
mg
patient
mean
age
year
male
mean
age
femal
mean
age
mean
durat
ill
month
time
patient
achr
antibodi
neg
wherea
patient
detect
antibodi
achr
diseas
sever
osserman
classif
grade
achr
antibodi
posit
seroneg
iia
seroposit
seroneg
iib
seroposit
patient
subject
classifi
iii
iv
regard
actual
sever
among
patient
achr
antibodi
posit
asymptomat
grade
iia
ii
b
among
seroneg
subject
classifi
iia
degre
improv
comput
achr
antibodi
posit
seroneg
time
diagnosi
percentag
achr
antibodi
posit
patient
significantli
higher
among
subject
iia
iib
compar
grade
chi
squar
exact
percentag
achr
antibodi
posit
patient
significantli
higher
among
patient
show
clinic
improv
compar
either
unchang
wors
chi
squar
exact
degre
improv
baselin
actual
sever
differ
significantli
achr
antibodi
posit
seroneg
subject
chi
squar
immunosuppress
treatment
modifi
number
phenotyp
circul
intrathym
regulatori
cell
myasthenia
gravi
fattorossi
battaglia
f
ciaraffa
c
di
schino
g
scambia
evoli
cathol
univers
rome
itali
analyz
immunosuppress
treg
cell
mg
patient
number
treg
cell
peripher
blood
untreat
patient
significantli
lower
healthi
subject
hs
increas
immunosuppress
therapi
therapyinduc
treg
cell
express
less
hladr
indic
expans
newli
gener
treg
cell
increas
treg
cell
number
follow
therapi
lower
suppress
thymectomi
suggest
thymu
contribut
peripher
pool
cell
number
circul
treg
cell
differ
patient
thymomat
nonthymomat
thymus
enhanc
effect
therapi
consider
promin
patient
nonneoplast
thymu
suggest
normal
thymic
epithelium
relev
maintain
peripher
treg
cell
homeostasi
thymu
function
howev
appear
dispens
govern
peripher
pool
treg
cell
thymectom
patient
number
circul
treg
cell
within
normal
rang
intrathym
treg
cell
frequenc
relat
thymu
histolog
influenc
therapi
moreov
correl
intrathym
circul
treg
cell
frequenc
collect
find
consist
possibl
treg
cell
defici
role
mg
develop
upmodul
cell
contribut
therapeut
effect
treatment
veab
main
clinic
present
ocular
omg
generalis
gmg
object
compar
agesex
distribut
mg
variant
onset
symptom
rather
ab
posit
determin
age
specif
incid
achr
abv
mg
method
studi
patient
clinic
valid
gmg
omg
test
achr
neg
musk
ab
result
achr
ab
gmg
omg
abv
gmg
omg
gmg
man
musk
abv
agesex
distribut
specif
incid
achr
abv
mg
increas
age
two
main
peak
fourth
ninth
decad
caus
respect
younger
gmg
women
older
omg
men
abv
gmg
start
women
age
abv
omg
increas
steadili
peak
eighth
decad
affect
sex
conclus
ab
mg
probabl
pathogeneticallyheterogen
disord
data
suggest
rel
common
present
gener
weak
women
age
ocular
weak
older
women
men
achrabv
mg
data
similar
repres
report
achr
ab
posit
uk
clarifi
distinct
immun
balanc
cerebrospin
fluid
csf
compart
investig
intraand
extracellular
level
variou
cytokin
chemokin
csf
chronic
inflammatori
demyelin
polyneuropathi
cidp
vasculit
neuropathi
vn
sixteen
cytokin
ifngamma
tnfalpha
gcsf
csf
supernat
measur
multiplex
fluorescentbead
base
immunoassay
intracellular
cytokin
product
ifngamma
csf
cell
flowcytometri
patient
cidp
patient
vn
noninflammatori
neurolog
diseas
ond
csf
supernat
signific
increas
signific
decreas
detect
pretreat
cidp
compar
ond
wherea
signific
increas
found
pretreat
vn
csf
cell
ifngamma
percentag
markedli
elev
cidp
compar
ond
vn
result
signific
increas
intracellular
ratio
cidp
even
absenc
csf
pleocytosi
nonrespond
intraven
immunoglobulin
show
significantli
lower
cell
percentag
tend
higher
intracellular
ratio
csf
respond
upregul
downregul
cytokin
pathognomon
cidp
cytokin
upregul
csf
vn
allerg
bronchial
asthma
induc
ngfantibodi
produc
rat
evid
non
proinflammatori
role
ngf
b
stampachiacchier
micera
bonini
l
alo
nation
research
council
cnr
rome
itali
anim
model
human
allerg
bronchial
asthma
aba
increas
nerv
growth
factor
ngf
level
blood
serum
bronchial
alveolar
lavag
balf
ngf
inflammatori
role
aba
clear
matter
discuss
present
studi
use
anim
model
aba
without
circul
level
ngf
antibodi
abngf
investig
role
ngf
neuroinflammatori
disord
aba
induc
adult
femal
rat
ovaalbumina
ova
immun
previous
describ
rat
circul
abngf
obtain
inject
purifi
ngf
freund
adjuv
ngf
tnfalpha
ige
measur
serum
balf
lung
tissu
use
elisa
kit
ova
treat
rat
reveal
signific
increas
ige
tnfalpha
level
mast
cell
lung
eosinophil
balf
lung
tissu
anim
show
also
increas
circul
ngf
serum
balf
ngf
administr
normal
adult
rat
lead
increas
eosinophil
ige
balf
lung
allerg
rat
find
suggest
ngf
stimul
aba
inflammatori
respons
increas
ngf
allerg
respons
may
associ
regul
neuroallerg
andor
neuroimmuno
protect
action
studi
aim
evalu
whether
serum
level
matrix
metalloproteinas
inhibitor
correl
symptomat
versu
asymptomat
carotid
stenosi
restenosi
follow
endarterectomi
serum
patient
symptomat
sever
carotid
stenosi
confirm
duplex
collect
pre
endarterectomi
year
postsurgeri
crp
level
measur
pre
endarterectomi
level
crp
similar
symptomat
asymptomat
patient
crp
level
chang
follow
surgeri
overal
mmp
level
decreas
year
post
surgeri
timp
level
increas
patient
stratifi
accord
presenc
absenc
concomit
ischem
heart
diseas
ihd
signific
decreas
mmp
level
observ
ihdfre
group
asymptomat
patient
trend
declin
level
observ
parallel
signific
increas
similar
chang
observ
symptomat
patient
fail
reach
statist
signific
eleven
patient
develop
restenosi
significantli
decreas
norestenosi
group
signific
increas
level
observ
result
studi
indic
year
postcarotid
endarterectomi
mmp
ratio
reduc
studi
requir
support
use
enzym
biomark
atherosclerot
activ
impend
stroke
vesicl
shed
mediat
releas
atp
stimul
microglia
cell
f
bianco
e
pravettoni
u
schenk
matteoli
b
c
verderio
cnrinstitut
neurosci
milan
itali
b
univers
milan
milan
itali
atp
indic
primari
factor
microgli
respons
brain
injuri
inflamm
mean
differ
receptor
atp
known
induc
chemotaxi
stimul
releas
sever
cytokin
cell
activ
receptor
microglia
trigger
either
atp
deriv
die
cell
site
brain
injuri
ferrari
et
al
atp
releas
astrocyt
mediat
celltocel
signal
absenc
cell
damag
verderio
matteoli
shipk
et
al
use
biochem
approach
integr
videomicroscopi
experi
investig
function
consequ
trigger
microglia
atp
releas
mechan
stimul
astrocyt
mix
glial
cocultur
astrocytederiv
atp
induc
nearbi
microglia
format
shed
membran
vesicl
vesicl
format
inhibit
atpdegrad
enzym
apyras
receptor
antagonist
shed
vesicl
isol
follow
evalu
specif
elisa
assay
reveal
presenc
cytokin
insid
vesicular
organel
subsequ
efflux
extracellular
medium
efflux
shed
vesicl
enhanc
atp
stimul
inhibit
pretreat
antagonist
oatp
thu
indic
crucial
involv
poreform
receptor
releas
cytokin
tolllik
receptor
tlr
evolv
conserv
patternrecognit
receptor
central
innat
immun
signal
tlr
may
also
regul
endogen
respons
injuri
central
nervou
system
cn
microglia
respond
rapidli
axon
injuri
transect
axon
entorhin
cortex
caus
anterograd
axon
degener
induc
microgli
reactiv
hippocampu
accompani
local
cytokin
chemokin
product
later
macrophag
cell
infiltr
lpsreceptor
induc
lesionreact
hippocampu
within
h
injuri
coincid
glial
cytokin
chemokin
respons
detect
leukocyt
infiltr
significantli
induc
h
induct
ikba
transcript
suggest
signal
transduct
via
tlr
reactiv
glial
cell
macrophag
cell
infiltr
reduc
mice
cell
infiltr
delay
follow
axon
lesion
mice
microgli
expans
occur
day
postles
reduc
mice
although
macrophag
influx
unaffect
inhibit
leukocyt
infiltr
microgli
expans
observ
follow
axon
lesion
mice
find
suggest
induct
signal
tlr
earli
innat
respons
cn
axon
injuri
select
regul
later
cellular
respons
implic
regener
repair
contrast
tissu
central
nervou
system
cn
essenti
devoid
mhc
express
shield
antibodi
bloodbrain
barrier
therefor
rapid
local
innat
immun
respons
resid
brain
cell
requir
effect
fight
infecti
agent
recognit
microbi
infect
mediat
invari
receptor
call
tolllik
receptor
tlr
upon
ligand
bind
immun
cell
mount
direct
respons
pathogen
addit
activ
adapt
immun
system
studi
analyz
express
ten
tlr
quantit
pcr
human
astrocyt
receptor
respons
recognit
viral
doublestrand
rna
constitut
express
level
could
enhanc
ifngamma
ifnbeta
tlr
bare
detect
induc
ligand
poli
c
trigger
product
cytokin
tnfalpha
chemokin
tlr
adapt
molecul
full
length
short
isoform
tirapm
express
astrocyt
summari
human
astrocyt
may
sens
viral
infect
respond
proinflammatori
activ
program
amplifi
recruit
immun
cell
tissu
hydroxychloroquin
hq
antimalari
agent
use
immunomodul
lupu
rheumatoid
arthriti
interfer
antigen
process
inhibit
cytokin
product
peripher
blood
mononuclear
cell
studi
effect
hq
cultur
microglia
activ
thought
crucial
pathogenesi
multipl
sclerosi
ms
cours
mice
afflict
experiment
autoimmun
encephalomyel
eae
anim
model
ms
human
fetal
adult
microglia
pretreat
hq
follow
lipopolysaccharid
lp
monocytoid
activ
overnight
cultur
medium
collect
subject
cytokin
measur
use
elisa
hq
microm
significantli
decreas
tnfalpha
level
superior
minocyclin
known
microglia
modul
inhibit
tnfalpha
product
pretreat
period
effect
without
use
cell
effect
hq
transcript
encod
matrixmetalloproteinas
mmp
evalu
hq
reduc
mrna
incrimin
pathogenesi
ms
eae
final
test
hq
monophas
eae
found
mgkg
given
pretreat
complet
prevent
develop
diseas
correl
lack
sign
microglia
activ
treat
anim
conclud
interf
microglia
activ
mmp
hq
deserv
test
diseas
modifi
therapi
eae
ms
dept
pharmacolog
univers
washington
seattl
usa
cell
produc
endocannabinoid
activ
cannabinoid
receptor
molecular
target
marijuana
bioactiv
ingredi
molecular
mechan
underli
product
abund
endocannabinoid
unclear
show
atp
increas
product
mous
microgli
cell
cultur
respons
mediat
phosphatidylinositolspecif
phospholipas
c
piplc
diacylglycerol
dg
lipas
howev
efficaci
activ
metabotrop
purinerg
receptor
coupl
piplc
increas
product
suggest
ionotrop
metabotrop
purinerg
receptor
control
product
unexpect
enzymat
step
metabol
pathway
show
activ
ionotrop
receptor
highli
permeabl
calcium
necessari
suffici
increas
product
microgli
cell
also
show
sustain
rise
intracellular
calcium
induc
activ
receptor
directli
increas
dglipas
activ
inhibit
activ
monoacylglycerol
mg
lipas
enzym
degrad
invers
sensit
dglipas
mglipas
calcium
constitut
origin
effici
modal
sustain
accumul
final
overnight
activ
microgli
cell
interferongamma
disrupt
atpinduc
product
prolong
increas
amount
brain
parenchyma
thought
orchestr
neuroinflamm
enzymat
step
involv
synthesi
degrad
microgli
cell
constitut
appeal
target
therapi
aim
control
exacerb
neuroinflamm
nicotin
acetylcholin
receptor
famili
ligandg
pentamer
ion
channel
whose
main
function
transmit
signal
neurotransmitt
acetylcholin
peripher
central
nervou
system
recent
nicotin
acetylcholin
receptor
subunit
found
peripher
macrophag
interact
specif
agonist
strongli
reduc
releas
cytokin
tnfalpha
epidemiolog
studi
show
nicotin
may
protect
neurodegen
patholog
alzheim
parkinson
diseas
chronic
inflamm
sustain
microgli
cell
play
crucial
role
present
studi
investig
express
function
role
purifi
rat
microgli
cultur
rtpcr
analysi
reveal
presenc
mrna
microgli
cell
strong
bind
microgli
surfac
fitcalphabungarotoxin
specif
bind
alpha
subunit
confirm
presenc
receptor
nicotin
slightli
reduc
releas
nitric
oxid
lp
activ
microglia
wherea
mrna
synthesi
lipid
mediat
potenti
antiinflammatori
effect
enhanc
studi
line
hypothesi
antiinflammatori
effect
nicotin
suggest
develop
molecul
abl
stimul
receptor
repres
potenti
therapeut
tool
treatment
sever
inflammatori
neuropatholog
support
iss
grant
n
adapt
immun
instruct
microglia
protect
aggreg
bamyloid
glutam
toxic
butovski
ea
talpalar
k
benyaakov
schwartz
weizmann
institut
scienc
revohot
israel
bprotect
autoimmunityq
refer
wellcontrol
tcellmedi
antiself
respons
help
bodi
resist
neurodegen
disord
show
respons
cytokin
interferon
ifn
gamma
interleukin
il
render
microglia
protect
rel
microgli
activ
ifngamma
activ
delay
effect
wider
concentr
rang
microglia
respond
diseaseassoci
selfcompound
aggreg
betaamyloid
glutam
aggress
bacteria
eg
bacteri
cell
wallderiv
lipopolysaccharid
cytotox
downregul
mhcii
express
mhc
classii
transactiv
invari
chain
partial
protect
achiev
downregul
tnfalpha
upregul
insulinlik
growth
factor
igfi
induc
find
suggest
whether
local
immun
respons
damag
cn
benefici
harm
depend
microglia
interpret
threat
wellregul
tcellmedi
respons
serv
selfcontain
mechan
repair
microglia
resid
tissu
macrophag
central
nervou
system
cn
activ
earli
common
featur
nearli
cn
neuropatholog
other
demonstr
microglia
phenotyp
function
distinct
tissu
cnsinfiltr
macrophag
popul
sought
defin
microgli
phenotyp
molecular
level
use
open
profil
method
toga
screen
gene
express
detect
novel
known
molecul
express
microglia
adult
neonat
sever
popul
macrophag
dendrit
cell
studi
identifi
pattern
gene
express
distinguish
microglia
myeloid
popul
reveal
microglia
highli
heterogen
healthi
cn
indic
microgli
respons
patholog
stimuli
heterogen
even
within
singl
patholog
current
examin
extent
multipl
microgli
phenotyp
consequ
differ
lineag
versu
differ
environment
cue
oligodendrocyt
recruit
multipl
sclerosi
ms
role
cxc
chemokin
km
omari
g
john
b
cs
rain
albert
einstein
colleg
medicin
ny
usa
b
mount
sinai
school
medicin
ny
usa
subsequ
demyelin
ms
oligodendrocyt
initi
retain
capac
remyelin
diminish
lesion
age
elucid
factor
affect
oligodendrocyt
recruit
investig
express
cxc
chemokin
receptor
ms
lesion
chemokin
detect
immunohistochemistri
western
blot
antibodi
receptor
found
strongli
induc
hypertroph
astrocyt
edg
activ
ms
lesion
weakli
express
silent
lesion
absent
control
interestingli
specif
express
correspond
receptor
found
oligodendrocyt
ms
nonm
tissu
human
astrocyt
oligodendrocyt
also
studi
vitro
chemokin
measur
sandwich
elisa
astrocyt
supernat
stimul
rna
northern
blot
quantitativepcr
chemokin
receptor
immunofluoresc
protein
rna
level
strongli
induc
astrocyt
ifngamma
induc
astrocyt
cultur
media
alon
produc
limit
amount
cxc
chemokin
moreov
immatur
matur
cnpase
oligodendrocyt
display
surfac
express
base
concurr
express
chemokin
hypertroph
astrocyt
receptor
oligodendrocyt
lesion
margin
propos
cxc
chemokin
play
import
role
recruit
oligodendrocyt
lesion
ms
atp
regul
oligodendrocyt
progenitor
migrat
prolifer
via
receptor
activ
c
agresti
meomartini
b
amadio
b
e
ambrosini
b
serafini
c
b
visentin
f
aloisi
istituto
superior
di
rome
itali
b
cnrfondazion
santa
lucia
rome
itali
atp
releas
high
amount
inflamm
may
influenc
cell
function
well
damag
repair
process
via
activ
ionotrop
metabotrop
receptor
better
understand
consequ
purinerg
receptor
stimul
oligodendrocyt
investig
express
receptor
subtyp
function
activ
oligodendrocyt
progenitor
op
purifi
rat
brain
cultur
use
western
blot
analysi
demonstr
op
express
sever
receptor
subtyp
analysi
transient
induc
agonist
specif
antagonist
oxatp
reveal
signal
op
mediat
mainli
receptor
activ
function
correl
find
show
atp
adp
select
receptor
agonist
adpbeta
utp
induc
op
migrat
moreov
atp
adp
utp
abl
inhibit
op
prolifer
induc
plateletderiv
growth
factor
promot
oligodendrocyt
differenti
effect
atp
adp
op
migrat
prolifer
prevent
antagonist
confoc
laser
scan
microscopi
also
show
receptor
express
op
develop
rat
brain
result
suggest
atp
regul
op
mobil
differenti
could
affect
remyelin
inflammatori
demyelin
diseas
central
nervou
system
like
multipl
sclerosi
interest
schwann
cell
sc
possibl
sourc
myelin
cell
transplant
cn
patient
multipl
sclerosi
ms
spinal
cord
injuri
migrat
sc
cn
limit
even
inject
directli
cn
glia
may
interfer
sc
surviv
matur
investig
effect
cn
glia
sc
cultur
neonat
rat
sc
expos
serum
free
supernat
sup
obtain
rat
mix
glial
cultur
sup
day
glial
cultur
induc
prolifer
sc
assay
day
concentr
depend
manner
sup
induc
sc
differenti
measur
induct
surfac
express
galactolipid
gall
assess
indirect
immunofluoresc
monoclon
antibodi
gall
sup
inhibit
cyclic
amp
camp
induct
sc
differenti
sup
appar
effect
sc
viabil
h
previous
demonstr
incub
sc
transform
growth
factorbeta
tgfbeta
tumor
necrosi
factoralpha
tnfalpha
induc
sc
death
via
apoptosi
sup
inhibit
tgfbetatnfalpha
induc
sc
death
data
suggest
solubl
product
cn
glia
potenti
alter
sc
function
may
effect
outcom
sc
transplant
migrat
cn
chemokin
alpha
stimul
oligodendrocyt
precursor
prolifer
enhanc
myelin
format
vitro
l
kadi
r
selvaraju
p
de
ly
proudfoot
well
b
chvatchko
u
boschert
serono
pharmaceut
research
institut
geneva
switzerland
b
serono
intern
sa
geneva
switzerland
chemokin
group
cytokin
involv
immun
system
signal
recent
postul
regul
central
nervou
system
cn
develop
function
particular
chemokin
may
play
role
regul
oligodendrocyt
cell
myelin
axon
within
cn
chosen
studi
role
sever
chemokin
mediat
myelin
process
lead
axon
ensheath
use
mous
oligodendrocyt
precursorlik
cell
line
olineu
assess
activ
chemokin
oligodendrocyt
develop
recombin
human
chemokin
groalpha
dosedepend
increas
prolifer
mous
olineu
cell
olineu
cell
express
receptor
induct
prolifer
could
inhibit
addit
block
antibodi
activ
groalpha
also
studi
use
primari
mix
cortic
cultur
embryon
mous
brain
vitro
model
myelin
treatment
chemokin
stimul
myelin
basic
protein
mbp
synthesi
dosedepend
manner
also
enhanc
myelin
segment
format
visual
via
antimbp
immunocytochemistri
keep
result
obtain
use
olineu
cell
chemokin
shown
stimul
prolifer
variou
cell
type
mix
cortic
cultur
cultur
shown
contain
subpopul
cell
express
receptor
marker
oligodendrocyt
precursor
cell
opc
plateletderiv
growth
factor
receptor
alpha
pdgfar
sever
clinic
experiment
line
evid
indic
glycolipid
gl
may
serv
autoantigen
demyelin
autoimmun
diseas
peripher
nervou
system
multipl
sclerosi
ms
humor
cellular
immun
mechan
direct
gl
suggest
play
pathogenet
role
howev
cellular
distribut
gl
glial
cell
situ
clearli
assess
thu
hamper
pathogenet
correl
autoimmun
respons
aim
studi
assess
pattern
express
situ
gl
glial
cell
adult
normal
central
nervou
system
cn
chronic
ms
lesion
focus
matur
oligodendrocyt
precursor
op
perform
doubl
stain
specif
glial
cell
marker
mab
frozen
section
normal
condit
gl
preferenti
express
astrocyt
except
present
oligodendrocyt
op
ms
lesion
gangliosid
diffus
downregul
astrocyt
upregul
op
particular
edg
ms
lesion
op
show
high
level
express
mab
present
oligodendrocyt
myelin
surround
white
matter
result
may
provid
interest
insight
pathogen
role
gl
autoantigen
ms
cn
autoimmun
diseas
sonic
hedgehog
shh
downstream
molecul
may
dysregul
ms
diseas
select
deplet
oligodendroglia
occur
studi
ms
lesion
differ
stage
cn
tissu
normal
diseas
control
evalu
express
shh
receptor
patch
ptc
immunocytochemistri
western
blot
oligodendrocyt
edg
chronic
activ
ms
lesion
intens
immunoreact
shh
ptc
western
confirm
increas
shh
ptc
level
expand
decreas
level
silent
ms
contrast
stain
oligodendrocyt
normalappear
white
matter
nawm
cell
astrocyt
oligodendrogli
featur
activ
lesion
edg
western
show
differ
among
group
select
stain
oligodendrocyt
tissu
examin
activ
ms
gradient
immunoreact
seen
oligodendrocyt
nawm
stain
intens
near
lesion
edg
less
intens
interestingli
western
reveal
markedli
increas
chronic
activ
ms
upregul
shh
oligodendrocyt
around
chronic
activ
lesion
suggest
gene
activ
ongo
demyelin
downregul
shh
may
explain
progress
chronic
activ
chronic
silent
lesion
support
ns
nmss
ca
adult
human
oligodendrocyt
prolifer
longterm
cultur
boullern
frim
b
b
arnason
c
dept
neurolog
univers
chicago
chicago
usa
b
section
neurosurgeri
brain
research
institut
univers
chicago
usa
c
dept
neurolog
brain
research
institut
univers
chicago
chicago
usa
human
oligodendrocyt
olg
isol
resect
specimen
epilepsi
patient
maintain
primari
cultur
assess
prolif
capac
variou
cultur
condit
immunostain
cell
prepar
show
surviv
cell
olg
lineag
time
isol
stain
olg
progenitor
marker
show
progenitor
cell
colabel
microglia
marker
neg
confirm
label
cell
olg
sever
time
point
two
month
cultur
continu
evid
cell
divis
bromodeoxyuridin
incorpor
along
increas
cell
densiti
document
confoc
imag
prolif
capac
olg
adult
brain
found
depend
upon
low
insulin
concentr
agml
inhibitori
agml
insulin
despit
presenc
growth
factor
maximum
prolifer
rate
olg
progenitor
olg
maintain
laminin
extracellular
matrix
protein
axon
central
nervou
system
retain
prolif
capac
find
relev
develop
therapeut
strategi
promot
remyelin
human
central
nervou
system
degen
diseas
lymphocyt
present
within
ethidiumbromid
eb
demyelin
lesion
central
nervou
system
cn
possibl
particip
possibl
immunemedi
respons
detach
myelin
sheath
rule
studi
aim
investig
consequ
lymphocyt
interfer
immunosuppress
agent
cyclophosphamid
cy
cyclosporin
csa
cn
repair
local
eb
inject
adult
wistar
rat
receiv
microlitr
eb
solut
cisterna
ponti
treat
intraperiton
cy
mgkg
twice
week
group
csa
mgkgday
group
ii
experiment
period
other
immunosuppress
group
iii
three
anim
group
perfus
glutaraldehyd
day
follow
eb
inject
brainstem
slice
collect
process
transmiss
electron
microscopi
studi
rat
group
show
greater
amount
myelinderiv
membran
nonimmunosuppress
rat
suggest
delay
macrophag
activ
remov
myelin
debri
rare
lymphocyt
found
oligodendrocyt
remyelin
activ
also
show
delay
pattern
clear
predomin
nake
axon
although
neovascular
decreas
astrocyt
reaction
appear
affect
rat
group
ii
import
find
presenc
higher
densiti
oligodendrocyt
near
remyelin
axon
peripheri
lymphocyt
still
present
result
group
ii
suggest
suppress
csa
prolif
effect
oligodendrocyt
progenitor
tumour
necrosi
factor
tnf
major
immunomodulatori
proinflammatori
cytokin
identifi
pathogen
role
number
inflammatori
diseas
within
central
nervou
system
includ
multipl
sclerosi
anim
model
experiment
autoimmun
encephalomyel
eae
tnf
synthesis
membran
bound
protein
cleav
solubl
form
proteinas
respons
cleavag
identifi
tnfaconvert
enzym
tace
shown
express
endotheli
astrocyt
cell
white
matter
normal
human
control
brain
report
distribut
level
express
within
spinal
cord
white
matter
narv
lewi
rat
well
rat
eae
assess
immunocytochemistri
western
blot
realtim
rtpcr
qrtpcr
associ
blood
vessel
endothelium
narv
prediseas
spinal
cord
wherea
abund
astrocyt
inflammatori
cell
express
peakdiseas
recoveri
appar
upregul
protein
coupl
fourfold
decreas
mrna
level
natur
inhibitor
tissu
inhibitor
metalloproteinas
determin
qrtpcr
coxsacki
adenoviru
receptor
express
ependym
cell
key
compon
brain
stem
cell
nich
hauwel
c
canova
p
gasqu
adult
vertebr
brain
subventricular
zone
svz
one
rare
neurogenesi
area
progenitor
svz
activ
prolifer
gener
neuron
precursor
migrat
olfactori
bulb
site
injuri
ependym
cell
cover
insid
ventricl
direct
contact
neural
stem
cell
nsc
interestingli
express
specif
coxsackieadenoviru
receptor
car
kda
transmembran
protein
member
immunoglobulin
super
famili
whose
function
remain
unknown
car
abundantli
express
brain
embryogenesi
restrict
ependym
cell
adult
brain
found
car
immunoreact
significantli
modifi
follow
broad
rang
brain
infarct
mass
spectrometri
analysi
coimmunoprecipit
car
new
born
svz
cell
lysat
reveal
sever
associ
protein
may
involv
stem
cell
differenti
furthermor
prolifer
nsc
vitro
modifi
presenc
car
substrat
conclus
car
express
ependym
cell
svz
element
regul
nsc
activ
ependym
cell
creat
microenviron
svz
maintain
pluripotenti
nsc
control
prolifer
object
investig
mechan
human
nsc
hnsc
migrat
site
cn
injuri
method
migrat
studi
perform
boyden
chamber
vivo
studi
hnsc
label
fluoresc
cell
tracker
inject
ventricl
stroke
anim
euthan
week
later
confoc
reconstruct
use
correl
migrat
hnsc
foci
patholog
express
vitro
measur
direct
develop
chain
migrat
neurospher
presenc
ischem
normal
rat
brain
organotyp
explant
antibodi
result
hnsc
prolifer
migrat
increment
vitro
addit
express
mrna
protein
exposur
hnsc
trigger
phosphoryl
erk
ikappab
paxilin
vivo
hnsc
implant
periventricular
area
migrat
toward
stroke
region
astrocyt
endothelium
upregul
vitro
neurospher
elabor
chain
nestincel
appar
direction
cocultur
ischem
brain
explant
neurospher
elabor
robust
migratori
chain
nestinnsc
direct
toward
explant
compar
neurospher
cocultur
nonischem
explant
direction
inhibit
blockad
conclus
data
implic
chemoattract
pathway
mammalian
neural
stem
cell
migrat
provid
new
insight
signal
activ
neural
stem
cell
molecular
program
bone
marrow
transfer
experi
shown
microglia
constantli
renew
precursor
cell
belong
hematopoiet
system
howev
exact
ident
precursor
remain
enigmat
develop
cultur
system
allow
vitro
gener
microgliallik
cell
bone
marrowderiv
myeloid
precursor
expand
presenc
mcsf
found
subset
class
iicel
give
rise
microgliallik
cell
presenc
glial
cell
condit
media
differenti
cell
present
phenotyp
morpholog
featur
microglia
assess
flow
cytometri
scan
electron
microscopi
interestingli
observ
microglia
deriv
mix
glial
cell
cultur
bone
marrow
myeloid
precursor
express
cell
neural
stem
cell
marker
nestin
cell
use
model
intracerebr
viral
infect
canin
distemp
viru
cdv
found
bone
marrow
deriv
microgli
precursor
expand
bone
marrow
infect
versu
control
anim
moreov
microgli
precursor
label
cfse
inject
iv
cdv
infect
mice
could
detect
isol
cell
brain
parenchyma
central
nervou
system
c
buonsanti
mariani
f
benigni
p
di
lucia
smiroldo
l
adorini
p
paninabordignon
bioxel
spa
milan
itali
cell
surfac
molecul
immunoglobulin
superfamili
express
monocytederiv
dendrit
cell
dc
associ
crosslink
promot
dc
migrat
activ
vitro
suggest
may
role
antigen
present
cell
stimul
vivo
genet
defect
human
result
rare
genet
syndrom
nasuhakola
diseas
character
presenil
dementia
bone
cyst
furthermor
mice
show
decreas
suscept
eae
induct
exhibit
function
defect
oligodendrocyt
osteoclast
observ
suggest
array
myeloid
cell
regul
may
extend
beyond
dc
includ
microgli
cell
osteoclat
show
complex
select
express
human
mous
microglia
express
downregul
brain
upon
intracerebr
inject
lp
mice
convers
transcript
protein
upregul
spinal
cord
mice
eae
induc
immun
mog
peptid
work
progress
evalu
effect
blockad
eae
lpsinduc
enceph
stain
solubl
form
reveal
primari
astrocyt
astrocytoma
cell
line
either
mous
human
origin
express
detect
level
ligand
current
data
suggest
might
modul
differenti
activ
microgli
cell
possibl
modul
respons
certain
cytokin
reinforc
signal
pathway
trigger
cytokin
receptor
integrin
chemokin
receptor
evid
distinct
express
proand
antiinflammatori
cytokin
within
subset
activ
brain
macrophag
cf
calvo
e
amig
j
glowinski
inserm
colleg
de
franc
pari
franc
brain
macrophag
bm
cell
popul
alreadi
consid
heterogen
term
phenotyp
express
pattern
also
exert
upon
activ
dual
function
result
either
benefici
detriment
effect
neuron
surviv
interest
character
bm
function
heterogen
tri
show
product
proand
antiinflammatori
cytokin
would
segreg
distinct
bm
cell
subset
bm
isol
newborn
mous
brain
cell
cultur
examin
bacteri
lipopolysaccharid
stimul
intracellular
immunofluoresc
stain
specif
antibodi
tnfalpha
candid
proand
antiinflammatori
famili
cytokin
respect
confoc
microscopi
show
total
cell
popul
produc
cytokin
wherea
produc
exclus
tnfalpha
respect
use
specif
map
kinas
inhibitor
show
immunofluoresc
elisa
cell
popul
could
regul
independ
inde
inhibit
map
kinas
inhibit
tnfalpha
product
blockad
mapk
pathway
abolish
tnfalpha
product
without
effect
altogeth
result
show
bm
respons
given
stimulu
repres
sum
independ
cell
subset
respons
therefor
postul
neurotroph
neurotox
function
bm
support
inflammatori
natur
cytokin
secret
distinct
subpopul
microgli
cell
bone
marrowderiv
antigen
present
cell
involv
cn
immun
surveil
microgli
function
brain
microenviron
compris
wide
rang
activ
phagocytosi
apoptoticnecrot
cell
antigen
process
present
patrol
cell
secret
cytokin
tune
function
capabl
microgli
cell
shape
fulli
compet
antigen
present
cell
bclassic
activationq
induc
phenotyp
mostli
associ
antiinflammatori
process
heal
induct
toler
often
call
baltern
activationq
gmcsf
growth
factor
present
inflammatori
condit
adult
brain
also
known
regul
antigen
present
cell
function
microglia
current
studi
regul
gmcsf
sever
protein
associ
either
classic
altern
microgli
activ
investig
result
show
murin
microglia
gmcsf
induc
primarili
marker
classic
activ
also
molecul
involv
altern
activ
underlin
uniqu
involv
pathway
apc
activ
influenc
ppargamma
agonist
prionprotein
induc
microglia
activ
wagner
r
mfssner
walter
k
fassbend
univers
germani
pathophysiolog
hallmark
prion
diseas
chronic
microgli
activ
consid
contribut
progress
neuron
injuri
releas
neurotox
product
alzheim
diseas
also
character
microglialinduc
proinflammatori
respons
use
agonist
peroxisom
proliferatoractiv
receptor
gamma
ppargamma
shown
reduc
amyloidbeta
stimul
cytokin
express
microglia
therefor
analyz
effect
drug
thiazolidindion
class
like
rosiglitazon
troglitazon
prionproteininduc
microgli
activ
murin
microglia
periton
macrophag
stimul
fibrillar
prion
protein
prp
fibrillar
peptid
control
electron
microscopi
control
experi
consist
stimul
nonfibrillar
prp
scrambl
stimul
cell
fibrillar
result
strong
induct
express
proinflammatori
cytokin
interleukin
tumornecrosefactor
alpha
tnfalpha
measur
elisa
wherea
nonfibrillar
scrambl
peptid
effect
microgli
cell
use
ppargamma
agonist
like
troglitazon
abl
reduc
prpinduc
express
tnfalpha
macrophagesmicroglia
dosedepend
manner
result
indic
use
ppargamma
agonist
potenti
new
therapeut
approach
prionprotein
induc
neuroinflamm
earli
cytoskelet
rearrang
occur
activ
microgli
cell
c
gallotti
l
grandbarb
e
morga
p
heuschl
stimul
proinflammatori
signal
microglia
brain
endogen
myeloid
cell
popul
rapidli
chang
cell
morpholog
order
adopt
shape
phagocyt
cell
use
cell
line
well
primari
rodent
microgliocyt
studi
earli
modif
occur
vitro
level
actin
cytoskeleton
actinbind
protein
well
focal
adhes
spot
morphometr
analysi
document
rapid
chang
cell
morpholog
first
h
activ
lp
actinfib
bundl
well
actinassoci
protein
lplastin
alphaactinin
studi
fluoresc
microscopi
link
cell
morpholog
intracellular
distribut
protein
observ
focal
adhes
spotassoci
protein
integrin
well
vinculin
studi
disposit
adhes
spot
chang
activ
lplastin
phosphoryl
form
alphaactinin
seen
close
associ
focal
adhes
spot
immunoblotanalysi
well
rtpcr
use
studi
kinet
express
protein
synthesi
lplastin
especi
phosphoryl
tightli
regul
first
min
activ
indic
lplastin
posttransl
chang
key
element
morpholog
chang
occur
microgli
activ
ischemiareperfus
injuri
associ
inflammatori
respons
may
play
deleteri
benef
role
neuron
damag
tacrolimu
immunosuppress
block
activ
immun
system
cell
exert
neuroprotect
neurotroph
action
traumat
brain
injuri
sciatic
nerv
injuri
focal
global
ischemia
found
neuroprotect
administ
mgkg
min
mcao
induc
male
wistar
rat
use
sutur
model
produc
signific
reduct
tnfalpha
mrna
level
observ
h
reperfus
associ
signific
downregul
protein
express
microglia
injur
side
studi
influenc
microglia
morpholog
cytokin
express
lpsactiv
microgli
cell
lpsinduc
chang
microglia
morpholog
complet
inhibit
cultur
microglia
constitut
express
cytokin
basal
level
cytokin
mrna
observ
untreat
cultur
howev
stimul
lp
induc
express
studi
cytokin
h
evid
chang
observ
level
tnfalpha
mrna
addit
block
lpsinduc
increas
cytokin
mrna
level
find
suggest
microgli
cell
target
modul
inflamm
may
mechan
neuroprotect
ischemia
neurodegen
disord
includ
multipl
sclerosi
parkinson
diseas
alzheim
diseas
massiv
neuron
cell
death
occur
consequ
uncontrol
inflammatori
respons
activ
microglia
cytotox
agent
play
crucial
patholog
role
activ
microglia
secret
inflammatori
mediat
cytokin
chemokin
contribut
pathophysiolog
chang
associ
sever
neuroimmunolog
disord
vasoact
intestin
peptid
vip
neuropeptid
function
potent
antiinflammatori
factor
peripheri
investig
effect
vip
chemokin
product
activ
microglia
vip
inhibit
express
microgliaderiv
cxc
chemokin
kc
cc
chemokin
rant
inhibit
chemokin
gene
express
correl
inhibitori
effect
vip
nfkb
bind
vip
inhibit
chemokin
product
nfkb
bind
mediat
specif
receptor
involv
campdepend
intracellular
pathway
biolog
signific
fact
inhibit
chemokin
product
vip
lead
signific
reduct
chemotact
activ
gener
activ
microglia
peripher
leukocyt
ie
neutrophil
macrophag
lymphocyt
vip
clear
neuroprotect
effect
inflammatori
condit
inhibit
product
microgliaderiv
proinflammatori
factor
tumor
necrosi
factor
alpha
nitric
oxid
therefor
vip
repres
import
factor
control
inflamm
central
nervou
system
emerg
valuabl
neuroprotect
agent
treatment
patholog
condit
central
nervou
system
inflammationinduc
neurodegener
occur
microgli
cell
intrins
immunocompet
cell
central
nervou
system
follow
brain
injuri
cell
rapidli
activ
transform
rest
activ
state
wide
believ
substanc
releas
damag
cell
within
brain
trigger
process
consequ
lead
longterm
chang
microgli
gene
express
reorgan
cell
phenotyp
investig
immunoglobulin
activ
microgli
cell
found
immunoglobulin
trigger
dosedepend
microgli
prolifer
well
nitric
oxid
releas
furthermor
immunoglobulin
led
cytokin
releas
tnfalpha
well
chang
surfac
antigen
express
immunoglobulin
found
high
concentr
serum
could
enter
cn
period
bloodbrain
barrier
breakdown
microglia
innat
refractori
nitric
oxideinduc
stimuli
acquir
respons
follow
differenti
colonystimul
factor
ca
brannan
mr
robert
depart
microbiolog
medicin
univers
virginia
charlottesvil
va
usa
microglia
immunoregulatori
cell
central
nervou
system
cn
share
mani
characterist
resid
macrophag
extracerebr
tissu
macrophag
secret
nitric
oxid
follow
nfkappabifndepend
transcript
activ
synthas
gene
stimuli
elicit
cell
respons
microbi
product
play
key
role
regul
adapt
innat
immun
respons
includ
inhibit
cell
prolifer
elimin
intracellular
pathogen
regul
product
microglia
poorli
understood
howev
find
microglia
healthi
adult
mice
produc
neglig
amount
compar
resid
macrophag
restimul
peptidespecif
cell
therefor
block
cell
prolifer
impair
respons
extend
stimuli
includ
cytokin
ligat
lipopolysaccharid
oper
level
rna
microglia
produc
proinflammatori
cytokin
respons
stimuli
howev
therefor
possess
rel
select
block
express
furthermor
microglia
acquir
profound
respons
noinduc
follow
differenti
gmcsf
mcsf
factor
constitut
requir
differenti
macrophag
popul
vivo
increas
cn
inflamm
diseas
therefor
propos
microglia
healthi
adult
brain
exist
bnoincompetentq
state
may
revers
set
cn
diseas
thu
facilit
tempor
modul
cn
immun
respons
increas
evid
inflammatori
activ
microglia
pathogen
influenc
alzheim
diseas
ad
accord
vitro
studi
microglia
activ
amyloidbeta
abeta
peptid
report
damag
kill
neuron
releas
neurotox
molecul
tumor
necrosi
factoralpha
tnfalpha
nitric
oxid
reactiv
oxygen
speci
wherea
report
phagocyt
engulf
apoptot
cell
activ
suppress
inflammatori
respons
releas
antiinflammatori
mediat
prostaglandin
thu
tempt
specul
activ
microglia
may
chang
proinflammatori
antiinflammatori
phagocytosi
apoptot
cell
studi
attempt
elucid
effect
psliposom
mimick
apoptot
cell
inflammatori
respons
abetaactiv
microglia
pretreat
psliposom
significantli
inhibit
releas
tnfalpha
microgli
cell
activ
abeta
combin
interferongamma
ifngamma
psliposom
also
reduc
express
mrna
encod
tnfalpha
abetaifngammaactiv
microglia
furthermor
pretreat
ps
liposom
substanti
decreas
gener
superoxid
radic
associ
microglia
activ
lipopolysaccharid
lp
combin
phorbol
pma
electron
spin
reson
esr
spectra
result
strongli
suggest
psliposom
appli
treatment
ad
stress
hormon
glucocorticoid
gc
key
reproduct
hormon
estrogen
play
central
role
neuroendocrineimmun
crosstalk
major
impact
astrogli
cell
function
context
innat
inflammatori
mechan
dysfunct
astrogli
cell
compart
believ
contribut
select
degener
da
neuron
substantia
nigra
par
compacta
sn
mptp
induc
parkinson
like
syndrom
show
chief
role
hormon
program
glial
respons
inflamm
oxid
stress
mptpinduc
loss
da
neuron
function
studi
carri
transgen
tg
mice
constitut
express
gr
antisens
rna
earli
embryon
life
establish
link
gr
inosderiv
demonstr
lack
gr
regul
exacerb
experiment
induc
parkinson
studi
carri
femal
mice
depriv
endogen
ovarian
hormon
show
exacerb
mptpinduc
loss
da
neuron
function
preced
strong
astrogli
activ
ino
express
result
massiv
death
astrocyt
neuron
wherea
replac
therapi
sharpli
inhibit
ino
express
counteract
astrocyt
apoptosi
restor
neurochem
paramet
da
neuron
function
point
endogen
steroid
hormon
prime
modul
ino
induc
crucial
checkpoint
mptpinduc
neuroinflamm
notch
pathway
fundament
cell
interact
mechan
influenc
cell
fate
decis
interact
cellular
neighbour
recent
year
shown
notch
signal
play
crucial
role
differenti
process
monocyt
macrophag
dendrit
cell
normal
brain
tissu
microgli
cell
found
quiescent
cell
upon
appropri
stimul
though
continu
previous
halt
differenti
process
becom
immunocompet
phagocyt
cell
present
studi
examin
involv
notch
pathway
microgli
activ
modul
notch
signal
solubl
form
ligand
indic
notch
signal
function
murin
microgli
cell
line
well
primari
microglia
data
show
notch
activ
modul
express
proinflammatori
cytokin
tnfalpha
moreov
attempt
modul
neurotox
properti
activ
microgli
cell
undertaken
character
pharmacolog
properti
hybrid
compound
combin
alkanol
structur
antioxid
moieti
compound
modul
via
notch
pathway
proinflammatori
activ
microgli
cell
togeth
result
suggest
notch
signal
import
immunomodulatori
function
brain
regul
astrocyt
cell
respons
nucleotid
receptor
n
chorna
ga
weisman
b
af
gonzalez
univers
puerto
rico
san
juan
puerto
rico
usa
b
univers
missouricolumbia
missouri
usa
immunoregulatori
properti
astrocyt
glial
cell
role
neurogenesi
respons
tissu
damag
remain
unknown
recogn
activ
gprotein
coupl
nucleotid
receptor
atp
utp
upon
injuri
inflamm
stimul
intens
signal
astrocyt
microglia
oligodendrocyt
neuron
neari
et
al
neari
et
al
burnstock
william
chorna
et
al
found
activ
receptor
astrocytoma
cell
transfect
human
receptor
coupl
phosphoryl
creb
kinas
trigger
credepend
upregul
cell
surviv
gene
bclxl
addit
use
cdna
microarray
analysi
rtpcr
receptor
found
upregul
express
gene
neurotrophin
neuropeptid
growth
factor
includ
nerv
growth
neurotrophin
gliaderiv
neuritepromot
factor
moreov
condit
media
utptreat
cell
express
receptor
stimul
outgrowth
neurit
cell
nucleotid
mediat
releas
neurotrophin
activ
credepend
cell
surviv
respons
may
assum
solid
rational
possibl
use
receptor
develop
new
therapeut
strategi
immun
neurolog
disord
calcium
channel
coloc
human
fetal
astrocyt
x
song
zhao
cf
brosnan
albert
einstein
colleg
medicin
new
york
usa
member
mammalian
transient
receptor
potenti
trp
famili
form
cationperm
channel
plasma
membran
implic
capacit
calcium
influx
follow
activ
either
secondmessengermedi
pathway
andor
store
deplet
show
rtpcr
western
blot
immunohistochemistri
rest
astrocyt
express
particularli
site
cellcel
contact
confoc
imag
immunoelectron
microscopi
detect
coloc
junction
protein
demonstr
associ
coimmunoprecipit
propos
target
cell
membran
depend
upon
interact
ctermin
trl
motif
pdz
domain
use
transfect
astrocyt
myctag
trlmotif
truncat
deltatrl
found
deltatrl
local
juxtanuclear
compart
wherea
wildtyp
channel
show
promin
cell
surfac
distribut
delet
trl
motif
also
reduc
plasma
membran
express
assess
cell
surfac
biotinyl
experi
use
gst
fusion
protein
found
interact
domain
interact
lost
construct
miss
trl
motif
thu
data
demonstr
pdzinteract
domain
control
local
surfac
express
sinc
also
interact
gap
junction
protein
data
implic
part
signal
complex
form
astrocyt
lost
astrocyt
activ
cytokin
characteris
jaggednotchh
pathway
activ
astrocyt
e
morga
l
grandbarb
k
hemmer
p
heuschl
du
luxembourg
luxembourg
luxembourg
shown
jaggednotchh
pathway
implic
mani
aspect
cn
develop
function
includ
differenti
myelin
develop
downregul
oligodendrocyt
precursor
matur
myelin
begin
human
oligodendrocyt
matur
block
presenc
cell
transfect
inflam
ms
tissu
express
reactiv
astrocyt
wherea
astrocyt
myelin
area
show
immunoreact
attempt
modul
express
astrocyt
undertaken
character
differ
element
jaggednotchh
pathway
part
work
studi
express
differ
element
activ
astrocyt
induc
activ
astrocyt
use
lp
simultan
incub
ifngamma
tnfalpha
lp
induc
upregul
ligand
like
deltaii
downregul
express
interestingli
lp
also
downregul
presenc
ifngamma
tnfalpha
astrocyt
inhibit
express
simultan
incub
two
cytokin
induc
clear
upregul
ligand
ifngammatnfalpha
also
inhibit
express
taken
togeth
preliminari
result
could
interest
issu
understand
pathway
astrocyt
fact
better
understand
express
notchligand
help
tool
demyelin
diseas
dexamethason
increas
astrocyt
immunoreact
gfap
follow
ethidium
bromid
inject
brainstem
wistar
rat
lallo
e
bondan
universidad
bandeirant
de
sao
paulo
sao
paulo
brasil
ethidium
bromid
eb
gliotox
agent
caus
focal
astrocyt
oligodendrogli
disappear
immunosuppress
antiinflammatori
drug
known
modifi
glial
express
studi
design
investig
astrocyt
immunoreact
glial
fibrillari
acid
protein
gfap
eb
inject
anim
submit
dexamethason
dx
treatment
adult
wistar
rat
inject
cisterna
ponti
eb
receiv
dx
mgkgday
intraperitoni
routegroup
group
inject
salin
solut
also
treat
dx
group
group
brainstem
sampl
collect
h
day
postinject
gfap
immunohistochem
stain
use
avidinbiotin
method
group
extens
lesion
seen
pon
mesencephalon
astrocyt
disappear
central
area
h
postinject
macrophag
infiltr
peripher
astrocyt
reaction
note
day
margin
astrocyt
present
increas
immunoreact
gfap
dxtreat
anim
present
greater
number
gfapposit
cell
group
discret
pontin
lesion
observ
show
central
astrocyt
preserv
peripher
gfap
stain
less
intens
compar
group
differ
found
gfap
immunostain
group
salin
inject
astrocyt
edg
ebinduc
lesion
present
increas
immunoreact
gfap
dx
seem
increas
express
chang
gene
express
induc
activ
receptor
c
santosberrio
n
chorna
g
weisman
b
f
gonzalez
univers
puerto
rico
san
juan
puerto
rico
b
univers
missouri
missouri
usa
activ
lymphocyt
macrophag
microglia
platelet
well
cell
undergo
necrosi
apoptosi
releas
high
concentr
nucleotid
diphosph
triphosph
extracellular
space
astrocyt
respond
extracellular
nucleotid
releas
upon
nerv
stimul
damag
brain
cell
receptor
mediat
respons
extracellular
nucleotid
famili
receptor
two
subtyp
knownth
g
proteincoupl
receptor
ligandg
ion
channel
receptor
studi
test
hypothesi
activ
receptor
bzatp
analog
atp
lead
modul
express
gene
relat
inflamm
result
show
timeand
dosedepend
increas
express
cox
cfo
mrna
studi
made
cdna
microarray
activ
receptor
reveal
addit
gene
modul
receptor
find
help
us
better
understand
role
nucleotid
receptor
inflammatori
respons
nervou
system
inform
bound
pharmacolog
applic
clinic
signific
member
adamt
famili
metalloproteinas
adamt
substrat
includ
extracellular
matrix
ecm
compon
aggrecan
versican
brevican
form
part
cn
ecm
therefor
enzym
may
role
cn
ecm
turnov
exhibit
antiangiogen
activ
tissu
inhibitor
natur
occur
inhibitor
adamtss
involv
adamtss
patholog
multipl
sclerosi
ms
stroke
may
includ
role
ecm
breakdown
demyelin
prevent
remyelin
stroke
prevent
angiogenesi
express
studi
primari
human
astrocyt
mrna
protein
level
use
real
time
rtpcr
western
blot
immunocytochemistri
cell
untreat
treat
proinflammatori
cytokin
tnfalpha
tgfbeta
increas
express
seen
follow
treatment
three
cytokin
express
increas
tgfbeta
tnfalpha
increas
tgfbeta
data
indic
inflamm
imbal
adamt
express
could
caus
increas
enzym
activ
result
breakdown
cn
ecm
prevent
angiogenesi
work
fund
wellcom
trust
neuroinflamm
oxid
stress
upregul
transloc
multidrug
resistanceassoci
protein
mous
astroglia
f
gennuso
c
tirolo
n
testa
caniglia
f
lepiscopo
mc
moral
c
fernetti
b
l
pascolo
b
ostrow
c
c
tiribelli
b
b
marchetti
neuropharmacolog
oasi
troina
itali
b
biochemistri
univers
triest
triest
itali
c
washington
univers
seattl
usa
pharmacolog
univers
sassari
sassari
itali
multidrug
resist
associ
protein
mrp
atpdriven
export
pump
mediat
export
organ
anion
cell
variou
mrp
famili
member
includ
express
enrich
astrocyt
microglia
oligodendrocyt
neuron
rodent
cultur
also
express
two
cn
barrier
endotheli
cell
brain
microvessel
epitheli
cell
choroid
plexu
import
prevent
cn
accumul
variou
xenobiot
demonstr
knockout
mice
golgi
apparatu
recent
shown
repres
key
station
involv
intracellular
traffick
mous
astrocyt
report
differenti
express
rest
vs
activ
astrocyt
microglia
exposur
oxidativenitros
stress
serum
depriv
lipopolysaccharid
lp
timeand
dosedepend
upregul
express
induc
extens
membran
target
function
level
effect
accompani
enhanc
activ
reduct
intracellular
reactiv
oxygen
speci
accumul
wherea
exposur
inhibitor
sharpli
impair
phenomena
implic
glial
key
redox
sensor
brain
inflamm
receptor
machineri
involv
mbpinduc
astrocyt
activ
r
businaro
l
fumag
leon
b
gm
lauro
b
univers
la
sapienza
rome
itali
b
univers
roma
tre
rome
itali
object
present
studi
identifi
receptor
involv
myelin
basic
protein
mbp
uptak
evalu
role
subsequ
mbp
process
present
human
astrogli
cell
central
event
demyelin
process
studi
deal
cultur
astrogli
cell
stimul
mbp
peptid
fragment
order
evalu
heme
hla
class
ii
antigen
express
cytometr
analysi
rtpcr
western
blot
attent
focus
role
bfgf
receptor
gangliosid
lowdens
lipoprotein
receptorrel
protein
lrp
detect
astrogli
membran
experi
perform
presenc
absenc
specif
inhibitor
abovement
put
receptor
suggest
mbp
carri
bind
lrp
undergo
subsequ
receptormedi
endocytosi
mechan
may
repres
first
step
antigen
process
present
function
astrocyt
cell
monocarboxyl
like
lactat
provid
astrocyt
use
fuel
neuron
oligodendrocyt
primari
lewi
rat
astrocyt
cocultur
mhc
class
iirestrict
myelin
basic
protein
mbp
specif
cell
result
mark
upregul
astrocyt
lactat
transport
export
lactat
extracellular
space
evid
increas
trigger
cell
antigendepend
manner
glial
isoform
glucos
transport
regul
condit
cell
blast
preactiv
antigen
splenic
antigen
present
cell
apc
beforehand
also
led
increas
astrocyt
even
rest
cell
stimul
express
antimhc
class
ii
antimhc
class
iantibodi
ad
cocultur
therefor
complex
mhc
class
ii
molecul
astrocyt
might
mandatori
regul
consist
vitroexperi
upregul
observ
spinal
cord
autoimmun
encephalit
rat
express
appear
unchang
cellmedi
regul
might
contribut
compensatori
protect
mechan
order
guarante
substrat
pool
neuron
oligodendrocyt
inflammatori
condit
recent
describ
contact
astrocyt
induc
develop
regulatori
cell
present
studi
investig
mechan
respons
suppress
properti
preincub
astrocyt
render
rat
cell
complet
unrespons
mitogen
stimuli
coincid
block
phase
cell
cycl
increas
number
subdiploid
apoptot
cell
anerg
cell
complet
prevent
mitogenor
antigeninduc
growth
lymphocyt
suppress
activ
resid
cell
compart
observ
inhibitori
effect
mediat
immunosuppress
factor
releas
apoptot
cell
appar
requir
metabol
activ
cell
heatsensit
protein
synthesi
inhibitionsensit
solubl
cell
factor
includ
tgfbeta
sole
respons
observ
suppress
depend
either
nitric
oxid
product
prostaglandin
releas
tryptophan
consumpt
interestingli
solubl
cell
product
induc
contact
astrocyt
also
abl
transfer
suppress
activ
bnormalq
cell
could
explain
extrem
high
potenc
astrocyteinduc
suppressor
cell
final
cell
suppress
properti
readili
gener
upon
contact
astrocyt
human
lymphocyt
indic
potenti
therapeut
valu
treatment
cn
autoimmun
inhibit
calpain
activ
express
interferonbeta
rat
astrocyt
implic
ms
pathogenesi
treatment
latronico
v
piscopo
fasano
p
riccio
b
mg
liuzzi
depart
biochemistri
molecular
biolog
univers
bari
bari
itali
b
univers
basilicata
potenza
itali
calpain
famili
calciumactiv
proteas
recent
implic
multipl
sclerosi
ms
pathogenesi
abil
degrad
myelin
protein
presenc
increas
level
activ
glialinflammatori
cell
ms
plaqu
aim
studi
investig
whether
interferonbeta
ifnbeta
could
modul
activ
andor
express
mcalpain
astrocyt
rat
astrocyt
cultur
activ
lp
simultan
treat
differ
dose
ifnbeta
cultur
supernat
cellular
extract
collect
astrocyt
subject
caseinzymographi
presenc
mcalpain
activ
determin
scan
densitometri
extent
casein
degrad
compar
control
total
rna
extract
glial
cell
subject
rtpcr
use
primer
specif
mcalpain
increas
activ
mcalpain
observ
cellular
extract
lpstreat
astrocyt
comparison
cellular
extract
nontreat
cell
control
cell
contrari
dosedepend
inhibit
mcalpain
activ
observ
cellular
extract
ifnbetatr
astrocyt
rtpcr
reveal
express
mcalpain
increas
lpsactiv
astrocyt
dosedepend
inhibit
ifnbeta
treatment
result
suggest
ifnbeta
could
modul
express
calpain
astrocyt
effect
could
repres
addit
mechan
ifnbeta
decreas
develop
new
cn
lesion
cours
ms
within
central
nervou
system
cn
multipl
sclerosi
ms
increas
express
two
key
chemokin
demonstr
chemoattract
involv
recruit
cn
cell
monocyt
express
correspond
receptor
cerebrospin
fluid
csf
ms
patient
time
relaps
increas
decreas
understand
vivo
find
investig
express
primari
adult
human
astrocyt
vitro
follow
treatment
proand
antiinflammatori
cytokin
secret
chemokin
measur
elisa
cellassoci
chemokin
visualis
immunofluoresc
confoc
microscopi
mrna
measur
realtim
pcr
interferon
gamma
ngml
induc
secret
h
level
pgml
respect
tnf
alpha
ngml
effect
express
increas
releas
pgml
increas
mrna
also
observ
tgf
beta
effect
chemokin
express
fine
control
chemokin
express
cytokin
may
explain
differ
chemokin
express
profil
csf
peopl
ms
express
function
role
tolllik
receptor
tlr
human
astrocyt
bsibsi
c
persoondeen
r
ravid
b
h
van
noort
tno
prevent
health
leiden
netherland
b
netherland
brain
bank
amsterdam
netherland
background
tolllik
receptor
play
key
role
recognit
invari
pathogenassoci
molecul
innat
immun
system
gener
mediat
proinflammatori
respons
agonist
previous
show
express
variou
tlr
famili
member
glial
cell
human
central
nervou
system
cn
elev
level
tlr
neuroinflamm
yet
function
signific
tlr
cn
still
larg
unexplor
object
investig
regul
tlr
express
cultur
human
astrocyt
evalu
function
respons
astrocyt
appropri
tlr
agonist
method
human
astrocyt
isol
postmortem
brain
healthi
donor
treat
cytokin
tlr
agonist
monitor
tlr
express
tlrencod
mrna
quantifi
realtim
pcr
monitor
function
respons
level
mrna
encod
gene
cytokin
chemokin
growth
factor
receptor
monitor
use
cdna
array
result
conclus
select
tlr
induct
observ
astrocyt
variou
stimuli
surprisingli
activ
induc
tlr
astrocyt
led
induct
sever
chemotact
factor
along
varieti
mediat
known
function
repair
process
tlr
activ
gener
activ
polar
proinflammatori
respons
togeth
data
suggest
astrogli
tlr
play
role
repair
function
rather
promot
inflamm
neuron
degener
mice
model
human
immunodefici
viru
hiv
induc
neurodegen
diseas
human
studi
show
increas
express
enzym
known
associ
inflammatori
neurodegen
diseas
brainstem
tissu
mice
section
tissu
find
astrocyt
area
spongiform
lesion
contain
increas
amount
immunoreact
also
upregul
cultur
astrocyt
effect
significantli
decreas
treatment
cell
curcumin
specif
inhibit
cjun
ntermin
kinas
jnk
cjun
pathway
contrast
alln
lactacystin
inhibit
extracellular
signalregul
kinas
erk
activ
proteasom
activ
effect
data
point
jnkcjun
pathway
mechan
express
induc
astrocyt
notabl
curcumin
also
decreas
level
ccaatenhancerbind
protein
chop
b
glucoserel
protein
c
phosphoryl
eukaryot
initi
factor
marker
endoplasm
reticulum
er
stress
signal
upregul
untreat
cell
infect
find
link
er
stress
signal
astrocyt
event
result
induct
tubercul
mening
astrocyt
deriv
matrix
metalloproteinas
je
harri
js
friedland
imperi
colleg
london
uk
tubercul
mening
tbm
deadli
form
tubercul
infect
patholog
characteris
extens
destruct
central
nervou
system
cn
tissu
matrix
implic
tissu
destruct
rang
cn
diseas
includ
tbm
astrocyt
popul
celltyp
cn
therefor
astrocytederiv
matrix
metalloproteinas
mmp
tissu
inhibitor
metalloproteinas
timp
mayb
key
mediat
cn
tissu
destruct
present
studi
regul
gene
express
secret
key
timp
analys
use
zymographi
elisa
western
blot
northern
blot
hour
astrocyt
stimul
condit
media
infect
monocyt
secret
control
concentr
rise
maximum
unit
concentr
significantli
differ
control
studi
period
upregul
inhibit
combin
antitnfalpha
receptor
antagonist
pertussi
toxin
block
g
proteinlink
process
inhibit
seen
respons
singl
inhibitor
tnfalpha
induc
express
astrocyt
cholera
toxin
data
suggest
network
activ
astrocyt
monocyt
play
key
role
creat
matrix
degrad
environ
tbm
combin
mediat
involv
tnfalpha
critic
role
astrocyteexpress
tissu
inhibitor
metalloproteinas
timp
import
molecul
cn
homeostasi
inflammatori
diseas
includ
dementia
recent
emerg
multifunct
molecul
promot
cell
surviv
addit
mmp
regul
previous
uniqu
demonstr
brain
reduc
level
express
differenti
regul
elev
level
acut
diminish
level
chronic
inflamm
observ
indic
replenish
may
therapeut
valu
laboratori
anim
model
system
use
examin
mechan
regul
neuroprotect
human
astrocytesneuron
neurotoxin
virusvir
protein
promoterluciferas
report
construct
rnai
gene
silenc
use
preliminari
data
confirm
acut
versu
chronic
respons
astrocyt
regul
predominantli
promot
level
neurotox
andor
neuroprotect
measur
mtt
activ
tunel
dna
fragment
elisa
sirnatransfect
astrocyt
enhanc
neurotox
correl
diminish
level
treatment
partial
revers
neurotox
challeng
neuron
addit
support
neuron
differenti
earli
develop
suggest
may
function
neurotrophin
may
mediat
activ
antiapoptot
protein
andor
neurotroph
activ
result
indic
complex
regul
may
influenc
neuroprotect
studi
relev
glial
inflamm
may
unravel
novel
mechan
glialneuron
interact
vagu
nerv
prevent
system
inflamm
inhibit
tnf
transcript
spleen
via
nachr
l
ulloa
h
liao
v
pavlov
ochani
kj
tracey
north
shore
univers
hospit
long
island
jewish
research
institut
manhasset
ny
usa
endotoxin
constitu
gramneg
bacteria
stimul
macrophag
releas
proinflammatori
cytokin
includ
tumor
necrosi
factor
tnf
caus
lethal
shock
tissu
injuri
recent
discov
vagu
nerv
stimul
attenu
circul
tnf
level
endotoxemia
mechan
name
bthe
cholinerg
antiinflammatori
pathwayq
acetylcholin
principl
neurotransmitt
vagu
nerv
inhibit
tnf
product
macrophag
object
studi
determin
vagu
nerv
regul
tnf
product
differ
organ
report
stimul
vagu
nerv
prevent
lethal
system
inflamm
inhibit
tnf
transcript
spleen
splenectomi
attenu
circul
tnf
level
endotoxemia
pg
tnf
ml
serum
vs
pg
tnfml
serum
vagu
nerv
stimul
fail
attenu
circul
tnf
level
splenectom
mice
electr
stimul
vagu
nerv
activ
splenic
neuron
network
section
common
celiac
trunk
vagu
nerv
proxim
spleen
ablat
vagu
nerv
regul
tnf
spleen
serum
vagu
nerv
stimul
fail
modul
splenic
circul
tnf
level
anim
defici
subunit
acetylcholin
receptor
thu
vagu
nerv
prevent
endotoxininduc
lethal
system
inflamm
cholinerg
signal
spleen
neuropeptid
npi
peptid
distribut
throughout
bodi
implic
regul
sever
physiolog
process
energi
balanc
feed
reproduct
anxieti
npi
action
mediat
five
gprotein
coupl
receptor
design
assess
effect
npi
receptor
regul
immun
respons
npi
found
inhibit
migrat
b
cell
chemokin
also
shown
express
receptor
murin
spleen
mice
smaller
spleen
less
matur
b
cell
naiv
cell
secondari
lymphoid
organ
furthermor
cell
differenti
cell
mice
appear
defect
lower
level
detect
serum
challeng
tdepend
tindepend
antigen
mice
still
produc
significantli
lower
level
antibodi
respons
mice
test
model
delayedtyp
hypersensit
dth
interestingli
mice
significantli
reduc
footpad
swell
compar
wildtyp
mice
final
macrophag
lack
receptor
produc
less
tnfalpha
follow
stimul
lp
vitro
data
strongli
suggest
receptor
key
molecul
control
fundament
immun
function
confirm
interplay
neuroendocrin
immun
system
neuropeptid
gener
tolerogen
dendrit
cell
ganea
delgado
b
rutger
univers
newark
usa
b
institut
parasitolog
biomedicin
granada
spain
dendrit
cell
dc
act
potent
antigen
present
cell
initi
cell
activ
toleranceinduc
agent
cellsfactor
molecular
mechan
control
opposit
function
dc
elucid
yet
studi
show
bone
marrow
dc
gener
presenc
neuropeptid
vip
pacap
vippacapdc
induc
activ
regulatori
cell
treg
contrast
dc
gener
absenc
vip
pacap
vippacapdc
secret
high
level
detect
tnf
upon
stimul
lp
lpsstimul
vip
pacapdc
induc
unrespons
cocultur
cell
term
prolifer
cytokin
releas
ifngamma
cocultur
agspecif
cell
secret
howev
high
level
treg
induc
cocultur
vipdc
inhibit
prolifer
respond
cell
inhibit
complet
revers
addit
mix
neutral
ab
suggest
suppress
activ
mediat
cellular
contact
cytokin
vipdc
induc
treg
gener
vivo
vivoinduc
treg
capabl
transfer
toler
narv
host
gener
antigenspecif
treg
vitro
control
environ
high
therapeut
potenti
autoimmun
diseas
transplant
endogen
cannabinoid
glycerol
chemoattract
dendrit
cell
adjuv
helper
cell
type
respons
solubl
antigen
g
maestroni
istituto
cantonal
di
patologia
locarno
switzerland
tolllik
receptor
tlr
express
dendrit
cell
dc
alert
innat
immun
system
presenc
pathogen
appropri
respons
mount
contain
infect
howev
decisionmak
mechan
determin
type
effector
respons
poorli
understood
preced
work
show
sympathet
nervou
system
may
influenc
antigenpres
th
prime
abil
dc
report
murin
epiderm
langheran
cell
well
lymphoid
myeloid
dc
express
mrna
code
cannabinoid
receptor
intraderm
inject
physiolog
ligand
receptor
shift
immun
respons
solubl
protein
agonist
mix
type
sheer
type
effect
evidenc
enhanc
hypersensit
respons
product
pattern
cytokin
product
drain
lymph
node
abolish
specif
antagonist
sr
mechan
interest
effect
might
relat
recruit
lymphoid
dc
precursor
consist
show
potent
chemotact
activ
vitro
toward
dc
product
may
induc
inflammatori
agent
identifi
endogen
lipid
mediat
might
influenc
choic
appropri
immun
respons
pathogen
evolutionari
scale
tolllik
receptor
tlr
famili
pattern
recognit
receptor
prr
involv
innat
adapt
immun
respons
stimul
mediat
signal
cascad
final
lead
express
inflammationrel
gene
vasoact
intestin
peptid
vip
immunopeptid
present
lymphoid
microenviron
exert
therapeut
effect
sever
anim
model
inflammatori
autoimmun
disord
demonstr
treatment
vip
reduc
clinic
histopatholog
sever
tnbsinduc
coliti
decreas
inflammatori
autoimmun
compon
diseas
noth
known
put
involv
tlr
diseas
heal
result
show
constitut
express
well
upregul
tnbstreatment
protein
mrna
level
colon
reduc
vip
treatment
behaviour
also
exhibit
express
receptor
macrophag
dendrit
cell
lymphocyt
mesenter
lymph
node
present
studi
demonstr
modul
receptor
involv
benefici
effect
vip
anim
model
crohn
diseas
repres
new
step
design
potenti
therapeut
strategi
ghrelin
recent
identifi
gastric
hormon
varieti
function
neuroendocrin
peptid
involv
releas
growth
hormon
gh
neuropeptid
npi
follow
activ
gh
secretagogu
receptor
ghsr
prior
studi
demonstr
npi
would
play
regulatori
role
eae
caus
immun
bia
toward
explor
ghrelin
might
also
exert
immunomodulatori
effect
similar
npi
protect
develop
eae
induc
eae
mice
myelin
oligodendrocyt
glycoprotein
mog
treat
mice
subcutan
inject
ghrelin
agkg
everi
day
result
reveal
continu
treatment
agkg
ghrelin
eae
induct
day
day
could
significantli
amelior
clinic
sever
eae
wherea
treatment
acylmodifi
ghrelin
show
effect
unexpectedli
ifngamma
product
drain
lymph
node
ln
cell
affect
ghrelin
treatment
indic
mechan
eae
suppress
independ
npi
result
indic
novel
role
ghrelin
modul
autoimmun
patholog
eae
endogen
catecholamin
ca
human
peripher
blood
mononuclear
cell
pbmc
modul
activationinduc
apoptosi
multipl
sclerosi
ms
pbmc
dysregul
ca
product
less
suscept
apoptosi
sinc
interferon
ifn
beta
benefici
ms
investig
effect
ca
product
apoptosi
pbmc
obtain
healthi
donor
stimul
phytohaemagglutinin
pha
agml
trigger
product
ca
incub
ifnbeta
uml
increas
ca
product
efflux
effect
prevent
antibodi
ifnbeta
receptor
percentag
apoptot
pbmc
increas
pha
reduc
alphamethylptyrosin
prevent
phainduc
ca
product
ifnbeta
per
se
affect
apoptosi
complet
revert
antiapoptot
effect
alphamethylptyrosin
incub
pbmc
ifngamma
pgml
per
se
complet
inhibit
ca
product
effect
revert
coincub
ifnbeta
uml
experiment
condit
howev
ifnbeta
fail
induc
ca
efflux
conclus
human
pbmc
ifnbeta
induc
ca
product
efflux
restor
impair
apoptosi
secondari
inhibit
ca
product
counteract
ifngammainduc
effect
ca
find
shed
new
light
mechan
action
ifnbeta
immunomodulatori
drug
ms
pregnanc
repres
physiolog
transitori
state
immun
toler
avoid
reject
foetu
multipl
sclerosi
ms
amelior
pregnanc
rebound
activ
deliveri
alter
regulatori
tcell
tr
known
caus
organspecif
autoimmun
diseas
experiment
model
goal
quantifi
tr
pregnanc
puerperium
ms
patient
conduct
prospect
studi
patient
definit
ms
pregnanc
compar
two
control
group
healthi
pregnant
nonpregn
women
quantifi
tr
activ
cell
flow
cytometri
pregnanc
observ
progress
increas
tlymphocyt
healthi
well
ms
patient
wherea
decreas
activ
tcell
note
proport
tr
cell
significantli
higher
pregnant
nonpregn
women
wherea
differ
observ
neither
percentag
total
activ
tcell
tcell
significantli
decreas
compar
third
trimest
puerper
proport
ms
patient
respect
signific
differ
note
healthi
ms
pregnant
neither
activ
tr
cell
gestat
trimest
postpartum
find
consist
expans
circul
regulatori
pool
pregnanc
may
repres
relev
factor
activ
cours
ms
postmortem
studi
investig
relationship
multipl
sclerosi
ms
lesion
hypothalamu
state
activ
corticotropin
releas
hormon
crh
produc
neuron
control
hypothalamuspituitaryadren
hpa
axi
high
incid
ms
lesion
found
hypothalamu
activ
ie
contain
activ
macrophag
ms
patient
increas
number
crhimmunoreact
neuron
coexpress
vasopressin
crhvp
neuron
sign
chronic
activ
crh
neuron
increas
crh
mrna
express
activ
ms
lesion
correl
low
number
hyperact
crhvp
neuron
high
hla
dr
dp
dq
express
measur
macrophag
microgli
activ
correl
low
crh
mrna
express
nearer
hla
express
situat
crh
neuron
stronger
inhibit
effect
suggest
activ
microgli
cell
macrophag
suppress
neuron
activ
ms
lesion
present
hypothalamu
shorter
diseas
durat
moment
death
indic
unfavor
cours
diseas
thu
ms
patient
chronic
activ
crh
system
subgroup
patient
activ
ms
lesion
hypothalamu
activ
impair
diseas
cours
wors
tissu
provid
netherland
brain
bank
recent
found
activ
neuron
mice
lack
nfkappab
subunit
show
deficit
specif
cognit
task
demonstr
strikingli
low
level
anxietylik
behavior
knockout
mous
open
field
mutant
mice
show
significantli
less
defec
rear
time
spent
center
compart
rel
wild
type
control
mice
knockout
mice
also
spent
time
investig
novel
object
place
open
field
elev
plu
maze
knockout
mice
spent
time
open
arm
increas
number
open
arm
entri
rel
wild
type
test
gener
health
sensorimotor
function
daili
activ
circadian
rhythm
knockout
mice
normal
thu
absenc
subunit
nfkappab
transcript
factor
result
alter
nfkappab
transcript
activ
cell
throughout
bodi
brain
alter
neuron
circuitri
underli
manifest
emot
behavior
subunit
appear
play
role
normal
express
certain
form
anxieti
evid
innerv
lymphoid
organ
sympathet
fiber
releas
noradrenalin
na
neuropeptid
npi
previou
work
observ
modulatori
vitro
effect
na
npi
sever
immun
function
aim
present
studi
evalu
vitro
effect
neurotransmitt
individu
jointli
sever
inflammatori
paramet
periton
leucocyt
adher
fibronectin
collagen
type
releas
well
suscept
h
induc
apoptosi
adult
femal
balbc
mice
use
obtain
periton
suspens
contain
macrophag
lymphocyt
concentr
na
npi
npi
na
result
show
inhibitori
effect
neurotransmitt
use
jointli
releas
ngml
respect
suscept
apoptosi
decreas
npi
ne
use
individu
jointli
basal
condit
well
presenc
h
mm
adher
fibronectin
collagen
decreas
npi
use
individu
na
result
suggest
bantiinflammatoryq
effect
sympathet
neurotransmitt
studi
npi
na
physiolog
concentr
murin
periton
leucocyt
work
support
fi
cm
grant
crohn
diseas
cd
chronic
inflammatori
patholog
colon
character
diarrhoea
weight
loss
vasoact
intestin
peptid
vip
immunoregulatori
neuropeptid
prove
benefici
mice
model
human
cd
trinitrobenzen
sulfon
acid
tnb
coliti
aim
present
studi
determin
molecular
mechan
action
vip
model
coliti
studi
timecours
express
proinflammatori
regulatori
mediat
implic
pathophysiolog
diseas
gene
array
realtim
pcr
analysi
perform
measur
mrna
level
sever
proinflammatori
mediat
beta
ifn
gamma
tnbsmice
show
increas
express
proinflammatori
mediat
studi
specif
time
cours
pattern
molecul
besid
tnbstreat
anim
show
lymphocyt
respons
high
level
ifn
gamma
mrna
low
correl
high
express
two
differenti
factor
vip
downregul
express
mediat
exert
antiinflammatori
function
explain
remiss
diseas
treat
anim
vip
also
favour
versu
respons
contribut
remiss
diseas
result
support
potenti
therapeut
action
vip
therapi
inflammatori
diseas
role
substanc
receptor
system
vanilloid
receptormedi
capsaicininduc
apoptosi
rat
thymocyt
c
amantini
r
lucciarini
mosca
martarelli
perfumi
p
ballarini
g
santoni
univers
camerino
camerino
itali
investig
involv
substanc
receptor
system
regul
vanilloid
receptor
mediat
capsaicin
cp
induc
apoptosi
rat
thymocyt
evalu
confoc
laser
scanner
microscopi
analysi
express
substanc
p
sp
receptor
rat
thymocyt
found
receptor
complet
coloc
plasma
membran
rat
thymocyt
moder
coloc
detect
compar
express
sp
rat
thymocyt
evid
involv
receptor
cpsinduc
apoptosi
provid
analyz
capabl
sp
protect
rat
thymocyt
cpsmediat
apoptot
cell
death
sp
inhibit
doseand
timedepend
manner
cpsinduc
apoptosi
rat
thymocyt
evalu
abil
complet
revers
cpsinduc
activ
oligonucleosom
dna
fragment
specif
receptor
antagonist
complet
revers
antiapoptot
effect
sp
cpsinduc
apoptosi
rat
thymocyt
cp
markedli
inhibit
timedepend
manner
express
sp
rat
thymocyt
specif
antagonist
capsazepin
markedli
block
timedepend
manner
cpsinduc
sp
synthesisreleas
rat
thymocyt
neuropeptid
npi
involv
modul
function
relat
immun
inflammatori
reaction
lymphocyt
prolifer
nk
cell
activ
immun
cell
traffick
cytokin
secret
releas
oxid
agent
npi
exert
biolog
effect
sever
receptor
subtyp
name
rat
investig
effect
npi
npyrel
peptid
differ
pharmacolog
profil
h
product
rat
granulocyt
obtain
rat
air
pouch
carrageenan
agrat
inject
directli
air
pouch
granulocyt
obtain
h
later
lavag
treat
vitro
npi
peptid
yy
pyy
pancreat
polypeptid
pp
receptor
agonist
leupronpi
receptor
agonist
receptor
agonist
halaaibnpi
receptor
agonist
concentr
stimul
lp
agml
h
zymosan
agml
min
h
product
npi
pyy
stimul
basal
lpsinduc
product
granulocyt
leupronpi
potenti
releas
lpsstimul
cell
halaaibnpi
decreas
product
cell
cultur
medium
npi
leupronpi
decreas
peroxid
product
zymosanstimul
granulocyt
conclud
npi
npyrel
peptid
differenti
modul
h
product
rat
granulocyt
support
mstd
republ
serbia
grant
induct
beta
substanc
p
sp
human
peripher
blood
mononuclear
cell
pbmc
braitch
chopra
fahey
c
constantinescu
univers
nottingham
nottingham
uk
substanc
p
sp
neuropeptid
store
termini
sensori
neuron
induc
proinflammatori
cytokin
mediat
neurogen
inflamm
aim
examin
effect
sp
product
beta
peripher
blood
mononuclear
cell
pbmc
method
pbmc
stimul
sp
alon
combin
lipopolysaccharid
lp
phytohaemagglutinin
pha
supernat
analys
elisa
result
sp
alon
combin
lp
pha
induc
signific
increas
product
pbmc
pha
strong
induc
concert
stimuli
lp
prove
effect
sp
induc
product
secret
alon
combin
lp
pha
concentr
sp
decreas
amount
produc
declin
effect
profound
stimul
conclus
studi
confirm
abil
sp
enhanc
product
human
pbmc
cell
show
first
time
product
human
pbmc
sp
abil
sp
augment
secret
proinflammatori
cytokin
support
role
sp
inflammatori
respons
sp
antagonist
may
repres
futur
tool
downregul
inflamm
environ
rich
sp
includ
peripher
nerv
gut
inflam
joint
brain
interact
neuroendocrin
immun
system
age
tradeoff
analysi
mean
mathemat
model
sannikova
romanyukha
yashin
b
institut
numer
mathemat
ra
moscow
russia
b
max
planck
institut
demograph
research
rostock
germani
aim
work
quantifi
tradeoff
human
immun
hormon
system
age
process
purpos
construct
mathemat
model
describ
mutual
influenc
aris
agerel
declin
function
immun
endocrin
system
suppos
close
coordin
system
chang
allostat
antigen
load
action
two
type
environment
pressur
affect
rate
resourc
exhaust
system
neuroendocrin
immun
system
respons
mainten
homeostasi
intern
milieu
intens
energi
metabol
hand
paramet
machin
energi
metabol
determin
activ
immun
endocrin
system
dynam
cell
concentr
rate
hormon
synthesi
intens
energi
transform
consumpt
process
take
place
mitochondria
model
ode
system
result
simul
reveal
explicit
tradeoff
immun
space
power
hormon
reaction
exist
tradeoff
taken
consider
hormon
therapi
use
elderli
peopl
mainten
bodi
weight
around
set
point
requir
regulatori
process
energi
homeostasi
depend
tightli
regul
interact
nervou
immun
endocrin
system
thu
obes
may
result
energi
homeostasi
deregul
multipl
caus
includ
viral
infect
associ
human
obes
viru
report
mous
model
obes
induc
brain
cdv
infect
may
give
insight
virusinduc
brain
damag
may
lead
obes
negativestrand
rna
viru
predominantli
target
neuron
locat
hypothalamu
key
structur
integr
central
peripher
signal
regul
energi
homeostasi
obes
syndrom
associ
persist
viru
hypothalamu
could
due
specif
neuron
loss
andor
epigenet
alter
hypothalam
gene
involv
food
intak
energet
control
basal
metabol
identifi
gene
use
differenti
display
pcr
ddrtpcr
subtract
librari
compar
hypothalam
mrna
profil
infectedlean
obes
mice
among
identifi
deregul
gene
urop
select
accord
magnitud
increas
novelti
sequenc
fulllength
sequenc
cellular
central
peripher
local
determin
function
relev
obes
demonstr
obes
model
leptin
defici
mice
obob
dbdb
high
fat
diet
data
point
new
gene
implic
emerg
mainten
obes
statu
like
regul
leptin
control
modul
crh
prostaglandin
product
rat
hypothalamu
vitro
g
tringali
vairano
g
pozzoli
p
navarra
institut
pharmacolog
cathol
univers
school
medicin
rome
itali
proinflammatori
cytokin
show
similar
structur
receptor
signal
mechan
well
biolog
function
previous
shown
directli
stimul
corticotrophinreleas
hormon
crh
secret
rat
hypothalamu
via
mechan
requir
increas
prostaglandin
product
investig
whether
share
abil
stimul
crh
gene
express
peptid
releas
rat
hypothalam
explant
shortterm
h
vitro
incub
b
modul
basal
stimul
prostaglandin
product
hypothalam
explant
well
primari
cultur
rat
cortic
microglia
astrocyt
experi
crh
releas
incub
medium
evalu
radioimmunoassay
ria
wherea
crh
mrna
level
analys
use
rnase
protect
assay
product
assess
ria
found
decreas
concentrationdepend
manner
basal
kclstimul
crh
releas
find
parallel
signific
decreas
crh
gene
express
effect
basal
product
hypothalam
explant
complet
abolish
product
stimul
moreov
produc
reduct
basal
product
releas
microglia
astrocyt
data
clearli
demonstr
show
profil
neuroendocrin
activ
vitro
oppos
even
antagon
control
stress
axi
increas
releas
prostaglandin
pg
preoptic
area
rat
anterior
hypothalamu
poa
vitro
without
alter
cytokin
gene
express
asc
fabricio
g
tringali
g
pozzoli
gep
souza
b
p
navarra
institut
pharmacolog
cathol
univers
medic
school
rome
itali
b
univers
paulo
faculti
pharmaceut
scienc
preto
brazil
aim
previous
shown
fever
induc
rat
inject
preoptic
area
rat
anterior
hypothalamu
poa
icv
induc
increas
cerebrospin
fluid
prostaglandin
pg
level
investig
increas
releas
pge
poa
posterior
hypothalamu
phyp
explant
effect
relat
chang
cytokin
gene
express
method
result
male
wistar
rat
g
whole
hypothalam
region
explant
divid
optic
chiasm
obtain
isol
poa
phyp
area
incub
experi
induc
concentrationdepend
increas
immunoreact
pge
releas
incub
medium
whole
hypothalamu
statist
signific
nm
nm
also
induc
increas
pge
releas
poa
phyp
rnase
protect
analys
total
rna
extract
explant
show
nm
produc
effect
interleukin
il
gene
express
conclus
induc
increas
pge
releas
major
thermoregulatori
area
brain
ie
poa
acut
stimulatori
effect
pge
releas
poa
appear
relat
action
cytokin
mrna
express
orchidectomi
affect
monoamin
content
rat
thymocyt
b
vidicdankov
k
radojev
g
leposav
b
institut
immunolog
virolog
btorlakq
belgrad
yugoslavia
b
faculti
pharmaci
belgrad
yugoslavia
object
studi
shown
orchidectomi
influenc
intrathym
concentr
monoamin
ii
tcell
line
produc
catecholamin
therefor
studi
design
investig
whether
thymocyt
contain
detect
level
monoamin
ii
whether
orchidectomi
affect
intrathymocyt
monoamin
content
method
concentr
noradrenalin
na
dopamin
da
serotonin
estim
whole
thymu
thymocyt
suspens
ao
rat
one
month
post
bilater
orchidectomi
perform
age
either
day
hplc
electrochem
detect
result
spite
age
surgeri
orchidectomi
diminish
intrathym
concentr
na
increas
da
thymocyt
orchidectom
orx
control
shamorx
rat
show
detect
level
na
da
orchidectomi
group
rat
increas
intrathymocyt
concentr
na
intrathymocyt
concentr
increas
rat
orx
age
day
reduc
orx
age
day
conclus
result
reveal
detect
level
na
rat
thymocyt
show
intrathymocyt
level
monoamin
influenc
gonad
hormon
milieu
regul
dipeptidyl
peptidas
iv
human
dermal
fibroblast
j
gabrilovac
b
cupic
j
jakicrazumov
b
ruder
institut
zagreb
croatia
b
clinic
hospit
centr
rebro
zagreb
croatia
dppiv
membranebound
peptidas
cleav
dipeptid
ntermin
polypeptid
prolin
penultim
posit
besid
enzym
activ
dppiv
act
adhes
costimulatori
molecul
transduc
growth
signal
express
regul
cytokin
tnfalpha
neuropeptid
also
regul
express
membran
peptidas
turn
cleav
neuropeptid
examin
whether
opioid
peptid
physiolog
dppiv
substrat
could
affect
express
dppiv
human
dermal
fibroblast
role
cleavag
site
interact
examin
use
synthet
resist
cleavag
dppiv
role
opioid
receptor
examin
use
opioid
receptor
antagonist
naloxon
dppiv
enzym
activ
measur
mean
hydrolysi
fluorochromelabel
substrat
immunohistochem
stain
timeand
concentrationdepend
upregul
dppiv
endogen
dppiv
sensit
synthet
dppiv
resist
observ
howev
naloxon
abrog
diminish
effect
dppivresist
suggest
may
use
differ
mechan
regul
dppiv
collect
data
show
upregul
dppiv
express
dermal
fibroblast
either
via
interact
enzym
via
opioid
receptor
increas
dppiv
express
fibroblast
may
affect
function
activ
growth
et
br
j
pharmacol
aim
present
studi
investig
effect
icv
inject
pat
increas
intracerebr
level
cytokin
induc
icv
inject
et
method
sever
group
rat
receiv
icv
inject
either
et
ag
al
et
preced
pat
ag
al
h
brain
tissu
sampl
brainstem
diencephalon
hippocampu
determin
level
tumor
necrosi
factor
tnf
alpha
interleukin
il
beta
elisa
result
pretreat
pat
produc
doserel
alter
increas
level
cytokin
et
inject
pat
produc
signific
alter
basal
concentr
cytokin
brain
conclus
observ
result
provid
evid
potenti
protect
role
pat
brain
tissu
damag
inflammatori
condit
melatonin
receptor
goat
membran
lymphocyt
light
stress
regul
g
carrillo
ci
gutierrez
universidad
nacion
experiment
bfrancisco
de
mirandaq
unefm
coro
estado
venezuela
neuroendocrin
immunolog
system
connect
structur
function
anatom
physiolog
pharmacolog
evid
support
close
interact
melatonin
neurohormon
play
import
role
immun
system
also
support
exist
melatoninspecif
bind
site
lymphoid
cell
central
nervou
system
peripher
organ
goat
domest
anim
widespread
venezuela
especi
arid
zone
like
n
state
lower
incid
neoplas
diseas
lower
suscept
infect
aim
work
character
melatonin
receptor
membran
lymphocyt
goat
peripher
blood
bind
studi
h
iodomelatonin
bind
depend
time
temperatur
cellular
concentr
also
stabl
revers
satur
satur
assay
demonstr
highaffin
bind
site
k
nm
low
capac
b
max
fmolmg
affin
suggest
caprin
receptor
may
recogn
serum
melatonin
level
physiolog
anim
stress
immers
immobil
water
find
increas
affin
without
capac
modif
light
constant
day
capac
increas
result
indic
adult
goat
highaffin
receptor
melatonin
lymphocyt
differ
condit
vari
show
interact
commun
pineal
gland
immun
system
regul
secret
nociceptinorphanin
fq
rat
splenocyt
fulford
univers
bristol
bristol
uk
nofq
mrna
express
variou
immunocyt
popul
although
signific
endogen
nofq
immun
system
poorli
understood
studi
regul
nofq
secret
rat
splenocyt
investig
splenocyt
cellsml
cultur
vari
concentr
mitogen
inflammatori
mediat
product
nofq
stimul
lp
agml
con
agml
beta
ngml
measur
incub
co
addit
splenocyt
activ
con
agml
h
prior
addit
crf
h
supernat
harvest
retain
measur
nofq
content
eia
lp
con
caus
dosedepend
stimul
nofq
secret
confirm
b
cell
capac
secret
nofq
basal
secret
ngml
h
lp
agml
con
agml
beta
stimul
splenocyt
h
also
stimul
n
ofq
secret
basal
beta
ngml
although
lower
dose
beta
without
effect
nofq
secret
con
aactiv
splenocyt
enhanc
crf
vitro
increas
crf
vs
con
alon
revers
alphahel
crf
observ
consist
find
opioid
identifi
possibl
sourc
immunederiv
nofq
may
contribut
inflammatori
process
rational
character
mediat
modul
growth
function
human
intestin
mast
cell
mc
method
mc
isol
intestin
surgeri
specimen
purifi
subsequ
cultur
day
presenc
stem
cell
factor
ngml
without
addit
adrenalin
salbutamol
mc
adhes
assay
perform
use
fibronectinco
plate
well
human
umbil
vein
endotheli
cell
huvec
cellular
factin
content
measur
flow
cytometri
label
fluoresc
phallacidin
result
agonist
dosedepend
reduc
mc
growth
salbutamol
adrenalin
control
condit
mainli
attribut
strong
inhibit
mc
prolifer
moreov
agonist
abolish
adhes
mc
huvec
monolay
well
adhes
fibronectinco
plate
follow
mc
activ
cellular
factin
content
decreas
basal
level
follow
challeng
mc
agonist
min
wherea
stimul
mc
ige
receptor
crosslink
lead
rapid
doubl
factin
content
activationinduc
increas
factin
content
howev
abrog
presenc
agonist
conclus
data
show
agonist
regul
human
intestin
mc
prolifer
interact
huvec
fibronectin
mechan
possibl
involv
alter
cellular
factin
homeostasi
electr
stimul
mesencephal
periaqueduct
gray
matter
rat
alter
nk
cell
function
pert
r
weber
b
nation
institut
health
bethesda
usa
b
univers
illinoi
colleg
medicin
peoria
usa
previous
report
scienc
microinject
morphin
periaqueduct
gray
matter
pag
rat
midbrain
suppress
natur
killer
nk
cell
activ
thu
implic
brain
region
regul
immun
function
opioid
purpos
studi
examin
effect
electr
stimul
pag
natur
killer
cell
nk
activ
bipolar
electrod
introduc
variou
aspect
periventricularperiaqueduct
axi
rostral
caudal
extent
one
week
follow
surgeri
anim
stimul
intermitt
train
biphas
puls
min
splenic
nk
cell
activ
determin
h
follow
termin
stimul
found
stimul
site
rostral
dorsal
raph
nucleu
rel
ineffect
decreas
nk
cell
activ
site
caudal
pag
caus
signific
suppress
nk
cell
activ
site
activ
found
ventral
pag
caudal
aspect
level
dorsal
raph
nucleu
studi
underway
determin
neural
peripher
circuitri
electr
stimul
pag
gain
access
immun
system
exogen
dehydroepiandrosteron
replac
human
induc
regulatori
cell
saj
thompson
curran
b
cox
k
chatterje
b
cole
depart
clinic
neurosci
univers
cambridg
uk
b
depart
endocrinolog
univers
cambridg
uk
dhea
adren
steroid
declin
age
implic
neurodegener
took
advantag
unusu
cohort
patient
studi
immunolog
effect
exogen
dhea
replac
patient
addison
diseas
autoimmun
gland
destruct
report
persist
fatigu
reduc
qualiti
life
cognit
abil
despit
standard
corticosteroid
replac
therapi
previous
shown
restor
serum
dhea
level
oral
administr
enhanc
cognit
reduc
fatigu
pbmc
extract
patient
treatment
dhea
nk
nkt
cell
defin
fac
surfac
cell
marker
regulatori
cell
identifi
hi
cytokin
protein
mrna
measur
elisa
realtim
quantif
found
dhea
treatment
patient
addison
diseas
reduc
peripher
nk
nkt
cell
number
also
induc
lymphocyt
cytokin
mrna
protein
express
without
particular
bia
helper
phenotyp
hi
cell
number
express
also
increas
suggest
dhea
induc
regulatori
lymphocyt
conclud
oral
dhea
treatment
signific
effect
immun
system
modul
immun
respons
mice
expos
toluen
noseonli
inhal
h
fujimaki
yamamoto
kakeyama
kurokawa
n
kunugita
b
h
hori
b
k
arashidani
b
nation
institut
environment
studi
ibaraki
japan
b
univers
occup
environment
health
fukuoka
japan
studi
examin
effect
low
level
toluen
inhal
immun
brain
region
male
mice
expos
filter
air
control
ppm
toluen
min
noseonli
inhal
day
one
day
last
inhal
mice
anesthet
inject
nembut
sodium
blood
thymu
spleen
olfactori
bulb
hippocampu
collect
spleen
cell
percentag
cell
significantli
decreas
tolueneexpos
mice
howev
percentag
cell
tolueneexpos
mice
increas
compar
airexpos
mice
mitogen
stimul
pha
lp
induc
product
ifngamma
spleen
cell
control
mice
exposur
toluen
gave
signific
increas
cytokin
product
total
ige
product
plasma
tolueneexpos
mice
significantli
decreas
possibl
specul
toluen
inhal
may
affect
immun
function
brain
region
via
olfactori
system
olfactori
bulb
hippocampu
tolueneexpos
mice
product
nerv
growth
factor
tnfalpha
equival
control
mice
thing
suggest
exposur
mice
low
dose
toluen
via
intranas
rout
may
induc
immun
abnorm
mind
neuroendocrin
system
product
might
modul
intrathym
matur
cell
aim
studi
investig
whether
central
appli
alter
relat
thymocyt
subpopul
adult
male
ao
rat
cannul
intracerebroventriculari
treat
three
dose
concentr
per
day
salin
everi
day
anim
sacrif
h
last
treatment
thymus
process
analysi
thymocyt
subpopul
apoptosi
flow
cytometri
evalu
morphometr
paramet
stereolog
analysi
result
show
significantli
decreas
volum
thymu
cortex
accompani
decreas
cellular
number
thymocyt
per
volum
unit
increas
percentag
apoptot
cell
percentag
singl
posit
thymocyt
subpopul
significantli
increas
percentag
cell
diminish
analys
cell
subset
rel
proport
express
tcrah
reveal
increas
percentag
least
matur
tcrah
tcrah
cell
matur
tcrah
hi
tcrah
hi
tcrah
hi
cell
percentag
posit
select
tcrah
hi
cell
decreas
increas
percentag
least
matur
matur
thymocyt
subset
suggest
involv
appli
intracerebroventriculari
modul
cell
matur
whose
consequ
could
appear
tcrah
regulatori
cell
subset
thyroid
hormon
regul
immun
respons
demonstr
addit
differenti
express
protein
kinas
c
pkc
isoenzym
high
nitric
oxid
synthas
no
activ
describ
tumor
respect
normal
lymphocyt
lthyroxin
mediat
action
enzymat
activ
relat
lymphocyt
lymphoma
cell
prolifer
studi
thyroid
hormon
increas
tumor
normal
cell
prolifer
potenti
mitogenstimul
lymphocyt
measur
tritiatedthymidin
incorpor
twentyfourhour
incub
induc
rise
total
membraneassoci
pkc
activ
measur
p
atp
phosphoryl
pkc
specif
substrat
cell
type
addit
potenti
mitogeninduc
pkc
transloc
normal
lymphocyt
lead
rapid
transient
effect
tumor
cell
increas
atyp
pkc
zeta
express
classic
pkc
isoenzym
mitogenstimul
normal
cell
immunoblot
analysi
addit
augment
no
activ
measur
product
c
citrullin
c
arginin
tumor
cell
result
show
first
time
differenti
intracellular
signal
involv
modul
lymphocyt
biolog
substanc
p
involv
chemotact
activ
human
brain
endothelium
c
cioni
p
annunziata
last
year
mechan
underli
recruit
lymphocyt
bloodbrain
barrier
receiv
increas
attent
recent
substanc
p
sp
neuropeptid
number
proinflammatori
properti
found
produc
releas
cytokinestimul
brain
endothelium
rodent
mediat
leakag
activ
brain
endothelium
cultur
expos
proinflammatori
cytokin
test
whether
sp
could
exert
chemotact
activ
human
bloodbrain
barrier
analys
sp
product
human
brain
endothelium
hbe
cultur
expos
proinflammatori
cytokin
tnfalpha
ifngamma
test
whether
sp
may
mediat
chemotact
activ
cytokinestimul
hbe
human
lymphocyt
biotinlabel
lymphocyt
seed
membran
hbe
cell
bottom
boyden
chamber
biotinlabel
cell
migrat
chamber
bottom
assay
elisa
sp
immunoreact
found
surfac
cytokinestimul
human
brain
endotheli
cell
cultur
supernat
low
rate
cell
migrat
chamber
membran
presenc
unstimul
hbe
increas
hbe
expos
proinflammatori
cytokin
percentag
return
baselin
valu
spantid
sp
antagonist
antisp
polyclon
antibodi
use
find
demonstr
sp
involv
chemotact
activ
vitro
cytokinestimul
hbe
object
analyz
beta
adrenerg
receptor
bar
regul
lymphocyt
prolifer
mice
accord
differ
thyroid
statu
method
specif
radioligand
bind
assay
perform
cell
eu
hypothyroid
propylthiouracil
treatment
hyperthyroid
mice
betaagonist
isoproterenol
effect
intracellular
level
cyclic
amp
camp
determin
mitogeninduc
tcell
prolifer
measur
tritiatedthymidin
incorpor
protein
kinas
c
pkc
activ
cytosol
membran
determin
use
radiolabel
enzymat
substrat
result
decreas
signific
increas
bar
number
found
respect
cell
hypoand
hyperthyroid
isostimul
camp
lower
hypothyroid
higher
hyperthyroid
lymphocyt
respect
control
tselect
mitogeninduc
prolifer
increas
hyperthyroid
decreas
hypothyroid
bar
downregul
prolifer
peak
anim
higher
lower
decreas
observ
respect
hyperand
hypothyroid
cell
higher
transloc
pkc
activ
hyperthyroid
cell
lower
one
hypothyroid
lymphocyt
observ
conclus
intracellular
signal
trigger
mitogen
activ
would
relat
differenti
bar
downregul
lymphocyt
depend
thyroid
statu
contribut
distinct
prolif
respons
found
hypoor
hyperthyroid
endogen
catecholamin
ca
peripher
blood
mononuclear
cell
pbmc
contribut
activationinduc
apoptosi
pbmc
multipl
sclerosi
ms
patient
less
suscept
apoptosi
previous
show
dysregul
ca
product
phytohaemagglutinin
pha
stimul
sinc
interferon
ifn
beta
posit
modifi
ms
cours
investig
ca
product
express
mrna
tyrosin
hydroxylas
th
limit
enzym
ca
synthesi
apoptosi
pbmc
patient
undergo
treatment
far
relapsingremit
ms
patient
includ
data
present
avail
patient
month
followup
respect
th
mrna
increas
first
month
decreas
baselin
level
ca
product
efflux
increas
similarli
first
quarter
maintain
high
plateau
level
capac
ifngamma
ad
vitro
inhibit
ca
product
decreas
progress
antagonist
effect
ifnbeta
vitro
increas
consist
treatment
pharmacolog
inhibit
ca
product
significantli
reduc
apoptosi
healthi
subject
effect
observ
ms
patient
even
ifnbeta
therapi
result
suggest
ifnbeta
treatment
antagonis
ifngamma
th
mrna
express
ca
product
relev
activationinduc
apoptosi
remain
unclear
longer
followup
warrant
assess
possibl
differ
respond
nonrespond
ifnbeta
eae
anim
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
serv
use
model
human
multipl
sclerosi
ms
previou
studi
shown
sever
ms
eae
reduc
increas
level
sex
hormon
pregnanc
studi
demonstr
estrogen
treatment
led
induct
novel
subpopul
regulatori
cell
also
occur
natur
pregnant
mice
previous
uncharacter
cell
display
low
level
express
dim
detect
express
mani
cell
surfac
marker
relat
tcr
signal
includ
tcr
howev
cell
retain
express
sever
line
evid
suggest
novel
cell
defin
dim
may
play
role
protect
effect
estrogen
eae
inject
purifi
dim
cell
confer
protect
spontan
eae
speae
dim
cell
also
suppress
antigenspecif
prolifer
prime
lymphocyt
cocultur
better
understand
dim
cell
suppress
harm
immun
respons
eae
may
explain
induct
immun
toler
pregnanc
lead
novel
therapeut
approach
combat
ms
autoimmun
diseas
effect
exposur
formaldehyd
neurotransmitterrel
mrna
express
mous
brain
kakeyama
kurokawa
yamamoto
r
hojo
n
kunigita
b
h
hori
b
k
arashidani
b
h
fujimaki
environment
health
scienc
divis
nation
institut
environment
studi
tsukuba
japan
b
univers
occup
environment
health
kitakyushu
japan
effect
lowdos
exposur
two
type
air
pollut
formaldehyd
fa
nitrogen
dioxid
brain
neural
transmitterrel
mrna
examin
mice
femal
mice
week
old
expos
ppb
fa
week
daili
daysweek
ppm
week
level
express
glutam
receptor
subunit
dopamin
receptor
serotonin
receptor
mrna
semiquantifi
rtpcr
neocortex
nc
hippocampu
hip
amygdala
amg
hypothalamu
ht
exposur
fa
result
increas
mrna
level
nc
hip
mrna
amg
mrna
ht
reduc
epsilon
mrna
level
nc
hip
hand
exposur
caus
reduct
mrna
nc
hip
ht
result
indic
brain
neurotransmitterrel
mrna
sensit
marker
effect
exposur
air
pollut
addit
aris
possibl
differ
pattern
chang
neurotransmitterrel
mrna
exposur
fa
reflect
differ
neurotox
fa
rational
cyclosporin
csa
attenu
antinociceptori
effect
morphin
develop
express
morphineinduc
toler
depend
via
nitric
oxid
pathway
object
studi
effect
system
csa
morphineinduc
condit
place
prefer
cpp
probabl
involv
nitric
oxid
assess
mice
method
effect
morphin
mgkg
csa
mgkg
n
g
nitrolarginin
methyl
ester
lname
mgkg
administr
induct
cpp
assess
effect
csa
lname
also
coadministr
csa
mg
kg
lname
mgkg
acquisit
cpp
induc
morphin
mgkg
studi
result
data
show
administr
morphin
significantli
increas
time
spent
drugpair
compart
dosedepend
manner
csa
mgkg
lname
mgkg
induc
either
cpp
condit
place
avers
cpa
csa
mgkg
induc
cpa
csa
mgkg
lname
mgkg
combin
morphin
mgkg
condit
significantli
suppress
acquisit
morphineinduc
cpp
lower
per
se
noneffect
dose
csa
mgkg
lname
mgkg
coadminist
exert
signific
potenti
inhibitori
effect
morphineinduc
cpp
conclus
csa
attenu
reinforc
effect
morphin
effect
potenti
inhibit
nitric
oxid
synthas
cortisol
cytokin
symptom
sever
patient
schizophrenia
treatment
risperidon
haloperidol
xy
zhang
peke
univers
beij
pr
china
background
aim
studi
investig
interrelationship
among
cortisol
cytokin
symptom
schizophrenia
compar
effect
typic
atyp
antipsychot
drug
variabl
method
seventyeight
schizophrenia
randomli
assign
week
treatment
mgday
risperidon
mgday
haloperidol
use
doubleblind
design
clinic
efficaci
determin
use
panss
serum
cortisol
assay
ria
serum
quantit
elisa
compar
sexand
agematch
normal
subject
result
serum
level
cortisol
elev
schizophrenia
elev
cortisol
associ
increas
schizophrenia
respect
cortisol
associ
neg
symptom
posit
symptom
compar
haloperidol
risperidon
decreas
elev
cortisol
improv
neg
symptom
significantli
similar
effect
well
posit
symptom
improv
neg
symptom
schizophrenia
relat
chang
cortisol
conclus
schizophrenia
may
hypothalamicpituitaryadren
hpa
axi
cytokin
dysregul
may
implic
clinic
symptom
schizophrenia
respons
antipsychot
treatment
aim
studi
investig
perceiv
stress
neuroimmun
function
cytokin
balanc
allergi
symptom
medic
student
without
atopi
calm
stress
exam
period
academ
studi
among
sever
studi
paramet
result
questionnair
phenotyp
white
blood
cell
cytokin
assay
urin
cortisol
measur
present
particip
perceiv
elev
stress
respons
examin
accompani
increas
urin
cortisol
ratio
increas
group
stress
total
number
cell
unalt
number
nk
cell
decreas
atop
subject
stress
interestingli
regulatori
cell
increas
stress
group
cytokin
profil
atop
subject
reflect
predomin
respons
stress
seen
healthi
subject
conclud
perceiv
stress
cytokin
profil
import
immunoregulatori
lymphocyt
subset
observ
respons
examin
immun
paramet
nk
cell
number
cytokin
profil
differenti
regul
atop
healthi
individu
respons
stress
howev
paramet
ratio
number
regulatori
cell
similarli
regul
group
result
indic
healthi
atop
subject
share
certain
featur
stress
respons
differ
other
autoimmun
sialaden
develop
nod
mice
suitabl
model
studi
ethiopathogen
mechan
lead
sicca
symptom
sjfgren
syndrom
nitric
oxid
vasoact
intestin
peptid
vip
common
messeng
nervou
immun
system
mediat
secretori
inflammatori
respons
examin
nitric
oxid
synthas
activ
special
focu
vipmedi
effect
salivari
gland
nod
mice
cytokin
balanc
sera
gland
measur
no
convers
l
c
arginin
citrulin
submandibular
parotid
gland
nod
balbc
mice
level
cytokin
sera
supernat
splenocyt
homogen
salivari
gland
found
decreas
no
activ
nomedi
signal
salivari
gland
nod
mice
start
week
coincid
onset
salivari
dysfunct
increas
tnfalpha
ifngamma
level
sera
detect
week
later
time
chang
cytokin
level
could
state
salivari
gland
infiltr
gland
appear
week
well
histolog
lesion
result
support
hypothesi
impair
product
signal
salivari
gland
earli
event
take
place
nod
gland
event
preced
autoimmun
respons
autoantibodi
brain
opiat
glutam
receptor
put
biomark
morphin
addict
granstrem
w
adriani
b
giannakopoul
b
dambinova
c
g
izykenova
c
g
laviola
b
ip
pavlov
state
medic
univers
st
petersburg
russia
b
depart
cell
biolog
neurosci
istituto
superior
di
rome
itali
c
emori
univers
atlanta
usa
knowledg
pathophysiolog
chang
underli
loss
control
drug
intak
still
rather
limit
recent
develop
novel
approach
base
hypothesi
autoimmun
respons
well
document
sever
nervoussystem
disord
may
also
occur
drugaddict
organ
human
heroin
addict
present
elev
level
autoantibodi
aab
opioid
receptor
present
studi
sd
rat
administ
morphin
mgkg
sc
daili
week
level
aab
mudelta
opioid
mdor
glutam
ampa
nmda
receptor
rat
serum
determin
synthet
peptid
antigen
ng
per
elisa
well
confirm
previou
report
morphin
treatment
increas
significantli
serum
titer
autoantibodi
opioid
ampa
glutam
receptor
nmda
glutam
receptor
possibl
hypothes
autoimmun
respons
repeat
drug
exposur
occur
relationship
presenc
plasma
autoantibodi
neuroreceptor
patholog
chang
brain
function
far
unknown
circul
autoantibodi
may
function
affect
ampa
glutamaterg
input
within
brain
noteworthi
ampa
receptor
recent
implic
drugseek
behavior
addict
habit
object
determin
neuropsychiatr
manifest
patient
system
lupu
erythematosu
sle
influenc
antidna
antibodi
crossreact
human
nmethyldaspart
nmda
receptor
type
method
decapeptid
synthes
contain
sequenc
motif
present
extracellular
ligandbind
domain
nmda
receptor
bound
monoclon
murin
antidna
antibodi
elisaassay
murin
monoclon
posit
control
plasma
sampl
patient
sle
examin
antipeptid
antibodi
patient
subject
comprehens
psycholog
cognit
test
result
seven
neuropsycholog
variabl
associ
elev
level
antibodi
correl
matrix
candid
variabl
enter
manova
statist
model
independ
variabl
poor
perform
visual
pair
associ
test
immedi
groov
pegboard
test
well
high
score
beck
depress
inventori
scale
depress
psychopath
deviat
schizophrenia
hypomania
significantli
associ
elev
level
antibodi
conclus
find
sever
domain
indic
associ
antibodi
depress
mood
addit
decreas
short
time
memori
learn
antibodi
nmdareceptor
may
repres
one
sever
mechan
cerebr
dysfunct
patient
sle
suggest
schizophrenia
affect
disord
may
associ
viral
infect
howev
search
viral
nucleic
acid
brain
patient
schizophrenia
reveal
pauciti
viru
hypothes
cell
found
csf
patient
schizophrenia
may
contain
popul
cell
initi
respond
viru
although
viru
longer
present
use
npapcrv
betaspecif
pcr
demonstr
high
proport
ident
betachain
tcr
transcript
csf
seven
seven
patient
schizophrenia
affect
disord
suggest
presenc
antigen
driven
clonal
expand
popul
cell
cell
clonal
expans
may
remain
trace
initi
viral
infect
altern
cell
may
gener
respons
reactiv
viral
infect
molecular
mimicri
epitop
spread
contrast
tcr
transcript
csf
normal
donor
polyclon
unknown
whether
clonal
expand
cell
csf
patient
schizophrenia
affect
disord
contribut
brain
tissu
loss
mentalcognit
impair
psychoimmunolog
evalu
stress
prevent
intervent
programm
u
sack
k
meier
k
bauer
stqck
univers
leipzig
leipzig
germani
aim
examin
immunolog
psycholog
paramet
reflect
stress
manag
capabl
particularli
correl
selfregul
therapeut
stimuli
immunoglobulin
saliva
part
integr
stress
manag
trainingconcept
school
stress
manag
train
well
intervent
method
biodanza
base
motion
emot
bodi
contact
carri
teacher
aim
intervent
enabl
teacher
better
cope
daili
pressur
effect
intervent
method
determin
accompani
processevalu
studi
purpos
healthpsycholog
stressrelev
psycholog
variabl
workrel
behaviour
experi
pattern
well
psycholog
blood
pressur
skin
resist
immunolog
variabl
immunoglobulin
saliva
taken
twentyfour
teacher
investig
session
intervent
studi
parallel
differ
emot
paramet
ascertain
method
overwhelm
effect
improv
stress
resist
could
verifi
saliva
increas
immunoglobulin
could
found
person
posit
respons
train
furthermor
signific
posit
correl
subject
sensat
relax
health
paramet
iga
could
measur
procedur
could
shown
effect
improv
stress
manag
capabl
psycholog
subject
paramet
correl
well
saliva
immunoglobulin
concentr
therefor
measur
simpl
immunolog
paramet
could
prove
reliabl
indic
stress
resist
well
train
effect
chang
immun
endocrin
paramet
ptsd
time
vidov
k
gotovac
vilib
b
sabioncello
rabat
v
folnegovicsmalc
b
dekari
institut
immunolog
zagreb
croatia
b
vrapc
psychiatri
hospit
zagreb
croatia
studi
perform
post
traumat
stress
disord
ptsd
patient
within
year
traumat
event
reveal
elev
plasma
cortisol
level
lower
glucocorticoid
receptor
gr
express
examin
lymphocyt
popul
opposit
studi
perform
decad
follow
exposur
trauma
assum
time
need
revers
hormon
receptor
express
take
place
due
hyperact
hypothalamicpituitaryadrenocort
hpa
axi
particip
croatian
war
veteran
ptsd
agematch
civilian
control
retest
year
later
proport
main
lymphocyt
popul
activ
subpopul
well
gr
express
popul
determin
flow
cytometri
cortisol
level
determin
ria
radioimmunoassay
nk
cell
activ
measur
crreleas
assay
platelet
activ
statu
determin
flow
cytometri
accord
express
activ
marker
proport
leukocyteplatelet
aggreg
circul
found
decreas
percentag
tc
total
memori
cell
reveal
signific
chang
time
gr
express
total
b
nk
cell
preliminari
followup
studi
brain
atrophi
aberr
behaviour
common
complic
system
lupu
erythematosu
sle
consid
etiolog
unknown
use
aberr
behaviour
lupuspron
mrllpr
mice
reveal
pathogen
mechan
autoimmunityinduc
cn
damag
previous
document
profound
damag
dopaminerg
system
human
anim
form
diseas
present
studi
explor
cours
selfinjuri
behaviour
sib
sustain
pharmacolog
challeng
quinpirol
qnp
agonist
mrllpr
mice
congen
control
inject
qnp
ip
mgkg
daili
day
treatment
gradual
decreas
groom
frequenc
increas
durat
groom
episod
strain
howev
effect
less
profound
mrllpr
group
anim
show
advanc
sib
repeat
qnp
administr
seen
agematch
nonautoimmun
strain
mice
suggest
autoimmun
requir
emerg
aberr
behaviour
respons
present
examin
whether
sib
associ
excess
damag
dopaminerg
system
whether
sib
induc
autoimmun
manifest
develop
current
obtain
result
support
hypothesi
chronic
inflamm
autoimmun
damag
dopaminerg
neuron
increas
sensit
cognat
receptor
thu
underli
sib
work
support
fund
nih
b
sakic
recipi
fsorc
career
develop
award
chun
recipi
nserc
graduat
scholarship
evid
bidirect
commun
central
nervou
system
cn
immun
system
opioid
exert
modulatori
role
immun
respons
main
goal
studi
influenc
acut
chronic
damphetamin
treatment
conainduc
lymphocyt
prolifer
rat
particip
dopaminerg
opioiderg
system
effect
amphetamineinduc
effect
proenkephalin
deriv
peptid
immun
organ
differ
cn
area
wistar
rat
receiv
chronic
mgkgday
day
ip
acut
mgkg
ip
amphetamin
day
last
inject
prolif
respons
assess
sinc
similar
immunosuppress
effect
observ
follow
acut
chronic
treatment
naloxon
sulpirid
given
mgkg
amphetamin
sinc
antagonist
abolish
amphetamineinduc
effect
dopamin
opioid
system
seem
involv
proenkephalin
deriv
peptid
level
cn
studi
follow
mgkg
amphetamin
increas
metenkephalin
observ
spleen
thymu
nucleu
accumben
prefront
cortex
chang
metenkephalin
point
could
use
common
biolog
marker
pertin
stimuli
ie
psychostimul
drug
act
si
snc
reflect
function
chang
level
morphofunct
characterist
rat
thymu
expos
forc
swim
stress
rakin
zivkov
petrovicdjergov
kosec
micic
mind
recent
studi
effect
stress
immun
system
investig
whether
chronic
stress
induc
forc
swim
procedur
alter
morphofuncion
paramet
rat
thymu
purpos
adult
male
rat
expos
forc
swim
day
first
day
min
follow
day
min
experiment
control
anim
sacrif
decapit
thymus
process
morphometr
flow
cytometri
analysi
blood
sampl
taken
measur
corticosteron
level
ria
result
show
everi
day
treatment
stimulu
lead
reduct
thymu
mass
cellular
ii
volum
thymu
cortex
medulla
iii
numer
densiti
thymocyt
inner
cortex
medulla
iv
number
thymocyt
thymu
compart
howev
percentag
apoptot
cell
level
corticosteron
significantli
increas
phenotyp
analysi
thymocyt
subpopul
show
significantli
decreas
percentag
least
matur
tcr
thymocyt
hand
percentag
tcr
lowhigh
tcrthymocyt
significantli
increas
result
show
adult
rat
recur
swim
procedur
induc
thymu
hypotrophi
chang
thymu
compart
volum
cellular
addit
elev
percentag
tcr
cell
suggest
chronic
stress
involv
modul
cell
matur
influenc
restraint
stress
betaendorphin
inflammatori
edema
macrophag
function
ao
rat
k
mitic
dimitrijev
v
vujic
b
v
kovacevicjovanov
stanojev
immunolog
research
center
bbranislav
jankovicq
institut
immunolog
virolog
btorlakq
belgrad
serbia
b
institut
chemistri
univers
belgrad
medic
school
belgrad
serbia
influenc
ipl
treatment
betaendorphin
betaend
ag
restraint
stress
rs
concanavalin
con
induc
paw
edema
investig
male
albino
oxford
ao
rat
besid
periton
macrophag
obtain
intact
stress
rat
strain
addit
vitro
treat
betaend
test
capac
produc
reactiv
oxygen
speci
reduc
nitro
blue
tetrazolium
salt
nbt
formazan
result
show
conainduc
paw
edema
suppress
ipl
treatment
ag
betaend
antagon
naltrindol
norbinaltorphimin
suggest
involv
delta
kappa
opioid
receptor
quit
opposit
h
rs
appli
inflamm
induct
significantli
increas
diamet
inflam
paw
ao
rat
influenc
nbt
reduct
capac
periton
macrophag
nbt
reduct
influenc
betaend
way
betaend
potenti
reactiv
oxygen
radic
product
unstimul
macrophag
anim
expos
rs
dosedepend
increas
decreas
nbt
reduct
cell
stimul
phorbol
myrist
acet
intact
stress
anim
could
conclud
rs
betaend
exert
opposit
effect
vivo
vitro
inflammatori
respons
ao
rat
proinflammatori
cytokin
beta
beta
influenc
neuroendocrin
activ
promot
central
effect
anxieti
anhedonia
melanocortin
neuropeptid
like
alpha
melanocyt
stimul
hormon
alphamsh
antagon
mani
action
includ
fever
anorexia
hpa
axi
activ
specif
melanocortin
receptor
central
nervou
system
howev
unknown
melanocortin
modul
betainduc
anxieti
object
present
studi
establish
effect
msh
peptid
betainduc
anxietylik
behavior
type
melanocortin
receptor
involv
present
studi
evalu
effect
intracerebroventricular
icv
administr
beta
ng
melanocortin
receptor
agonist
alphamsh
agonist
ag
gammamsh
agonist
ag
antagonist
ag
elev
plusmaz
test
inject
beta
induc
axiogeniclik
respons
indic
reduc
open
arm
entri
time
spent
open
arm
administr
alphamsh
revers
betainduc
anxieti
coadministr
inhibit
effect
alphamsh
associ
treatment
gammamsh
affect
anxieti
respons
data
suggest
melanocortin
central
modul
anxietylik
behavior
induc
beta
express
tolllik
receptor
mg
thymu
p
bernasconi
barberi
b
cannon
b
f
baggi
e
arnoldi
c
cappelletti
f
cornelio
r
mantegazza
nation
neurolog
institut
bcarlo
bestaq
milan
itali
b
multimedica
milan
itali
myasthenia
gravi
mg
often
associ
thymic
alter
hyperplasia
thymoma
thymiti
howev
aetiopatholog
basi
associ
still
unknown
intercellular
signal
well
surfac
molecul
may
repres
key
factor
character
thymic
microenviron
element
innat
immun
emerg
contributor
develop
autoimmun
studi
semiquantit
rtpcr
express
tolllik
receptor
tlr
myasthen
thymus
nonpatholog
young
thymus
tlr
transcript
found
differ
express
among
group
except
realtim
pcr
mrna
express
significantli
higher
thymiti
hyperplast
nonpatholog
young
thymus
thymoma
immunohistochemistri
protein
detect
thymic
subgroup
analys
extent
posit
greatli
variabl
thymiti
hyperplast
thymus
strong
posit
detect
correspond
cytokeratinposit
cell
within
thymic
medulla
surround
cortex
border
cortic
medullari
region
thymoma
young
nonpatholog
thymus
protein
rare
detect
find
suggest
possibl
involv
innat
immun
thymu
alter
character
abnorm
cell
prolifer
evok
possibl
antigen
mimicri
might
play
crucial
role
mg
pathogenesi
earlyonset
mg
eomg
thymic
infiltr
well
establish
howev
thymu
musclelik
myoid
cell
well
studi
patient
without
antiachr
autoantibodi
seroneg
mg
ie
musk
ab
without
musk
ab
antimusk
antibodi
histopatholog
usual
report
normal
involut
patient
rare
thymectomis
unlik
eomg
compar
thymic
histolog
patient
eomg
musk
ab
musk
ab
snmg
label
paraffin
section
matur
cell
germin
centr
gc
marker
inflamm
complement
activ
musk
ab
musk
ab
snmg
case
thymu
appear
normalforag
b
cell
express
mainli
medullari
epitheli
area
mea
near
appar
normal
myoid
cell
interestingli
musk
ab
case
see
mild
infiltr
similar
eomg
b
cell
follicular
dendrit
cell
gc
express
receptor
activ
complement
compon
myoid
cell
close
within
infiltr
appear
immun
attack
eomg
conclud
thymu
normal
bburntoutq
musk
ab
snmg
contrast
musk
ab
snmg
heterogen
one
form
target
antigen
may
express
thymic
myoid
cell
seem
involv
pathogenesi
target
organ
myasthenia
gravi
mg
postsynapt
membran
neuromuscular
junction
nmj
primari
autoantigen
acetylcholin
receptor
achr
cluster
anchor
postsynapt
membran
nmj
rapsyn
previous
found
natur
increas
rapsyn
concentr
age
rat
correl
resist
experiment
autoimmun
mg
eamg
report
overexpress
rapsyn
vivo
electropor
confer
resist
eamg
treat
leg
suscept
rat
rapsyn
overexpress
increas
level
achr
muscl
week
electropor
eamg
rat
rapsynoverexpress
muscl
show
loss
achr
contrast
control
muscl
repetit
nerv
stimul
show
decrement
compound
muscl
action
potenti
rapsynoverexpress
muscl
wherea
shamtreat
muscl
eamg
anim
electron
microscop
examin
show
endplat
rapsynoverexpress
muscl
eamg
rat
normal
morpholog
postsynapt
fold
endplat
shamtreat
muscl
anim
damag
fold
rapsyn
overexpress
effect
increas
achr
level
ongo
diseas
chronic
eamg
presenc
high
titer
antiachr
antibodi
result
suggest
import
role
rapsyn
suscept
eamg
show
new
promis
therapeut
treat
myasthenia
gravi
human
induct
experiment
autoimmun
myasthenia
gravi
acetylcholin
receptor
peptid
conjug
lipopolysaccharid
wirguin
c
sicsic
b
bersudski
brenner
b
bengurion
univers
beersheva
israel
b
hadassah
univers
hospit
jerusalem
israel
background
molecular
mimicri
implic
caus
autoimmun
disord
syndrom
attribut
crossreact
carbohydr
epitop
campylobact
jejuni
lipopolysaccharid
lp
nerv
gangliosid
show
coval
bond
lp
gangliosid
enhanc
immun
selfgangliosid
object
test
hypothesi
lpsbound
antigen
could
overcom
toler
protein
antigen
method
decapeptid
wnpddyggvk
main
immunogen
region
mir
chain
acetylcholin
receptor
achr
conjug
salmonella
relp
heterodimer
crosslink
lewi
rat
subcutan
present
torpedo
achr
mir
day
receiv
intraperiton
ag
mirlp
conjug
day
control
rat
receiv
mir
relp
anim
test
repetit
nerv
stimul
treadmil
exercis
toler
immunoassay
achr
antibodi
result
lpsmir
inject
rat
show
patholog
decrement
repetit
nerv
stimul
hz
compar
control
mirlp
inject
rat
fail
complet
min
treadmil
exercis
compar
control
rat
achr
antibodi
detect
ria
mirlp
inject
rat
none
control
conclus
mirlp
conjug
induc
eamg
without
addit
adjuv
molecular
bond
lp
antigen
appear
play
import
role
overcom
toler
selfantigen
achr
express
level
relat
polymorph
ga
tc
ac
promotor
region
gene
constitut
three
haplotyp
gcc
ata
acc
haplotyp
combin
gccgcc
associ
high
express
wherea
gccata
gccacc
associ
medium
ataata
ataacc
accacc
low
express
distribut
polymorph
analys
myasthenia
gravi
patient
control
determin
whether
could
influenc
diseas
suscept
found
differ
genotyp
distribut
mg
patient
compar
control
accacc
ataata
frequent
mg
patient
reflect
higher
frequenc
accacc
vs
thymoma
mg
patient
titin
antibodi
posit
mg
patient
regardless
thymu
patholog
earlyonset
mg
patient
titin
antibodi
neg
mg
patient
regardless
age
onset
thymu
patholog
higher
frequenc
ataata
vs
differ
mg
patient
control
high
medium
low
express
conclus
mg
patient
thymoma
thymu
hyperplasia
associ
differ
genotyp
mg
patient
titin
antibodi
similar
thymoma
patient
titin
antibodi
neg
patient
similar
earli
onset
mg
patient
regard
genotyp
function
plastic
dendrit
cell
dc
make
ideal
target
immunotherapi
cancer
immunolog
learn
plastic
dc
function
ensur
capabl
dc
produc
respond
certain
cytokin
exampl
melanoma
breast
cancer
abl
produc
larg
amount
modul
tumorassoci
dc
immatur
dc
induc
anerg
cell
howev
cytokinematur
dc
induc
effector
cell
tumor
investig
therapeut
potenti
dc
eamg
rat
modul
effect
lpsmatur
dc
autolog
cell
respons
mg
compar
healthi
control
hc
also
investig
dc
deriv
eamg
rat
modul
vitro
amelior
ongo
eamg
associ
suppress
cytokin
b
cell
respons
surprisingli
human
mg
like
matur
dc
increas
cell
express
ie
activ
cell
compar
hc
induc
product
cell
mg
patient
product
hc
without
affect
cytokin
conclus
differ
affect
eamg
vs
mg
term
cell
activ
cytokin
product
b
mg
pronounc
costimulatori
capac
cell
reflect
increas
cell
express
increas
product
compar
hc
lamberteaton
myasthen
syndrom
progress
cours
patient
small
cell
lung
carcinoma
p
wirtz
wintzen
j
verschuuren
leiden
univers
medic
centr
leiden
netherland
hla
studi
suggest
major
differ
immunopathogenesi
lem
small
cell
lung
cancer
sclclem
nonhlaassoci
lem
without
associ
tumour
nontumour
ntlem
contrast
known
differ
neurolog
sign
symptom
sclclem
ntlem
patient
report
suggest
progress
cours
diseas
sclclem
assess
detail
chronolog
symptom
develop
lem
patient
sclc
patient
interview
use
structur
checklist
back
review
clinic
record
compar
frequenc
time
scale
symptom
cours
lem
sclclem
patient
proxim
leg
weak
dri
mouth
impot
male
first
symptom
follow
proxim
arm
weak
doubl
vision
hand
weak
slur
speech
least
sclclem
patient
symptom
occur
within
month
ntlem
patient
start
proxim
leg
weak
dri
mouth
symptom
occur
least
patient
within
month
start
leg
weak
symptom
sclclem
patient
develop
within
shorter
timefram
ntlem
patient
indic
progress
cours
diseas
sclclem
therefor
patient
aggress
cours
lem
one
extra
alert
underli
lung
carcinoma
experiment
autoimmun
neuriti
ean
inflammatori
autoimmun
demyelin
diseas
peripher
nervou
system
pn
repres
anim
model
syndrom
gb
man
inflammatori
cell
infiltr
pn
prerequisit
develop
ean
explor
role
cc
chemokin
receptor
inflammatori
process
ean
induc
ean
defici
mice
protein
peptid
found
mice
show
similar
ean
clinic
cours
sever
well
profil
infiltr
macrophag
cell
cauda
equina
ce
ean
level
spleen
mononuclear
cell
mnc
respons
antigen
mitogen
compar
control
mice
howev
increas
product
sciatic
nerv
seen
mice
result
suggest
defici
prevent
peptid
immun
mice
ean
increas
sciatic
nerv
may
compens
defici
contribut
inflammatori
cell
infiltr
pn
syndrom
gb
post
infecti
polyradiculoneuropathi
character
demyelin
axon
degener
peripher
nerv
inflammatori
cell
predominantli
macrophag
cell
humor
factor
includ
autoantibodi
implic
diseas
pathogenesi
recent
document
capac
gbsassoci
igg
induc
igg
receptor
fcgammar
mediat
leukocyt
activ
measur
leukocyt
degranul
phagocytosi
investig
associ
antibodi
function
diseas
develop
use
recent
describ
gb
rabbit
model
immun
rabbit
gangliosid
mixtur
result
format
high
igg
antibodi
titer
nevertheless
specif
antibodi
rabbit
clinic
overt
gb
induc
leukocyt
activ
next
phagocyt
activ
capac
sequenti
drawn
sera
gbsaffect
rabbit
test
maxim
phagocyt
activ
detect
week
occurr
clinic
symptom
increas
function
may
explain
increas
specif
antibodi
titer
increas
antibodi
avid
taken
togeth
data
suggest
function
antigangliosid
antibodi
measur
vitro
assay
associ
presenc
gb
clinic
symptom
rabbit
thu
provid
addit
evid
pathogen
role
vivo
gangliosid
implic
target
antigen
variou
autoimmun
neurolog
disord
igm
antibodi
bseri
gangliosid
includ
associ
chronic
sensori
atax
neuropathi
anim
model
sensori
atax
neuropathi
induc
sensit
howev
yet
clarifi
whether
express
propriocept
neuron
dorsal
root
ganglia
drg
genet
engin
mice
lack
bseri
gangliosid
immunolog
narv
immun
gener
monoclon
antibodi
mab
gener
antigangliosid
antibodi
upon
immun
greatli
enhanc
exhibit
class
switch
igg
isotyp
immunolog
memori
indic
toler
selfgangliosid
major
regulatori
factor
six
clone
igg
activ
obtain
three
react
exclus
one
monospecif
mab
preferenti
stain
larg
cell
bodi
rat
drg
immunohistochem
studi
show
coloc
parvalbumin
calcitonin
generel
peptid
substanc
p
somatostatin
indic
express
propriocept
neuron
rat
drg
result
support
concept
antibodi
may
caus
select
injuri
propriocept
sensat
primari
affer
neuron
develop
sensori
atax
neuropathi
effect
prevent
treatment
experiment
autoimmun
neuriti
rapamycin
tyh
lin
j
spi
univers
sydney
sydney
australia
object
determin
whether
rapamycin
rel
new
immunosuppress
agent
effect
prevent
transplant
reject
effect
treatment
ean
anim
model
human
inflammatori
demyelin
neuropathi
background
chronic
inflammatori
demyelin
polyradiculoneuropathi
cidp
respond
immunomodulatori
therapi
long
term
immunosuppress
therapi
often
requir
signific
associ
toxic
rapamycin
favor
side
effect
profil
agent
cyclosporin
current
use
treat
cidp
method
ean
induc
lewi
rat
immun
peripher
nerv
myelin
passiv
transfer
cell
rapamycin
placebo
administ
daili
intraperiton
inject
commenc
prior
expect
onset
paralysi
prevent
first
sign
ean
treatment
clinic
grade
weight
record
daili
neurophysiolog
histolog
examin
perform
predetermin
interv
result
rapamycin
given
prior
onset
diseas
prevent
develop
signific
paralysi
ean
mean
clinic
grade
vs
adopt
transfer
ean
mean
clinic
grade
vs
rapamycin
given
onset
clinic
weak
effect
reduc
sever
mean
clinic
grade
vs
hasten
recoveri
clinic
weak
electrophysiolog
abnorm
conclus
rapamycin
effect
prevent
treatment
ean
adopt
transfer
ean
lewi
rat
may
effect
less
toxic
altern
treatment
refractori
cidp
base
evid
suppress
protein
product
prevent
therapeut
effect
agent
immunemedi
neuropathi
studi
ean
prevent
effect
neurolog
symptom
remark
lessen
durat
diseas
clearli
shorten
group
receiv
intraperiton
mgkgday
everi
day
inocul
compar
nontreat
control
group
therapeut
effect
remark
suppress
effect
neurolog
symptom
clear
shorten
durat
diseas
also
note
earli
phasetr
group
receiv
day
onset
limp
tail
activ
phasetr
group
receiv
agent
day
onset
paraparesi
compar
nontreat
group
patholog
observ
day
antigen
inocul
remark
demyelin
fibrosi
found
nontreat
group
wherea
mild
perivascular
cell
infiltr
note
prevent
treat
group
mild
cellular
infiltr
demyelin
earli
phasetr
group
moder
cellular
infiltr
demyelin
fibrosi
activ
phasetr
group
result
suggest
exert
prevent
therapeut
effect
ean
campylobact
jejunideriv
lp
abrog
oral
toler
experiment
autoimmun
neuriti
jung
j
voss
frosch
b
h
karch
b
k
toyka
c
c
depart
neurolog
univers
saarland
homburg
germani
b
institut
hygien
microbiolog
univers
germani
c
depart
neurolog
univers
germani
inflammatori
form
syndrom
gb
acut
polyradiculoneur
mediat
lymphocyt
macrophag
antibodi
associ
recent
infect
campylobact
jejuni
anim
model
gb
experiment
autoimmun
neuriti
ean
lewi
rat
induc
immun
pn
myelin
immun
antigen
prepar
variou
c
jejuni
strain
deriv
gb
patient
induc
clinic
histopatholog
sign
neuriti
nevertheless
anim
gener
high
titer
c
jejunispecif
antibodi
subsequ
inject
cell
caus
typic
neuriti
open
bloodnerv
barrier
clinic
diseas
cours
nerv
histopatholog
aggrav
c
jejuniimmun
rat
compar
cfasensit
anim
sign
activ
ean
induc
immun
pnsmyelin
could
mitig
preced
feed
myelin
oral
toler
ad
pronasedigest
lp
prepar
c
jejuni
enter
appli
myelin
toler
induct
complet
prevent
rat
develop
acceler
cours
neuriti
feed
lp
alon
modul
ean
find
demonstr
c
jejunideriv
lp
disturb
natur
immunoregul
gutassoci
lymphoid
tissu
object
determin
whether
human
immunoglobulin
ig
effect
mechan
action
treatment
experiment
allerg
neuriti
ean
anim
model
human
inflammatori
demyelin
neuropathi
background
administr
highdos
intraven
immunoglobulin
ivig
becom
one
success
therapi
inflammatori
demyelin
neuropathi
yet
mechan
action
fulli
understood
method
induc
ean
lewi
rat
administ
human
ig
albumin
intraven
commenc
onset
neurolog
deficit
clinic
grade
weight
record
daili
neurophysiolog
histolog
examin
perform
predetermin
interv
result
igg
treatment
effect
reduc
sever
fasten
recoveri
clinic
weak
improv
associ
acceler
rate
recoveri
electrophysiolog
abnorm
conclus
human
ig
effect
treatment
ean
lewi
rat
investig
underway
determin
whether
fc
fab
compon
ivig
respons
observ
therapeut
efficaci
antigangliosid
antibodi
intrathec
igg
synthesi
syndrom
e
galli
amantini
f
pinto
sorbi
f
lolli
univers
florenc
florenc
itali
object
investig
relationship
clinic
electrophysiolog
immunolog
find
csf
chang
syndrom
gb
background
increas
antigangliosid
antibodi
titer
frequent
find
gb
patient
lesser
extent
patient
chronic
inflammatori
demyelin
polyneuropathi
cidp
anoth
frequent
featur
diseas
dysfunct
bloodbrain
barrier
bbb
wherea
intrathec
synthesi
immunoglobulin
still
matter
debat
relationship
find
unknown
method
author
studi
cohort
gb
patient
examin
standard
emg
elisa
antigangliosid
antibodi
standard
laboratori
procedur
csf
examin
use
four
formula
calcul
intrathec
synthesi
igg
igg
index
reiber
felgenhau
formula
blennow
et
al
formula
iggtot
protein
ratio
control
consist
patient
nondysimmun
polyneuropathi
inflammatori
noninflammatori
cn
disord
blood
donor
result
thirtyeight
percent
gb
patient
cidp
patient
detect
serum
titer
antigangliosid
antibodi
patient
group
antigangliosid
reactiv
associ
high
incid
motor
conduct
block
prolong
f
wave
latenc
gb
patient
clear
associ
antigangliosid
antibodi
high
valu
intrathec
igg
product
index
conclus
associ
antigangliosid
antibodi
high
csf
igg
product
index
valu
gb
patient
suggest
pathogenet
relationship
find
object
campylobact
jejuni
cj
lead
caus
syndrom
gb
japanes
recent
clone
character
ironbind
protein
dp
cj
cdp
aim
studi
determin
whether
cdp
contribut
pathogenesi
gb
method
anticdp
antibodi
sera
determin
elisa
patient
gb
patient
cj
enter
patient
inflammatori
neurolog
diseas
healthi
control
bind
cdp
variou
glycolipid
rat
neural
tissu
studi
furthermor
cell
expos
variou
concentr
cdp
ldh
releas
measur
h
later
result
found
anticdp
antibodi
present
gb
patient
preced
cj
infect
cj
enter
b
cdp
bound
neuron
rat
spinal
cord
myelin
sheath
rat
peripher
nerv
c
cdp
bound
specif
sulfatid
vitro
cdp
bound
cell
surfac
induc
ldh
releas
cell
ldh
releas
inhibit
heartinactiv
coincub
anticdp
monoclon
antibodi
conclus
cdp
consid
bind
neural
cell
bodi
myelin
sheath
sulfatid
bind
cdp
exert
direct
neurotox
may
contribut
axon
damag
gb
preced
cj
infect
paper
updat
cochran
systemat
review
immunotherapi
syndrom
primari
outcom
chang
sevenpoint
disabl
grade
scale
week
plasma
exchang
test
exchang
five
trial
particip
weight
mean
differ
ci
grade
improv
plasma
exchang
without
intraven
immunoglobulin
compar
plasma
exchang
five
trial
involv
particip
grade
improv
intraven
immunoglobulin
plasma
exchang
ci
improv
less
improv
treatment
consid
equival
one
trial
involv
particip
compar
plasma
exchang
follow
intraven
immunoglobulin
plasma
exchang
alon
sequenti
treat
group
ci
grade
improv
five
trial
particip
compar
corticosteroid
placebo
despit
margin
signific
result
one
trial
seek
synergist
effect
intraven
immunoglobulin
synthesi
trial
show
signific
differ
weight
mean
differ
ci
corticosteroid
treat
particip
synthesi
show
intraven
immunoglobulin
plasma
exchang
equival
efficaci
syndrom
effect
corticosteroid
alon
neutral
object
determin
neuropath
process
select
affect
smalldiamet
epiderm
nerv
fiber
enf
patient
system
lupu
erythematosu
sle
method
sixti
patient
age
year
subject
clinic
examin
neuropathi
impair
score
ni
neuropathi
symptom
chang
score
nsc
emphasi
sensori
symptom
obtain
quantit
estim
neurolog
deficit
symptom
small
largediamet
nerv
fiber
function
two
punch
biopsi
taken
distal
part
leg
enf
visual
stain
rabbit
polyclon
antibodi
panaxon
marker
anti
protein
gene
product
densiti
enf
consid
abnorm
number
enf
less
percentil
control
fibersmm
nerv
conduct
veloc
studi
ncv
perform
evalu
presenc
largediamet
nerv
fiber
neuropathi
result
densiti
enf
control
eight
patient
less
fibersmm
thirtyseven
patient
abnorm
ni
score
patient
abnorm
nsc
subscor
sensori
symptom
patient
abnorm
ncv
associ
found
reduc
number
enf
symptom
clinic
find
ncv
conclus
select
patholog
process
affect
enf
preval
patient
sle
motor
nerv
fiber
block
dynam
variat
along
first
month
intraven
immunoglobulin
treatment
multifoc
motor
neuropathi
villa
g
sandov
b
r
saizar
di
egidio
morillo
b
garcea
g
nore
c
r
sica
ramo
mejia
hospit
bueno
air
argentina
b
hospit
aleman
bueno
air
argentina
c
facultad
de
ciencia
quimica
universidad
nacion
de
cordoba
cordoba
argentina
object
examin
effect
nerv
conduct
studi
nc
administr
gkg
ivig
patient
suffer
mmn
materi
method
nc
perform
patient
affect
mmn
high
titer
igm
treatment
day
ivig
administr
multisegment
motor
nerv
conduct
studi
perform
measur
compound
muscl
action
potenti
cmap
conduct
veloc
cv
result
neurophysiolog
chang
first
seen
day
postivig
proxim
conduct
block
cb
site
camp
amplitud
area
increas
simultan
motor
nerv
conduct
veloc
valu
across
cb
site
becam
faster
day
postigiv
progress
declin
cmap
amplitud
area
cv
slow
wave
amplitud
increas
origin
valu
day
treatment
declin
day
discuss
find
show
revers
chang
cmap
characterist
cb
site
fact
suggest
axon
ion
channel
modifi
somehow
permeabl
properti
due
activ
pathogen
factor
possibl
igm
antibodi
signal
dynam
modif
rather
structur
chang
rituximab
treatment
multifoc
motor
neuropathi
antibodi
case
report
rf
bunyan
mr
swenson
b
king
faisal
univers
alkhobar
saudi
arabia
b
univers
louisvil
louisvil
ky
usa
object
rituxamab
chimer
monoclon
antibodi
use
treatment
b
cell
lymphoma
new
evid
efficaci
antibodymedi
autoimmun
disord
multifoc
motor
neuropathi
uncommon
progress
autoimmun
neuropathi
often
associ
antibodi
poorli
respond
convent
immunosuppress
therapi
describ
case
multifoc
motor
neuropathi
antibodi
respons
rituximab
method
caucasian
gentleman
develop
gener
progress
motor
weak
durat
predominantli
involv
hand
complain
cold
sensat
distal
extrem
neither
bulbar
symptom
sphincter
disturb
clinic
examin
reveal
gener
loss
muscl
bulk
weak
appendicular
axial
muscl
areflexia
distal
loss
sensat
electrodiagnost
studi
reveal
motor
neuropathi
laboratori
studi
show
igm
antibodi
titer
normal
laboratori
csf
analys
normal
result
initi
treatment
intraven
immunoglobulin
benefit
rituximab
initi
four
weekli
dose
mgm
follow
mgm
monthli
mainten
dose
result
object
clinic
improv
motor
power
hand
function
suffer
advers
effect
treatment
conclus
rituximab
use
patient
multifoc
motor
neuropathi
associ
antibodi
mainten
therapi
result
progress
improv
advers
effect
detect
autoantibodi
gangliosid
routin
carri
laboratori
immunostain
thinlay
chromatographi
itlc
use
gangliosid
purifi
partit
total
lipid
extract
human
peripher
nerv
spinal
cord
signific
number
sera
taken
patient
peripher
neuropathi
show
stain
lipid
identifi
phospholipid
pl
recov
upper
phase
partit
along
gangliosid
sera
test
itlc
panel
standard
phospholipid
result
show
antiphospholipid
antibodi
react
mostli
phosphatidylserin
ps
phosphatidylinositol
pi
phosphatidylglycerol
pg
less
frequent
cardiolipin
cl
patient
also
show
autoantibodi
glycosphingolipid
presenc
antibodi
pl
often
associ
reactiv
sgpg
rare
case
antibodi
bind
sgpg
pl
alway
isotyp
mostli
igm
igg
antibodi
sometim
prevail
presenc
antiphospholipid
antibodi
antiphospholipid
syndrom
gener
associ
promin
clinic
manifest
neurolog
disord
predominantli
relat
focal
central
nervou
system
thromboocclus
event
howev
none
patient
peripher
neuropathi
test
studi
histori
thromboocclus
problem
comprehens
studi
anteced
infect
fisher
syndrom
fs
therefor
mechan
igg
antibodi
product
still
unclear
conduct
prospect
casecontrol
serolog
studi
five
anteced
infect
campylobact
jejuni
cytomegaloviru
epsteinbarr
viru
mycoplasma
pneumonia
haemophilu
influenza
fs
patient
sexand
agematch
hospit
control
hc
fs
patient
serolog
evid
recent
infect
c
jejuni
h
influenza
found
significantli
often
hc
igg
antibodi
detect
fs
patient
c
jejuni
infect
patient
h
influenza
infect
tlc
immunostain
show
fsrelat
c
jejuni
strain
lipooligosaccharid
lo
often
syndrom
gb
enteritisrel
strain
fsrelat
strain
also
epitop
frequenc
lower
gbsrelat
strain
epitop
detect
fsrelat
h
influenza
strain
none
strain
patient
gb
uncompl
respiratori
infect
find
provid
evid
c
jejuni
h
influenza
causal
agent
fs
product
autoantibodi
mediat
bacteri
lo
synchron
immunomodulatori
combin
therapi
initi
treatment
chronic
inflammatori
demyelin
polyradiculoneuropathi
j
ikeda
harada
kohriyama
b
higaki
b
katayama
b
matsumoto
b
hiroshima
prefectur
hospit
hiroshima
japan
b
hiroshima
univers
hospit
hiroshima
japan
chronic
inflammatori
demyelin
polyradiculoneuropathi
cidp
respond
treatment
immunomodulatori
therapi
howev
plasma
exchang
intraven
immunoglobulin
therapi
ivig
shortterm
clinic
benefit
patient
may
need
therapi
repeatedli
mani
patient
relaps
dose
steroid
reduc
fewer
patient
complet
remiss
treatment
studi
perform
investig
whether
synchron
immunomodulatori
combin
therapi
sict
cidp
lead
shortand
longterm
remiss
seven
patient
hiroshima
prefectur
hospit
present
includ
studi
sict
design
immunoadsorpt
therapi
iat
methylprednisolon
puls
therapi
ivig
maintain
mg
prednisolon
everi
day
given
oral
sict
clinic
symptom
evalu
neurolog
disabl
score
nd
modifi
rankin
scale
mr
serum
tumor
necrosi
factor
tnf
alpha
interferongamma
interleukin
il
macrophagecoloni
stimul
factor
mcsf
measur
enzymelink
immunosorb
assay
elisa
six
patient
show
improv
decreas
nd
mr
one
cours
sict
oral
prednisolon
gradual
reduc
discontinu
four
patient
remiss
observ
case
tnfalpha
mcsf
chang
greatli
sict
respons
therapi
observ
one
patient
sict
use
initi
treatment
cidp
fluctuat
cytokin
may
reflect
favor
respons
immunotherapi
case
chronic
inflammatori
demyelin
polyradiculoneuropathi
present
extern
ophthalmoplegia
sugawara
imota
b
k
obara
watanab
toyoshima
akita
univers
school
medicin
akita
japan
b
akita
citi
hospit
akita
japan
patient
present
man
develop
extern
ophthalmoplegia
cours
chronic
inflammatori
demyelin
polyradiculoneuropathi
cidp
report
right
ankl
weak
run
year
old
becam
slow
run
easi
fall
diagnos
cidp
age
nerv
biopsi
reveal
segment
demyelin
corticosteroid
puls
therapi
follow
oral
corticosteroid
cyclosporin
result
mild
improv
muscl
power
admit
hospit
due
aggrav
weak
leg
extern
ophthalmoplegia
bilater
blepharoptosi
complet
palsi
horizont
gaze
vertic
gaze
limit
present
cranial
nerv
v
vii
viii
ix
x
xi
xii
intact
antibodi
antibodi
detect
antiachr
antibodi
posit
thymoma
detect
manag
four
time
doublefiltr
plasmapheresi
result
complet
disappear
extern
ophthalmoplegia
improv
weak
extrem
high
dose
inject
immunoglobulin
ivig
improv
muscl
power
patient
remark
promptli
effect
continu
month
muscl
power
limb
maintain
extern
ophthalmoplegia
never
occur
intermitt
ivig
everi
month
conclus
case
suggest
patient
cidp
produc
wide
divers
antibodi
caus
muscl
weak
extern
ophthalmoplegia
maintain
recoveri
ivig
cidp
associ
lung
cancer
paraneoplast
diseas
r
fazio
raffael
hospit
milan
itali
describ
smoker
male
follow
year
pure
motor
demyelin
peripher
neuropathi
patient
monthli
motor
relaps
sever
weak
restrict
wheelchair
monthli
need
high
dose
ig
ev
emg
mcv
slow
without
evid
conduct
block
scv
normal
rang
csf
disclos
high
protein
level
laboratori
find
reveal
abnorm
except
presenc
monoclon
gammopathi
igmk
hightit
serum
igm
antibodi
march
sever
relaps
flaccid
tetraplegia
sever
respiratori
failur
requir
ventilatori
support
total
bodi
ct
scan
reveal
nodular
lung
lesion
diffus
lymphangi
biopsi
disclos
lung
adenocarcinoma
sever
infiltr
cell
surgic
erad
tumor
caus
last
sever
relaps
moment
patient
relapsefre
treatment
administ
clinic
cours
motor
demyelin
relaps
neuropathi
suggest
possibl
paraneoplast
pathogenesi
neurolog
ill
also
support
sever
inflammatori
infiltr
tumor
immunomodul
possibl
antifibrot
therapi
muscular
dystrophi
data
murin
anim
model
f
andreetta
p
bernasconi
p
ferro
e
arnoldi
l
oliva
f
cornelio
r
mantegazza
p
confalonieri
nation
neurolog
institut
bc
bestaq
milan
itali
irrevers
connect
tissu
prolifer
muscl
patholog
hallmark
duchenn
muscular
dystrophi
dmd
focal
releas
consid
key
factor
fibrosi
develop
murin
muscular
dystrophi
mdx
genet
homolog
dmd
histopatholog
alter
compar
dmd
limb
muscl
report
diaphragm
older
mdx
mice
investig
earli
develop
fibrosi
involv
murin
diseas
evalu
diaphragm
mdx
mice
morphometr
analysi
immunohistochemistri
collagen
express
realtim
pcr
elisa
signific
increas
extracellular
matrix
express
found
mdx
mice
deposit
type
iii
collagen
basi
data
treat
mdx
mice
either
neutral
monoclon
antibodi
nonimmun
murin
igg
week
alternateday
intraperiton
inject
morphometr
analysi
show
week
age
signific
decreas
fibrosi
mrna
level
group
treat
antitgfbeta
antibodi
studi
describ
first
time
earli
progress
develop
fibrosi
overexpress
mdx
diaphragm
suggest
immunomodul
fibrogen
cytokin
promis
therapeut
approach
muscl
fibrosi
granulysin
express
infiltr
cell
inflammatori
myopathi
k
ikezo
oshima
osoegawa
k
ogawa
b
k
nagata
b
j
kira
kyushu
univers
fukuoka
japan
b
bml
kawago
japan
object
granulysin
effector
molecul
present
cytolyt
granul
nk
cell
cytotox
cell
aim
studi
clarifi
differ
express
granulysin
infiltr
cell
variou
inflammatori
myopathi
correl
express
steroid
resist
method
analyz
express
granulysin
perforin
muscl
case
polymyos
pm
dermatomyos
dm
inclus
bodi
myositi
ibm
immunohistochemistri
also
carri
doubl
stain
granulysin
result
pm
ibm
infiltr
cell
granulysin
found
endomysium
posit
result
perforin
ratio
number
granulysin
posit
cell
cell
ratio
steroid
respons
pm
lower
steroidresist
pm
mannwhitney
ibm
ratio
dm
infiltr
cell
granulysin
conclus
possibl
granulysin
concern
steroid
resist
pm
ibm
steroid
resist
base
factor
granulysin
dm
granulysin
particip
muscl
fiber
damag
sporad
inclus
bodi
myositi
immunotherapi
downregul
inflamm
betaamyloid
associ
factor
repeat
muscl
biopsi
j
schmidt
j
g
voss
r
raju
c
dalaka
nation
institut
health
bethesda
md
usa
investig
effect
high
dose
prednison
pred
intraven
immun
globulin
ivig
chemokin
cytokin
betaamyloid
associ
protein
crucial
sibmpathogenesi
ivig
pred
ineffect
sibm
although
proven
benefici
inflammatori
muscl
disord
mrna
extract
sibm
muscl
biopsi
month
treatment
ivigpr
pred
cdna
analyz
quantit
realtim
pcr
relat
gapdhexpress
use
sequenc
specif
primer
chemokineligand
interferon
ifn
gamma
tumornecrosisfactor
tnf
alpha
interleukin
il
transforminggrowthfactor
tgf
beta
induciblecostimul
ico
ligand
icosl
perforin
amyloidprecursorprotein
app
ubiquitin
ivigpr
pred
observ
downregul
mrnaexpress
strongest
decreas
note
follow
ifngamma
tgfbeta
patient
app
ubiquitin
clearli
diminish
tnfalpha
ico
icosl
perforin
modestli
reduc
immunohistochem
greyscaleanalysi
confirm
downregul
proteinlevel
sibm
ivigpr
pred
drastic
reduc
express
proinflammatori
chemokin
cytokin
app
ubiquitin
result
suggest
stronger
downregul
molecul
may
necessari
achiev
clinic
efficaci
factor
relev
immunologicaldegen
interplay
sibmpathogenesi
rage
pathway
inflammatori
myopathi
haslbeck
u
fri
b
e
schleicher
b
bierhau
c
b
neundfrfer
heuss
depart
neurolog
univers
germani
b
depart
medicin
iv
univers
germani
c
depart
medicin
univers
heidelberg
heidelberg
germani
oxid
stress
nfkb
activ
link
pathogenesi
mani
metabol
degen
chronic
inflammatori
diseas
activ
receptor
advanc
glycat
end
product
rage
specif
ligand
ne
carboxymethyl
lysin
cml
result
activ
nfkb
product
proinflammatori
cytokin
order
determin
whether
engag
rage
might
contribut
pathogenesi
inflammatori
myopathi
studi
presenc
cml
rage
activ
nfkb
immunohistochemistri
muscl
biopsi
patient
polymyos
pm
dermatomyos
dm
eight
healthi
control
inflammatori
myopathi
cml
rage
nfkb
detect
mononuclear
cell
regener
muscl
fiber
degener
muscl
fiber
colocalis
cml
rage
nfkb
seen
infiltr
mononuclear
cell
regener
muscl
fiber
data
suggest
cmlragenfkb
pathway
evid
proinflammatori
pathomechan
mononuclear
effector
cell
pm
dm
ragemedi
nfkb
express
may
play
role
muscl
fiber
regener
inflammatori
myopathi
autoimmun
cell
myasthenia
gravi
mg
recogn
sever
region
human
muscl
acetylcholin
receptor
achr
present
hla
class
ii
dr
molecul
tepitop
analysi
identifi
eight
synthet
achr
sequenc
test
cell
respons
pbmc
mg
patient
healthi
control
prolifer
studi
overal
reactiv
observ
among
patient
significantli
higher
healthi
control
frequenc
respons
vari
specif
hladr
phenotyp
sequenc
poorli
recogn
mg
patient
wherea
strongli
recogn
mg
individu
hla
bind
assay
peptid
reveal
vari
capac
bind
eight
test
hladr
class
ii
molecul
femal
mg
subject
mainli
sever
diseas
display
significantli
higher
respons
male
mg
patient
year
show
strong
reactiv
reactiv
significantli
higher
nonthymectom
patient
well
patient
short
durat
diseas
find
may
import
implic
design
futur
therapeut
strategi
diseas
support
fapesp
immunolog
ryanodin
receptor
myasthenia
gravi
takamori
neurolog
center
kanazawanishi
hospit
kanazawa
japan
studi
implic
antistri
antibodi
muscl
contract
fatigu
myasthenia
gravi
mg
antibodi
ryanodin
receptor
ryr
essenti
excitationcontract
coupl
muscl
measur
sera
mg
patient
thymoma
without
thymoma
use
three
synthet
peptid
deduc
amino
acid
sequenc
one
region
close
nterminu
implic
inactiv
high
cytoplasm
calcium
concentr
two
peptid
ctermin
transmembran
region
ctermin
tail
region
respons
function
calcium
releas
channel
antibodi
frequent
posit
two
ctermin
peptid
particularli
thymomaassoci
mg
ntermin
peptid
antibodi
uncommonli
detect
patient
select
mg
patient
base
author
criteria
therapeut
trail
treatment
design
give
immunosuppress
act
calcineurin
inhibitor
also
affect
ryrrel
muscl
contract
acceler
sarcoplasm
calcium
releas
efficaci
estim
reduct
diseas
sever
score
prednison
dosag
antiacetylcholin
receptor
antibodi
titer
medic
result
show
earli
sustain
benefit
patient
posit
antibodi
ctermin
peptid
earli
effect
may
reflect
action
enhanc
ryrrel
sarcoplasm
calcium
releas
effect
ryr
ntermin
region
myasthenia
gravi
patient
sera
exhibit
cytotox
effect
human
primari
muscl
cell
cultur
sp
luckman
go
skeie
g
helgeland
ne
gilhu
haukeland
univers
hospit
bergen
norway
myasthenia
gravi
mg
caus
primarili
autoantibodi
direct
nicotin
acetylcholin
receptor
achr
addit
antimuscl
autoantibodi
detect
mg
patient
role
nonachr
autoantibodi
remain
elucid
order
investig
role
autoantibodi
mg
primari
human
muscl
cell
cultur
expos
mg
patient
sera
morpholog
effect
observ
cell
death
cultur
also
examin
cultur
human
muscl
cell
expos
mg
patient
control
sera
normal
donor
system
lupu
erythematosu
sjogren
syndrom
patient
sera
day
observ
crystal
violet
stain
light
microscopi
sera
sever
mg
patient
mg
crisi
patient
induc
dramat
chang
cell
morpholog
lead
multinucl
cell
cluster
oppos
elong
multinucl
myotub
observ
control
cultur
obviou
inclus
bodi
vesicl
format
dramat
reduct
total
cell
number
also
observ
indic
cytotox
effect
effect
doseand
timedepend
complementmedi
cytotox
effect
mg
patient
sera
appear
due
induct
apoptosi
studi
demonstr
direct
cytotox
effect
mg
patient
sera
normal
human
muscl
cell
cultur
sera
sever
affect
patient
demonstr
greatest
cytotox
effect
order
know
whether
acetylcholinesteras
ach
autoimmun
play
role
myasthenia
gravi
mg
associ
antibodi
direct
nicotin
acetylcholin
receptor
achr
patient
grave
diseas
gd
analys
elisa
abil
sera
patient
mg
without
antibodi
achr
gd
antibodi
thyreoglobulin
tg
healthi
control
cr
react
ach
human
brain
human
tg
result
show
significantli
increas
antiach
activ
exhibit
high
proport
mg
nearli
unchang
antiach
activ
observ
gd
sera
similar
cr
antiach
activ
detect
antitg
activ
detect
mg
patient
posit
cr
posit
suggest
ach
autoimmun
anoth
import
reason
result
mg
play
role
gd
tg
autoimmun
may
ignor
mg
vivo
role
complement
activ
myasthenia
gravi
f
romi
ek
kristoffersen
ja
aarli
ne
gilhu
haukeland
univers
hospit
bergen
norway
background
antibodi
acetylcholin
receptor
achr
titin
ryanodin
receptor
ryr
occur
myasthenia
gravi
antibodi
found
capabl
complement
activ
vitro
involv
complement
system
theoret
caus
consumpt
complement
compon
materi
method
complement
compon
assay
sera
achr
antibodi
posit
mg
patient
titin
antibodi
posit
also
ryr
antibodi
posit
titin
ryr
antibodi
neg
earlyonset
mg
lateonset
mg
healthi
control
result
mg
patient
achr
antibodi
concentr
median
significantli
lower
mean
concentr
compar
achr
antibodi
concentr
median
titin
antibodi
posit
mg
patient
titin
antibodi
neg
earlyonset
mg
patient
titin
antibodi
neg
lateonset
mg
patient
control
similar
concentr
mean
concentr
differ
mg
patient
ryr
antibodi
patient
sever
mg
similar
similar
level
compar
mild
mg
conclus
serolog
evid
increas
consumpt
mg
vivo
patient
high
achr
antibodi
concentr
unrel
mg
sever
muscl
antibodi
studi
exclud
howev
role
complement
activ
pathophysiolog
muscl
antibodi
mg
modul
antigen
specif
respons
achr
recombin
erythropoietin
f
ubiali
nava
c
antozzi
p
ghezzi
b
c
cappelletti
f
cornelio
r
mantegazza
f
baggi
nation
neurolog
institut
c
besta
milan
itali
b
mario
negri
institut
pharmacolog
research
milan
itali
recombin
erythropoietin
repo
treatment
alter
number
circul
tcell
ratio
effect
might
influenc
immun
respons
pathway
antigen
present
andor
recognit
cell
aim
studi
evalu
repo
effect
tcell
line
specif
peptid
ratachr
alphasubunit
myasthenogen
tcell
epitop
lewi
rat
tcell
challeng
cona
presenc
repo
ngml
specif
respons
measur
hthymidin
incorpor
prolif
respons
cona
cpm
cpm
significantli
reduc
spleen
cell
convent
apc
preincub
repo
ngml
h
cona
cpm
cpm
similar
result
obtain
preincub
ng
ml
repo
cona
cpm
cpm
experi
repeat
use
apc
bone
marrowderiv
dc
differenti
gmcsf
respons
cpm
reduc
cpm
repo
directli
ad
well
result
enhanc
dc
preincub
h
repo
cpm
repo
also
test
tachrspecif
respons
lymph
node
cell
lnc
deriv
tachrimmun
lewi
rat
lnc
prolifer
reduc
repo
ad
cultur
lnc
confirm
modulatori
properti
result
suggest
repo
might
implic
regul
autoimmun
respons
achr
use
elispot
monitor
clone
achrspecif
tcell
myasthenia
gravi
patient
w
zhang
leit
u
kishor
p
water
n
willcox
neurosci
group
weatheral
institut
molecular
medicin
univers
oxford
oxford
uk
autoimmun
tcell
recognis
peptid
acetylcholin
receptor
achr
play
import
role
initi
progress
myasthenia
gravi
mg
complex
achr
molecul
difficulti
purifi
subunit
low
frequenc
achrspecif
tcell
peripher
blood
lymphocyt
pbl
clone
labori
ineffici
modifi
specif
elispot
assay
use
monitor
recent
tcell
clone
assay
enabl
us
determin
precis
whether
patient
pbl
respond
specif
one
round
vitro
stimul
achr
subunit
peptid
also
make
quicker
easier
defin
epitop
recognis
estim
frequenc
respond
tcell
identifi
two
promis
line
clone
musk
antibodi
myasthenia
gravi
n
desai
farrugia
j
mcconvil
vincent
oxford
univers
oxford
uk
antibodi
receptor
tyrosin
kinas
musk
found
patient
generalis
myasthenia
gravi
without
acetylcholin
receptor
antibodi
bseronegativeq
snmg
describ
characterist
antibodi
frequenc
myasthenia
gravi
patient
kindli
provid
neurologist
countri
antibodi
high
affin
kd
around
pm
predominantli
igg
subclass
titr
rang
nm
patient
muskantibodi
posit
mg
frequent
femal
tend
mark
bulbar
weak
age
onset
mainli
year
older
patient
rel
common
countri
altogeth
antibodi
musk
detect
total
snmg
patient
repres
snmg
patient
differ
centr
includ
nine
europ
three
north
america
five
far
east
highest
preval
patient
origin
countri
equat
high
affin
antibodi
variabl
frequenc
snmg
patient
differ
geograph
locat
rais
possibl
antibodi
induc
specif
environment
antigen
myasthenia
gravi
mg
autoantibodi
muscl
specif
kinas
musk
autoimmun
disord
neuromuscular
transmiss
characteris
fluctuat
weak
predominantli
bulbar
muscl
studi
epidemiolog
antimusk
mg
distinct
area
provinc
south
holland
million
inhabit
review
chart
patient
diagnos
mg
nine
hospit
two
hospit
without
registr
diagnosi
examin
chart
patient
test
antiachr
antibodi
januari
januari
mg
diagnos
patient
antiachr
antibodi
neg
first
symptom
within
period
incid
per
million
per
year
among
two
patient
antimusk
incid
per
million
per
year
preval
antimusk
mg
januari
per
million
base
patient
group
antiachr
patient
aliv
among
patient
generalis
antiachr
mg
patient
test
antimusk
posit
restrict
group
emg
confirm
mg
proport
antimusk
mg
increas
netherland
found
patient
generalis
antiachr
mg
antimusk
test
populationbas
studi
preval
antimusk
mg
lower
suggest
previou
report
analysi
lif
oncostatin
myasthen
thymus
e
arnoldi
p
bernasconi
f
baggi
f
cornelio
r
mantegazza
nation
neurolog
institut
c
besta
milan
itali
thymu
crucial
tissu
pathogenesi
myasthenia
gravi
mg
thought
site
loss
toler
diseas
thymic
abnorm
often
found
mg
patient
includ
abnorm
presenc
b
cell
germin
center
investig
transcript
level
cytokin
involv
thymopoiesi
b
cell
function
leukemia
inhibitori
factor
lif
oncostatin
osm
real
timepcr
studi
express
cytokin
myasthen
thymus
involut
hyperplast
thymoma
osm
transcript
level
higher
case
hyperplast
thymus
thymoma
case
involut
thymus
lif
express
higher
hyperplast
thymus
involut
thymus
thymoma
case
observ
increas
express
level
data
suggest
express
analyz
cytokin
might
relat
presenc
intrathym
cellular
prolifer
correl
cytokin
level
serum
antiachr
antibodi
titer
evid
object
describ
develop
treatment
myasthen
syndrom
local
botulinumtoxin
inject
cervic
dystonia
method
male
suffer
cerebr
palsi
tetraparesi
dystonia
present
sever
cervic
pain
secondari
spasmod
torticolli
treat
sever
local
inject
botulinum
toxin
type
good
result
report
longlast
month
bilater
proxim
brachial
paresi
last
treatment
inject
stop
year
pain
becam
sever
patient
ask
treatment
botulinumtoxin
type
b
administ
four
time
rapidli
evolv
progress
tetraparesi
present
day
fourth
inject
result
myasthen
syndrom
facilit
emg
increas
titter
antibodi
ca
channel
diagnos
studi
includ
nerv
conduct
veloc
sf
analysi
normal
neoplasia
found
immunoglobulin
administ
intraven
progress
paresi
immedi
stop
patient
quickli
improv
steroid
given
later
good
result
conclus
causal
relationship
administr
botulinum
toxin
develop
myasthen
syndrom
warrant
consider
imposs
know
whether
toxin
causal
particip
immunolog
respons
neural
structur
simpli
toxin
b
unmask
preexist
myasthen
syndrom
respons
treatment
immunoglobulin
remark
prognost
signific
thymectomi
autoimmun
myasthenia
gravi
mg
ariatti
p
faglioni
g
galassi
object
verifi
efficaci
thymectomi
mg
method
retrospect
studi
conduct
mg
patient
male
mean
age
femal
mean
age
rang
year
mean
age
year
mean
durat
patient
ill
month
sever
defin
accord
osserman
classif
asymptomat
patient
score
statist
purpos
time
diagnosi
patient
grade
grade
iia
grade
iib
patient
classifi
grade
iii
iv
accord
actual
sever
patient
includ
grade
grade
iia
grade
iib
patient
grade
iii
iv
patient
asymptomat
time
clinic
evalu
clinic
outcom
evalu
patient
underw
surgeri
either
thymoma
nonneoplast
thymu
treat
surgic
result
percentag
subject
improv
among
thymectom
patient
either
thymoma
hyperplast
thymu
respect
patient
improv
undergo
thymectomi
three
percentag
differ
significantli
chi
squar
decomposit
total
chi
squar
reveal
thymectomi
rais
chanc
improv
vs
chi
squar
one
tail
furthermor
hyperplast
thymu
benefit
thymectomi
often
neoplast
thymu
vs
chi
squar
one
tail
paraneoplast
neurolog
syndrom
pn
immunemedi
nonmetastat
disord
associ
cancer
start
tumor
evid
involv
central
peripher
nervou
system
role
antineuron
antibodi
uncertain
import
diagnosi
myasthenia
gravi
mg
autoimmun
neuromuscular
disord
sometim
associ
thymoma
combin
mg
hodgkin
diseas
hd
rare
report
case
femal
gener
mg
radiolog
suspect
thymoma
antiacetylcholinereceptor
achr
antibodi
result
posit
antititin
antiryanodin
antibodi
neg
neurolog
therapi
patient
submit
thymectomi
nodularscleros
syncizi
hd
plu
thymic
atrophi
diagnos
oncolog
screen
confirm
clinic
ii
hd
mediastin
bulk
neurolog
treatment
stop
chemo
plu
radiotherapi
start
success
year
follow
reveal
complet
remiss
mg
hd
progress
decreas
antiachr
antibodi
combin
seroposit
mg
thymic
atrophi
hd
may
suggest
myasthen
symptom
could
trigger
immunolog
alter
underli
hd
stabl
complet
resolut
mg
hd
remiss
well
progress
decreas
antiachr
antibodi
may
reinforc
hypothesi
suggest
pathogenet
role
antibodi
paraneoplast
mg
associ
hd
autoimmun
diseas
aid
known
cluster
famili
studi
frequenc
natur
addit
aid
patient
lamberteaton
myasthen
syndrom
lem
famili
member
small
cell
lung
carcinoma
sclc
relat
nontumour
nt
relat
case
addit
aid
patient
lem
assess
interview
patient
studi
medic
record
famili
histori
seconddegre
famili
member
establish
interview
patient
control
famili
member
fortyfour
patient
lem
assess
eighteen
sclc
nt
group
seven
patient
addit
aid
sclc
group
two
thyroid
disord
five
patient
insulindepend
diabet
mellitu
two
patient
common
aid
aid
significantli
frequent
famili
patient
ntlem
control
famili
famili
sclclem
patient
affect
famili
member
link
ntlem
patient
matern
line
case
conclus
aid
frequent
found
ntlem
patient
famili
sclclem
patient
famili
suggest
ntlem
share
immunolog
risk
factor
aid
find
remark
preponder
matern
inherit
report
previous
myasthenia
gravi
might
help
identifi
respons
mechan
gene
involv
daili
versu
altern
day
plasmapharesi
induct
remiss
patient
sever
myasthenia
gravi
randomis
trial
singh
trikha
v
goyal
g
shukla
srivastava
r
bhasin
behari
india
institut
medic
scienc
new
delhi
india
object
assess
compar
efficaci
daili
versu
altern
day
plasmapharesi
induc
remiss
patient
sever
myasthenia
gravi
method
thirtythre
patient
myasthenia
gravi
osserman
stage
iib
iii
randomli
alloc
receiv
altern
day
daili
plasma
exchang
myasthenia
gravi
diseas
scale
mgd
score
compar
procedur
subject
improv
symptom
time
taken
wean
ventil
remov
nasogastr
tube
total
durat
hospit
stay
also
assess
result
four
five
session
plasma
exchang
carri
patient
mlkg
plasma
remov
session
statist
signific
differ
found
daili
vs
altern
day
group
regard
chang
mgd
score
percentag
chang
mgd
score
discharg
total
durat
stay
hospit
less
daili
group
compar
altern
day
group
almost
reach
statist
signific
complic
two
group
also
similar
conclus
conclud
daili
altern
day
plasma
pharesi
similar
efficaci
complic
rate
durat
hospit
stay
less
daili
plasma
pharesi
henc
prefer
method
perform
plasma
exchang
patient
myasthenia
gravi
induc
remiss
symptom
variou
mutant
human
antihumanacetylcholin
receptor
achr
antibodi
produc
characteris
includ
two
mutant
chang
complementbind
site
two
mutat
gener
bispecif
antibodi
mutat
delet
affin
antigen
moreov
flag
tag
ad
analysi
purif
differ
heavi
chain
transient
express
system
use
cell
success
use
product
agml
noncomplementbind
antibodi
test
passiv
transfer
eamg
model
rhesu
monkey
abil
compet
pathogen
parent
antibodi
drug
candid
treatment
myasthenia
gravi
efficaci
novel
immunosuppress
experiment
autoimmun
myasthenia
gravi
kohno
k
hirayama
r
iwatsuki
hiros
k
watab
h
yoshikawa
b
matsumoto
c
kohno
c
fujita
c
hayashi
faculti
phamaceut
scienc
setsunan
univers
osaka
japan
b
kanazawa
univers
ishikawa
japan
c
research
institut
product
develop
kyoto
japan
uwajima
citi
hospit
ehim
japan
discov
chemic
modif
ispi
metabolit
fungu
isaria
sinclairii
fujita
one
author
efficaci
well
establish
preclin
transplant
model
recent
proven
effect
renal
transplant
human
studi
efficaci
examin
prevent
experiment
autoimmun
myasthenia
gravi
eamg
develop
treatment
eamg
eight
mice
immun
three
time
torpedo
californica
acetylcholin
receptor
achr
receiv
water
develop
eamg
six
mice
immun
receiv
continu
mgkg
oral
three
time
week
start
immun
eamg
symptom
observ
eight
eamg
mice
divid
placebo
group
receiv
water
treatment
group
receiv
describ
develop
eamg
hold
time
invert
grid
test
significantli
improv
treatment
group
find
show
effect
prevent
also
treatment
eamg
addit
clarifi
mechan
pharmacolog
action
cytokin
mrna
level
antiachr
igg
level
elisa
use
mous
achr
antigen
achr
muscl
fluoresc
microscop
detect
use
fitclabel
bungarotoxin
examin
pyridostigmin
induct
regimen
effect
myasthenia
gravi
rs
nichola
robert
b
j
sussman
b
j
winer
c
ik
hart
walton
centr
liverpool
uk
b
hope
hospit
manchest
uk
c
queen
elizabeth
hospit
birmingham
uk
introduct
pyridostigmin
firstlin
treatment
myasthenia
gravi
mg
howev
studi
optimum
use
neurologist
often
see
patient
subtherapeut
dose
drug
advers
effect
aim
studi
mg
patient
pyridostigmin
induct
regimen
develop
drug
pharmacokinet
profil
method
patient
enter
openlabel
studi
regimen
work
use
dose
mg
twiceday
day
mg
five
timesday
day
mg
per
day
day
mg
five
timesday
maximum
dose
patient
neurologist
rank
diseas
symptom
sever
entri
month
along
drug
advers
effect
result
preliminari
result
patient
ocular
mg
omg
averag
symptom
oculobulbar
mg
obmg
averag
symptom
generalis
mg
gmg
averag
symptom
patient
improv
complet
trial
severest
omg
symptom
ptosi
diplopia
fell
grade
meanfsd
severest
obmg
symptom
dysphagia
ptosi
diplopia
fell
grade
severest
gmg
symptom
weak
dysarthria
diplopia
fell
grade
patient
report
advers
effect
pyridostigmin
stop
conclus
pyridostigmin
induct
regimen
well
toler
effect
mg
work
support
unrestrict
research
grant
valeant
pharmaceut
cyclosporin
treatment
myasthenia
gravi
patient
antimusk
antibodi
dm
bonifati
r
padoan
vincent
b
e
pegoraro
c
angelini
univers
padua
padua
itali
b
univers
oxford
oxford
uk
object
evalu
treatment
myasthen
patient
present
antireceptor
tyrosin
kinas
musk
antibodi
background
recent
antibodi
musk
identifi
seroneg
generalis
myasthenia
gravi
mg
patient
often
present
bulbar
weak
difficult
treat
designmethod
larg
popul
mg
patient
screen
seroneg
patient
antimusk
antibodi
retrospect
evalu
efficaci
thymectomi
choic
immunosuppress
treatment
result
four
patient
posit
antimusk
antibodi
man
affect
class
iib
myasthenia
year
atroph
thymu
remov
surgeri
worsen
condit
requir
plasmapheresi
refractori
steroid
therapi
treat
cyclosporin
mg
daili
woman
present
sinc
age
class
iv
myasthenia
treat
ivig
cyclosporin
mg
daili
mark
improv
woman
bulbar
myasthenia
thymectomi
need
sever
plasmapheresi
cycl
steroid
azathioprin
use
benefit
patient
ocular
myasthenia
underw
thymectomi
month
present
relaps
upper
limb
weak
treat
steroid
benefit
conclus
two
patient
antimusk
antibodi
respond
well
cyclosporin
might
therefor
effect
treatment
group
myasthen
patient
thymectomi
seem
benefit
patient
dramat
respons
ocular
symptom
ivig
treatment
myasthenia
gravi
kurn
em
arsava
dalkara
hacettep
univers
ankara
turkey
introduct
myasthenia
gravi
autoimmun
disord
character
ocular
bulbar
gener
weak
nineti
percent
myasthen
patient
suffer
ocular
involv
sometim
cours
diseas
ocular
symptom
patient
myasthenia
gravi
respond
incomplet
anticholinesteras
immunosuppress
therapi
object
report
six
myasthen
patient
whose
ocular
symptom
dramat
respond
intraven
immunoglobulin
ivig
therapi
gener
refractori
anticholinesteras
immunosuppress
treatment
modal
case
report
characterist
patient
treatment
featur
summar
tabl
propos
ivig
consid
myasthen
patient
whose
ocular
symptom
respond
convent
therapi
futur
studi
may
disclos
whether
patient
ocular
symptom
subset
patient
dramat
respond
ivig
pyridostigmin
corticosteroid
ngf
regul
cgrp
express
human
monocyt
effect
express
product
l
braccilaudiero
l
alo
c
caroleo
b
p
buann
c
n
costa
g
starac
lundeberg
e
cnr
institut
neurobiolog
molecular
medicin
rome
itali
b
univers
calabria
cosenza
itali
c
univers
laquila
laquila
itali
univers
bmagna
greciaq
catanzaro
itali
e
karolinska
institutet
stockholm
sweden
administr
nerv
growth
factor
ngf
eae
model
delay
onset
prevent
full
develop
eae
lesion
line
antiinflammatori
activ
ngf
recent
result
autocrin
ngf
synthesi
b
lymphocyt
directli
regul
cell
express
calcitonin
generel
peptid
cgrp
neuropeptid
potent
inhibitor
cell
prolifer
antigen
present
macrophag
monocyt
use
cultur
human
monocyt
investig
rtpcr
immunofluoresc
flow
cytometri
analysi
whether
ngf
regul
express
cgrp
also
cell
influenc
express
data
indic
monocyt
synthesis
basal
level
ngf
lp
stimul
upregul
ngf
express
dosedepend
fashion
cultur
depriv
endogen
ngf
cgrp
express
rest
cell
decreas
upregul
cgrp
induc
lp
prevent
addit
observ
endogen
ngf
reduct
affect
costimulatori
molecul
express
synthesi
effect
partial
mimick
use
cgrp
receptor
antagonist
find
indic
endogen
synthesi
ngf
monocyt
function
role
influenc
express
product
contribut
downregul
immun
respons
strongli
support
newli
found
antiinflammatori
activ
ngf
background
myasthenia
gravi
mg
caus
autoantibodi
direct
acetylcholin
receptor
achr
neuromuscular
junction
lead
muscl
weak
dendrit
cell
dc
usual
regard
antigenpres
cell
involv
cell
activ
also
affect
b
cell
function
immatur
dc
may
induc
toler
matur
dc
induc
immun
presenc
matur
dc
inhibit
termin
differenti
explor
potenti
immunotherapi
experiment
autoimmun
myasthenia
gravi
eamg
lewi
rat
method
splenic
dc
isol
onset
eamg
day
post
immun
pi
expos
vitro
inject
intraperiton
ip
ongo
eamg
rat
dose
cellsrat
day
pi
achrcomplet
freund
adjuv
result
lower
clinic
score
less
bodi
weight
loss
lower
number
antiachr
igg
antibodi
secret
cell
lower
affin
antiachr
antibodi
observ
rat
receiv
dc
accompani
lower
express
lower
lymphocyt
prolifer
compar
control
eamg
rat
lower
level
ifngamma
also
found
supernat
achrstimul
lymph
node
mononuclear
cell
cultur
rat
receiv
dc
conclus
dc
induc
hyporespons
downregul
costimulatori
molecul
reduc
product
antiachr
antibodi
possibl
inhibit
product
eamg
immatur
matur
dendrit
cell
multipl
sclerosi
lesion
b
serafini
b
rosicarelli
r
magliozzi
e
capello
b
gl
mancardi
b
f
aloisi
depart
cell
biolog
neurosci
istituto
superior
di
rome
itali
b
univers
genova
genova
itali
dendrit
cell
dc
accumul
target
organ
autoimmun
diseas
thought
key
role
stimul
autoreact
cell
address
function
relev
dc
multipl
sclerosi
ms
evalu
degre
dc
infiltr
ms
brain
use
immunohistochem
techniqu
panel
antibodi
recogn
dc
subset
matur
marker
ms
lesion
examin
chronic
activ
inact
type
ctype
lectin
dcsign
present
immatur
myeloid
dc
express
cell
accumul
around
inflam
blood
vessel
predominantli
chronic
activ
lesion
immatur
dc
detect
marker
matur
dc
like
dclysosomeassoci
membran
protein
dclamp
express
isol
cell
perivascular
space
parenchyma
chronic
activ
lesion
chemokin
receptor
typic
matur
dc
detect
numer
cell
edg
chronic
activ
lesion
cell
tent
identifi
microglia
due
ramifi
morpholog
scatter
intraparenchym
distribut
coexpress
normal
brain
dcsign
cell
detect
mening
presenc
immatur
matur
dc
chronic
activ
ms
lesion
suggest
abnorm
present
myelin
antigen
potent
antigen
present
cell
could
break
immun
toler
toward
cn
antigen
allow
continu
stimul
autoimmun
respons
upon
stimul
microbi
product
tolllik
receptor
tlr
dendrit
cell
dc
prime
naiv
cell
initi
proinflammatori
immun
respons
recent
shown
apc
within
cn
ms
patient
contain
peptidoglycan
pgn
major
cell
wall
compon
gramposit
bacteria
signal
report
staphylococcu
aureu
pgn
singl
compon
replac
whole
mycobacterium
tuberculosi
freund
complet
adjuv
eae
mice
immun
encephalitogen
mogpeptid
incomplet
freund
adjuv
develop
eae
contrast
addit
pgn
emuls
suffici
prime
autoreact
cell
develop
eae
vitro
studi
demonstr
pgn
stimul
dcmediat
process
reflect
increas
antigen
uptak
dc
matur
cell
expans
activ
proinflammatori
cytokin
product
data
indic
pgnmediat
interact
result
proinflammatori
stimul
antigen
specif
effector
function
import
develop
eae
pgnmediat
process
may
occur
within
peripher
lymph
node
well
cn
like
involv
recognit
tlr
dc
pgn
signal
pathway
may
serv
novel
target
treatment
ms
dendrit
cell
dc
key
regul
toler
immun
selfantigen
sampl
present
cell
depend
matur
state
dc
either
induc
regulatori
cell
immatur
dc
autoreact
helper
cell
matur
dc
dc
matur
control
balanc
ctype
lectin
receptor
clr
toll
receptor
tlr
tlr
recogn
pathogenassoci
molecular
patter
induc
dc
matur
yang
clr
recognit
carbohydr
structur
selfantigen
antagon
dc
matur
yin
essenti
extracellular
protein
glycosyl
envisag
self
glycoprotein
maintain
toler
self
healthi
individu
yin
yang
balanc
hypothes
lack
yin
disturb
normal
glycosyl
self
glycoprotein
affect
capac
clr
inhibit
dc
matur
consequ
dc
matur
induc
autoreact
cell
defect
glycoprotein
discuss
new
data
nonhuman
primat
model
experiment
autoimmun
encephalomyel
support
hypothesi
modul
experiment
autoimmun
encephalomyel
infecti
agent
trypanosoma
brucei
brucei
ra
harri
karolinska
insitut
stockholm
sweden
protozoan
parasit
trypanosoma
brucei
brucei
tbb
caus
african
sleep
sick
cattl
also
experiment
mice
human
form
parasit
caus
diseas
throughout
equatori
africa
mice
harbour
tbb
infect
develop
experiment
autoimmun
encephalomyel
eae
anim
model
human
diseas
multipl
sclerosi
ms
upon
immunis
recombin
myelin
oligodendrocyt
glycoprotein
rmog
complet
freund
adjuv
cfa
mice
infect
parasit
time
immunis
week
later
develop
less
sever
eae
protect
mice
display
markedli
diminish
rmogspecif
prolifer
ifngamma
product
lymph
node
cell
correspondingli
low
titr
serum
antirmog
igg
antigen
present
cell
apc
spleen
tbb
infect
mice
present
rmog
less
effici
rmog
specif
cell
vitro
apc
control
spleen
also
inhibit
antigen
specif
prolifer
control
vitro
cultur
transfer
splenic
apc
tbb
infect
mice
mice
immunis
rmogcfa
day
previous
abrog
diseas
significantli
visual
peracut
antigen
presentationt
cell
activ
spleen
follow
highdos
solubl
antigen
applic
f
odoardi
z
li
n
kawakami
w
klinkert
j
bauer
h
lassmann
h
studi
mechan
intraven
high
dose
solubl
mbp
applic
hsm
adopt
transfer
experiment
autoimmun
encephalomyel
teae
lewi
rat
use
gene
engin
myelin
basic
protein
specif
cell
express
green
fluoresc
protein
tmbpgfp
cell
marker
gene
hsm
prevent
cn
inflamm
clinic
diseas
appli
hour
entri
encephalitogen
cell
brain
trap
effector
cell
peripher
immun
organ
lymph
node
liveimag
show
dramat
reduc
motil
tmbpgfp
cell
form
stabl
aggreg
resid
phagocyt
spleen
hsm
treatment
induc
redistribut
tmbpgfp
cell
red
white
pulp
morpholog
chang
associ
fast
cell
activ
increas
cytokin
mrna
express
observ
within
h
membran
phenotyp
rearrang
h
hsm
applic
cell
activ
block
antimhc
ii
antibodi
indic
rapid
antigen
process
cell
recognit
process
underli
hsm
effect
twentyfour
hour
hsm
applic
entir
tmbpgfp
cell
popul
elimin
activ
induc
cell
death
conclus
hsm
treatment
elucid
crucial
role
cnsinfiltr
autoreact
cell
cn
autoimmun
serv
ideal
model
system
visual
peracut
antigen
processingt
cell
recognit
vivo
matrix
metalloproteinas
mmp
involv
immunopathogenesi
multipl
sclerosi
ms
implic
activ
process
demyelin
mmp
may
contribut
demyelin
cleav
myelin
protein
consequ
propag
immun
respons
gener
new
immunodomin
epitop
littl
known
role
mmp
influenc
mhc
class
ii
relat
peptid
present
domin
myelin
epitop
thu
influenc
epitop
spread
limit
show
princip
human
epitopeamino
acid
myelin
basic
protein
mbp
contain
cleavag
site
present
epitop
antigen
present
cell
complet
abolish
presenc
demonstr
use
mbp
specif
tcrtransfect
contrast
myelin
oligodendrocyt
glycoprotein
mog
cleav
immunohistochemistri
could
detect
activ
ms
lesion
predominantli
express
cell
indic
macrophag
activ
microglia
cell
moreov
proteolyt
activ
measur
csf
patient
ms
control
data
demonstr
found
ms
patient
exhibit
novel
function
destroy
immunodomin
mbpepitop
proteas
could
directli
influenc
cascad
mbpspecif
tcell
autoreact
ms
find
consider
relev
deeper
understand
mechan
amplifi
limit
local
cn
autoreact
also
gener
consider
central
peripher
toler
criteria
definit
driver
cell
clone
js
menez
ametani
p
van
den
elzen
e
maveraki
v
kumar
ee
sercarz
torrey
pine
institut
molecular
studi
san
diego
ca
usa
driver
cell
dtc
defin
necessari
suffici
induct
eae
autoimmun
diseas
recent
report
mous
small
group
clone
respons
causat
eae
clone
downregul
diseas
occur
anim
enter
remiss
thu
diseas
cours
follow
life
histori
dtc
fact
becom
one
criteria
defin
bdriversq
spent
consider
effort
model
deriv
set
criteria
might
use
defin
clone
high
affin
antigen
underli
success
competit
perform
driver
becom
domin
member
repertoir
b
dtc
appear
earli
lymph
node
end
second
week
migrat
spinal
cord
spleen
c
characterist
driver
sequenti
appear
central
lymphoid
organ
public
e
proinflammatori
natur
dtc
like
public
clone
present
individu
also
usual
cytokin
pattern
call
clone
fit
criteria
driver
cell
clone
found
mous
eae
well
nod
model
type
diabet
immun
myelin
antigen
lead
develop
experiment
autoimmun
encephalomyel
eae
autoaggress
lymphocyt
migrat
cn
recogn
cognat
antigen
initi
inflammatori
cascad
lead
tissu
damag
cell
need
reencount
cognat
antigen
context
mhcii
bear
antigen
present
cell
apc
order
recogn
target
whether
antigen
present
cell
apc
mediat
cell
entri
cn
locat
within
cn
system
immun
compart
remain
heavili
debat
determin
contribut
system
immun
compart
guid
autoaggress
cell
cn
splenectom
alymphoplasia
ali
mice
secondari
lymphoid
structur
use
demonstr
mice
fulli
suscept
eae
indic
encephalitogen
cell
need
home
secondari
lymphoid
tissu
prior
cn
infiltr
order
assess
capac
cn
resid
microglia
present
ag
vivo
mice
mhciidefici
cn
parenchyma
use
recipi
mogreact
cell
surprisingli
mice
fulli
suscept
develop
eae
induc
adopt
transfer
final
demonstr
transgen
mice
express
mhcii
molecul
exclus
dendrit
cell
develop
eae
induc
adopt
transfer
data
clearli
show
dendrit
cell
suffici
present
ag
autoreact
cell
thu
mediat
cn
inflamm
clinic
diseas
develop
multipl
sclerosi
impair
phenotyp
matur
plasmacytoid
dendrit
cell
stasiolek
baya
b
n
kruse
c
kv
toyka
b
r
gold
k
selmaj
medic
univers
lodz
poland
b
univers
germani
c
univers
gfttingen
germani
dendrit
cell
dc
subtyp
possess
strong
diversifi
immunoregulatori
properti
plasmacytoid
dc
pdc
demonstr
pronounc
abil
prime
regulatori
cell
type
immun
respons
consid
put
immunoregulatori
function
pdc
multipl
sclerosi
ms
assess
phenotyp
pdc
isol
blood
ms
patient
matur
pdc
cultur
blood
sampl
untreat
rrm
patient
healthi
control
includ
ex
vivo
phenotyp
analysi
perform
flow
cytometri
pdc
assess
express
matur
antigen
costimulatori
molecul
matur
experi
pdc
isol
magnet
leucapheresi
materi
ms
patient
control
cultur
h
everi
h
cultur
pdc
analys
express
matur
marker
costimulatori
molecul
pdc
ms
show
immatur
phenotyp
compar
pdc
healthi
subject
express
costimulatori
molecul
pdc
significantli
lower
ms
sampl
control
pdc
ms
patient
also
show
impair
matur
demonstr
significantli
lower
delay
upregul
observ
abnorm
ex
vivo
phenotyp
matur
process
may
contribut
immunoregulatori
imbal
ms
serum
patient
multipl
sclerosi
induc
activ
antigen
present
cell
karni
azulai
korczyn
h
weiner
b
depart
neurolog
tel
aviv
souraski
medic
center
tel
aviv
israel
b
center
neurolog
diseas
brigham
women
hospit
harvard
medic
school
boston
ms
usa
object
studi
effect
serum
patient
multipl
sclerosi
ms
activ
antigen
present
cell
apc
method
peripher
mononuclear
cell
pbmc
healthi
donor
incub
serum
healthi
control
hc
ms
patient
remiss
relaps
product
tnfalpha
dendrit
cell
dc
monocyt
express
hladr
measur
flow
cytometri
result
increas
percentag
produc
dc
detect
incub
serum
secondari
progress
sp
ms
compar
relapsingremit
rr
ms
hc
search
serum
ms
patient
cytokin
known
activ
dc
ifngamma
consist
detect
pbmc
incub
eight
serum
spm
presenc
antiifngamma
block
antibodi
isotyp
control
ifngamma
blockad
decreas
percentag
produc
dc
comparison
serum
patient
remiss
serum
patient
relaps
induc
increas
express
hladr
monocyt
mean
floresc
intens
vs
increas
percentag
tnfalpha
produc
cell
vs
respect
conclus
serum
ms
patient
includ
factor
activ
apc
serum
ifngamma
appear
one
factor
serum
effect
may
provid
proinflammatori
signal
via
apc
myelin
autoreact
cell
cn
microvascular
pericyt
polar
altern
activ
phenotyp
p
doreduffi
r
balabanov
b
j
william
wayn
state
univers
school
medicin
detroit
medic
center
detroit
usa
b
univers
chicago
chicago
usa
cn
microvascular
pericyt
thought
highli
complex
regulatori
cell
import
tissu
homeostasi
vascular
hemostasi
previous
shown
rat
primari
capillari
pericyt
immun
potenti
present
antigen
sensit
leukocyt
drive
narv
cell
phenotyp
pericyt
may
therefor
function
cn
antigen
present
cell
apc
undergo
polar
associ
altern
activ
phenotyp
test
hypothesi
examin
freshli
isol
rat
pericyt
pericyt
found
prime
apc
phenotyp
produc
high
level
low
level
pge
sevendayold
primari
pericyt
constitut
releas
adher
cell
cytokin
secret
phenotyp
presenc
ifn
gamma
express
class
ii
antigen
process
antigen
presenc
stress
stimuli
low
oxygen
cytokin
product
decreas
eicosanoid
synthesi
increas
pericyt
synthes
tgf
beta
stage
differenti
pericyt
poor
apc
select
adher
cell
express
vascular
endotheli
cell
growth
factor
vegf
stimul
angiogenesi
data
suggest
pericyt
multipl
state
activationdifferenti
compar
tradit
apc
like
pericyt
apc
import
role
cn
inflamm
perivascular
macrophag
pvm
subpopul
macrophag
central
nervou
system
base
anim
studi
strateg
locat
pvm
interfac
circul
brain
parenchyma
postul
pvm
play
role
antigen
recognit
present
show
hemoglobinhaptoglobin
scaveng
receptor
use
marker
pvm
human
brain
mean
doubl
immunofluoresc
stain
normal
control
brain
tissu
section
sever
multipl
sclerosi
ms
lesion
stage
appear
pvm
express
dcsign
mhc
ii
sever
costimulatori
molecul
furthermor
observ
increas
number
dcsign
macrophag
well
express
dcsign
foami
macrophag
doubl
stain
suggest
pvm
necessari
tool
antigen
recognit
present
supposedli
play
role
antigenpres
cell
brain
studi
requir
establish
immun
regulatori
role
cell
exert
upon
antigen
recognit
multipl
sclerosi
ms
relapsingremit
natur
patient
period
diseas
recoveri
altern
impli
balanc
detriment
protect
mechan
cervic
lymph
node
cln
major
site
drainag
brain
shown
brainderiv
myelin
compon
present
antigen
present
cell
apc
within
cln
ms
hypothes
apc
play
import
role
regul
peripher
immun
system
ms
immunohistochemistri
reveal
apc
cervic
lymph
node
contain
myelin
compon
also
central
nervou
system
cn
compon
astrocyt
neuron
protein
immunohistochemistri
also
use
determin
immunophenotyp
cn
antigencontain
cell
mogcontain
cell
express
antiinflammatori
molecul
tgfbeta
express
proinflammatori
cytokin
tnfalpha
determin
antigenpres
capac
myelinladen
cell
vitro
monocytederiv
macrophag
puls
myelin
coincub
cell
mix
leukocyt
reaction
preliminari
data
demonstr
puls
macrophag
increas
cell
prolifer
addit
ifngamma
product
cell
parallel
cell
prolifer
suggest
enhanc
antigen
present
data
suggest
phagocyt
apc
cln
may
display
regulatori
function
peripheri
ms
accumul
evid
suggest
apart
clonal
delet
anergi
cell
mediat
control
selfreact
cell
contribut
mainten
natur
immunolog
selftoler
exampl
expans
cell
constitut
peripher
cell
rodent
human
prevent
autoimmun
suppress
activ
selfreact
cell
observ
dendrit
cell
dc
prime
cell
acquir
suppress
properti
context
gene
express
analysi
murin
model
autoimmun
reveal
function
role
glucocorticoidinduc
tnf
receptor
gitr
cell
recent
shown
human
forc
express
gene
encod
transcript
repressor
gene
convert
cell
suppressor
cell
preliminari
analysi
use
real
time
pcr
could
observ
signific
differ
gitr
mrna
express
level
ms
patient
healthi
donor
therefor
extend
studi
employ
gene
express
microarray
technolog
assess
gene
express
differ
cell
dc
multipl
sclerosi
ms
patient
young
healthi
donor
differenti
express
gene
key
cell
immunolog
toler
may
understand
molecular
pathogenesi
ms
provid
new
diseas
marker
brain
dendrit
cell
origin
matur
function
g
reichmann
mausberg
jander
schlqter
b
hg
fischer
heinrichheineunivers
germani
b
univers
mannheimheidelberg
germani
gener
accept
dc
lack
normal
brain
howev
dc
appear
intracerebr
site
inflammatori
condit
absenc
braindirect
cell
respons
cerebr
ischemia
dc
remain
immatur
wherea
pathogeninduc
neuroinflamm
brain
dc
function
matur
intracerebr
dc
matur
preced
histopatholog
evid
earli
induct
ex
vivo
allostimulatori
activ
contribut
microglia
intracerebr
dc
popul
delin
amyloidrel
phenotyp
brain
dc
exhibit
microglialik
morpholog
cell
express
dc
marker
parenchym
site
cellular
infiltr
lack
featur
microglia
share
immatur
dc
find
microglia
purifi
adult
brain
gener
function
dc
final
proof
microglia
constitut
portion
dc
popul
obtain
sort
donor
versu
hosttyp
dc
inflam
brain
bone
marrow
chimera
distinct
stage
microgliatodc
differenti
demonstr
vitro
gmcsf
drive
microglia
acquir
immatur
dclike
phenotyp
ligat
trigger
termin
activ
sinc
inflammatori
neural
environ
like
sourc
stimuli
microglia
must
regard
organotyp
reservoir
predc
antigen
present
brain
dc
situ
substanti
find
dc
brain
mice
toxoplasmosi
spontan
activ
pathogenspecif
cell
ex
vivo
object
studi
evalu
effect
simvastatin
microglia
immun
function
treat
primari
mous
human
microglia
simvastatin
evalu
membran
express
sever
immun
regulatori
molecul
fac
analysi
next
subject
simvastatin
treat
primari
human
microglia
chemotaxi
assay
toward
variou
chemokin
final
evalu
impact
simvastatin
treatment
subcellular
structur
human
microglia
cytoskeleton
stain
structur
electron
microscopi
show
simvastatin
abl
reduc
primari
microglia
express
mhc
class
ii
costimulatori
molecul
adhes
molecul
chemokin
receptor
addit
demonstr
simvastatin
reduc
capac
microglia
migrat
toward
chemokin
rant
final
show
simvastatin
treatment
result
alter
subcellular
structur
microglia
togeth
data
suggest
simvastatin
abl
reduc
capac
microglia
migrat
interact
environ
disturb
metabol
sever
import
membranebound
molecul
support
dutch
ms
research
foundat
grant
ms
inflamm
cn
usual
local
limit
avoid
otherwis
devast
consequ
critic
player
implic
process
microgli
cell
famili
ligand
receptor
recogn
pathway
regul
immun
respons
human
murin
microgli
cell
analyz
express
molecul
function
relev
express
moginduc
eae
investig
human
mous
microgli
cell
constitut
express
mrna
protein
inflammatori
condit
signific
upregul
mrna
cell
surfac
protein
notabl
microgli
express
level
protein
substanti
higher
compar
astrocyt
monocyt
cocultur
experi
differ
apc
cell
demonstr
function
consequ
express
product
inflammatori
cytokin
ifngamma
cell
markedli
enhanc
presenc
neutral
antibodi
effect
clearli
pronounc
microglia
cell
use
apc
compar
monocyt
astrocyt
highli
upregul
cours
moginduc
eae
vivo
express
predominantli
locat
area
inflamm
taken
togeth
data
point
microgli
import
immuneinhibitori
molecul
downregul
cell
activ
cn
would
contribut
regul
local
level
inflammatori
respons
regul
immunoproteasom
mhc
class
express
human
brain
endotheli
cell
h
lau
van
zwam
k
liu
k
dorovinizi
vancouv
gener
hospit
univers
british
columbia
vancouv
canada
proteasom
multisubunit
proteas
respons
breakdown
misfold
regulatori
protein
small
peptid
poss
anchor
site
mhc
class
molecul
mhc
complet
fold
mhc
ipeptid
complex
deliv
cell
surfac
present
cell
tc
recent
studi
suggest
proteasom
play
import
role
leukocyteendotheli
interact
inflammatori
cn
diseas
tc
subset
cross
bloodbrain
barrier
bbb
initi
immun
respons
mechan
present
poorli
defin
studi
regul
proteasom
express
role
mhc
express
hbmec
investig
vitro
bbb
model
mrna
protein
express
constitut
subunit
induc
subunit
hbemc
investig
rtpcr
elisa
mhc
express
elisa
unstimul
hbmec
express
low
level
subunit
subunit
upregul
follow
treatment
ifngamma
uml
tnfalpha
uml
mhc
express
hbmec
significantli
upregul
treatment
ifngamma
h
downregul
proteasom
inhibitor
lactacystin
result
indic
cytokineinduc
upregul
immunoproteasom
subunit
requir
mhc
upregul
hbmec
suggest
proteasom
may
influenc
antigen
process
present
bbb
cn
inflamm
peptid
motif
rat
mhc
class
ii
molecul
h
duyar
j
dengjel
kl
de
graaf
stevanov
r
weissert
univers
germani
moginduc
eae
da
rat
model
multipl
sclerosi
ms
reproduc
major
aspect
detriment
diseas
far
mhc
class
ii
peptid
bind
motif
da
rat
molecul
describ
interest
obtain
peptid
bind
motif
allow
subsequ
function
studi
rat
model
autoimmun
infecti
diseas
sequenc
align
betachain
rat
mhc
class
ii
molecul
human
hla
class
ii
molecul
reveal
strong
similar
residu
peptid
bind
groov
accord
put
peptid
bind
pocket
comparison
pocket
predict
peptid
motif
verifi
predict
motif
natur
process
peptid
elut
acid
treatment
immunoaffinitypurifi
molecul
lymphoid
tissu
mog
immun
da
rat
subsequ
analyz
esi
tandem
mass
spectrometri
identifi
peptid
align
peptid
bind
pocket
accord
put
peptid
motif
addit
perform
bind
studi
nonamer
combinatori
peptid
librari
purifi
molecul
base
studi
could
defin
peptid
bind
motif
peptid
motif
allow
epitop
predict
analysi
peptid
relev
autoimmun
diseas
search
autoimmun
cell
type
thymoma
kadota
jone
b
meager
c
n
willcox
neurosci
wimm
b
cellular
scienc
univers
oxford
oxford
uk
c
nation
institut
biolog
standard
control
london
uk
thymoma
neoplasm
thymic
epitheli
cell
tec
often
gener
abund
develop
thymocyt
around
thymoma
patient
develop
myasthenia
gravi
mg
antibodi
muscl
acetylcholin
receptor
antiachr
recent
also
found
high
titr
neutralis
autoantibodi
interferonalpha
ifnalpha
thymoma
patient
diagnosi
regardless
histolog
hlatyp
titr
increas
sharpli
thymoma
recur
unlik
achr
cultur
thymoma
cell
spontan
produc
antiifnalpha
antiachr
suggest
direct
autoimmun
ifnalpha
tumour
identifi
autoimmun
cell
label
paraffin
section
mg
patient
thymoma
typeab
typea
antiifnalpha
titr
high
medium
lowneg
ifnalpha
express
appear
strong
mostli
high
serum
antiifnalpha
intermedi
low
neg
ifnalpha
cell
appear
larg
dendrit
morpholog
consist
posit
neg
cytokeratin
convers
cell
also
seen
thymoma
weakneg
ifnalpha
label
ifnalpha
cell
also
hladrint
current
label
costimulatori
molecul
conclus
obviou
autoimmun
cell
appear
ifnalpha
macrophag
rather
tec
unusu
dendrit
subset
exclud
object
investig
express
role
novel
famili
member
icosl
cultur
muscl
cell
inflammatori
myopathi
method
express
regul
icosl
analyz
cultur
myoblast
muscl
biopsi
specimen
qrtpcr
flow
cytometri
immunohistochemistri
function
relev
investig
cocultur
experi
myoblast
cell
result
cultur
human
muscl
cell
constitut
express
icosl
stimul
ifngamma
strongli
upregul
express
cocultur
experi
mhcclass
iiiposit
myoblast
cell
presenc
antigen
demonstr
function
consequ
musclerel
icosl
express
wherea
icosl
provid
stimul
cell
strong
inhibitor
cell
cytokin
product
activ
muscl
fiber
show
constitut
express
icosl
vivo
importantli
molecul
upregul
specimen
patient
polymyos
dermatomyos
inclus
bodi
myositi
predominantli
locat
area
strongest
inflamm
conclus
cultur
muscl
cell
muscl
fiber
vivo
express
icosl
wherea
icosl
provid
augmentatori
signal
muscl
immun
cell
interact
induc
express
immun
inhibitori
molecul
provid
evid
capabl
muscl
promot
immunoprotect
mechan
put
involv
regul
local
inflamm
recent
discov
induc
costimul
ico
like
molecul
interact
like
ligand
icosl
antigenpres
cell
apc
express
preferenti
activ
cell
recent
data
indic
ico
icosl
repres
import
pathway
regul
autoimmun
infecti
diseas
defin
express
ico
icosl
inflammatori
demyelin
pn
studi
express
distribut
pattern
sural
nerv
biopsi
patient
syndrom
gb
chronic
inflammatori
demyelin
polyradiculoneuropathi
cidp
comparison
variou
noninflammatori
neuropathi
nin
rtpcr
immunohistochemistri
patient
diagnos
gb
cidp
nin
signific
upregul
ico
mrna
found
cell
identifi
primari
cellular
sourc
express
ico
inflam
pn
thu
corrobor
state
activ
similarli
significantli
increas
mrna
express
level
ligand
icosl
found
gb
cidp
sampl
nin
control
macrophag
deciph
cellular
sourc
icosl
within
endoneurium
schwann
cell
neg
icosl
data
show
ico
ligand
icosl
express
immunemedi
peripher
neuropathi
might
play
import
role
augment
cellular
immun
respons
inflammatori
peripher
nerv
disord
surfac
unit
msrv
envelop
protein
activ
innat
immun
receptor
promot
like
respons
rolland
e
jouvinmarch
c
viret
h
perron
b
pn
march
ceainserm
grenobl
franc
b
biomerieux
marci
franc
multipl
sclerosi
ms
proinflammatori
autoimmun
diseas
caus
lesion
white
matter
central
nervou
system
cn
etiolog
understood
appear
involv
genet
environment
factor
includ
viral
infect
msrv
retrovir
element
previous
isol
cell
cultur
ms
patient
bear
proinflammatori
properti
character
induct
proinflammatori
cytokin
human
pbmc
cultur
increasingli
clear
pattern
recognit
receptor
primari
import
innat
immun
respons
viral
compon
initi
inflamm
toll
like
receptor
two
member
receptor
group
abil
sens
microbi
product
bacteria
virus
report
surfac
unit
msrv
envelop
protein
envsu
specif
induc
human
monocyt
produc
major
proinflammatori
cytokin
depend
mechan
envsu
also
induc
dendrit
cell
matur
confer
capac
support
helper
type
cell
differenti
thu
appear
msrv
proinflammatori
properti
surfac
envelop
protein
could
constitut
upstream
event
immunopatholog
cascad
lead
autoimmun
andor
neuroinflamm
diseas
ms
encephalitogen
benefici
role
amyloid
betaspecif
cell
alzheim
diseas
monsonego
v
zota
petrov
j
imitola
owen
b
selko
hl
weiner
harvard
institut
medicin
brigham
women
hospit
center
neurolog
diseas
boston
usa
b
montreal
neurolog
institut
montreal
canada
amyloid
beta
ab
vaccin
patient
alzheim
diseas
ad
result
enceph
observ
patient
recent
shown
significantli
higher
portion
healthi
elderli
ad
subject
strong
abreact
tcell
respons
occur
middleag
adult
strongli
depend
certain
hladr
class
ii
allel
examin
mous
model
ad
whether
abspecif
cell
migrat
site
ab
plaqu
affect
diseas
pathogen
show
singl
immun
domin
ab
tcell
epitop
induc
agedepend
transient
meningoenceph
ifngamma
express
cn
immun
infiltr
target
site
ab
plaqu
brain
associ
enhanc
microglia
activ
clearanc
ab
overal
demonstr
accumul
ab
cn
mhc
genet
background
inflammatori
signal
ifngamma
requir
induc
abspecif
tcell
respons
brain
apptg
mice
similar
observ
abvaccin
patient
ad
tcell
respons
cn
ab
depend
local
milieu
may
benefici
detriment
depend
type
tcell
respons
wide
accept
cytotox
cell
play
domin
role
viral
enceph
aim
studi
determin
role
variou
cytotox
pathway
use
cell
acut
chronic
viral
enceph
investig
distribut
cell
viru
infect
brain
pattern
activ
cytotox
mechan
induct
cell
death
target
cell
use
immunohistochem
confoc
fluoresc
doubl
label
techniqu
formalinfix
paraffin
embed
section
select
viral
enceph
brain
cytomegaloviru
enceph
cmv
tick
born
enceph
tbe
subacut
scleros
panenceph
sspe
result
show
predomin
cell
inflammatori
infiltr
enceph
case
cmv
case
percentag
grb
cell
remain
high
studi
cours
diseas
week
wherea
tbe
found
gradual
decreas
percentag
grb
cell
diseas
cours
week
preliminari
studi
perform
confoc
laser
scan
microscop
reveal
close
contact
cell
cmv
infect
astrocyt
tbe
sspe
also
found
close
apposit
grb
cell
neuron
earli
cours
diseas
result
indic
especi
earli
stage
diseas
grbmediat
cytotox
import
viral
enceph
work
support
grant
austrian
fwf
autoimmun
respons
axon
protein
experiment
autoimmun
encephalomyel
eae
hg
huizinga
jagessa
p
smith
n
heijman
amor
biomed
primat
research
centr
rijswijk
netherland
object
axon
patholog
play
import
role
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
mechan
axon
degener
howev
yet
known
hypothesis
immun
respons
axon
protein
contribut
axon
patholog
eae
therefor
investig
whether
autoimmun
respons
axon
protein
develop
eae
correl
clinic
diseas
addit
studi
encephalitogen
potenti
neuron
antigen
deriv
newborn
spinal
cord
myelin
start
method
biozzi
abh
mice
immunis
newborn
adult
spinal
cord
homogen
sch
tcell
antibodi
respons
neurofila
heavi
light
measur
variou
stage
diseas
cervic
lymph
node
isol
studi
present
neuron
antigen
result
tcell
antibodi
respons
neurofila
light
heavi
observ
adult
schinduc
eae
antibodi
level
howev
correl
necessarili
diseas
stage
sever
neurofila
stain
observ
cervic
lymph
node
mice
eae
indic
neuron
antigen
present
lymph
node
although
newborn
schimmunis
induc
tcell
antibodi
respons
sch
neurofila
anim
develop
eae
conclus
data
indic
tcell
antibodi
respons
neurofila
develop
chronic
relaps
eae
mice
howev
neuron
antigen
newborn
sch
encephalitogen
mice
relev
find
discuss
inflamm
play
import
role
pathophysiolog
ischem
stroke
mucos
administ
myelin
oligodendrocyt
glycoprotein
mog
peptid
mice
prior
middl
cerebr
arteri
occlus
mcao
induc
antiinflammatori
tcell
respons
direct
cn
myelin
found
nasal
oral
administr
mog
peptid
decreas
ischem
infarct
size
h
mcao
surgeri
nasal
mog
peptid
efficaci
reduc
ischem
infarct
size
h
h
vs
control
well
improv
behavior
score
immunohistochemistri
demonstr
increas
reduc
ifngamma
area
surround
ischem
infarct
follow
nasal
treatment
nasal
mog
reduc
ischem
infarct
size
defici
mice
adopt
transfer
tcell
nasal
toler
mice
untreat
mice
prior
mcao
surgeri
significantli
decreas
stroke
size
vs
control
wherea
tcell
nasal
toler
defici
mice
effect
furthermor
result
demonstr
secret
cell
induc
nasal
mog
reduc
ischem
injuri
follow
stroke
modul
cerebr
inflamm
mucos
toler
myelin
antigen
may
improv
outcom
stroke
enhanc
mechan
selfrecoveri
helper
cell
type
stimul
axon
outgrowth
attract
cortic
axon
sallach
c
brandt
lqdeck
schwanzar
e
kwidzinski
b
heimrich
r
nitsch
univers
hospit
berlin
germani
mechan
lesion
nervou
system
activ
cell
suggest
exert
neuroprotect
effect
howev
structur
basi
effect
clear
stimul
axon
outgrowth
cell
might
key
mechan
regener
therefor
investig
effect
activ
helper
cell
type
type
neuron
outgrowth
murin
organotyp
brain
explant
vitro
cell
explant
cocultur
cell
stimul
axon
outgrowth
attract
axon
cortic
explant
significantli
sinc
helper
cell
subtyp
might
exert
neuroregen
effect
secret
neurotrophin
analyz
neurotrophin
express
pattern
use
rtpcr
elisa
compar
express
pattern
nerv
growth
factor
ngf
brainderiv
neurotroph
factor
bdnf
well
interferongamma
ifngamma
transform
growth
factorbeta
tgfbeta
cell
subtyp
express
mrna
investig
factor
except
ifngamma
mrna
express
limit
cell
protein
level
cell
secret
significantli
higher
level
ngf
compar
cell
applic
function
inhibit
antibodi
ngf
substanti
reduc
axon
outgrowth
cellexpl
cocultur
data
suggest
one
import
structur
element
bprotect
autoimmunityq
stimul
neurotrophindepend
axon
outgrowth
cell
etiolog
neurodegen
disord
present
unknown
although
small
percentag
disord
famili
case
link
specif
genet
defect
idiopath
thu
environment
factor
thought
play
import
role
onset
progress
disord
determin
effect
exposur
h
day
per
week
week
concentr
airborn
particul
matter
brain
inflammatori
indic
cortic
tissu
balbc
mice
anim
divid
three
exposur
group
filter
air
control
ultrafin
particl
fine
ultrafin
particl
level
proinflammatori
cytokin
alpha
tumor
necrosi
factor
alpha
tnfalpha
increas
cortic
tissu
mice
expos
particul
matter
compar
control
mice
level
immunerel
transcript
factor
nfkb
also
found
substanti
elev
brain
expos
group
compar
control
group
data
indic
compon
inhal
particul
matter
may
trigger
proinflammatori
respons
nervou
tissu
sinc
inflammatori
event
may
contribut
pathogenesi
neurodegen
disord
result
suggest
environment
exposur
particul
matter
may
enhanc
pathogen
process
within
nervou
tissu
induct
antiphospholipid
syndrom
exacerb
amyloid
plaqu
deposit
well
memori
impair
anim
model
alzheim
diseas
katzav
cg
pick
shoenfeld
j
chapman
tel
aviv
univers
tel
aviv
israel
immun
inflammatori
mechan
may
involv
pathogenesi
neurodegen
diseas
immun
mediat
diseas
central
nervou
system
lead
eventu
neurodegener
antiphospholipid
syndrom
ap
associ
dementia
induc
experiment
mice
immun
autoantigen
investig
effect
ap
induct
cours
neurodegener
anim
model
alzheim
diseas
transgen
mice
pathogen
betaapp
mutat
immun
age
month
later
test
hyperact
staircas
apparatu
cognit
function
swim
tmaze
altern
test
brain
examin
matur
plaqu
format
signific
differ
behavior
app
transgen
mice
compar
control
test
total
hamyloid
stain
induct
ap
significantli
reduc
hyperact
app
mice
cognit
impair
matur
plaqu
found
appap
mice
induct
ap
result
rapid
onset
amyloid
deposit
cognit
impair
betaapp
mice
similar
mechan
may
involv
patient
ap
dementia
lp
receptor
link
alzheim
diseas
innat
immun
k
fassbend
univers
germani
pathophysiolog
hallmark
alzheim
diseas
ad
chronic
neuroinflamm
appear
contribut
progress
neuron
injuri
ad
lipopolysaccharid
receptor
key
cellular
receptor
compon
gramneg
microorgan
coimmunoprecipit
experi
studi
defici
microglia
monocyt
demonstr
recogn
alzheim
amyloid
peptid
therebi
mediat
microgli
monocyt
activ
releas
neurotoxin
show
express
increas
brain
ad
patient
correl
senil
plaqu
suggest
clinic
relev
receptor
ad
thu
mediat
microgli
activ
amyloid
peptid
may
explain
chronic
neuroinflamm
subsequ
neurodegener
ad
hypothes
structur
mimicri
amyloid
fibril
microbi
compon
may
underli
mechan
chronic
neuroinflamm
mediat
ligat
lipopolysaccharid
receptor
may
thu
repres
novel
therapeut
target
prevent
progress
ad
axon
injuri
onset
murin
experiment
autoimmun
encephalomyel
eae
role
astrocyt
wang
ayer
b
catmul
l
hazelwood
c
bernard
j
orian
la
trobe
univers
melbourn
australia
b
univers
melbourn
melbourn
australia
recent
data
chang
view
multipl
sclerosi
ms
primari
inflammatori
demyelin
diseas
one
cumul
axon
damag
drive
diseas
progress
concurr
studi
axonglia
gliaglia
commun
emphas
import
interact
central
nervou
system
cell
perspect
studi
axon
damag
context
inflamm
glial
respons
preclin
stage
murin
eae
establish
ms
model
report
sever
major
find
provid
evid
axon
injuri
signific
parenchym
tcell
entri
demonstr
associ
axon
injuri
astrocyt
respons
presymptomat
stage
differ
astrocyt
respons
two
form
diseas
data
clearli
show
mechan
addit
mediat
cell
oper
earli
stage
strongli
implic
astrocyt
diseas
initi
common
data
grow
number
neurodegen
condit
show
murin
eae
character
earli
activ
contribut
astrocyt
observ
mark
chang
understand
role
astrocyt
diseas
pathogenesi
import
implic
develop
neuroprotect
strategi
neurodegener
inflamm
fundament
aspect
mani
neurolog
diseas
numer
molecular
pathway
regul
process
identifi
recent
year
knowledg
aspect
neurodegener
cn
inflamm
regul
genom
level
still
limit
current
dissect
featur
use
standard
nerv
trauma
model
adult
rat
ventral
root
avuls
vra
combin
experiment
genet
protocol
unravel
genet
influenc
intercross
da
pvg
rat
four
quantit
trait
loci
qtl
control
nerv
cell
death
express
mhc
class
ii
microglia
andor
cell
infiltr
vra
identifi
find
extend
advanc
intercross
line
reproduc
qtl
regul
mhc
class
ii
neurodegener
fine
map
genom
region
current
perform
gener
ail
parallel
congen
strain
bred
allow
mechanist
studi
model
preliminari
experi
perform
founder
strain
reproduc
consider
phenotyp
differ
also
experiment
spinal
cord
cortic
contus
injuri
demonstr
polymorph
gene
differ
loci
control
neurodegener
cn
inflamm
implic
variou
experiment
rodent
nervou
system
paradigm
approach
may
lead
identif
evolutionari
conserv
genet
polymorph
key
control
gene
serv
prime
candid
associ
studi
sever
human
cn
diseas
multipl
sclerosi
chronic
inflammatori
diseas
cn
lead
focal
destruct
myelin
still
earliest
chang
lead
lesion
format
known
studi
geneexpress
pattern
sampl
normalappear
white
matter
postmortem
ms
brain
microarray
analysi
reveal
upregul
gene
involv
mainten
cellular
homeostasi
neural
protect
mechan
known
induc
upon
ischem
precondit
best
illustr
upregul
transcript
factor
associ
signal
pathway
well
upregul
target
gene
vegf
receptor
addit
gener
neuroprotect
reaction
oxid
stress
suggest
molecular
chang
might
reflect
adapt
cell
chronic
progress
pathophysiolog
ms
altern
might
also
indic
activ
neural
protect
mechan
allow
preserv
cellular
function
properti
cn
data
introduc
novel
concept
molecular
pathogenesi
ms
ischem
precondit
major
mechan
neuroprotect
increas
understand
underli
mechan
may
lead
develop
new
specif
treatment
protect
resid
cell
thu
minim
progress
oligodendrocyt
axon
loss
heavi
metal
free
radic
relat
ms
pathogenesi
serum
level
element
compar
within
coupl
diseas
discord
monozygot
twin
develop
reliabl
method
simultan
quantif
al
ba
bi
ca
cd
co
cr
cu
fe
hg
li
mg
mn
mo
ni
pb
sb
si
sn
sr
tl
v
w
zn
zr
use
sector
field
induct
coupl
plasma
mass
spectrometri
sficpm
icp
atom
emiss
spectrometri
icpa
carri
similar
comparison
photometr
assay
serum
oxid
statu
so
serum
antioxid
capac
sac
signific
differ
emergedat
nonparametr
testfor
element
studi
well
paramet
relat
oxid
stress
except
mg
median
valu
patient
ngml
control
affect
twin
observ
decreas
trend
al
co
sr
especi
case
co
median
vs
ngml
tendenc
higher
concentr
zn
median
vs
ngml
vs
ngml
result
larger
seri
patient
present
role
plasminogen
activ
experiment
allerg
encephalomyel
inflamm
axon
patholog
e
east
baker
g
pryce
ml
cuzner
gveric
institut
neurolog
univers
colleg
london
london
uk
entri
fibrin
normal
exclud
cn
upregul
urokinas
plasminogen
activ
pa
receptor
upar
pa
one
earliest
sign
inflammatori
demyelin
concentr
tissu
pa
tpa
key
fibrinolyt
enzym
decreas
cn
due
higher
amount
inhibitor
thu
ensur
fibrin
enter
cn
effici
remov
addit
proteolyt
activ
upa
upar
involv
migrat
adhes
inflammatori
cell
role
tpa
upar
investig
eae
use
knockout
mice
wild
type
mice
experienc
acut
diseas
last
day
howev
anim
incur
signific
degre
neurolog
deficit
contrast
mice
prolong
acut
phase
diseas
peak
significantli
delay
accompani
decreas
leucocyt
infiltr
loss
neurofila
indic
axon
integr
observ
earli
group
mice
indic
axon
loss
earli
featur
eae
multipl
sclerosi
high
level
cn
fibrin
persist
anim
acut
chronic
phase
diseas
deposit
fibrin
could
localis
damag
axon
conclus
data
enforc
concept
involv
pa
system
neuroinflamm
neuroinflammatori
condit
may
disrupt
normal
function
adrenomedullin
adm
bloodbrain
barrier
bbb
e
liverani
wood
c
bolton
b
c
paul
univers
west
england
bristol
uk
b
william
harvey
research
institut
london
uk
adm
appear
intim
involv
mainten
bbb
function
vitro
studi
clearli
shown
adm
capabl
regul
key
featur
bbb
includ
transendotheli
electr
resist
teer
permeabl
pglycoprotein
pump
activ
bbb
form
highli
select
barrier
peripher
circul
central
nervou
system
part
control
glucocorticoid
loss
normal
bbb
integr
integr
featur
neuroinflammatori
process
multipl
sclerosi
ms
neurovascular
function
intim
link
glutamatemedi
event
shown
restor
normal
bbb
permeabl
associ
improv
clinic
outcom
model
ms
examin
effect
glutam
glucocorticoid
adm
function
vitro
use
human
endotheli
cell
rat
astroglioma
cell
alon
cocultur
preliminari
immunocytochemistri
studi
indic
receptoract
modifi
normal
express
cell
howev
exposur
mm
glutam
express
significantli
reduc
addit
teer
measur
cocultur
bbb
model
significantli
elev
presenc
coadminist
adm
dexamethason
compar
control
valu
data
suggest
glutam
affect
endotheli
express
adm
receptor
protein
furthermor
result
indic
steroid
compound
influenc
adm
control
neuroendotheli
permeabl
role
inflamm
central
nervou
system
cn
damag
repair
controversi
inflamm
consid
major
caus
neurodegener
cn
disord
contrast
autoreact
immun
respons
induc
injuri
found
part
physiolog
repair
mechan
thu
control
boost
protect
immun
propos
mean
attenu
neurodegener
facilit
heal
implant
educ
macrophag
produc
monocyt
coincub
peripher
tissu
skin
sciatic
nerv
central
tissu
optic
nerv
shown
improv
function
recoveri
follow
optic
nerv
spinal
cord
injuri
rat
sinc
incub
condit
influenc
activ
result
macrophag
skincoincub
macrophag
character
compar
macrophag
activ
lipopolysaccharid
bclassic
activationq
baltern
activationq
incub
cell
analyz
morpholog
characterist
express
membran
marker
cytokin
secret
activ
skin
lipopolysaccharid
increas
significantli
number
size
cytoplasm
granul
secret
proinflammatori
cytokin
contrast
opposit
effect
lipopolysaccharid
activ
induc
secret
tumor
necrosi
factor
alpha
well
elev
express
costimulatori
molecul
secret
unaffect
activ
skincoincub
macrophag
thu
repres
uniqu
cellular
phenotyp
distinct
bclassic
q
balternativelyactivatedq
macrophag
propos
phenotyp
promot
immun
respons
support
neuron
cell
surviv
repair
result
function
recoveri
effect
inflammatori
mediat
axon
transport
synapt
vesicl
protein
stagi
n
frank
h
neumann
european
neurosci
institut
germani
axon
transport
disturb
earli
sign
inflammatori
brain
diseas
molecular
mechan
dysfunct
remain
elus
activ
microgli
cell
found
close
proxim
dystroph
neurit
releas
nitric
oxid
inflammatori
cytokin
tumor
necrosi
factoralpha
tnfalpha
confoc
microscopi
fluoresc
recoveri
photobleach
frap
perform
analyz
axon
transport
synapt
vesicl
precursor
protein
synaptophysin
tag
green
fluoresc
protein
synaptophysinegfp
transfect
cultur
hippocamp
neuron
microglia
prestimul
inflammatori
cytokin
produc
tnfalpha
focal
suppress
axon
motil
synaptophysinegfp
contact
point
direct
applic
tnfalpha
shortterm
donor
cultur
hippocamp
neuron
inhibit
axon
motil
synaptophysinegfp
within
min
inhibit
axon
transport
inflammatori
mediat
significantli
increas
immobil
fraction
synaptophysinegfp
depend
phosphoryl
cjun
nh
termin
kinas
jnk
particular
tnfalpha
stimul
phosphoryl
jnk
axon
reduc
motil
synaptophysinegfp
tnfalpha
treatment
depend
phosphoryl
jnk
determin
jnk
inhibitor
thu
overt
product
tnfalpha
reactiv
activ
microgli
cell
block
motil
synapt
vesicl
precursor
via
phosphoryl
jnk
may
caus
axon
synapt
dysfunct
inflammatori
degen
brain
diseas
amyotroph
later
sclerosi
al
lateonset
neurodegener
diseas
involv
upper
lower
motor
neuron
although
microglia
activ
promin
featur
al
mechan
microglia
contribut
motor
neuron
degener
remain
unknown
supernat
deriv
lpsactiv
microgli
cell
induc
death
motor
neuron
hybridoma
cell
line
cell
tnf
alpha
depend
pathway
studi
use
cdna
superarray
real
time
pcr
observ
signific
increas
mrna
level
tnf
receptor
superfamili
includ
death
ligand
ltbeta
follow
exposur
cell
lpsactiv
supernat
presenc
cycloheximid
lpsactiv
supernat
induc
apoptosi
caspas
activ
parp
cleavag
caspas
activ
suggest
role
mitochondria
microglialmedi
apoptosi
order
determin
whether
due
tnf
alpha
recombin
murin
tnf
alpha
appli
cell
presenc
cycloheximid
result
ident
obtain
lpsactiv
supernat
find
suggest
lp
activ
microgli
supernat
induc
motor
neuron
cell
apoptosi
mitochondriadepend
signal
pathway
tnf
alpha
major
contributor
process
research
support
scottish
rite
charit
foundat
canada
glutam
stimul
peroxynitrit
product
brainderiv
endotheli
cell
line
via
nmethyldaspart
nmda
receptor
activ
sr
bowman
gs
scott
c
bolton
william
harvey
research
institut
london
uk
compel
evid
indic
role
glutam
pathogenesi
multipl
sclerosi
ms
studi
experiment
allerg
encephalomyel
eae
model
ms
demonstr
pharmacolog
inhibit
specif
glutam
receptor
suppress
symptom
prevent
bloodbrain
barrier
bbb
breakdown
mechan
glutam
influenc
bbb
function
diseas
remain
undefin
glutam
known
trigger
product
nitric
oxid
superoxid
lead
format
peroxynitrit
recent
studi
implic
peroxynitrit
loss
neurovascular
integr
eae
propos
glutam
contribut
bbb
breakdown
action
peroxynitrit
current
studi
aim
determin
whether
glutam
induc
peroxynitrit
format
brainderiv
endotheli
cell
line
cell
incub
glutam
mm
h
product
peroxynitrit
assess
quantit
oxid
dihydrorhodamin
result
show
concentrationand
timedepend
increas
peroxynitrit
level
glutamatetr
cell
furthermor
glutamateinduc
chang
suppress
peroxynitrit
decomposit
catalyst
fetpp
inhibitor
uric
acid
addit
glutamatemedi
gener
peroxynitrit
cell
reduc
nmda
receptor
antagonist
studi
reconfirm
import
glutam
loss
neuroendotheli
integr
highlight
deleteri
effect
molecul
action
peroxynitrit
nmda
receptor
activ
development
morpholog
chang
found
cerebellar
cortex
singl
inject
cytostat
drug
cisplatin
agg
bw
rat
one
day
treatment
extern
granular
layer
vermi
show
sever
apoptot
cell
recoveri
prolifer
activ
ectop
granul
cell
found
lobul
viviii
respect
purkinj
cell
slow
differenti
end
histogenesi
changedreori
dendrit
branch
calbindin
immunoreact
howev
degener
purkinj
cell
also
describ
scherini
bernocchi
autofluoresc
depend
natur
amount
distribut
endogen
fluorophor
optic
properti
provid
inform
structur
metabol
activ
biolog
tissu
autofluoresc
potenti
diagnosi
cerebellum
structur
chang
develop
investig
pattern
profil
analys
nonlinear
regress
estim
depth
tissu
involv
mm
signal
incid
light
neocerebellar
lobul
viviii
mm
control
rat
day
mm
correspond
treat
rat
paleocerebellum
show
neither
structur
alter
depth
valu
chang
microspectrofluorometri
spectral
fit
analysi
indic
increas
oxidis
state
result
show
great
influenc
structur
organ
thu
optic
properti
autofluoresc
emiss
addit
biochem
composit
research
grant
cofin
gb
miuritali
junction
tubulin
na
katpas
calf
brain
stem
neuron
nm
vladimirova
en
sautkina
tv
ovchinnikova
na
potapenko
shemyakinovchinnikov
institut
bioorgan
chemistri
russian
academi
scienc
moscow
russia
function
na
katpas
brain
poorli
studi
least
understood
shown
brain
addit
convent
function
na
katpas
involv
intercellular
interact
neuron
glial
cell
bind
cytoskeleton
protein
brain
cell
known
isoform
na
katpas
subunit
express
goal
studi
isol
structur
character
search
structur
peculiar
isozym
na
katpas
realli
function
variou
brain
cell
glial
cell
shown
contain
mainli
na
katpas
type
minor
amount
isozym
type
axolemma
contain
isozym
enhanc
sensit
catalyt
subunit
na
katpas
neuron
endogen
proteolysi
found
presenc
cytoskeleton
protein
tubulin
isoform
highmolecularweight
complex
na
katpas
isozym
brain
stem
axolemma
junction
na
katpas
subunit
tubulin
subunit
shown
first
time
note
dysfunct
na
katpas
lead
set
neurodegen
diseas
enzym
trigger
apoptot
way
neuron
find
connect
na
katpas
cytoskeleton
protein
may
lead
discoveri
novel
function
sodium
pump
brain
understand
reason
diseas
inflammatori
respons
contribut
evolut
brain
ischemia
reperfus
injuri
studi
effect
helperdepend
adenovir
vector
ad
engin
antiinflammatori
cytokin
interleukin
il
gene
green
fluoresc
protein
gfp
report
gene
model
transient
focal
ischemia
mice
ischemia
induc
mice
occlus
middl
cerebr
arteri
mca
use
nylon
monofila
introduc
intern
carotid
arteri
advanc
block
origin
mca
end
min
ischemia
filament
remov
reperfus
allow
vector
express
report
gene
alon
adgfp
infus
intracerebroventricularli
dose
al
end
ischem
period
five
day
later
gener
focal
neurolog
deficit
significantli
improv
mice
receiv
gene
compar
receiv
control
vector
mice
treat
also
significantli
reduc
infarct
volum
adgfp
mm
mm
thu
gene
deliveri
use
ad
vector
induc
protect
ischemiareperfus
injuri
identif
signal
pathway
associ
rat
straindepend
suscept
nerv
injuri
microarraybas
express
profil
swanberg
k
duvefelt
j
hillert
olsson
f
piehl
lidman
karolinska
institut
stockholm
sweden
axon
damag
common
featur
mani
neurolog
diseas
although
certain
regul
retrograd
axotomi
reaction
identifi
inform
regul
process
global
genomewid
transcript
level
limit
known
extent
genet
background
influenc
respons
global
gene
express
pattern
examin
ventral
root
avuls
vra
wellcharacter
model
nerv
injuryinduc
neurodegener
inflamm
two
inbr
rat
strain
gene
express
analys
affymetrix
array
spinal
cord
tissu
sampl
narv
da
pvg
rat
day
vra
regul
shown
strain
studi
transcript
transcript
significantli
differ
strain
one
studi
time
point
da
rat
display
higher
degre
neuron
loss
intens
glial
activ
pvg
strain
associ
higher
level
sever
mrna
code
protein
known
involv
inflammatori
reaction
princip
compon
analysi
reveal
segreg
strain
almost
magnitud
narv
injur
rat
result
suggest
common
vra
respons
pattern
significantli
modifi
genet
background
underscor
import
strict
control
genet
background
experiment
design
agerel
respons
brain
cell
proinflammatori
cytokin
mous
bentivoglio
sadki
xh
deng
univers
verona
verona
itali
neurolog
diseas
show
well
known
agedepend
preval
eg
multipl
sclerosi
prevail
young
middl
age
neurodegen
diseas
increas
age
indic
respons
inflammatori
neuron
deathinduc
process
vari
cn
lifetim
recent
evid
also
indic
age
character
lowgrad
chronic
inflammatori
activ
increas
product
proinflammatori
cytokin
basi
investig
brain
respons
inflammatori
challeng
intracerebroventricular
icv
stereotax
inject
mixtur
recombin
interferongamma
tumor
necrosi
factoralpha
made
young
month
old
month
mice
salin
inject
control
examin
neuron
activ
use
fo
marker
express
antiapoptot
protein
glial
respons
immunocytochemistri
cytokin
inject
result
fo
induct
neuron
sever
brain
site
piriform
cortex
midlin
thalamu
hypothalam
structur
includ
suprachiasmat
nucleu
play
role
biolog
clock
site
fo
induct
even
robust
icv
cytokin
inject
old
mice
young
one
subregion
differ
cytokin
treatment
mark
activ
astrocyt
microglia
induct
neuron
glial
cell
seen
age
group
agerel
differ
data
point
brain
cell
respons
inflammatori
challeng
agedepend
involv
gene
express
differ
cell
type
support
ec
grant
qlrt
advanc
glycat
glycooxid
condition
loss
neuroprotect
growth
factor
increas
product
neurotox
cytokin
alzheim
diseas
fioravanti
lapolla
b
sb
solert
depart
intern
medicin
geriatr
univers
pavia
pavia
itali
b
depart
metabol
scienc
metabol
univers
padova
padova
itali
advanc
glycat
end
product
age
glycooxid
mechan
could
induc
proinflammatori
burst
cytokin
immun
microgli
cell
loss
neuroprotect
within
context
age
pentosidin
studi
subject
alzheim
diseas
ad
also
measur
tnfalpha
ifngamma
vascular
endotheli
growth
factor
vegf
releas
supern
natur
killer
nk
cell
cytokin
vegf
evalu
exposur
lp
agml
betaamyloid
abeta
agml
lpsabeta
coincub
glycat
human
serum
albumin
ghsa
agml
tnfalpha
ifngamma
also
determin
ghsa
agml
age
pentosidin
significantli
increas
ad
healthi
subject
agml
pmolml
vs
agml
pmoml
respect
signific
dose
respons
increas
tnfalpha
ifngamma
demonstr
ad
ghsa
moreov
ghsa
amplifi
overproduct
cytokin
lp
abeta
final
signific
reduct
vegf
found
ad
subject
compar
healthi
subject
coincub
nk
cell
ghsa
determin
reduct
vegf
summari
advanc
glycat
glycooxid
significantli
enhanc
ad
mechan
could
condition
overexpress
neurotox
cytokin
also
induc
impair
neuroprotect
induc
vegf
innat
immun
receptor
play
key
role
alzheim
diseas
walter
univers
gfttingen
germani
pathophysiolog
hallmark
alzheim
diseas
chronic
microgli
activ
consid
contribut
progress
neuron
injuri
releas
neurotox
product
tolllikereceptor
local
surfac
microglia
recent
shown
play
key
role
innat
immun
respons
show
studi
murin
mutant
microglia
periton
macrophag
human
monocyt
crucial
microgli
monocyt
activ
contribut
microgli
toxic
neuron
investig
cell
demonstr
interact
defin
trimolecular
receptor
complex
consist
necessari
full
cellular
respons
amyloid
peptid
fibril
suggest
clinic
relev
ad
patholog
vivo
observ
express
upregul
app
transgen
mice
anim
model
ad
close
associ
microglia
togeth
observ
provid
first
evid
role
key
innat
immun
receptor
neuroinflamm
ad
pathophysiolog
new
potenti
therapeut
target
ad
oxid
stress
rat
brain
induc
amyloidbeta
continu
light
condit
rosalescorr
g
ortiz
instituto
mexicano
del
seguro
social
imss
guadalajara
jalisco
mexico
brain
especi
sensit
oxid
damag
hand
chief
secretori
product
pineal
gland
melatonin
may
reduc
tissu
destruct
inflammatori
respons
scaveng
free
radic
indirectli
lower
product
cell
damag
agent
cytokin
adhes
molecul
age
chang
amplitud
time
melatonin
rhythm
report
human
use
male
adult
wistar
rat
separ
two
group
continu
light
day
b
continu
dark
besid
surgic
manipul
control
group
fibrillar
amyloidbeta
ag
intracerebr
inject
onto
hydrogen
peroxideinject
rat
use
posit
control
day
continu
light
melatonin
level
serum
decreas
significantli
compar
observ
concentr
anim
hous
lightdark
cycl
phenomenon
relat
increas
brain
lipoperoxid
nitrit
hand
increas
serum
level
melatonin
either
exogen
administr
increment
endogen
product
due
continu
dark
relat
signific
reduct
oxid
stress
induc
amyloidbeta
even
highli
signific
product
lipoperoxid
nitrit
induc
hydrogen
peroxid
inject
also
reduc
melatonin
microgli
activ
assess
immunohistochemistri
show
mark
increas
hippocampu
around
amyloidbeta
deposit
region
polycyst
lipomembran
osteodysplasia
scleros
leukoencephalopathi
plosl
nasuhakola
diseas
recess
inherit
diseas
character
unusu
combin
bone
cyst
earlyonset
dementia
group
recent
establish
molecular
background
plosl
identifi
mutat
encod
protein
form
activ
signal
transduct
complex
immun
cell
function
target
tissu
plosl
central
nervou
system
cn
bone
larg
unknown
start
point
understand
loss
function
activ
signal
complex
lead
dementia
loss
myelin
analyz
express
mous
cn
analys
transcript
mous
cn
show
express
embryon
stage
adulthood
highli
similar
express
pattern
addit
microgli
cell
oligodendrocyt
identifi
major
produc
cell
cn
consequ
microgli
cell
oligodendrocyt
consid
predomin
cell
type
involv
plosl
pathogenesi
myeloid
origin
microgli
cell
osteoclast
provid
biolog
link
cn
bone
patholog
plosl
patient
express
oligodendrocyt
myelin
produc
cell
cn
agre
well
histopatholog
clinic
find
plosl
patient
find
provid
basi
studi
molecular
mechan
behind
inherit
dementia
new
evid
involv
immun
system
neuron
degener
known
stress
induc
increas
chemotaxi
may
contribut
increas
migrat
recruit
immun
cell
site
inflamm
chemokin
play
role
neuroinflamm
chemokin
receptor
bind
ligand
sdf
stromal
cellderiv
factor
receptor
fractalkin
studi
focus
whether
two
chemokin
system
involv
stressinduc
neurodegener
purpos
rat
submit
chronic
stress
consist
daili
restraint
h
week
level
measur
homogen
sever
brain
structur
chemokin
quantifi
elisa
assay
protein
level
reduc
hippocampu
howev
upregul
level
found
cerebellum
olfactori
bulb
interestingli
sdf
significantli
increas
hypothalamu
olfactori
bulb
wherea
fractalkin
upregul
olfactori
bulb
control
group
show
high
neg
correl
sdf
hippocamp
bax
level
togeth
data
suggest
hippocamp
sdf
decreas
level
might
reduc
neuroprotect
chronic
restraint
stress
contrast
differenti
chemokin
modul
found
brain
area
fund
une
grant
spain
alzheim
diseas
ad
amyloid
plaqu
within
brain
surround
activ
microglia
astrocyt
dystroph
neurit
elev
level
proinflammatori
cytokin
found
ad
brain
earli
stage
diseas
impli
inflamm
earli
event
ad
inflamm
regul
least
part
transcript
factor
nfkappab
mechan
amyloidbeta
abeta
mediat
neurotox
unknown
suggest
oxid
stress
play
key
role
although
abeta
may
act
directli
neuron
cell
increas
level
oxid
stress
due
activ
glial
cell
may
import
upon
activ
glial
cell
produc
proinflammatori
cytokin
put
neurotox
factor
includ
superoxid
anion
hydroxyl
radic
nitric
oxid
reactiv
oxygen
speci
ro
caus
great
damag
lipid
peroxid
oxid
protein
may
lead
cell
death
aim
studi
investig
effect
abeta
proinflammatori
cytokin
glial
activ
product
ro
rat
primari
mix
glial
cell
cultur
investig
nfkappab
activ
mrna
level
ino
h
secret
medium
analys
absenc
presenc
antioxid
alphatocopherol
vitamin
e
parkinson
diseas
pd
agerel
neurodegen
disord
unknown
etiolog
involv
immun
mechan
etiopathogenesi
pd
document
neuroinflamm
regul
numer
signal
molecul
includ
nitric
oxid
nitric
oxidesynthes
enzym
nitric
oxid
synthas
no
present
cn
three
differ
isoform
two
constitut
enzym
neuronalnno
endothelialeno
induc
enzym
ino
present
studi
examin
nno
eno
ino
gene
express
striatum
male
mice
month
old
murin
model
pd
induc
mptp
anim
sacrif
h
day
mptp
intox
level
mrna
assay
rtpcr
method
observ
increas
nno
gene
express
day
peak
within
day
eno
mrna
express
show
increas
h
continu
day
peak
time
point
ino
mrna
express
rapidli
increas
earli
h
mptp
intox
peak
h
significantli
decreas
day
observ
day
conclus
work
extend
knowledg
potenti
role
no
isoform
neurodegen
disord
may
becom
futur
target
therapeut
intervent
patient
suffer
parkinson
diseas
character
mononuclear
cell
isol
bone
marrow
potenti
transplant
anim
model
huntington
diseas
serranosanchez
centro
internacion
de
ciren
havana
citi
cuba
huntington
diseas
hd
inherit
neurodegen
disord
intrastriat
administr
neurotox
serv
frequent
anim
model
hd
anim
model
allow
extens
research
therapeut
strategi
hd
recent
cellular
sourc
demonstr
import
role
bone
marrow
cell
easili
access
adult
rat
rich
sourc
stem
progenitor
cell
grow
number
recent
public
shown
adult
stem
cell
bone
marrow
abl
exhibit
neural
phenotyp
vitro
vivo
transplant
studi
base
immunocytochem
techniqu
obtain
descript
phenotyp
marker
avail
cell
identif
report
perform
isol
cell
antibodi
titrat
character
cell
rat
bone
marrow
phenotyp
cell
compris
mononuclear
cell
system
present
marrow
popul
character
result
show
differ
contribut
percentag
marker
given
major
comprehens
real
contribut
one
popul
cell
effect
transplant
gluten
sensit
alter
immunolog
respons
ingest
gluten
extraintestin
organ
cerebellum
might
uniqu
target
diseas
occur
gluten
ataxia
ga
syndrom
report
patient
ataxia
yield
antigliadin
antibodi
aga
develop
ramsay
hunt
syndrom
rh
instrument
exam
biochem
genet
histolog
analys
exclud
vascular
inflammatori
metabol
heredodegen
ataxia
coeliac
diseas
mild
limb
ataxia
sever
gait
ataxia
cognit
impair
bladder
dysfunct
high
valu
aga
without
intestin
involv
resembl
pattern
ga
patient
show
temporari
clinic
improv
gluten
free
diet
aga
becam
neg
five
month
later
clinic
condit
rapidli
worsen
patient
becam
bedridden
confus
develop
myoclonu
pseudoabs
episod
serial
eeg
show
progress
slow
background
activ
multifoc
period
epileptiform
activ
aga
titer
higher
onset
rh
suggest
throughout
last
month
clinic
electrophysiolog
condit
improv
aga
test
becam
neg
rh
previous
report
coeliac
diseas
never
ga
consid
mild
monophas
diseas
report
associ
aga
rh
clinic
sever
rh
aga
titer
aga
also
found
healthi
control
patient
heredodegen
ataxia
signific
presenc
fluctuat
need
clarifi
role
antigangliosid
antibodi
nerv
injuri
david
jm
spi
jd
pollard
g
zhang
b
pj
armati
k
sheikh
b
univers
sydney
sydney
australia
b
john
hopkin
univers
baltimor
maryland
usa
object
determin
whether
antibodi
directli
mediat
nerv
injuri
background
chronic
inflammatori
demyelin
polyradiculoneuropathi
guillainbarr
syndrom
gb
consid
organ
specif
autoimmun
disord
antibodi
long
suspect
mediat
nerv
damag
neuropathi
antibodi
major
gangliosid
strongli
associ
acut
motor
axon
neuropathi
variant
gb
implic
gangliosid
target
antigen
recent
attempt
develop
anim
model
antigangliosid
antibodi
mediat
nerv
injuri
given
inconsist
result
recent
avail
high
affin
monoclon
antigangliosid
antibodi
enabl
develop
new
anim
model
clarifi
issu
method
monoclon
igg
antibodi
control
igg
inject
rat
sciatic
nerv
motor
nerv
conduct
studi
stimul
proxim
distal
site
inject
record
compound
muscl
action
potenti
cmap
foot
muscl
perform
interv
inject
result
inject
igg
caus
signific
decreas
proxim
cmap
amplitud
rel
preserv
distal
amplitud
preliminari
patholog
studi
show
mild
axon
degener
without
demyelin
conclus
find
suggest
caus
nerv
dysfunct
whether
via
axon
degener
conduct
failur
remain
determin
buckthorn
karwinskia
humboldtiana
poison
shrub
ingest
produc
distal
ascend
symmetr
flaccid
paralysi
slow
recoveri
death
buckthorn
polyneuropathi
frequent
misdiagnos
gb
cidp
histolog
peripher
nerv
present
demyelin
axon
degener
mechan
implic
particip
immun
system
unknown
develop
new
experiment
neuropathi
model
resembl
human
intox
stage
rat
classifi
four
group
onset
paresi
weak
limb
paralysi
paralysi
recov
sciatic
nerv
histopatholog
studi
statist
analys
perform
hematoxylineosin
toluidineblu
klqverbarrera
marslandgle
erickson
silver
stain
immunohistochemistri
igg
igmantimyelin
search
westernblot
sciatic
nerv
treat
rat
show
demyelin
axon
degener
import
increment
mast
cell
lymphocyt
comparison
control
mani
lymphocyt
group
show
great
degranul
mast
cell
endoneurium
perineurim
shrunken
broken
axon
sera
includ
control
present
igmantibodi
four
myelin
protein
contrast
iggantibodi
treat
anim
react
protein
none
igg
control
propos
mast
cell
lymphocyt
immunoglobulin
particip
buckthorn
polyneuropathi
demyelin
model
use
pathogen
mechan
studi
polyneuropathi
grant
conacyt
paicyt
aim
present
studi
investig
cytokin
chang
peripher
nerv
injuri
rat
sciatic
nerv
correspond
sensori
ganglion
left
sciatic
nerv
male
rat
transact
level
hip
joint
pentobarbit
anesthesia
sampl
taqman
pcr
studi
collect
proxim
distal
point
transect
well
contralater
intact
sciatic
nerv
h
day
postoper
po
correspond
sensori
ganglion
also
collect
nonoper
rat
serv
control
studi
cytokin
rna
ifngamma
tnfalpha
tnfalpha
markedli
express
first
week
transect
distal
proxim
area
express
sensori
ganglion
correl
partli
find
upregul
almost
sampl
taken
injur
side
day
promin
express
day
contralater
sciatic
nerv
show
increas
express
tnfalpha
day
po
contralater
ganglion
show
mark
express
tnfalpha
time
point
express
pattern
cytokin
tnfalpha
similar
sciatic
nerv
ganglion
transect
side
note
strong
express
could
relat
properti
increas
axon
growth
induc
fibrosi
effect
nordihydroguairet
acid
thermal
hyperalgesia
cold
allodynia
stzinduc
diabet
rat
mice
anjaneyulu
k
chopra
pharmacolog
divis
univers
institut
pharmaceut
scienc
panjab
univers
chandigarh
india
although
pain
experienc
mani
patient
diabet
neuropathi
pathophysiolog
pain
diabet
neuropathi
fulli
understood
thu
studi
design
examin
effect
antioxid
lipoxygenas
inhibitor
nordihydroguairet
acid
ndga
thermal
nocicept
streptozotocin
stz
induc
diabet
rat
mice
assess
tailimmers
paw
withdraw
assay
diabet
induc
rat
mice
singl
inject
stz
mgkgip
respect
week
stz
diabet
rat
mice
subject
tailimmers
paw
withdraw
assay
diabet
rat
exhibit
signific
decreas
tailimmers
paw
withdraw
latenc
compar
control
similarli
diabet
mice
signific
decreas
tailimmers
latenc
observ
acut
studi
mice
week
stz
ndga
mgkgsc
dose
depend
attenu
tailimmers
latenc
diabet
mice
chronic
treatment
ndga
mgkgsc
week
start
week
stz
signific
attenu
tailimmers
paw
withdraw
lenienc
absorb
diabet
ndga
show
chang
control
anim
latenc
result
emphas
role
oxid
stress
develop
signific
hyperalgesia
cold
allodynia
diabet
anim
point
toward
potenti
ndga
complementari
therapi
preventiontreat
diabet
neuropath
pain
regulatori
cell
human
malign
glioma
waziri
rc
anderson
jn
bruce
de
anderson
b
columbiapresbyterian
medic
center
new
york
usa
b
harvard
medic
school
boston
usa
isol
analyz
tumor
cell
tumor
infiltr
lymphocyt
til
present
ex
vivo
central
nervou
system
cn
tumor
specimen
use
flow
cytometri
examin
immunolog
import
cell
surfac
molecul
glioblastoma
multiforma
gbm
tumor
cell
prior
cultur
vitro
screen
supernat
ex
vivo
gbm
secret
cytokin
tumor
cell
express
moder
high
level
hla
class
class
ii
molecul
suggest
tumor
cell
could
directli
interact
influenc
til
addit
major
gbm
examin
secret
high
amount
immunosuppress
cytokin
base
observ
hypothes
gbm
tumor
cell
promot
differenti
andor
expans
type
regulatori
cell
turn
suppress
tumor
immun
situ
consist
hypothesi
addit
preliminari
observ
suggest
popul
til
appear
repres
effector
cell
activ
situ
infiltr
gbm
cell
notabl
secret
contrast
til
lack
express
notabl
secret
ifngamma
absenc
data
suggest
novel
mechan
tumor
microenviron
influenc
function
til
hinder
abil
mount
effect
tumor
respons
determin
whether
tcell
infiltr
brain
tumor
compris
oligoclon
tcell
popul
amplifi
clone
sequenc
betachain
tcr
transcript
tumor
biopsi
specimen
one
patient
glioblastoma
multiform
identifi
presenc
multipl
ident
copi
betachain
tcr
transcript
npapcr
amplif
clone
sequenc
suggest
presenc
oligoclon
popul
cell
nonpalindrom
adaptor
npa
pcr
method
develop
laboratori
sequenc
transcript
unknown
variabl
immunoglobulin
tcr
pcr
amplif
follow
clone
sequenc
reveal
presenc
strong
clonal
expans
account
betachain
transcript
sequenc
similarli
pcr
amplif
follow
clone
sequenc
reveal
clonal
expans
account
betachain
transcript
sequenc
respect
oligoclon
expans
betachain
tcr
transcript
also
identifi
two
patient
one
recur
glioblastoma
multiform
one
recurr
malign
astrocytoma
use
twosid
vbetaspecif
pcr
presenc
oligoclon
tcell
popul
indic
cell
may
undergon
antigendriven
prolifer
clonal
expans
situ
site
tumor
respons
yet
unknown
tumor
antigen
increas
ifn
gamma
secret
restimul
lymphocyt
patient
immun
autolog
glioma
cell
correl
prolong
surviv
p
siesjf
e
viss
lund
univers
lund
sweden
introduct
order
monitor
immun
respons
patient
immun
ifn
gamma
secret
tumor
cell
peripher
blood
leucocyt
assay
restimul
day
tumor
cell
method
blood
sampl
collect
immun
pbl
isol
frozen
thaw
pbl
restimul
tumor
cell
vitro
day
restimul
cell
assay
cytokin
product
flow
cytometri
elispot
prolifer
thymidin
incorpor
lymphocyt
subset
distribut
fac
result
sampl
five
patient
analyz
compar
surviv
data
immun
infiltr
dth
reaction
vaccin
site
correl
discern
pattern
could
observ
prolifer
lymphocyt
subset
analys
increas
ifn
gamma
level
measur
flow
cytometri
elispot
seen
patient
prolong
surviv
decreas
ifn
gamma
product
observ
tumor
recurr
detect
level
observ
display
weak
associ
shorter
surviv
lymphocyt
cytokin
product
correl
lymphocyt
infiltr
dth
reaction
immun
site
conclus
ifn
gamma
secret
restimul
lymphocyt
lymphocyt
infiltr
immun
site
promin
patient
prolong
surviv
result
underscor
import
use
relev
paramet
evalu
immunotherapi
tumor
patient
glioblastoma
common
lethal
intrins
human
brain
tumor
report
show
decreas
express
activ
immunoreceptor
nk
cell
solubl
factor
releas
glioma
cell
downregul
express
nk
cell
vitro
unexpectedli
solubl
factor
solubl
ligand
transform
growth
factorbeta
tgfbeta
inhibit
gene
transcript
moreov
tgfbeta
inhibit
transcript
ligand
mica
promot
releas
matrix
metalloproteinas
mmp
glioma
cell
turn
mediat
shed
mica
surfac
glioma
cell
interfer
tgfbeta
synthesi
sirna
technolog
glioma
cell
prevent
downregul
immun
cell
suppress
mmp
express
strongli
enhanc
mica
express
glioma
cell
furthermor
tgfbeta
knockdown
lead
decreas
migratori
invas
tumor
phenotyp
altogeth
knockdown
tgfbeta
result
glioma
cell
phenotyp
less
motil
sensit
immun
cell
lysi
nontumorigen
nude
mice
identif
novel
neuroblastomaassoci
molecul
protect
nkmediat
lysi
r
castriconi
dondero
c
bottino
b
moretta
dipartimento
di
medicina
sperimental
univers
genova
genova
itali
b
istituto
giannina
gaslini
genova
itali
order
identifi
novel
marker
use
specif
recognit
neuroblastoma
cell
immun
mice
neuroblastoma
cell
line
cell
fusion
mab
term
select
stain
neuroblastoma
cell
line
test
well
tumor
differ
origin
includ
melanoma
carcinoma
importantli
bone
marrow
aspir
deriv
stage
patient
infiltr
neuroblastoma
cell
select
recogn
mab
molecul
recogn
mab
molecular
mass
approxim
kda
thereaft
term
molecul
protein
purif
follow
ingel
tryptic
digest
liquid
chromatographi
tandem
mass
spectrometri
allow
identif
protein
purifi
neuroblastoma
cell
use
target
cell
cytotox
assay
effector
cell
repres
polyclon
nk
cell
experi
demonstr
molecul
play
import
role
protect
tumor
cell
nkmediat
lysi
inde
nk
cellmedi
kill
inhibit
interact
inhibit
revers
mabmedi
mask
observ
reminisc
effect
antihla
class
mab
revers
nkmediat
lysi
hla
class
target
cell
thu
appear
conceiv
nk
cell
may
equip
specif
inhibitori
receptor
upon
interact
new
ligand
transduc
signal
downregul
cytotox
erad
murin
brain
tumor
direct
inocul
concentr
high
titerrecombin
retroviru
harbor
herp
simplex
viru
thymidin
kinas
gene
k
shimizu
yawata
tsuchiya
kc
park
toyonaga
yamada
h
nakabayashi
e
nakai
n
ikawa
k
ikenaka
b
kochi
medic
school
nankoku
citi
japan
b
nation
institut
physiolog
scienc
okazaki
japan
implant
retrovirusproduc
cell
within
tumor
demonstr
elimin
malign
brain
tumor
effect
anim
model
previou
studi
implant
hightit
retrovirusproduc
fibroblast
tumor
result
highli
effici
transduct
vivo
transduc
glioma
cell
migrat
far
implant
site
potenti
induct
remark
bystand
effect
also
possibl
howev
implant
murin
fibroblastderiv
virusproduc
cell
may
induc
immun
respons
patient
studi
prepar
retrovirus
carri
herp
simplex
viru
thymidin
kinas
htk
gene
titer
colonyform
unit
cfu
ml
stereotact
inocul
al
htkbear
retrovirus
brain
tumor
mice
follow
repetit
ganciclovir
gcv
intraperiton
inject
effect
kill
glioma
cell
mous
brain
observ
transduct
effici
nearli
high
observ
implant
hightit
retrovirusproduc
fibroblast
eighti
percent
brain
tumorbear
mice
complet
cure
treatment
protocol
use
concentr
htkharbor
retrovirus
result
suggest
repeat
inocul
hightit
retrovirus
carri
htk
gene
follow
gcv
treatment
may
promis
strategi
clinic
treatment
malign
glioma
deliveri
interleukin
experiment
glioma
viral
vector
neural
stemprogenitor
cell
p
tunici
g
finocchiaro
laboratori
experiment
neurooncolog
gene
therapi
istituto
nazional
neurologico
besta
milan
itali
previou
experi
show
retrovir
deliveri
restrain
growth
malign
glioma
rat
subsequ
inject
ratimmort
murin
primari
neural
stem
progenitor
cell
nspc
overexpress
could
even
effect
treatment
malign
glioma
mlvderiv
retrovir
vector
use
experi
deliv
cdna
brain
tumor
nspc
limit
transduc
divid
cell
ltrdriven
express
transgen
silenc
test
lentivir
vector
could
effect
prepar
lentivir
vector
gene
deliveri
plasmid
obtain
laboratori
dr
luigi
naldini
lentivir
prepar
contain
ngal
nspc
transduc
al
produc
h
inject
glioblastoma
cell
striatum
mice
seven
experiment
group
day
al
lenti
lenti
gfp
nspcgfp
respect
use
control
mice
inject
cell
surviv
significantli
longer
control
logrank
mantelcox
effect
howev
decreas
gbm
cell
inject
experi
confirm
cell
signific
antitumor
effect
glioma
howev
nspc
transduc
lentiviru
appear
effect
nspc
transduc
mlvderiv
retroviru
deliveri
lentiviru
yield
antitumor
activ
cancer
partial
attribut
defect
regul
apoptot
cell
death
failur
trigger
cellular
suicid
program
predispos
develop
malign
also
increas
resist
tumor
anticanc
drug
irradi
recent
observ
taurolidin
antibacteri
drug
display
potent
antineoplast
effect
sever
tumor
cell
line
decid
test
taurolidin
human
ex
vivo
glioma
cell
perform
cytotox
coloni
format
assay
found
high
suscept
glioma
cell
high
activ
taurolidin
assay
elucid
mechan
antineoplast
effect
result
studi
reveal
taurolidin
induc
program
cell
death
gener
intracellular
roi
prevent
radic
scaveng
nacetylcystein
nac
pancaspas
inhibitor
zvadfmk
confoc
laser
scan
confoc
microscopi
identifi
apoptosisinduc
factor
aif
major
player
caspaseindepend
cell
death
interestingli
taurolidin
suppress
constitut
vegf
product
glioma
cell
display
thu
antiangiogen
effect
besid
antineoplast
activ
taken
togeth
taurolidin
treatment
glioblastoma
cell
result
caspaseindepend
program
cell
death
preced
roi
gener
mitochondri
dysfunct
aif
releas
mitochondria
interestingli
taurolidineinduc
cell
death
also
initi
lysosom
level
lead
mitochondri
dysfunct
program
cell
death
either
directli
autophagi
damag
mitochondria
multifunct
fusion
cytokin
break
cancerinduc
immun
anergi
paul
transgen
sa
strasbourg
franc
idea
tumor
must
bescapeq
immun
recognit
contain
implicit
assumpt
tumor
destroy
immun
respons
either
spontan
result
immunotherapeut
intervent
bnatur
selectionq
heterogen
tumor
cell
result
surviv
prolifer
variant
happen
possess
genet
epigenet
trait
facilit
growth
immun
evas
sever
mechan
develop
tumor
cell
enabl
escap
host
immun
due
reduct
antigen
present
tumor
cell
due
local
gener
declin
patient
immun
previou
work
shown
cytokin
immun
effector
enhanc
host
immun
thu
overcom
tumorinduc
state
immun
anergi
recent
mani
studi
mous
human
tumor
model
shown
import
cytokin
combin
develop
optim
immun
respons
describ
novel
fusion
protein
also
call
bfusokinetmq
use
enhanc
nonspecif
specif
immun
respons
murin
fusokin
provid
high
rate
tumor
reject
intratumor
deliveri
encod
adenovir
vector
variou
anim
model
evid
immunostimul
limit
toxic
antitumor
effect
murin
fusokin
correl
activ
ctl
nk
antigen
present
cell
microglia
glioma
may
symbiot
relationship
graeber
flqgel
b
imperi
colleg
london
london
uk
b
maxplanckinstitut
neurobiolog
martinsri
germani
number
microgli
glial
cellsbrain
macrophag
malign
astrocytoma
surprisingli
high
base
vitro
find
specul
brain
macrophag
deriv
microgli
cell
may
exert
tumour
cytotox
function
howev
biolog
bsuccessq
malign
astrocytoma
strongli
suggest
potenti
exploit
vivo
test
effect
nativ
microglia
isol
neonat
lewi
rat
brain
kept
primari
cultur
day
supernat
taken
cell
glioma
cell
grown
vitro
use
convent
cell
death
assay
determin
absolut
number
tumour
cell
carri
bgreen
fluoresc
proteinq
gfp
marker
gene
use
fluorescenceactiv
cell
sorter
fac
signific
cytotox
microglia
instead
experi
show
clear
growth
promot
effect
glioma
cell
fact
supernat
alon
deriv
unstimul
microglia
contact
tumour
cell
suffici
promot
surviv
neoplast
cell
suggest
need
complic
microgliatumour
interact
explain
surviv
glioma
cell
presenc
microglia
vivo
molecular
basi
observ
effect
current
studi
symbiosi
microglia
glial
tumour
seem
distinct
possibl
glioma
known
stimul
microgli
prolifer
vascular
endotheli
growth
factor
vegf
brain
tumour
r
kumar
b
l
madden
k
hill
b
crook
b
j
greenman
obrien
b
univers
hull
hull
uk
b
hull
east
yorkshir
hospit
hull
uk
immunosuppress
cytokin
produc
tlymphocyt
report
regulatori
molecul
angiogenesi
primarili
mediat
vegf
aim
work
investig
relationship
vegf
brain
tumour
patient
prospect
analysi
compar
level
serum
cyst
tumour
express
vegf
patient
newli
diagnos
brain
tumour
immunohistochemistri
perform
vegf
receptor
patient
recruit
serum
sampl
obtain
prior
surgeri
cyst
fluid
surgeri
serum
cyst
vegf
measur
quantit
elisa
patient
divid
benign
low
grade
high
grade
metastat
group
patient
benign
low
grade
tumour
median
serum
vegf
level
pgml
median
serum
vegf
level
high
grade
metastat
group
pgml
respect
serum
detect
patient
pgml
immunohistochemistri
result
follow
trend
toward
higher
serum
vegf
level
advanc
tumour
grade
highest
level
seen
metastat
group
serum
detect
patient
relationship
tumour
grade
associ
serum
vegf
signific
increas
cyst
fluid
vegf
compar
serum
pilot
studi
present
compar
level
panel
cytokin
intracavitari
cyst
fluid
patient
brain
tumour
serum
normal
serum
control
design
prospect
analysi
cyst
fluid
vegf
tnf
alpha
level
patient
brain
tumour
serum
obtain
prior
surgeri
cyst
fluid
obtain
time
surgeri
outcom
measur
quantit
elisa
use
measur
intracavitari
cytokin
serum
level
sampl
analys
duplic
cytokin
level
compar
serum
valu
normal
serum
control
result
level
cytokin
significantli
higher
intracavitari
cyst
fluid
compar
patient
normal
serum
level
vegf
approxim
higher
normal
serum
mean
vs
pgml
tnfalpha
concentr
approxim
lower
vs
pgml
concentr
approxim
higher
vs
pgml
concentr
approxim
higher
vs
pgml
approxim
higher
vs
pgml
conclus
except
tnfalpha
signific
increas
cytokin
studi
signific
increas
cytokin
level
requir
analysi
larger
seri
patient
express
novel
molecul
human
glioma
cell
vitro
vivo
potenti
mechan
immun
paralysi
wintterl
b
schreiner
mitsdoerff
schneider
l
chen
b
r
meyermann
weller
h
wiendl
univers
germani
b
mayo
clinic
rochest
mn
usa
human
glioblastoma
highli
lethal
tumor
known
immun
inhibitori
capabl
recent
identifi
homolog
describ
exert
costimulatori
immun
regulatori
function
investig
express
function
activ
novel
costimulatori
molecul
human
glioma
cell
vitro
vivo
lack
glioma
cell
line
constitut
express
mrna
protein
exposur
ifngamma
strongli
enhanc
express
immunohistochem
analysi
malign
glioma
specimen
reveal
strong
express
sampl
examin
wherea
express
detect
normal
brain
tissu
elucid
function
signific
glioma
cellrel
express
perform
cocultur
experi
glioma
cell
alloreact
cell
gliomarel
identifi
strong
inhibitor
well
cell
activ
assess
increas
cytokin
product
ifngamma
express
level
cell
activ
marker
presenc
neutral
antibodi
mab
express
may
thu
significantli
influenc
outcom
cell
tumor
cell
interact
repres
novel
mechan
glioma
cell
evad
immun
recognit
destruct
microglia
respons
brain
patholog
undergo
activ
process
becom
capabl
phagocytosi
antigen
present
lymphocyt
activ
recent
studi
suggest
microglia
accumul
glial
tumor
may
reflect
particip
cell
support
promot
invas
phenotyp
mutual
interact
microglia
glioma
cell
well
establish
therefor
studi
effect
solubl
factor
releas
rat
microgli
cell
prolifer
signal
pathway
rat
glioma
cell
lp
treat
microgliacondit
medium
weak
activatori
effect
glioma
prolifer
determin
use
mtt
metabol
assay
presenc
condit
medium
rest
lpsactiv
microglia
cultur
observ
chang
activ
mapk
erk
jnk
kinas
glioma
cell
analys
western
blot
analysi
specif
antibodi
howev
signific
activ
akt
signal
pathway
observ
kinas
signal
pathway
regul
mani
cellular
process
includ
surviv
prolifer
differenti
chemotaxi
angiogenesi
furthermor
studi
effect
gliomacondit
medium
rest
microglia
found
activ
morpholog
chang
stimul
map
kinas
microglia
result
suggest
glioma
cell
may
activ
microgli
cell
exert
activatori
effect
glioma
cell
contribut
glioma
patholog
support
gene
immunotherapi
brain
look
antitumour
activ
microglia
r
geibig
deutsch
krebsforschungszentrum
heidelberg
germani
common
strategi
tumour
gene
therapi
mainli
focu
induc
cell
death
stimul
immun
system
order
elimin
tumour
mass
case
brain
tumour
new
therapi
desper
need
due
poor
prognosi
patient
failur
classic
therapi
microglia
repres
potenti
though
poorli
exploit
arm
defens
antitumour
activ
could
trigger
tumourtarget
gene
immunotherapi
autonom
parvovirusbas
vector
promis
tool
deliveri
therapeut
gene
brain
given
natur
oncotrop
virus
oncosuppress
activ
vivo
capac
select
deliveri
toxicimmunostimulatori
gene
tumour
cell
first
investig
permiss
primari
mous
glial
cell
murin
parvoviru
astrocyt
microglia
readili
take
viru
cell
express
viral
transduc
protein
nevertheless
viral
life
cycl
complet
cell
lyse
second
start
character
antitumour
capac
microglia
show
microglia
kill
glioma
cell
via
solubl
compound
stimul
lipopolysaccharid
ifngamma
ii
phagocytos
live
apoptot
glioma
cell
taken
togeth
data
suggest
microglia
potenti
fight
brain
tumour
immunostimulatori
molecul
produc
viral
transduc
tumour
cell
astrocyt
could
regul
potenti
glioma
cell
stimul
proinflammatori
cytokin
produc
high
amount
nitric
oxid
highli
reactiv
free
radic
anticanc
cancerpromot
properti
aloeemodin
ae
herbal
compound
tumoricid
activ
strongli
downregul
synthesi
rat
astrocytoma
cell
stimul
ifngamma
tnfalpha
ae
affect
express
transcript
translat
product
noproduc
enzym
induc
synthas
ino
rather
enzymat
activ
treatment
ae
significantli
reduc
cytokinetrigg
express
import
ino
transcript
factor
cell
activ
nfkappab
remain
unalt
furthermor
ae
partial
interf
activ
mitogenactiv
protein
kinas
mapk
pathway
activ
cjun
ntermin
mapk
suppress
upon
ae
treatment
conclus
aemedi
downregul
erk
pathway
subsequ
inhibit
ino
transcript
synthesi
glioma
cell
might
import
implic
potenti
therapeut
use
antraquinon
aloeemodin
ae
natur
occur
compound
wide
spectrum
biolog
properti
antraquinon
induc
apoptosi
sever
tumor
cell
line
special
affin
tumor
neuroectoderm
origin
high
amount
nitric
oxid
releas
activ
macrophag
induc
tumor
cell
death
therefor
explor
capac
ae
modul
macrophag
nomedi
kill
glioma
cell
vitro
interestingli
ae
markedli
suppress
releas
macrophag
alon
significantli
potenti
product
cocultur
macrophag
rat
astrocytoma
cell
accordingli
viabil
cell
cocultiv
macrophag
significantli
reduc
presenc
ae
contrast
aeimpos
effect
macrophag
releas
close
relat
macrophag
densiti
increas
readili
convert
observ
inhibit
potenti
synthesi
stimul
synthesi
high
densiti
macrophag
cultur
ae
affect
transcript
translat
inhibitor
indic
enzymat
activ
rather
gene
express
target
drug
action
accordingli
express
ino
macrophag
affect
ae
therefor
capac
ae
modul
macrophag
releas
surviv
glioma
cell
might
consider
depend
contact
macrophag
macrophag
tumor
cell
express
central
nervou
system
cn
implic
cn
immun
p
mahad
rm
ransohoff
cleveland
clinic
foundat
cleveland
oh
usa
unclear
immun
cell
traffic
lymphoid
compart
cn
defin
express
traffick
determin
cell
dendrit
cell
dc
cerebrospin
fluid
csf
brain
parenchyma
well
endotheli
cell
differ
compart
within
cn
gain
insight
pathway
immun
cell
traffick
brain
nineti
percent
csf
cell
patient
multipl
sclerosi
ms
noninflammatori
neurolog
diseas
nind
centralmemori
cell
contrast
cell
parenchym
ms
lesion
lack
consist
effectormemori
phenotyp
postcapillari
venul
choroid
plexu
subarachnoid
space
brain
parenchym
microvessel
autopsi
section
nind
patient
express
adhes
molecul
support
recruit
cell
find
suggest
immun
surveil
noninflam
cn
immun
execut
centralmemori
cell
enter
csf
directli
system
circul
retain
capac
differenti
effectormemori
cell
upon
local
antigen
restimul
inflam
ms
lesion
contain
numer
cell
phenotyp
featur
matur
dc
activ
microglia
dc
identifi
csf
ms
patient
find
indic
effer
limb
cn
immun
compris
part
dc
migrat
deep
cervic
lymph
node
csf
natur
myeloid
cell
cn
parenchyma
investig
identif
put
trigger
agent
multipl
sclerosi
use
unbias
approach
sospedra
zhao
p
muraro
jacobson
c
pinilla
b
r
martin
nation
institut
health
bethesda
usa
b
torrey
pine
institut
san
diego
usa
multipl
sclerosi
ms
cellmedi
autoimmun
diseas
central
nervou
system
cn
viral
infect
often
preced
exacerb
henc
infecti
agent
consid
trigger
although
natur
unknown
molecular
mimicri
provid
eleg
framework
similar
foreign
agent
autoantigen
trigger
autoimmun
diseas
studi
determin
specif
cerebrospin
fluid
csf
infiltr
cell
patient
rrm
exacerb
use
unbias
approach
order
identifi
foreign
agent
might
activ
cell
csf
cell
clone
limit
dilut
use
pha
subsequ
analyz
tcr
express
spectratyp
identifi
cell
clone
tcc
clonal
expand
vivo
vivo
expand
tcc
test
synthet
combinatori
peptid
librari
psscl
recent
describ
search
algorithm
appli
predict
peptid
entir
bacterialand
viral
protein
databas
might
recogn
tcc
interest
peptid
synthes
stimulatori
potenti
test
sever
stimulatori
natur
peptid
origin
foreign
agent
identifi
interestingli
two
five
tcc
recogn
multipl
peptid
relat
organ
mainli
human
herp
virus
ttviru
data
strongli
indic
ubiquit
viral
agent
activ
csfinfiltr
cell
ms
similar
low
frequenc
antimog
igg
igm
ms
patient
healthi
subject
v
lampasona
franciotta
b
r
furlan
zanaboni
r
fazio
e
bonifacio
g
comi
g
martino
san
raffael
scientif
institut
milan
itali
b
univers
pavia
pavia
itali
antimog
antibodi
induc
extens
demyelin
cellmedi
experiment
autoimmun
encephalomyel
eae
bind
disintegr
myelin
acut
multipl
sclerosi
ms
marmoset
model
eae
observ
motiv
search
antimog
antibodi
ms
increas
mogspecif
b
cell
respons
report
report
data
neglig
impact
patient
care
berger
et
al
show
serum
antimog
igm
strongli
predict
earli
convers
first
demyelin
event
clinic
definit
ms
use
liquidphas
radiobind
assay
measur
serum
antimog
igg
multipl
sclerosi
patient
ms
encephalomyel
patient
healthi
subject
antimog
igm
determin
sampl
obtain
onset
ms
patient
control
frequenc
posit
sampl
low
titer
antimog
igg
igm
similar
groupssubgroup
bind
competit
experi
show
antibodi
low
affin
antimog
antibodi
diseasespecif
interact
complement
immunoglobulin
igg
iggreceptor
fcgammar
could
contribut
inflamm
demyelin
multipl
sclerosi
ms
ms
lesion
recent
classifi
four
subtyp
one
character
deposit
complement
igg
express
fcgammar
activ
lesion
describ
anoth
studi
investig
presenc
complement
igg
fcgammar
differ
stage
ms
lesion
immunohistochemistri
perform
lesion
patient
deriv
frozen
autopsi
materi
stain
complement
igg
mhc
class
ii
myelin
protein
fcgammar
fcgammari
fcgammarii
fcgammariii
immunoposit
score
semiquantit
lesion
mhc
class
iiposit
macrophag
contain
intracellular
myelin
debri
plp
macrophag
classifi
activ
demyelin
igg
detect
astrocyt
ms
lesion
stage
contrast
presenc
igg
within
macrophag
restrict
activ
demyelin
lesion
complement
igg
coloc
intracellularli
contrast
earlier
public
complement
igg
deposit
observ
activ
demyelin
lesion
enhanc
express
fcgammari
fcgammarii
fcgammariii
observ
plp
macrophag
alway
associ
enhanc
express
mhc
class
ii
suggest
presenc
complement
macrophag
associ
activ
demyelin
wherea
express
fcgammar
associ
inflamm
doubl
stain
coloc
complement
igg
fcgammar
within
plp
macrophag
current
perform
new
antigen
candid
multipl
sclerosi
identif
serolog
proteom
analysi
lefranc
l
almera
h
drobecq
b
j
de
seze
c
dubucquoi
p
vermersch
c
l
prin
depart
immunolog
chru
lill
lill
franc
b
biolog
institut
lill
lill
franc
c
depart
neurolog
chru
lill
lill
franc
myelin
antigen
target
clearli
associ
pathogen
event
multipl
sclerosi
ms
patient
remain
defin
recent
demonstr
analysi
global
igg
antibodi
respons
human
brain
antigen
use
onedimension
immunoblot
allow
us
discrimin
ms
patient
control
healthi
subject
sjfgren
syndrom
addit
approach
also
differenti
three
clinic
form
ms
diseas
inde
brain
antigen
band
healthi
brain
ms
brain
show
discrimin
igg
immun
respons
aim
studi
character
discrimin
antigen
band
detect
healthi
brain
protein
identif
success
perform
onedimension
twodimension
immunoblot
use
sera
ms
patient
follow
ms
analysi
databas
search
one
hundr
two
antigen
spot
detect
immunoblot
ms
sera
healthi
brain
sixtyfour
spot
success
match
coomassi
brilliant
blue
cbb
stain
gel
select
ms
analysi
annot
lead
identif
discrimin
antigen
thu
serolog
proteom
analysi
serpa
may
provid
use
tool
identif
potenti
new
msassoci
antigen
whose
relev
physiopatholog
event
remain
defin
multipl
sclerosi
ms
autoimmun
inflammatori
demyelin
diseas
central
nervou
system
cn
diseas
mechan
ms
molecular
level
remain
poorli
understood
reliabl
proteinac
diseas
marker
avail
yet
goal
present
studi
construct
protein
databas
cerebrospin
fluid
csf
ms
patient
proteom
approach
particularli
suitabl
molecular
dissect
diseas
phenotyp
cn
larg
inaccess
meaning
mrna
express
base
analysi
csf
secret
product
sever
cn
structur
protein
profil
affect
sever
diseas
cn
proteom
analysi
csf
could
provid
insight
pathogenesi
diseas
csf
protein
relapsingremit
ms
patient
sampl
analyz
mean
twodimension
gel
electrophoresi
liquid
chromatographi
coupl
tandem
mass
spectrometri
use
two
complementari
techniqu
result
identif
differ
protein
major
protein
analyz
alreadi
csf
studi
howev
protein
describ
far
investig
provid
addit
inform
whether
implic
ms
pathogenesi
construct
csf
databas
use
futur
studi
differenti
express
protein
import
applic
identif
diagnost
paragnost
theranost
protein
marker
role
haplotyp
multipl
sclerosi
k
kawamura
l
fugger
b
forsthub
institut
patholog
school
medicin
case
western
reserv
univers
cleveland
oh
usa
b
weatheral
institut
molecular
medicin
john
radcliff
hospit
univers
oxford
oxford
uk
multipl
sclerosi
ms
autoimmun
diseas
strongli
associ
mhc
class
ii
gene
almost
alway
inherit
togeth
haplotypeq
reason
associ
haplotyp
ms
unknown
postul
mhc
class
ii
gene
could
defici
abil
induc
central
peripher
toler
myelin
antigen
inde
cell
respons
myelin
antigen
readili
detect
ms
patient
indic
selftoler
regulatori
mechan
fail
understand
role
complex
induct
toler
mbp
gener
mice
express
haplotyp
mhc
molecul
defici
mbp
mbp
mbp
mice
immun
human
mbp
protein
epitop
map
mbp
perform
cytokin
elispot
assay
overlap
set
mbp
peptid
span
complet
mbp
sequenc
epitop
map
show
immunodomin
epitop
mbpdefici
tg
mice
surprisingli
mbp
hladr
transgen
mice
toler
suggest
mhc
class
ii
molecul
defici
abil
induc
central
peripher
toler
myelin
antigen
suggest
altern
mechan
account
role
haplotyp
ms
microarray
provid
global
view
gene
express
multifactori
diseas
uncertain
etiolog
repres
power
method
disclos
unknown
caus
factor
place
known
alter
right
context
howev
microarray
subject
mani
variabl
complic
interpret
result
tri
limit
variabl
studi
monozygot
twin
four
set
mean
age
discord
ms
affect
twin
free
immunomodulatori
treatment
follow
leukapheresi
cell
separ
studi
microarray
agil
human
oligo
microarray
kit
affect
cotwin
gene
overwhil
underexpress
cell
cell
express
increas
gene
decreas
fold
chang
differenti
express
gene
includ
transcript
immunolog
signific
gene
involv
cell
structur
remodel
regul
cellular
electrolyt
balanc
experi
progress
materi
affymetrix
platform
far
result
show
differenti
express
gene
cell
numer
exceed
lymphocyt
result
valid
gene
present
function
genom
analysi
multipl
sclerosi
j
wuerfel
weber
j
kraetzschmar
b
prozorovski
j
bellmannstrobl
akta
cs
stuerzebech
b
f
zipp
c
infanteduart
institut
neuroimmunolog
berlin
germani
b
schere
ag
berlin
germani
multipl
sclerosi
ms
complex
multifactori
diseas
character
enorm
variabl
clinic
present
cours
clear
diagnost
paramet
lack
order
identifi
gene
express
pattern
peripher
immun
cell
ms
patient
potenti
diagnost
prognost
implic
perform
largescal
gene
express
analysi
use
dnamicroarray
gene
relapsingremit
rrm
primari
progress
ppm
patient
well
healthi
individu
repres
gene
differenti
regul
ms
select
accord
stringent
select
criteria
ten
gene
subsequ
use
confirm
array
data
realtim
rtpcr
extend
control
patient
cohort
approach
defin
ms
express
profil
character
increas
express
gene
involv
cellular
activ
chemotaxi
adhes
process
transendotheli
migrat
diminish
express
factor
relat
regul
bcell
respons
respons
interferon
factor
distinguish
rrm
ppm
detect
appli
select
criteria
identifi
express
profil
indic
import
aspect
ms
pathophysiolog
highlight
role
transendotheli
migrat
well
bcell
ifnrel
process
ms
immunopatholog
offer
basi
develop
diagnost
marker
ms
human
endogen
retrovirusw
envelop
abund
infect
multipl
sclerosi
j
antoni
izad
b
k
zhang
k
warren
c
vodjgani
b
c
power
univers
calgari
calgari
ab
canada
b
tehran
univers
medic
scienc
tehran
iran
c
univers
alberta
edmonton
ab
canada
human
endogen
retrovirus
herv
constitut
human
genom
yet
role
health
diseas
remain
uncertain
determin
diseas
statu
associ
hervw
envelop
env
abund
develop
hervw
env
pcrbase
viral
load
assay
quantit
proviru
viral
rna
copi
number
brain
blood
provir
copi
number
blood
copiesmg
dna
brain
copiesmg
dna
significantli
increas
ms
patient
compar
control
copiesmg
dna
respect
addit
viral
rna
level
brain
ms
patient
copiesmg
rna
higher
control
copiesmg
rna
whether
increas
hervw
env
copi
number
reflect
increas
infect
neural
cell
examin
infect
human
brainderiv
cell
pseudotyp
viru
consist
hervw
envelop
envelopedelet
pseudotyp
viru
infect
astrocyt
macrophag
neuron
despit
express
put
hervw
receptor
cell
data
indic
hervw
env
proviru
viral
rna
level
increas
ms
patient
may
reflect
infect
mediat
hervw
envelop
astrocyt
macrophag
like
driven
concurr
innat
immun
activ
express
modul
cytokin
multipl
sclerosi
ms
associ
retroviru
msrv
epiphenomenon
pathogen
factor
c
serra
g
mame
g
arru
b
v
aston
sotgiu
b
dolei
section
microbiolog
depart
biomed
scienc
univers
sassari
sassari
itali
b
institut
clinic
neurolog
univers
sassari
sassari
itali
multipl
sclerosi
ms
unknown
etiolog
debat
immunemedi
pathogenesi
includ
genet
environment
factor
sever
virus
suggest
involv
particularli
msrv
member
hervw
famili
human
endogen
retrovirus
gliotox
fusogen
superantigen
properti
extracellular
msrv
detect
plasma
ms
patient
sardinia
italian
island
high
ms
risk
patient
msrvfree
csf
remain
stabl
wherea
msrvposit
csf
disclos
sever
treatmentrequir
diseas
select
msrv
mrsv
healthi
volunt
evalu
effect
msrv
releas
cultur
pbmc
exert
cytokin
suppos
detriment
benefici
effect
ms
immunopathogenesi
evalu
virion
rna
semiquantit
rtpcr
data
show
cultur
pbmc
msrv
donor
spontan
releas
msrv
accumul
time
mitogen
cytokinesensit
highest
effect
seen
msdetriment
tnfalpha
ifngamma
cytokin
ifnbeta
strongli
inhibitori
pbmc
msrv
individu
releas
msrv
neither
spontan
treatment
although
msrv
role
ms
still
defin
intrigu
parallel
effect
cytokin
msrv
product
vitro
ms
diseas
vivo
observ
multipl
sclerosi
associ
retroviru
msrv
seem
import
candid
viral
etiolog
ms
aim
studi
analyz
msrv
pol
sequenc
ms
control
group
serum
rna
msrv
pol
sequenc
identifi
ms
patient
msrv
pol
sequenc
detect
serum
cdna
myasthenia
gravi
patient
parkinson
diseas
migrain
patient
healthi
individu
msrv
pol
sequenc
observ
also
rna
lymphocyt
ms
patient
myasthenia
gravi
patient
parkinson
diseas
migrain
patient
healthi
donor
genom
dna
studi
case
msrv
pol
sequenc
found
pattern
fiberfish
signal
suggest
presenc
multipl
copi
msrv
pol
sequenc
tandemli
dispers
genom
conclud
msrv
pol
sequenc
endogen
widespread
lymphocyt
dna
transcrib
rna
ms
patient
well
studi
patient
healthi
individu
howev
frequent
express
msrv
sequenc
detect
lymphocyt
rna
well
presenc
higher
frequenc
serum
ms
patient
may
suggest
involv
msrv
etiopathogenesi
ms
clonal
expand
popul
identifi
brain
specimen
peripher
blood
csf
patient
ms
although
antigenspecif
unknown
date
genuin
cn
autoantigen
viral
antigen
obviou
candid
notabl
diseas
onset
exacerb
correl
concomit
viral
infect
especi
ebv
mhcclassi
tetram
synthes
domin
epitop
ebv
cmv
herp
virus
antigenspecif
cell
analyz
multicolour
flowcytometri
peripher
blood
ms
patient
control
ms
patient
compar
healthi
donor
hd
use
ebv
peptid
rppifirrl
tetram
wherea
ms
patient
show
reactiv
domin
ebv
epitop
hd
posit
addit
frequenc
ebvreact
ms
group
higher
control
mean
ebvspecif
cell
predominantli
belong
effector
memori
phenotyp
assess
costain
overal
ms
patient
show
signific
downregul
ebvreact
suggest
chronic
vivo
stimul
two
seven
patient
acut
relaps
major
ebvreact
tcell
consist
cytotox
effector
cell
contrast
ebv
cmvspecif
cell
show
signific
differ
ms
control
taken
togeth
ebvspecif
cell
ms
patient
differ
hd
frequenc
phenotyp
corrobor
put
involv
immunopathogenesi
cell
acut
multipl
sclerosi
patient
display
select
increas
adhes
brain
venul
critic
role
pselectin
glycoprotein
l
piccio
l
battistini
c
b
rossi
bach
l
ottoboni
e
scarpini
b
g
borsellino
c
g
constantin
univers
verona
verona
itali
b
univers
milan
milan
itali
c
ircc
santa
lucia
foundat
rome
itali
lymphocyt
migrat
brain
repres
critic
step
pathogenesi
multipl
sclerosi
ms
cell
obtain
healthi
donor
relapsingremit
rr
ms
patient
relaps
onset
adhes
molecul
express
studi
flow
cytometri
intravit
microscopi
studi
vitro
roll
assay
perform
patient
rrm
cell
display
increas
roll
arrest
inflam
murin
brain
venul
increas
roll
pselectin
vitro
antilselectin
antibodi
block
recruit
cell
ms
patient
vivo
antipselectin
glycoprotein
antibodi
dramat
inhibit
recruit
cell
ms
patient
brain
vessel
moreov
vascular
cell
adhes
critic
adhes
cell
ms
patient
fac
analysi
function
data
indic
larg
fraction
cell
ms
patient
display
memoryeffector
phenotyp
result
show
cell
ms
patient
acut
phase
display
increas
abil
recruit
inflam
brain
venul
key
molecul
mediat
cell
migrat
brain
dichotomi
adhes
mechan
versu
lymphocyt
provid
import
inform
select
block
recruit
lymphocyt
subpopul
acut
ms
dopamin
fail
regul
cell
activ
multipl
sclerosi
effect
ifn
beta
giorelli
p
livrea
trojano
depart
neurolog
psychiatr
scienc
univers
bari
bari
itali
object
assess
whether
dopamin
network
lymphocyt
involv
pathophysiolog
multipl
sclerosi
ms
method
peripher
blood
mononuclear
cell
pbmc
isol
stabl
relapsingremit
ms
patient
relaps
ms
patient
treat
ms
patient
patient
affect
inflammatori
neurolog
diseas
healthi
control
assess
express
dopamin
receptor
investig
dopamin
agml
capabl
regul
cell
prolifer
express
ifn
gamma
cytokin
result
reduc
pbmc
stabl
ifnbeta
treat
ms
patient
express
normal
level
pbmc
stabl
ms
patient
reduc
pbmc
ms
patient
undergo
ifnbeta
treatment
dopamin
inhibit
cell
prolifer
express
enhanc
cytokin
mrna
pbmc
hd
ms
patient
differ
regulatori
effect
dopamin
renew
pbmc
ifnbeta
treat
ms
patient
conclus
differenti
express
dopamin
receptor
subtyp
underli
loss
inhibitori
effect
dopamin
cell
prolifer
express
mrna
secret
ifn
gamma
ms
avail
agonistsantagonist
dopamin
receptor
effect
ifnbeta
might
open
novel
path
therapeut
intervent
human
cell
util
cell
receptor
respond
phosphat
antigen
found
pathogen
mycobacterium
tuberculosi
rapidli
produc
larg
amount
proinflammatori
cytokin
chemokin
cytotox
factor
reason
implic
contributor
inflammatori
diseas
deplet
gammadelta
cell
mice
delay
protect
experiment
autoimmun
encephalomyel
model
multipl
sclerosi
ms
use
transcript
profil
phosphateantigenactiv
cell
observ
potent
upregul
proinflammatori
cytokin
cytotox
factor
also
note
upregul
vitamin
receptor
vdr
confirm
western
blot
depend
pkc
erk
signal
pathway
vdr
implic
downregul
cell
promot
product
regulatori
activ
dendrit
cell
less
known
direct
effect
vitd
cell
show
vitd
significantli
reduc
ippinduc
ifngamma
express
vitd
also
increas
activationinduc
cell
death
determin
indic
apoptosi
given
recent
data
support
protect
effect
vitd
intak
risk
develop
ms
munger
kl
et
al
neurolog
result
suggest
effect
vitd
reduc
proinflammatori
activ
gammadelta
cell
may
contribut
effect
spread
autoreact
antigen
present
thyroid
gland
spinal
cord
vice
versa
altern
pathogen
mechan
multipl
sclerosi
jm
greer
mp
pender
univers
queensland
brisban
australia
identifi
subgroup
patient
multipl
sclerosi
ms
coexist
autoimmun
thyroid
diseas
aitd
patient
aitd
develop
prior
onset
ms
patient
shown
predomin
involv
spinal
cord
outset
ms
much
less
involv
cerebrum
optic
nerv
normal
seen
patient
also
high
preval
autoimmun
diseas
especi
aitd
famili
member
class
ii
hla
allel
carri
patient
link
autoimmun
diseas
first
aris
patient
ie
patient
develop
ms
first
tend
carri
wherea
patient
first
develop
aitd
carri
increas
cell
antibodi
reactiv
detect
patient
sever
antigen
present
predominantli
exclus
spinal
cord
thyroid
gland
increas
reactiv
antigen
found
patient
ms
aitd
find
suggest
possibl
interorgan
spread
autoimmun
thyroid
gland
nervou
system
vice
versa
individu
genet
suscept
autoimmun
diseas
express
k
channel
tlymphocyt
multipl
sclerosi
patient
p
sarchielli
l
greco
candelier
ar
floridi
al
floridi
g
capocchi
univers
perugia
perugia
itali
aim
studi
aim
assess
express
k
channel
mrna
level
cell
patient
relapsingremit
rr
multipl
sclerosi
patient
method
rr
ms
patient
assess
stabl
clinic
phase
rr
ms
patient
relaps
control
group
consist
agematch
healthi
individu
express
assess
rtpcr
lymphocyt
prolifer
assay
measur
ifngamma
elisa
ca
measur
method
also
carri
result
rtpcr
analysi
show
higher
express
band
tcell
ms
patient
particularli
relaps
healthi
control
higher
express
band
present
mbp
tcell
k
blocker
ktxk
shk
shkdap
mgtx
inhibit
mitogenand
antigenspecif
prolifer
total
cell
ms
patient
k
blocker
also
reduc
ca
intracellular
level
product
ifngamma
discuss
confirm
express
channel
tcell
mbp
encephalitogen
cell
ms
patient
particularli
activ
phase
diseas
channel
relev
target
immunosuppress
blocker
channel
put
drug
candid
treat
ms
multipl
sclerosi
autoimmun
disord
central
nervou
system
immun
attack
direct
myelin
antigen
role
gammadelta
lymphocyt
nk
cell
diseas
pathogenesi
suggest
upon
exposur
phosphoantigen
human
lymphocyt
enter
lineag
differenti
pattern
determin
gener
memori
cell
rang
effector
function
show
within
effector
memori
popul
base
express
two
distinct
complementari
subset
regard
phenotyp
mode
activ
type
respons
identifi
cell
cell
latter
refractori
phosphoantigen
respond
activ
via
fcgammariii
highli
activ
tumor
target
cell
gammadelta
cell
like
repres
final
differenti
step
effector
cell
interestingli
cohort
ms
patient
found
expans
fraction
within
cell
popul
implic
diseas
pathogenesi
discuss
dendrit
cell
dc
essenti
orchestr
immun
toler
investig
immunoregulatori
function
freshli
isol
plasmacytoid
dendrit
cell
pdc
impair
multipl
sclerosi
ms
studi
pdc
untreat
ms
patient
healthi
control
allogen
cocultur
assay
irradi
peripher
blood
mononuclear
cell
pbmc
alway
obtain
healthi
donor
increas
ratio
pdc
ad
autolog
pbmc
effector
cell
deplet
pdc
respons
effector
cell
measur
prolifer
prolifer
calcul
stimul
index
si
repres
xfold
increas
compar
pbmc
deplet
pdc
found
dose
depend
increas
prolifer
ad
increas
number
pdc
cocultur
healthi
control
increas
pdc
pdc
pdc
ms
patient
modulatori
effect
could
observ
statist
signific
differ
ms
control
pdc
ratio
mannwhitney
utest
cocultur
supplement
also
found
dose
depend
differ
ms
patient
control
reach
signific
ratio
result
demonstr
pdc
deriv
ms
patient
alter
regulatori
function
compar
control
may
influenc
immun
imbal
ms
reactiv
immun
respons
caus
increas
cerebr
blood
volum
ka
broom
anthoni
b
blamir
water
b
vh
perri
b
p
style
n
sibson
univers
oxford
oxford
uk
b
univers
southampton
southampton
uk
long
postul
environment
factor
caus
exacerb
multipl
sclerosi
ms
use
magnet
reson
imag
mri
investig
whether
system
inflamm
induc
periton
inject
bacteri
cell
wall
product
reactiv
quiescent
cn
lesion
bear
mani
hallmark
ms
lesion
heatkil
bcg
organisms
inject
stereotax
striatum
male
lewi
rat
addit
al
bcg
deposit
cortic
surfac
initi
spontan
delay
type
hypersensit
dth
respons
lesion
resolv
day
agml
ip
e
coli
lipopolysaccharid
lp
endotoxin
inject
mri
perform
throughout
acut
dth
respons
follow
lp
challeng
h
initi
intracerebr
inject
caus
acut
dth
inflammatori
respons
includ
increas
region
cerebr
blood
volum
rcbv
bloodbrain
barrier
bbb
breakdown
oedema
accumul
resolv
day
h
lp
challeng
new
increas
rcbv
observ
throughout
inject
striatum
compar
prechalleng
valu
addit
increas
bbb
permeabl
observ
h
postlp
challeng
shown
system
inflammatori
respons
reactiv
dth
lesion
rodent
brain
increas
rcbv
alter
bbb
permeabl
find
may
implic
ms
patient
suggest
monitor
region
perfus
may
valuabl
detect
earli
cn
inflamm
cours
multipl
sclerosi
ms
gene
express
level
immun
system
gene
modifi
aim
studi
assess
differ
gene
express
level
set
eight
immun
system
gene
peripher
blood
mononuclear
cell
pbmc
patient
ms
assess
gene
express
level
hladra
ifngamma
tnfalpha
ido
solubl
full
length
pbmc
ms
patient
healthi
control
realtim
pcr
found
gene
express
level
ifngamma
significantli
lower
patient
control
ratio
significantli
lower
ms
patient
also
found
correl
ifngamma
tnfalpha
express
level
group
reduct
ratio
ifngamma
tnfalpha
patient
final
ifngamma
level
lower
untreat
treat
ms
patient
differ
found
group
studi
gene
result
show
imbal
cytokin
pbmc
patient
ms
whether
decreas
indic
ifngamma
produc
cell
decreas
sequest
peripher
tissu
brain
requir
studi
cerebrospin
fluid
serum
level
intrathec
product
activ
matrix
elev
multipl
sclerosi
patient
diseas
activ
castellazzi
bellini
mc
manfrinato
e
baldi
e
paolino
e
granieri
f
dallocchio
e
fainardi
univers
ferrara
ferrara
itali
measur
cerebrospin
fluid
csf
serum
level
matrix
tissu
inhibitor
activ
assay
system
elisa
respect
relapsingremit
rr
secondari
progress
sp
primari
progress
pp
multipl
sclerosi
ms
patient
stratifi
accord
clinic
magnet
reson
imag
mri
evid
diseas
activ
patient
inflammatori
neurolog
disord
oind
noninflammatori
neurolog
disord
nind
intrathec
synthesi
activ
frequent
ms
nind
clinic
mri
activ
clinic
mri
stabl
ms
patient
respect
serum
activ
ratio
higher
ms
oind
nind
clinic
mri
activ
clinic
mri
inact
ms
patient
csf
activ
ratio
elev
ms
nind
mri
activ
mri
stabl
ms
patient
result
suggest
intrathec
synthesi
activ
form
could
repres
sensit
marker
diseas
activ
ms
associ
csf
serum
activ
ratio
brain
plaqu
patient
multipl
sclerosi
ms
short
durat
contain
oligoclon
popul
infiltr
cell
x
zhang
wl
lin
c
platsouca
e
oleszak
templ
univers
philadelphia
usa
amplifi
npapcr
andor
valphaor
vbetaspecif
pcr
alphaand
betachain
tcr
transcript
cell
infiltr
acut
demyelin
brain
lesion
four
patient
chronic
progress
ms
die
within
year
clinic
diagnosi
amplifi
transcript
clone
sequenc
sequenc
analysi
reveal
multipl
ident
copi
tcr
transcript
strongli
suggest
presenc
clonal
expand
popul
cell
limit
number
clonal
expand
tcell
clone
found
brain
plaqu
patient
die
year
diagnosi
patient
die
acut
sever
necrot
ms
year
diagnosi
contrast
sever
alpha
betachain
tcr
transcript
clonal
expand
brain
plaqu
patient
die
chronic
ms
year
diagnosi
result
demonstr
presenc
oligoclon
popul
cell
brain
plaqu
patient
chronic
progress
ms
compris
number
expand
tcell
clone
multipl
sclerosi
consid
predominantli
affect
white
matter
human
cn
howev
demyelin
grey
matter
structur
promin
ms
case
present
studi
systemat
analyz
cortic
demyelin
plaqu
larg
sampl
multipl
sclerosi
brain
differ
stage
diseas
hemispher
doubl
hemispher
paraffinembed
tissu
section
examin
cortic
demyelin
offer
uniqu
opportun
evalu
diseas
involv
larg
cortic
area
demyelin
plaquesin
cerebr
cerebellar
cortexwer
abund
patient
primari
secondari
progress
ms
virtual
absent
patient
acut
relapsingremit
ms
extent
demyelin
white
matter
almost
four
group
addit
primari
secondari
ms
characterist
pallor
myelin
normal
appear
white
matter
observ
associ
signific
inflamm
also
microglia
macrophag
activ
patholog
chang
absent
acut
rrm
brain
incid
distribut
cortic
lesion
diffus
white
matter
injuri
multipl
sclerosi
may
patholog
correl
diseas
progress
suggest
fundament
differ
patholog
mechan
may
play
role
differ
stage
diseas
vivo
dynam
neuropatholog
brain
new
lesion
multipl
sclerosi
barilaro
f
zellini
f
caleri
passeri
c
gasperini
b
c
pozzilli
c
l
massacesi
univers
florenc
florenc
itali
b
san
camillo
forlanini
hospit
rome
itali
c
univers
rome
b
la
sapienzaq
rome
itali
present
studi
describ
relapsingremit
multipl
sclerosi
ms
patient
natur
histori
new
brain
lesion
visual
gd
enhanc
gd
mri
scan
two
differ
gd
dosag
persist
lesion
evalu
monthli
month
month
persist
lesion
analyz
weekli
week
lesion
two
differ
enhanc
volum
observ
accord
differ
gd
dosag
administ
volum
smaller
volum
evalu
time
w
scan
larger
correspond
outcom
evalu
month
therefor
acut
phase
tissu
damag
factor
present
mainli
centr
lesion
interpol
volum
kinet
lesion
multiparametr
fit
suitabl
repres
diffus
expans
contract
biolog
phenomena
random
walk
type
curv
obtain
noteworthi
kinet
volum
result
two
differ
kinet
part
overlap
correl
outcom
lesion
correspond
enhanc
lesion
high
provid
zenith
gd
volum
consid
correl
usual
high
also
patient
patient
specif
correl
coeffici
observ
data
indic
brain
ms
lesion
follow
common
biolog
rule
addit
data
indic
outcom
correl
correspond
gd
lesion
better
previous
report
effort
simplifi
diagnost
process
ms
incorpor
magnet
reson
imag
mri
diagnosi
diagnosi
continu
requir
two
attack
separ
space
time
util
mri
establish
new
ms
activ
cerebrospin
fluid
csf
analysi
evok
potenti
studi
may
still
employ
provid
paraclin
evid
diseas
materi
method
measur
tau
protein
concentr
csf
patient
ms
control
group
patient
result
statist
analys
tau
protein
measur
doubl
antibodi
sandwich
elisa
innogenet
ghent
belgium
result
outcom
diagnost
process
decid
patient
two
group
csf
tau
concentr
patient
ms
differ
control
find
correl
age
patient
durat
diseas
conclus
concentr
tau
protein
two
group
patient
without
ms
statist
differ
role
immun
mechan
multipl
sclerosi
ms
patient
epilepsi
kountouri
k
koutsob
neurolog
diagnost
center
athen
greec
background
aim
studi
check
role
immun
mechan
ms
patient
epilepsi
method
electroencephalogram
eeg
sleep
eeg
perform
eight
ms
patient
two
male
six
femal
epilepsi
mean
diseas
durat
year
differ
stage
diseas
period
year
time
partial
patholog
eeg
find
immunolog
paramet
collect
assess
end
studi
kurtzki
epss
also
taken
consider
result
found
signific
increas
lymphocyt
relat
sleep
eeg
edss
find
also
notic
analog
clinic
symptom
eeg
find
conclus
result
show
ms
patient
epilepsi
deterior
gener
clinic
imag
eeg
due
occasion
immunolog
disord
therefor
treatment
accordingli
direct
multipl
sclerosi
associ
autoimmun
diseas
petkovskaboskova
v
bojkovski
v
daskalovska
clinic
centr
skopj
r
macedonia
background
multipl
sclerosi
ms
commonli
associ
autoimmun
diseas
uveiti
thyreoid
crohn
diseas
etc
case
histori
present
seven
case
definit
ms
three
diseas
rang
year
develop
uveiti
one
patient
relapsingremit
rr
ms
present
two
attack
erythema
nodosum
en
one
develop
crohn
diseas
year
diagnos
ms
anoth
one
durat
psoriasi
develop
ms
last
one
present
coexist
diabet
mellitu
type
rr
form
ms
mean
disabl
degre
edss
conclus
intermedi
uveiti
may
belong
constel
relat
disord
includ
ms
although
ms
chronic
inflammatori
bowel
diseas
ibd
may
share
common
predispos
factor
unsuffici
inform
avail
specul
possibl
mechan
individu
genet
suscept
infect
downregul
inflamm
occur
proper
way
initi
autoimmun
process
en
selfincreas
cycl
found
haplotyp
link
diabet
mellitu
increas
among
patient
primari
progress
subtyp
ms
whether
patient
autoimmun
genet
associ
ms
anoth
diseas
remain
indetermin
possibl
environment
factor
could
bcomplicateq
condit
antiphospholipid
syndrom
livedo
reticulari
multipl
sclerosi
c
dikova
medic
univers
sofia
bulgaria
last
coupl
year
patient
multipl
sclerosi
ms
antiphospholipid
syndrom
ap
report
presenc
migrain
miscarriag
livedo
reticulari
lr
increas
level
anticardiolipin
antibodi
aca
present
women
livedo
reticulari
diagnos
multipl
sclerosi
purpos
studi
find
clinic
laboratori
data
ap
five
women
elev
igm
anticardiolipin
antibodi
aca
two
elev
igg
aca
six
miscarriag
two
migrain
suffer
two
tension
type
headach
three
deep
vein
thrombosi
three
occasion
high
blood
pressur
astrocyt
loss
rasmussen
enceph
j
bauer
c
elgar
b
pietsch
b
j
schramm
b
h
urbach
b
h
lassmann
cg
bien
b
brain
research
institut
vienna
austria
b
univers
bonn
bonn
germani
rasmussen
enceph
inflammatori
unihemispher
epilept
brain
disord
current
histopatholog
criteria
includ
presenc
tcell
domin
inflamm
microgli
activ
microgli
nodul
well
neuron
loss
astrocyt
activ
antibodi
impli
play
pathogen
role
mix
cell
cultur
antibodi
could
activ
glutam
receptor
shown
destroy
neuron
astrocyt
prompt
us
investig
astrocyt
cell
loss
situ
respect
epilepsi
surgeri
diagnost
brain
biopsi
patient
studi
activ
degener
apoptosi
loss
gfap
astrocyt
fluoresc
confoc
light
microscopi
astrocyt
apoptosi
found
cortic
area
insepar
neuron
loss
well
white
matter
area
result
astrocyt
defici
lesion
like
parenchym
cell
neuron
microgli
cell
astrocyt
tissu
reveal
mhc
class
express
furthermor
granzymeb
posit
lymphocyt
found
close
apposit
astrocyt
border
astrocytedefici
lesion
granzymeb
posit
granul
lymphocyt
polaris
face
astrocyt
membran
therefor
suggest
specif
attack
cytotox
lymphocyt
possibl
mechan
respons
astrocyt
degener
loss
astrocyt
import
homeostat
regul
glutam
neuron
transmitt
addit
cytotox
mechan
might
play
role
neuron
dysfunct
seizur
induct
enhanc
neuron
cell
death
rasmussen
enceph
sever
epilept
disord
may
respond
transient
immunotherapi
suggest
possibl
autoimmun
aetiolog
antibodi
glutam
receptor
type
report
recent
comprehens
studi
fail
confirm
presenc
antibodi
sera
intract
epilepsi
ie
patient
watson
et
al
press
look
antibodi
neuron
alpha
acetylcholin
receptor
nachr
sera
patient
ie
healthi
individu
test
rang
techniqu
antibodi
nachr
two
sera
patient
block
agonistinduc
current
nachr
express
xenopu
oocyt
addit
sera
deriv
igg
inhibit
agonistinduc
calcium
ion
influx
nachrtransfect
human
endotheli
cell
line
confirm
antibodi
direct
nachr
use
immunoprecipit
deterg
extract
cell
nachr
antibodi
present
activ
diseas
neg
later
diseas
process
patient
bburnoutq
result
demonstr
first
time
nachr
antibodi
antibodi
inhibit
nachr
channel
function
potenti
pathogen
ongo
studi
look
antibodi
patient
differ
form
sever
epilepsi
test
pathogen
vivo
hla
studi
indic
immunogenet
suscept
adult
rasmussen
ik
hart
j
darroch
b
univers
liverpool
liverpool
uk
b
royal
liverpool
univers
hospit
liverpool
uk
rasmussen
syndrom
rs
caus
sever
drug
resist
epilepsi
neurolog
cognit
deficit
present
childhood
adulthood
autoimmun
implic
pathogenesi
although
crucial
mechan
clear
object
studi
hla
associ
adult
rs
method
perform
dna
base
hla
type
six
rs
adult
respond
immunomodulatori
therapi
result
compar
control
datath
allel
preval
gener
uk
populationour
patient
increas
frequenc
hla
versu
hla
versu
hla
versu
hla
versu
gener
popul
hla
posit
patient
haplotyp
conclus
find
provid
evid
albeit
indirect
autoimmun
contribut
trigger
mainten
adult
rs
immun
dysregul
genet
depend
studi
establish
whether
hla
type
help
identifi
adult
present
focal
epilepsi
risk
progress
sever
chronic
focal
autoimmun
enceph
may
benefit
immun
therapi
morpholog
function
analysi
effect
gadantibodi
posit
sera
rat
hippocamp
neuron
cultur
vianello
c
mucignat
vassanelli
k
fountzoula
b
giometto
b
depart
human
anatomi
physiolog
univers
padova
padova
itali
b
depart
neurolog
hospit
treviso
treviso
itali
addit
stiffperson
syndrom
sp
ataxia
gadantibodi
ab
detect
drugresist
epilepsi
ep
test
reactiv
sera
cultur
rat
hippocamp
neuron
record
postsynapt
inhibitori
potenti
ipp
cell
assess
pathogenet
role
autoantibodi
test
sera
gadab
posit
patient
ep
cultur
neuron
use
immunohistochem
ihc
method
control
test
sera
gadab
posit
patient
sp
ataxia
diabet
gadab
neg
epilept
individu
sera
gadab
posit
epilept
diabet
patient
normal
control
select
ipp
record
cultur
hippocamp
neuron
applic
dilut
sera
patch
clamp
studi
ihc
specif
reactiv
soma
neuron
detect
appli
sera
gadab
epilept
patient
differ
stain
obtain
sera
sp
atax
patient
specif
label
found
patient
gadab
neg
epilepsi
diabet
control
signific
reduct
amplitud
increas
frequenc
ipp
observ
applic
serum
posit
epilept
case
effect
note
use
control
observ
morpholog
function
effect
hippocamp
neuron
may
suggest
pathogenet
role
gadab
develop
diseas
cytotox
cell
pathogenesi
paraneoplast
enceph
nonparaneoplast
limbic
enceph
rasmussen
enceph
cg
bien
h
lassmann
b
ce
elger
j
bauer
b
univers
bonn
bonn
germani
b
medic
univers
vienna
vienna
austria
recent
immunohistochem
investig
immunopatholog
rasmussen
enceph
provid
evid
cytotox
cell
reaction
neuron
present
studi
sought
determin
composit
inflammatori
cell
patient
paraneoplast
enceph
pe
nonparaneoplast
limbic
enceph
nple
two
chronic
encephalit
condit
suggest
cell
mediat
disord
similar
studi
paraffinembed
brain
specimen
pe
nple
case
specimen
stain
immunohistochem
antibodi
granzymeb
immunoglobulin
fa
mhc
class
quantit
evalu
cell
densiti
perform
statist
analyz
use
nonparametr
parametr
test
appropri
ratio
ratio
frequenc
fa
cell
differ
three
diseas
mhc
class
neuron
astrocyt
oligodendrocyt
observ
similar
proport
pe
specimen
howev
contain
significantli
higher
densiti
cell
b
cell
plasma
cell
macrophag
compar
nple
conclud
cell
cytotox
form
bbackboneq
condit
higher
inflammatori
activ
broader
spectrum
inflammatori
cell
pe
may
indic
inflammatori
mechan
beyond
cell
cytotox
work
support
grant
austrian
scienc
foundat
fwf
sinc
first
descript
report
patient
antima
patient
antita
reactiv
updat
clinic
inform
two
reactiv
addit
antima
addit
antita
posit
patient
identifi
sera
test
use
westernblot
analysi
semipurifi
recombin
protein
clinic
data
collect
retrospect
nine
antima
posit
patient
femal
mean
age
present
brainstemcerebellar
limbic
extrapyramid
symptom
polyneuropathi
tumor
identifi
twice
renal
rhabdosarcoma
breast
lung
patient
lung
tumor
overlap
antihu
antibodi
detect
antitaposit
patient
male
mean
age
present
limbic
syndrom
one
obsessivecompuls
symptom
brainstemcerebellar
symptom
polyneuropathi
sign
motor
neuron
involv
tumor
identifi
includ
germ
cell
tumor
one
extragonad
one
orchiectomi
one
autopsi
one
melanoma
lymphoma
lungcarcinoma
one
patient
past
histori
seminoma
without
known
relaps
anoth
recogn
suspici
testicular
swell
disappear
spontan
biopsi
antima
antita
reactiv
prove
high
clinic
relev
patient
present
subacut
brainstem
limbic
symptom
present
thorough
tumor
search
warrant
proteasom
antibodi
paraneoplast
cerebellar
degener
storstein
knudsen
ca
vedel
haukeland
univers
hospit
bergen
norway
paraneoplast
neurolog
syndrom
pn
often
associ
specif
onconeur
antibodi
pathogen
import
humor
immun
respons
unclear
activ
specif
lymphocyt
paraneoplast
cerebellar
degener
pcd
paraneoplast
encephalomyelitissensori
neuropathi
pemsn
suggest
cellular
immun
respons
particip
pathogenesi
studi
detect
proteasom
antibodi
sera
patient
pcd
western
blot
sera
patient
pemsn
proteasom
antibodi
found
control
serum
blood
donor
sera
serum
pool
blood
donor
patient
cancer
pn
immunohistochemistri
found
serum
antibodi
pcd
patient
stain
cytospin
variou
cancer
cell
line
stain
colocalis
proteasomeassoci
promyelocyt
protein
pcd
sera
also
stain
live
cancer
cell
affect
cell
viabil
proteasom
antibodi
detect
cerebrospin
fluid
one
pcd
three
pemsn
patient
proteasom
import
nonlysosom
protein
degrad
antigen
process
present
major
histocompat
complex
class
molecul
proteasom
antibodi
pcd
may
pathogen
import
regul
cellular
metabol
immun
respons
conform
epitop
prevent
recognit
target
antigen
autoantibodi
paraneoplast
syndrom
target
antigen
antitr
antibodiescharacter
patient
paraneoplast
cerebellar
degener
pcd
hodgkin
diseas
hd
still
elus
owe
failur
identif
use
convent
proteom
approach
appli
new
procedur
base
direct
tissu
isoelectr
focus
gradient
electrophoresi
nondenatur
polyacrylamid
gel
test
hypothesi
antitr
antibodi
recogn
conform
epitop
studi
sera
two
patient
pcd
hd
use
rat
human
cerebellum
sourc
antigen
sera
recogn
sharp
band
approxim
kda
rat
human
tissu
mass
spectrometri
malditof
identifi
cytoplasm
protein
correspond
mass
rat
human
protein
candid
ligand
antitr
antibodi
antibodi
associ
limbic
enceph
thymoma
knudsen
g
bredholt
storstein
l
olted
b
davang
b
ca
vedel
haukeland
univers
hospit
bergen
norway
b
univers
bergen
bergen
norway
introduct
paraneoplast
neurolog
syndrom
aris
remot
effect
sever
differ
tumor
thymoma
associ
variou
antibodi
antiachr
antititin
antiryr
antivgkc
method
patient
develop
limbic
enceph
focal
epilept
seizur
screen
occult
cancer
reveal
thymoma
paraneoplast
antibodi
relat
limbic
enceph
antihu
antiamphiphysin
antiri
relat
thymoma
neg
patient
serum
test
tissu
section
rat
brain
primari
cultur
neuron
hippocampu
use
screen
cdna
express
librari
rat
cerebellum
rabbit
polyclon
antibodi
use
stain
hippocampu
result
patient
serum
stain
cellular
region
hippocampu
synapt
bouton
nuclei
cell
dentat
gyru
similar
stain
observ
pyramid
cell
cultur
antibodi
also
stain
hippocampu
western
blot
rat
brain
extract
incub
patient
serum
reveal
two
band
approxim
kda
screen
cdna
librari
identifi
two
differ
clone
one
code
nuclear
protein
discuss
antibodi
associ
thymoma
limbic
enceph
present
hippocampu
may
relev
pathogenesi
limbic
enceph
seizur
involv
complex
neurophysiolog
neurochem
event
involv
detriment
consequ
reoccurr
seizur
establish
chronic
epilepsi
event
includ
neuroinflamm
manifest
quickli
follow
seizur
although
inflamm
brain
follow
seizur
well
character
role
could
adapt
detriment
still
debat
order
clarifi
problem
treat
mice
corticosteron
potent
suppressor
inflamm
character
effect
seizur
associ
neurolog
neuroimmun
consequ
wellestablish
model
pilocarpin
administr
mice
use
situ
hybridis
immunocytochemisti
variou
marker
cell
death
damag
found
even
corticosteron
abl
suppress
neuroinflamm
associ
seizur
seizur
associ
neuron
cell
death
still
occur
howev
suppress
immun
system
spare
specif
popul
neuron
hippocampu
express
npi
region
believ
indic
mossi
fiber
sprout
neuroprotect
greatli
affect
thu
conclud
neuroinflamm
could
play
major
role
reorgan
take
place
key
region
follow
seizur
could
implic
possibl
immun
intervent
prevent
detriment
event
follow
seizur
lead
epilepsi
antiepileptogen
anticonvuls
activ
amygdalakindl
rat
sayyah
beheshti
b
institut
pasteur
iran
tehran
iran
b
tehran
univers
tehran
iran
ischaem
excitotox
traumat
brain
injuri
associ
occurr
epilept
seizur
microglia
princip
immun
cell
brain
produc
varieti
proinflammatori
cytotox
factor
especi
earli
acut
insult
studi
effect
ngrat
icv
seizur
acquisit
fulli
kindl
seizur
amygdala
kindl
model
epilepsi
retard
acquisit
kindl
behavior
seizur
growth
afterdischarg
ad
also
exhibit
signific
anticonvuls
effect
establish
kindl
seizur
ad
durat
pretreat
kindl
anim
nitric
oxid
synthas
inhibitor
n
g
nitrolarginin
methyl
ester
cyclooxygenas
inhibitor
piroxicam
complet
revers
anticonvuls
effect
although
previou
studi
indic
proconvuls
convuls
properti
result
support
protect
antiepileptogen
role
seizur
common
sequel
brain
insult
case
stroke
trauma
infect
certain
neuroinflamm
intracerebroventricular
icv
administr
lipopolysaccharid
lp
induc
inflammatori
state
brain
use
model
neuroinflamm
studi
effect
lp
agrat
icv
develop
electr
kindl
amygdala
fulli
kindl
seizur
lp
dose
use
effect
fulli
kindl
seizur
afterdischarg
ad
durat
h
administr
howev
daili
inject
lp
agrat
retard
acquisit
kindl
behavior
seizur
antiepileptogen
effect
could
due
releas
inflammatori
mediat
microglia
relat
morpholog
function
chang
synapt
neurotransmiss
increas
serum
level
patient
epilepsi
l
baston
ferraro
casaletto
n
romeo
l
cresciben
institut
neurolog
scienc
cnr
mangon
cs
itali
evid
inflammatori
process
may
involv
clinic
neuropatholog
manifest
epilepsi
proinflammatori
cytokin
tnfalpha
known
indirect
direct
effect
neuron
neurotox
neurotransmitt
releas
excit
inflamm
studi
patient
epilepsi
anim
experiment
induc
seizur
indic
cytokin
may
influenc
electrophisiolog
properti
neuron
adult
rat
statu
epilepticu
induc
cytokin
product
glia
especi
seizur
associ
neuron
injuri
suggest
cytokin
may
play
role
seizuresinduc
neuron
damag
chemokin
produc
monocyt
endotheli
cell
cell
act
chemotact
activ
neutrophili
effect
manli
proinflammatori
investig
level
proinflammatori
cytokin
serum
normal
epilept
patient
use
enzymelink
immunosorb
assay
found
elev
concentr
serum
epilept
patient
data
support
hypothesi
cytokin
group
activ
whether
elev
cytokin
level
role
pathogenesi
epilepsi
must
investig
experiment
studi
demonstr
epilept
seizur
follow
increas
product
cytokin
human
patient
increas
level
report
csf
plasma
seizur
howev
whether
increas
caus
seizur
per
se
underli
diseas
caus
seizur
controversi
electroconvuls
seizur
ec
commonli
use
experiment
approach
antiepilept
drug
develop
ec
also
employ
treatment
drug
refractori
depress
present
studi
determin
plasma
level
cytokin
sever
time
point
administr
ec
level
significantli
increas
h
time
point
return
basal
level
h
level
unchang
level
increas
significantli
h
time
point
return
basal
level
h
result
clearli
demonstr
ec
follow
transient
increas
system
level
proinflammatori
cytokin
find
provid
evid
seizur
induc
product
cytokin
cn
addit
activ
cytokin
cascad
ec
may
import
therapeut
effect
ec
major
depress
antinuclear
cytoskelet
antineuron
antibodi
creactiv
protein
level
sera
children
tic
disord
obsess
compuls
disord
gorker
g
akmandemir
n
gqrel
polat
r
eker
meroglu
icoz
p
serdaroglu
u
tuzun
istanbul
medic
faculti
istanbul
turkey
immunohistochem
analysi
serum
antibodi
central
nervou
system
antigen
antiphospolipid
syndrom
e
aykutlu
e
tqzqn
b
b
baykan
n
polatgqrel
icoz
p
christadoss
b
c
gqrse
inanc
g
akmandemir
gfkyigit
istanbul
medic
faculti
istanbul
turkey
b
univers
texa
medic
branch
galveston
tx
usa
order
detect
antibodi
central
nervou
system
cn
antigen
patient
seizur
primari
secondari
antiphospholipid
apl
antibodi
syndrom
serum
sampl
test
immunohistochemistri
four
case
apl
syndrom
seizur
show
bind
neuron
bind
predominantli
nuclear
two
case
strong
stain
cytoplasm
two
case
moder
stain
strength
immunohistochem
stain
correl
age
patient
durat
seizur
patient
strong
nuclear
stain
also
sle
three
patient
partial
epilepsi
wherea
one
patient
gener
epilepsi
one
patient
strong
stain
seizur
sequel
apl
syndrom
relatedcerebr
infarct
wherea
remain
three
case
seizur
relat
focal
cerebr
lesion
apl
syndrom
patient
serum
antibodi
cn
might
emerg
due
certain
antiepilept
drug
disrupt
bloodbrain
barrier
stroke
certain
case
might
play
causal
role
strong
nuclear
stain
might
simpli
relat
antinuclear
antibodi
frequent
detect
apl
syndrom
sle
patient
wherea
cytoplasm
stain
might
indic
presenc
cnsspecif
antibodi
develop
either
epiphenomenon
cours
diseas
contribut
factor
epilepsi
autoantibodi
central
nervou
system
case
lafora
diseasel
onset
variant
e
aykutlu
e
tqzqn
b
g
akmandemir
n
bebek
icfz
p
christadoss
b
b
baykan
istanbul
medic
faculti
istanbul
turkey
b
univers
texa
medic
branch
galveston
tx
usa
sera
sibl
age
year
lafora
diseas
ld
late
onset
variant
diagnos
axillari
skin
biopsi
also
high
titer
antigliadin
igg
antibodi
test
immunohistochemistri
antibodi
capabl
bind
mous
central
nervou
system
cn
antigen
serum
sampl
three
four
patient
ld
show
bind
neuron
includ
cerebellar
purkinj
cell
cortic
neuron
stain
observ
beyond
dilut
control
serum
sampl
bind
predominantli
nuclear
three
case
notabl
patient
also
high
titer
antigliadin
igg
antibodi
although
coeliac
diseas
could
demonstr
intestin
biopsi
four
patient
treat
valproat
clonazepam
lamotrigin
strength
immunohistochem
stain
correl
neither
sever
length
pme
syndrom
sinc
one
patient
famili
similar
clinic
condit
reveal
detect
amount
antibodi
cn
like
autoantibodi
emerg
byproduct
ongo
diseas
rather
primari
causal
factor
coexist
ld
coeliac
diseas
previous
report
result
provid
support
two
diseas
might
associ
introduct
onconeur
antibodi
associ
small
cell
lung
cancer
sclc
thymoma
preval
antibodi
patient
tumour
well
correl
prognosi
larg
unknown
patient
method
sera
patient
sclc
patient
thymoma
myasthenia
gravi
healthi
blood
donor
examin
antibodi
vitro
transcriptiontransl
itt
base
immunoprecipit
assay
posit
sera
also
examin
western
blot
use
cn
extract
recombin
commerci
dot
blot
kit
result
antibodi
found
sclc
thymoma
none
healthi
control
sera
itt
immunoprecipit
assay
high
index
found
seven
thymoma
four
sclc
patient
highindex
sera
also
posit
western
blot
dot
blot
conclus
antibodi
detect
approxim
sclc
thymoma
patient
itt
immunoprecipit
assay
assay
sensit
western
blot
dot
blot
background
presenc
antineuron
autoantibodi
ab
well
describ
associ
late
onset
cerebellar
ataxia
loca
paraneoplast
manifest
identifi
presenc
certain
cancer
may
also
rare
seen
absenc
neoplasia
howev
frequenc
ab
relev
wider
loca
popul
remain
unclear
explor
signific
preval
populationbas
sampl
patient
idiopath
loca
iloca
south
wale
method
materi
sera
patient
mean
diseas
durat
year
rang
analys
use
indirect
immunohistochemistri
andor
western
blot
ihcwb
antihu
ri
tr
yo
ab
use
immunoprecipit
ip
pqtype
voltageg
calcium
channel
vgcc
voltageg
potassium
channel
vgkc
result
assay
compar
known
neg
normal
posit
control
result
ihcwb
sera
show
stain
pattern
initi
suggest
antiyo
hu
tr
exclud
wb
sera
reveal
batypicalq
stain
pattern
ip
none
posit
antivgcc
antivgkc
ab
discuss
iloca
patient
posit
antineuron
ab
screen
antihu
ri
tr
yo
vgcc
vgkc
howev
show
atyp
stain
pattern
unknown
signific
indic
possibl
undetermin
immunolog
patholog
signific
proport
patient
neuroprotect
multipl
sclerosi
r
diem
hobom
depart
neurolog
univers
gfttingen
gfttingen
germani
longterm
disabl
multipl
sclerosi
ms
patient
primarili
caus
axon
neuron
lesion
date
neuroor
axonoprotect
therapi
avail
previous
demonstr
neuron
apoptosi
occur
earli
myelin
oligodendrocyt
glycoprotein
mog
induc
experiment
autoimmun
encephalomyel
eae
highdosag
methylprednisolon
treatment
establish
standard
therapi
acut
inflamm
optic
nerv
investig
influenc
methylprednisolon
therapi
surviv
retin
ganglion
cell
rgc
whose
axon
form
use
mog
induc
eae
involv
assess
record
visual
evok
potenti
vep
rgc
function
monitor
measur
electroretinogram
erg
methylprednisolon
treatment
significantli
increas
rgc
apoptosi
mogea
lead
recoveri
erg
vep
underli
molecular
mechan
rgc
death
involv
suppress
mitogenactiv
protein
kinas
phosphoryl
calciumdepend
henc
provid
evid
neg
effect
steroid
treatment
neuron
surviv
thu
besid
immunosuppress
strategi
neuroprotect
approach
design
end
could
show
system
treatment
erythropoietin
rat
mogea
includ
sever
optic
neuriti
reduc
clinic
sever
diseas
moreov
surviv
function
rgc
document
histolog
erg
measur
significantli
improv
neurodegener
multipl
sclerosi
high
vulner
neuron
lymphocyt
f
giuliani
baror
b
vw
yong
univers
calgari
calgari
canada
b
mcgill
univers
montreal
canada
ms
consid
cellmedi
diseas
cn
character
inflamm
demyelin
neuron
degener
current
object
determin
whether
polar
cell
differ
capac
neurodegener
vitro
eae
use
cocultur
system
human
leukocyt
human
fetal
neuron
cell
activ
antigenspecif
manner
polar
line
bia
follow
period
cocultur
neuron
stain
antibodi
count
assess
cytotox
antigenspecif
mix
popul
induc
neuron
death
wherea
polar
popul
induc
death
within
h
polar
cell
unabl
kill
neuron
eae
induc
mice
clinic
score
daili
basi
sacrif
histolog
analysi
coloc
inflamm
axon
loss
show
signific
correl
spinal
cord
eae
anim
overal
data
demonstr
cell
toxic
human
neuron
line
axon
loss
occur
vivo
eae
area
cell
inflamm
suggest
cell
appropri
activ
traffic
cn
induc
neuron
death
shift
cell
toward
phenotyp
decreas
potenti
toxic
direct
impact
cell
neuron
potenti
damag
mechan
neuroinflammatori
disord
akta
e
pohl
b
smorodchenko
c
infanteduart
r
nitsch
b
f
zipp
institut
neuroimmunolog
humboldt
univers
medic
school
berlin
germani
b
institut
anatomi
humboldt
univers
medic
school
berlin
germani
precis
mechan
neuron
damag
multipl
sclerosi
ms
anim
model
experiment
autoimmun
encephalomyel
eae
poorli
understood
appli
two
photon
laserscan
microscopi
track
direct
interact
proteolipid
protein
plp
specif
cell
within
complex
cellular
network
live
brain
tissu
cell
line
releas
high
amount
ifngamma
tnfalpha
use
induct
eae
label
red
fluoresc
dye
cmtmr
appli
live
brain
slice
incub
calciumsensit
dye
plpspecif
cell
directli
contact
neuron
induc
calcium
oscil
final
result
lethal
increas
neuron
calcium
level
prevent
calcium
overload
achiev
blockad
perforinmedi
cytotox
cell
concanamycina
washin
experi
glutamaterg
neuron
connect
hippocampu
inhibit
use
blocker
differ
glutam
receptor
revers
cellinduc
calcium
oscil
effect
independ
antigen
present
sinc
ovaspecif
cell
also
abl
induc
increas
neuron
calcium
contrast
unstimul
cell
elicit
effect
thu
data
provid
direct
insight
detriment
impact
cell
neuron
show
stimul
cell
independ
target
antigen
enabl
induc
collater
damag
neuron
via
direct
cellcel
contact
within
brain
parenchyma
complement
activ
involv
initi
antibodymedi
inflammatori
demyelin
experiment
autoimmun
encephalomyel
eae
sublyt
dose
membran
attack
complex
mac
protect
oligodendrocyt
apoptosi
use
mice
previous
show
dual
role
enhanc
inflammatori
demyelin
acut
eae
promot
remyelin
recoveri
studi
investig
role
apoptosi
myelininduc
eae
acut
eae
mice
similar
number
total
apoptot
cell
wherea
significantli
fewer
recoveri
addit
group
mice
display
tunel
oligodendrocyt
significantli
fewer
acut
eae
recoveri
gene
array
immunostain
apoptosisrel
gene
show
fasl
express
higher
mice
fa
cell
also
higher
mice
acut
eae
howev
cell
significantli
reduc
recoveri
togeth
find
consist
role
possibl
form
mac
limit
oligodendrocyt
apoptosi
eae
thu
promot
remyelin
recoveri
jnk
activ
involv
trailinduc
death
adult
human
oligodendrocyt
matysiak
jurewicz
andrzejak
k
selmaj
medic
univers
lodz
lodz
poland
trail
report
induc
apoptosi
tumour
cell
line
normal
cell
trail
demonstr
autoreact
cell
may
involv
immun
mediat
apoptosi
brain
target
cell
suscept
resist
trailinduc
death
relat
differ
trail
receptor
express
orand
differ
involv
intracellular
apoptot
molecul
assess
death
adult
human
oligodendrocyt
ahol
trail
stimul
use
annexin
pi
stain
jnk
activ
trail
stimul
assess
use
antibodi
phosphoryl
form
kinas
western
blot
cjun
phosphoryl
cell
lysat
assess
autoradiographi
caspas
pathway
activ
analys
western
blot
use
gener
caspas
inhibitor
role
jnk
activ
oligodendrocyt
death
determin
inhibit
jnk
use
dominantneg
mutant
trail
induc
ahol
death
condit
protein
synthesi
inhibit
pretreat
ifngamma
microglia
cell
resist
trail
mediat
cytotox
detect
caspas
pathway
activ
ahol
trail
stimul
caspas
inhibitor
prevent
ahol
death
observ
persist
activ
jnk
oligodendrocyt
microglia
cell
trail
stimul
inhibit
jnk
activ
protect
oligodendrocyt
trailinduc
death
result
may
implic
jnk
pathway
involv
trailinduc
select
oligodendrocyt
demis
inflammatorydemyelin
condit
inappropri
crosstalk
activ
lymphocyt
infiltr
central
nervou
system
cn
neural
cell
sustain
onset
progress
demyelin
axon
degener
neuroinflammatori
diseas
mimic
deleteri
crosstalk
design
experiment
paradigm
consist
transient
cocultur
lymphocyt
chronic
activ
retroviru
infect
viru
product
human
multipot
neural
precursor
primari
oligodendrocyt
rat
brain
show
activ
lymphocyt
induc
apoptot
death
multipot
neural
progenitor
immatur
oligodendrocyt
progress
collaps
process
extens
effect
reminisc
induc
brain
semaphorin
neural
cell
blockad
specif
antibodi
solubl
releas
activ
cell
treatment
recombin
demonstr
immun
semaphorin
abil
collaps
oligodendrocyt
process
extens
trigger
neural
cell
apoptosi
like
receptor
plexin
famili
specif
presenc
csf
expressingt
lymphocyt
spinal
cord
patient
suffer
neuroinflammatori
demyelin
point
potenti
patholog
effect
cn
thu
result
show
new
import
element
deleteri
cellneur
cell
crosstalk
neuroinflamm
suggest
role
demyelin
absenc
remyelin
neuroinflammatori
diseas
includ
multipl
sclerosi
myelopathi
proteinaseactiv
express
neuroprotect
lentivirusinduc
neuroinflamm
f
noorbakhsh
n
vergnol
vodjgani
b
hollenberg
c
power
univers
calgari
calgari
canada
b
tehran
univers
medic
scienc
tehran
iran
proteinaseactiv
receptor
par
famili
gprotein
coupl
receptor
activ
proteolyt
cleavag
aminoterminu
previou
studi
group
shown
pathogen
role
lentivirusinduc
neuroinflamm
explor
role
receptor
analys
role
context
lentiviru
human
immunodefici
virushiv
felin
immunodefici
virusfiv
induc
neuroinflamm
mrna
protein
level
increas
hivand
fivinfect
brain
princip
neuron
local
analys
realtim
rtpcr
immunocytochemistri
treatment
human
mous
neuron
cell
line
recombin
tnfalpha
increas
mrna
protein
level
overexpress
neuron
cell
decreas
neuron
cell
death
induc
exposur
hiv
tatinduc
neurotoxin
intracerebr
implant
activ
peptid
sligrl
decreas
neurobehavior
effect
hiv
tat
inde
null
anim
exhibit
promin
astrocytosi
neuron
loss
togeth
greater
neurobehavior
effect
wildtyp
litterm
follow
implant
hiv
tatinduc
neurotoxin
studi
indic
exert
neuroprotect
effect
lentivirusinduc
brain
diseas
augment
proinflammatori
cytokin
neuron
death
mice
like
due
loss
glial
support
releas
cytokin
neurotoxin
glial
cell
investig
whether
er
stress
signal
involv
neuron
loss
brain
infect
mice
brainstem
found
show
signific
increas
phosphoryl
doublestrand
rnadepend
protein
kinaselik
er
kinas
eukaryot
initi
factor
addit
increas
express
growth
arrest
dna
damag
glucoseregul
protein
accompani
increas
process
downstream
target
event
marker
er
stress
observ
cleav
present
degen
neuron
lesion
infect
mice
uninfect
control
phosphoryl
calmodulindepend
protein
kinas
iia
significantli
increas
coexpress
larg
proport
neuron
undergo
earli
advanc
degen
chang
final
neuron
degener
spongiform
lesion
associ
increas
calcium
accumul
mitochondria
togeth
result
suggest
infectionmedi
neuron
degener
mice
may
result
activ
er
stress
signal
pathway
presum
initi
perturb
homeostasi
find
highlight
import
er
stress
signal
pathway
infectioninduc
neuron
degener
death
radic
scaveng
edaravon
prevent
oxid
neurotox
induc
peroxynitrit
activ
microglia
banno
mizuno
g
zhang
j
kawanokuchi
r
kuno
jin
h
kato
h
takeuchi
suzumura
univers
nagoya
nagoya
japan
free
radic
scaveng
edaravon
use
antioxid
agent
acut
ischem
brain
disord
examin
effect
edaravon
product
nitric
oxid
reactiv
oxygen
speci
ro
proinflammatori
cytokin
activ
microglia
also
examin
neuroprotect
role
cortic
neuron
cultur
oxid
stress
peroxynitrit
donor
nmorpholinosydoniamin
activ
microglia
edaravon
significantli
suppress
product
ro
activ
microglia
though
suppress
product
inflammatori
cytokin
addit
edaravon
significantli
suppress
neuron
cell
death
dendrotox
induc
either
activ
microglia
dose
depend
manner
result
suggest
edaravon
may
use
neuroprotect
agent
counteract
oxid
neurotox
aris
activ
microglia
occur
either
inflammatori
neurodegen
disord
central
nervou
system
effect
nitric
oxid
adult
neural
stem
cell
r
covacu
aguilarsantelis
olsson
l
brundin
karolinska
institutet
stockholm
sweden
aim
determin
long
short
time
effect
nitric
oxid
adult
neural
stem
cell
background
nitric
oxid
produc
high
concentr
cn
multipl
sclerosi
patient
contribut
tissu
damag
seen
ms
method
adult
neural
stem
cell
rat
expos
detanono
ate
mm
h
releas
calibr
use
sensit
electrod
noeffect
cell
viabil
differenti
assess
h
necrosi
apoptosi
studi
use
propidium
iodideannexin
v
flow
cytometri
stain
also
assess
immunocytochemistri
effect
differenti
assess
immunolabel
cell
neuron
tuj
oligodendrocyt
astrocyt
gfap
lineag
marker
result
nitric
oxid
administ
stem
cell
cultur
dose
depend
effect
surviv
differenti
cell
dose
depend
damag
cell
determin
flow
cytometri
annexin
vpropidiumiodid
level
releas
donor
mm
compar
level
found
patient
mm
capac
stem
cell
form
neuron
oligodendrocyt
lost
astrocyt
form
nodeplet
detanono
ate
use
control
conclus
csf
nitric
oxid
level
ms
patient
affect
stem
cell
surviv
differenti
neurotox
induc
ltaactiv
glial
cell
mediat
nitric
oxid
product
caspas
activ
kinsner
coeck
hartung
b
price
ecvam
european
commiss
join
research
centr
ispra
va
itali
b
dept
biochem
pharmacolog
univers
konstanz
konstanz
germani
central
nervou
system
cn
proinflammatori
potenti
lipoteicho
acid
lta
deriv
gramposit
bacteri
cell
wall
still
controversi
investig
whether
ltafmdp
muramyl
dipeptid
could
activ
rat
cortic
glial
cell
astrocyt
andor
microglia
measur
tnfalpha
nitric
oxid
product
subsequ
could
induc
neuron
cell
death
mechan
inde
lta
synergi
mdp
activ
principl
peptidoglycan
induc
strong
inflammatori
respons
type
glial
cell
timeand
dosedepend
product
tnfalpha
observ
studi
whether
activ
glia
could
induc
neuron
cell
death
expos
cerebellar
granul
cell
cgc
cultur
presenc
glia
nonneuron
cell
lta
agml
mdp
ngml
h
signific
neuron
cell
death
observ
assess
propidium
iodid
hoechst
stain
inde
death
cgc
caus
activ
glia
absenc
glia
treatment
cytosinedarabinosid
inhibit
nonneuron
cell
prolifer
ltamdp
caus
signific
cell
death
neuron
cell
death
induc
lta
mdpactiv
glia
significantli
block
ino
inhibitor
w
broadspectrum
caspas
inhibitor
zvadfmk
suggest
neuron
cell
death
mediat
product
caspaseactiv
mechan
may
contribut
neurodegener
observ
cn
infect
caus
gramposit
bacteria
aim
cytotox
cell
involv
west
nile
viru
wnv
enceph
predomin
lymphocyt
popul
infiltr
brain
aim
determin
role
tc
cell
cytolyt
pathway
granul
exocytosi
mediat
perforin
granzym
fastrigg
kill
either
viru
clearanc
immunopatholog
method
wildtyp
mutant
mice
defect
cytolyt
effector
molecul
infect
iv
wnv
sarafend
strain
viru
detect
plaqu
titrat
immunohistochemistri
cytotox
splenocyt
measur
vitro
result
infect
celldefici
mice
high
dose
wnv
pfu
result
reduc
mortal
prolong
mean
surviv
time
mst
wherea
infect
low
dose
pfu
led
increas
mortal
prolong
mst
transfer
wnvimmun
cell
reduc
wnvmediat
mortal
mice
defect
granul
exocytosi
pathway
cytotox
higher
risk
enceph
death
perforin
play
crucial
role
recoveri
wnv
infect
defici
either
fa
fasl
markedli
affect
suscept
mice
wnv
howev
mice
defici
fa
perf
display
higher
incid
enceph
death
infect
conclus
granul
exocytosi
well
fa
pathway
cytotox
involv
recoveri
immunopatholog
mous
wnv
infect
tmev
induc
sjl
mice
earli
acut
diseas
follow
late
chronic
demyelin
diseas
earli
acut
diseas
viru
partial
clear
cn
cell
cell
express
fa
fasl
neglig
level
day
post
infect
dpi
dpi
cell
infiltr
cn
sjl
mice
express
significantli
higher
proport
versu
mice
vivo
label
brdu
reveal
cnsinfiltr
cell
cycl
earli
acut
diseas
larg
proport
cell
show
phenotyp
activ
effector
cell
cell
undergo
aicd
result
downsiz
inflammatori
respons
tunel
assay
reveal
cell
undergo
apoptosi
dpi
contrast
late
chronic
demyelin
diseas
mononuclear
cell
apoptot
cn
infiltr
cell
express
high
level
fa
fasl
cell
memori
cell
arrest
lack
situ
prolifer
cell
express
high
level
cn
pauciti
apoptosi
like
respons
accumul
cell
cn
late
chronic
demyelin
diseas
sjl
mice
identif
astrocytederiv
gene
induc
apoptosi
autoreact
cell
h
hara
tabira
nation
institut
longev
scienc
obu
citi
japan
eae
apoptosi
cell
mainli
seen
site
cn
inflamm
report
astrocyt
may
render
cell
suscept
induct
apoptot
cell
death
studi
identifi
clone
gene
deriv
ifngammatr
astrocyt
cell
line
induc
apoptosi
autoreact
cell
made
subtract
cdna
librari
ifngammatr
astrocyt
cell
line
got
posit
clone
clone
sequenc
gene
interest
transfect
cho
cell
individu
activ
plpreactiv
cell
line
cocultur
transfect
cho
cell
cell
harvest
stain
annexin
vfitc
pi
analyz
flow
cytometri
identifi
two
candid
gene
induc
apoptosi
plpreactiv
cell
line
first
gene
unknown
gene
name
astrocytederiv
immun
suppressor
factor
adif
length
bp
amino
acid
recombin
adif
protein
made
drosophila
express
system
acut
eae
induc
mice
immun
mog
peptid
plu
cfa
adif
protein
inject
intraven
treat
group
show
signific
amelior
clinic
eae
score
patholog
chang
cn
adif
may
effect
treatment
multipl
sclerosi
regul
natur
killer
cell
stimulatori
inhibitori
molecul
mous
nervou
system
e
afj
drenth
h
sjflin
b
hg
ljunggren
c
k
kristensson
depart
neurosci
karolinska
institutet
stockholm
sweden
b
microbiolog
tumor
biolog
center
karolinska
institutet
stockholm
sweden
c
center
infecti
medicin
karolinska
institutet
hudding
univers
hospit
stockholm
sweden
express
ligand
stimulatori
inhibitori
natur
killer
nk
cell
receptor
may
determin
whether
neuron
suscept
resist
nk
cellmedi
cytolysi
use
real
time
pcr
express
ligand
stimulatori
receptor
well
ligand
nk
cell
inhibitori
receptor
dorsal
root
ganglia
drg
analyz
vivo
peripher
nerv
lesion
vitro
drg
neuron
cultur
expos
interferon
ifn
gamma
lp
infect
murin
cytomegaloviru
mcmv
neurotrop
influenza
viru
strain
peripher
nerv
lesion
associ
decreas
level
murin
proteinlik
transcript
increas
level
classic
mhc
class
transcript
drg
adult
mice
studi
also
show
ifngamma
lp
caus
mark
induct
classic
nonclass
major
histocompat
complex
mhc
class
encod
transcript
drg
cultur
cultur
infect
either
mcmv
show
signific
increas
express
transcript
encod
classic
nonclass
mhc
class
exogen
agent
well
peripher
nerv
lesion
alter
express
nk
cell
stimulatori
inhibitori
ligand
nervou
tissu
mechan
resist
microglia
quinolin
acidmedi
cell
death
cm
figueiredo
faria
pai
chatterje
instituto
gulbenkian
oeira
portug
brain
macrophag
microglia
respond
traumat
injuri
pathogen
central
nervou
system
migrat
site
injuri
may
prolifer
releas
inflammatori
cytokin
potenti
neurotoxin
addit
microglia
activ
releas
metabolit
tryptophankynurenin
pathway
quinolin
acid
qa
implic
neurodegen
diseas
qa
induc
neurotox
nmethyldaspart
receptor
nmdar
nmdar
heteromer
complex
compos
two
class
subunit
essenti
potenti
activ
confer
function
variabl
nmdar
interestingli
unlik
neuron
primari
microglia
resist
qa
challeng
therefor
analysi
mechan
resist
microglia
quinolin
acidmedi
cell
death
perform
result
fluoresc
stain
propidium
iodid
calcium
imag
western
blot
rtpcr
analysi
show
qa
stimul
nmdar
primari
cerebellar
granul
neuron
microglia
induc
increas
influx
activ
extracellular
signal
regul
kinas
consequ
cell
death
two
cell
type
possess
protein
level
subunit
microglia
express
mrna
nmdar
subunit
specif
complex
blocker
ifenprodil
rescu
cell
death
suggest
qa
may
bind
subunit
absent
microglia
character
function
implic
nmdar
microglia
neuron
perspect
differenti
respons
qa
discuss
present
beta
amyloid
peptid
select
downregul
product
differenti
neuron
cell
line
ruggieri
f
roselli
c
pica
lia
c
avolio
b
trojano
p
livrea
univers
bari
bari
itali
b
univers
foggia
foggia
itali
object
neuron
matrix
metalloproteinas
mmp
may
involv
memori
consolid
process
synapt
plastic
express
detect
dentat
gyru
neuron
cell
bodi
dendrit
amyloid
accumul
strateg
brain
area
induc
memori
dysfunct
effect
amyloid
peptid
neuron
mmp
unknown
test
whether
amyloid
peptid
could
alter
mmp
inhibitor
product
neuron
vitro
method
human
neuroblastoma
cell
cultur
treat
abeta
vehicl
supernat
collect
h
incub
activ
assay
elisa
detect
cell
death
evalu
vital
dye
exclus
test
result
level
markedli
reduc
abeta
treat
cell
supernat
versu
neg
control
h
h
differ
detect
abeta
treat
cell
unchang
sampl
vital
differ
treat
untreat
cell
conclus
abeta
select
inhibit
product
neuron
effect
could
due
cell
toxic
restrict
unchang
timp
unchang
cell
death
treat
versu
untreat
cell
regul
induc
abeta
may
play
role
age
relat
memori
impair
alzheim
diseas
immun
myelin
oligodendrocyt
glycoprotein
mog
slow
recoveri
dopaminerg
neuron
injur
mptp
kurkowskajastrzebska
e
balkowieciskra
b
joniec
b
czlonkowski
b
czlonkowska
b
institut
psychiatri
neurolog
warsaw
poland
b
medic
univers
warsaw
warsaw
poland
mptp
administr
caus
injuri
nigrostriat
dopaminerg
neuron
inflammatori
reaction
follow
dopaminerg
neuron
impair
believ
contribut
neuron
death
surviv
postul
addit
brain
inflamm
may
modul
neurodegen
process
would
like
examin
influenc
immun
system
enhanc
recoveri
toxic
insult
caus
mptp
male
month
old
mice
receiv
mgkg
mptp
ip
day
immun
mog
peptid
cfa
mice
receiv
mptp
show
decreas
dopamin
content
striatum
day
follow
mptp
administr
compar
control
mice
day
dopamin
content
increas
less
control
day
respect
group
mice
receiv
addit
immun
recoveri
howev
slower
compar
nonimmun
mice
dopamin
content
decreas
less
control
day
respect
thu
immun
mog
mptp
intox
result
deeper
dopamin
deplet
wors
recoveri
dopaminerg
neuron
insult
tumor
necrosi
factor
tnf
induc
apoptoticlik
cell
death
oligodendrocyt
cell
target
multipl
sclerosi
ms
human
adult
oligodendrocyt
hol
microgli
cell
mg
prepar
human
brain
specimen
obtain
neurosurg
procedur
cell
stimul
tnf
cell
death
detect
annexinvfitc
pi
stain
flow
cytometri
defin
intracellular
transduct
pathway
involv
tnfinduc
death
hol
noncaspas
depend
evidenc
lack
gener
activ
subunit
detect
western
blot
well
lack
cleavag
fluorogen
substrat
measur
flow
cytometri
addit
gener
caspas
inhibitor
zvadfmk
prevent
tnfinduc
hol
death
also
calpain
inhibitor
zllyfmk
serin
proteas
inhibitor
tpck
cathepsin
inhibitor
zfl
ineffici
prevent
tnfinduc
hol
cell
death
electrophoresi
tnfexpos
hol
dna
reveal
larg
scale
dna
fragment
characterist
apoptosi
induc
factor
aif
induc
cell
death
tnfstimul
hol
aif
transloc
nuclei
accordingli
hol
death
prevent
inhibit
aif
use
antisens
strategi
asaif
inhibit
aif
asaif
led
signific
decreas
aif
express
hol
affect
tnfinduc
chang
mitochondri
membran
potenti
result
indic
tnfinduc
hol
death
depend
critic
aif
activ
might
signific
import
design
new
molecul
protect
hol
multipl
sclerosi
leukemia
inhibitori
factor
produc
myelin
reactiv
tcell
protect
cytokin
induc
oligodendrocyt
cell
death
j
vanderlocht
n
hell
f
vandenabeel
moreel
j
antel
b
j
rau
p
stinissen
limburg
universitair
centrum
diepenbeek
belgium
b
mcgill
univers
montreal
canada
leukemia
inhibitori
factor
lif
ciliari
neurotroph
factor
cntf
member
neuropoiet
famili
neurotrophin
amelior
experiment
autoimmun
encephalomyel
eae
examin
whether
human
tcell
specif
myelin
basic
protein
mbp
myelin
oligodendrocyt
protein
mog
abl
secret
lif
myelin
reactiv
tcell
linesclon
tcl
eight
multipl
sclerosi
ms
patient
tcl
five
healthi
control
hc
produc
lif
upon
stimul
mean
net
lif
secret
ms
tcl
significantli
differ
hc
tcl
lif
express
confirm
rtpcr
addit
tcl
specif
tetanu
toxoid
monocyt
tcell
bcell
secret
lif
lif
secret
tlymphocyt
macrophag
could
also
identifi
immunohistochem
activ
chronic
activ
ms
lesion
demonstr
dosedepend
protect
effect
cntf
lif
tnfalpha
induc
apoptosi
hog
cell
rat
oligodendrocyt
cultur
concentr
ngml
neurokin
complet
protect
oligodendrocyt
cytokin
induc
apoptosi
posttreat
neurokin
effect
pretreat
conclus
vitro
studi
indic
lif
cntf
possibl
candid
therapeut
intervent
ms
factor
enhanc
product
neurotrophin
cell
may
provid
new
tool
ms
therapi
elucid
pathogen
circuit
immun
neuroendocrin
system
examin
emerg
behavior
deficit
tempor
coincid
impair
dopamin
catabol
lupuspron
mrllpr
mice
hypothesi
system
autoimmun
affect
central
dopaminerg
system
diseas
mice
function
damag
nigrostriat
pathway
assess
rotat
behavior
singl
inject
apomorphin
amphetamin
employ
probe
relationship
mesolimb
damag
depressivelik
behavior
neurodegener
midbrain
estim
fluoro
jade
b
fjb
stain
tyrosinehydroxylas
th
immunocytochemistri
comparison
young
agematch
control
diseas
mrllpr
mice
show
increas
circl
follow
apomorphin
inject
fail
increas
palat
food
consumpt
receiv
amphetamin
increas
fjbposit
neuron
profound
reduct
thposit
soma
confirm
mesencephalon
cell
loss
behavior
impair
mice
studi
coincid
death
npsle
patient
neuropatholog
chang
observ
patient
basal
ganglia
similar
mrllpr
neuropatholog
strengthen
valid
npsle
model
summari
result
suggest
system
autoimmun
damag
dopaminerg
system
induc
behavior
deficit
electron
microscopi
present
employ
elucid
mode
neuron
death
result
report
meet
support
fund
nih
cihr
bs
dab
immunoglobulin
cytotox
csf
autoimmun
mice
mm
sidor
b
sakic
neuropsychiatr
lupu
npsle
complex
manifest
unknown
etiolog
occur
cours
system
lupu
erythematosu
use
lupuspron
mrllpr
murin
model
studi
etiolog
npsle
previou
experi
reveal
leukocyt
infiltr
brain
cell
loss
periventricular
area
cytotox
cerebrospin
fluid
csf
coincid
tempor
behaviour
deficit
diseas
mrllpr
mice
presenc
bcell
choroid
plexu
toxic
iggrich
csf
fraction
suggest
intrathec
synthesi
autoantibodi
neuron
tissu
present
studi
examin
whether
cytotox
csf
diseas
mrllpr
mice
exhibit
uniqu
protein
profil
western
blot
reveal
distinct
igg
band
csf
mrllpr
mice
band
occur
frequent
agematch
control
vs
band
absent
asymptomat
group
intens
igg
band
show
posit
correl
splenomegali
suggest
progress
system
autoimmun
inflamm
associ
chang
csf
content
meet
report
whether
vitro
csf
toxic
associ
presenc
band
whether
band
produc
intrathec
whether
product
caus
brain
damag
work
support
fund
nih
b
sakic
recipi
father
sean
osullivan
research
centr
career
develop
award
glatiram
acet
induc
proapoptot
mechan
involv
bax
cytc
multipl
sclerosi
treat
patient
ruggieri
scacco
c
pica
lia
papa
p
livrea
trojano
c
avolio
b
univers
bari
bari
itali
b
univers
foggia
foggia
itali
apoptot
delet
autoreact
cell
defect
patient
multipl
sclerosi
ms
glatiram
acet
ga
may
effect
induc
apoptosi
detriment
cell
analyz
pro
bax
cytc
anti
apoptot
protein
peripher
blood
mononuclear
cell
pbmnc
cytosol
mitochondria
membran
ga
treatment
relapsingremit
rr
ms
patient
blood
sampl
eight
rr
ms
patient
collect
everi
month
month
ga
treatment
six
healthi
control
hc
pbmnc
bax
cytc
quantifi
western
blot
follow
densitometr
scan
percentag
apoptot
cell
assess
dye
exclus
test
tcell
vitro
test
oxigen
consumpt
respirometr
analysi
decreas
increas
bax
ga
treatment
observ
cytosol
cytc
trend
increas
treatment
suggest
releas
cytc
mitochondria
membran
cytosol
wherea
remain
unchang
increas
percentag
apoptot
pbmnc
observ
treatment
reduct
oxygen
consumpt
tcell
evid
ga
treatment
vitro
find
suggest
ga
might
exert
regulatori
effect
peripher
lymphocyt
proapoptosi
mechan
involv
downregul
upregul
bax
cytosol
cytc
modul
solubl
fa
level
patient
herp
simplex
enceph
hse
f
sabri
hjalmarsson
f
granath
k
lfvgren
b
skfldenberg
karolinska
univers
hospit
stockholm
sweden
herp
simplex
enceph
hse
common
caus
sporad
sever
viral
enceph
evid
vigor
intrathec
immun
respons
acut
phase
hse
longterm
follow
hypothes
sever
progress
cerebr
injuri
result
hse
evalu
quantit
measur
differ
compart
immun
activ
molecul
solubl
fa
sfa
molecul
involv
apoptosi
cerebr
spinal
fluid
csf
serum
sfa
level
consecut
sampl
hse
patient
vidarabin
acyclovir
trial
analyz
captur
elisa
interestingli
sfa
level
csf
highest
hse
patient
die
lowest
mild
sequel
inbetween
patient
moder
sever
outcom
detect
sfa
found
csf
sampl
patient
nonhs
enceph
person
headach
sfa
level
last
serum
sampl
obtain
higher
hse
patient
comatos
state
compar
semicomatos
letharg
present
similar
pattern
observ
serum
sampl
highest
sfa
diseas
progress
three
hse
group
observ
enforc
role
immun
activ
state
observ
serum
acut
phase
hse
csf
particular
diseas
progress
might
reflect
apoptot
state
brain
oxid
stress
nfkb
activ
suggest
link
acut
chronic
inflamm
recent
studi
show
activ
receptor
advanc
glycat
end
product
rage
specif
ligand
cml
result
activ
nfkb
product
proinflammatori
cytokin
determin
possibl
role
pathway
pathogenesi
vasculit
neuropathi
investig
immunolocalis
cml
rage
nfkb
sural
nerv
biopsi
patient
vasculit
neuropathi
eight
control
normal
hmsn
cml
rage
nfkb
could
local
infiltr
mononuclear
cell
epineuri
endoneuri
vessel
perineurium
vasculit
neuropathi
control
show
sporad
weak
stain
four
antigen
vessel
wall
perineurium
colocalis
studi
demonstr
cml
rage
expess
cell
vascul
activ
nfkb
express
mononuclear
infiltr
cell
data
suggest
cml
induc
rage
mediat
nfkb
activ
result
elev
product
proinflammatori
mechan
pathogenesi
vasculit
neuropathi
therapeut
use
antioxid
like
vitamin
e
alphalipoicacid
benfotiamin
caus
reduct
intracellular
oxid
stress
extracellular
cml
format
shown
variou
model
late
diabet
complic
evalu
vasculit
neuropathi
ngf
ngfreceptor
myastenia
gravi
thymu
l
alo
ts
marinova
b
petrov
c
l
manni
institut
neurobiolog
molecular
medicin
cnr
rome
itali
b
depart
biolog
medic
univers
sofia
bulgaria
c
depart
gener
clinic
patholog
medic
univers
sofia
bulgaria
previous
report
autoimmun
inflammatori
disord
associ
alter
level
nerv
growth
factor
ngf
immun
cell
produc
ngf
express
ngfreceptor
ngfr
prospect
hypothesi
two
ngf
marker
consid
signal
celltocel
recognit
immun
system
analyz
distribut
ngf
ngfr
thymu
subject
myasthenia
gravi
mg
thymus
healthi
mg
subject
remov
accord
helsinki
convent
ethic
medic
board
consent
use
structur
ultrastructur
biochem
molecular
analysi
result
show
presenc
ngf
ngfr
thymic
epitheli
cell
mast
cell
control
subject
alter
express
ngf
marker
protein
gene
express
level
mg
thymus
observ
studi
show
administr
ngf
laboratori
anim
retard
thymic
cell
death
suggest
thymic
cell
regul
ngf
autocrin
mechan
thu
ngf
repres
import
biolog
mediat
nerv
cell
also
immun
cell
probabl
transmit
signal
back
forth
nervou
immun
system
support
progetto
di
ricerca
multicentrico
triennal
carisbo
itali
spinal
neuroimmun
activ
induc
behavior
sensit
anim
model
chronic
pain
v
raghavendra
j
deleo
anesthesiologypharmacolog
dartmouthhitchcock
medic
center
lebanon
usa
recent
evid
suggest
activ
intrins
inflammatori
immun
respons
cn
contribut
develop
mainten
behavior
sensit
studi
examin
pattern
glial
activ
proinflammatori
cytokin
express
lumbar
spinal
cord
rat
model
neuropath
chronic
inflammatori
pain
role
spinal
neuroimmun
activ
develop
allodynia
hyperlagesia
investig
gene
express
studi
realtim
rtpcr
glial
marker
gfap
astrocyt
microglia
prinflammatori
cytokin
tnfalpha
show
differenti
upregul
follow
nerv
injuri
inflamm
protein
quantif
immunohistochemistri
elisa
western
blot
analysi
rat
also
reveal
glial
activ
enhanc
proinflammatori
cytokin
express
lumbar
spinal
cord
central
administr
dexamethason
attenu
neuroimmun
activ
develop
behavior
allodynia
hyperalgesia
anim
model
neuropath
inflammatori
pain
studi
provid
data
implic
role
glia
proinflammatori
cytokin
develop
behavior
hypersensit
peripher
nerv
injuri
inflamm
immunolog
mechan
autolog
hematopoiet
stem
cell
transplant
therapi
multipl
sclerosi
pa
muraro
k
chung
douek
hf
mcfarland
rk
burt
b
r
martin
nation
institut
health
bethesda
md
usa
b
northwestern
univers
chicago
il
usa
highdos
immunosuppress
therapi
follow
autolog
hematopoiet
stem
cell
transplant
hsct
shown
strikingli
benefici
effect
diseas
cours
subset
patient
sever
autoimmun
diseas
mechan
action
hsct
howev
remain
elus
far
studi
seven
patient
multipl
sclerosi
ms
hsct
toxic
infecti
advers
event
sign
residu
inflammatori
diseas
activ
followup
year
narv
cell
doubl
expens
central
memori
cell
cell
receptor
excis
circl
analysi
confirm
output
thymusderiv
narv
cell
immun
reconstitut
substanti
increas
reach
level
compar
healthi
agematch
control
peripher
mechan
contribut
recoveri
immun
toler
includ
propens
cell
apoptosi
prolif
senesc
expand
cell
find
demonstr
abrog
diseas
activ
hsct
associ
profound
reconfigur
immun
system
simpli
effect
protract
immunosuppress
intens
immunosuppress
follow
autolog
stem
cell
transplant
treatment
sever
multipl
sclerosi
gl
mancardi
uccelli
italian
gitmoneuro
intergroup
asct
multipl
sclerosi
univers
genoa
genoa
itali
base
studi
experiment
model
autoimmun
intens
immunosuppress
follow
autolog
stem
cell
transplant
asct
recent
propos
treatment
rapidli
progress
multipl
sclerosi
ms
unrespons
convent
therapi
report
therapi
effect
mri
paramet
diseas
activ
halt
diseas
progress
sever
ms
form
despit
relev
mortal
risk
report
mri
clinic
follow
rapidli
worsen
ms
patient
high
number
gadoliniumenhanc
lesion
treat
cyclophosphamid
gm
mobil
regimen
beam
bcnu
cytosinearabinosid
etoposid
melphalan
condit
treatment
mean
follow
month
rang
month
treatment
rel
well
toler
importantli
strikingli
abolish
mri
activ
although
influenc
progress
brain
atrophi
time
patient
observ
also
clinic
improv
stabil
diseas
present
result
demonstr
intens
immunosuppress
follow
asct
effect
inflamm
detect
mri
compar
current
avail
therapi
may
success
stabil
diseas
cours
thu
consid
therapeut
option
ms
subject
poor
prognost
factor
respond
convent
therapi
antiergotyp
cell
respons
healthi
control
multipl
sclerosi
patient
n
hell
c
govart
j
rau
p
stinissen
biomedisch
onderzoeksinstituut
liburg
universitair
centrum
diepenbeek
belgium
peripher
regulatori
mechan
may
prevent
expans
autoreact
tcell
play
role
autoimmun
diseas
multipl
sclerosi
ms
antiidiotyp
antiergotyp
tcell
take
part
regulatori
network
boost
tcell
vaccin
tcv
show
tcv
induc
longterm
clonotyp
tempor
antiergotyp
respons
activ
tcell
studi
aim
character
antiergotyp
tcell
ms
patient
healthi
control
hc
pbmc
stimul
phaactiv
tcell
blast
sourc
activ
cell
prolif
antiergotyp
respons
found
hc
ms
patient
test
antiergotyp
shortterm
line
mix
phenotyp
produc
high
amount
ifngamma
predominantli
hladr
restrict
deplet
experi
show
tcell
mainli
respons
observ
vitro
antiergotyp
respons
cytokin
receptor
includ
receptor
identifi
candid
target
antiergotyp
tt
interact
eae
test
reactiv
peptid
deriv
alpha
chain
contain
domin
epitop
abl
isol
cell
line
tcl
specif
peptid
four
hc
tcl
phenotyp
prolifer
strongli
activ
rest
tetanu
toxoid
specif
tcl
current
test
whether
tcl
similar
properti
isol
ms
patient
tcv
help
unravel
actual
role
tcell
immunoregul
boost
regulatori
cell
multipl
sclerosi
immunogen
safeti
trival
vaccin
incomplet
freund
adjuv
vandenbark
r
bartholom
b
bourdett
c
veteran
affair
medic
center
portland
usa
b
immun
respons
corpor
carlsbad
ca
usa
c
oregon
health
scienc
univers
oregon
health
scienc
univers
portland
usa
cell
receptor
tcr
peptid
vaccin
repres
novel
approach
boost
regulatori
cell
multipl
sclerosi
ms
develop
tcr
peptid
vaccin
treatment
ms
hinder
rel
low
immunogen
previous
avail
tcr
peptid
vaccin
exampl
intraderm
vaccin
singl
tcr
peptid
given
without
adjuv
induc
regulatori
tcr
reactiv
cell
ms
subject
effort
develop
effect
vaccin
compar
intramuscular
inject
trival
tcr
vaccin
contain
peptid
emulsifi
incomplet
freund
adjuv
ifa
intraderm
inject
peptid
without
ifa
six
monthli
inject
trivalentifa
vaccin
induc
vigor
cell
respons
subject
significantli
immunogen
peptidesalin
vaccin
induc
respons
subject
asid
inject
site
reaction
signific
advers
event
attribut
treatment
signific
clinic
chang
cours
short
trial
subject
cell
respons
trival
tcr
peptid
vaccin
show
trend
toward
reduc
mri
activ
trival
tcr
peptid
ifa
vaccin
repres
signific
improv
previou
tcr
peptid
vaccin
warrant
investig
abil
treat
ms
atorvastatin
regul
cell
anergi
via
extracellular
signalrel
kinas
pathway
novel
immunomodulatori
function
reductas
inhibitor
waiczi
c
infanteduart
prozorovski
pikol
f
zipp
institut
neuroimmunolog
neurosci
research
center
humboldt
univers
berlin
germani
coenzym
reductas
hmgcoar
inhibitor
statin
oral
administ
cholesterollow
drug
shown
exhibit
immunomodulatori
properti
previous
report
vivo
atorvastatin
treatment
could
prevent
revers
diseas
progress
anim
model
multipl
sclerosi
howev
mechan
immunomodul
statin
yet
fulli
clarifi
human
system
report
influenc
atorvastatin
cell
cycl
progress
peripher
cell
antigenspecif
cell
line
could
explain
failur
atorvastatintr
cell
downregul
neg
cell
cycl
regul
follow
product
stimulu
specif
requir
induct
mainten
cell
anergi
fact
report
follow
incub
atorvastatin
cell
lose
capac
respond
specif
antigen
anergi
induct
shown
depend
hmgcoar
sinc
could
revers
mevalon
intermediari
product
pathway
preliminari
result
also
show
atorvastatin
induc
unexpect
activ
extracellular
signalrel
kinas
pathway
show
via
block
experi
necessari
induct
anergi
result
indic
atorvastatin
regul
cell
expans
via
induct
anergi
portray
novel
immunomodulatori
function
hmgcoar
inhibitor
treatment
autoimmun
diseas
multipl
sclerosi
glatiram
acet
copaxon
therapi
induc
oligoclon
cell
respons
cytotox
abil
r
mehta
yan
b
biegler
ortega
rack
n
karandikar
ut
southwestern
medic
center
dalla
tx
usa
multipl
sclerosi
ms
inflammatori
demyelin
disord
central
nervou
system
featur
suggest
tcellmedi
autoimmun
treatment
glatiram
acet
ga
copaxon
decreas
rate
exacerb
relaps
ms
shown
ga
therapi
upregul
gaspecif
tcell
respons
level
found
healthi
subject
studi
evalu
function
profil
clonal
complex
gainduc
tcell
sequenc
tcell
receptorbeta
chain
flowsort
gaspecif
tcell
reveal
strikingli
oligoclon
gareact
respons
ms
patient
cours
therapi
domin
clone
tcell
persist
long
period
time
certain
patient
contrast
gareact
tcell
polyclon
reveal
differ
clonal
composit
differ
time
point
therapi
heighten
tcell
respons
correspond
longitudin
upregul
ex
vivo
cytotox
activ
gaspecif
tcell
ga
therapi
also
induc
chang
function
molecular
profil
tcell
result
demonstr
domin
clone
tcell
contribut
gainduc
respons
may
mediat
immunomodulatori
effect
direct
cytotox
kill
relev
immun
popul
also
rais
import
question
immunolog
effect
chronic
ga
therapi
develop
tcell
senesc
support
part
grant
nih
nmss
wadsworth
foundat
effect
rituximab
peripher
blood
cerebrospin
fluid
b
cell
patient
primari
progress
multipl
sclerosi
n
monson
k
hawker
e
frohman
rack
ut
southwestern
medic
center
dalla
tx
usa
context
rituximab
monoclon
antibodi
deplet
b
cell
whether
efficaci
rituximab
peripher
neurolog
diseas
translat
neurolog
diseas
central
nervou
system
cn
possibl
autoimmun
b
cell
involv
remain
unknown
object
determin
effect
rituximab
cerebrospin
fluid
csf
b
cell
popul
patient
multipl
sclerosi
ms
chronic
inflammatori
demyelin
diseas
cn
like
involv
autoimmun
mechan
design
four
patient
primari
progress
ms
ppm
subtyp
ms
present
slow
deterior
neurolog
function
without
relaps
treat
rituximab
peripher
blood
pb
andor
csf
collect
patient
preand
postrituximab
pb
csf
cell
analyz
flow
cytometri
identifi
b
cell
subset
result
csf
b
cell
effect
deplet
peripher
counterpart
like
major
csf
b
cell
highli
activ
advanc
memori
plasma
b
cell
rituximab
suppress
activ
state
csf
b
cell
b
cell
peripheri
csf
expand
beyond
normal
frequenc
postrituximab
conclus
effect
rituximab
csf
b
cell
compart
limit
comparison
peripheri
need
confirm
larger
group
ms
patient
current
therapi
multipl
sclerosi
moder
effect
recent
shown
human
monoclon
antibodi
receptor
alpha
chain
daclizumab
substanti
reduc
brain
inflamm
ms
patient
incomplet
respons
standard
interferon
beta
therapi
aim
studi
determin
vivo
immun
chang
respons
profound
therapeut
effect
prospect
analyz
function
statu
lymphocyt
patient
therapi
daclizumab
evalu
surfac
express
activ
marker
chemokin
receptor
cytokin
chain
employ
cfsebas
prolifer
assay
addit
vitro
experi
requir
cellular
separ
magnet
bead
intracellular
cytokin
stain
cytotox
assay
demonstr
daclizumab
act
via
anticip
direct
functionaland
activ
blockad
cell
central
popul
ms
pathogenesi
instead
daclizumab
therapi
led
promin
expans
immunoregulatori
natur
killer
nk
cell
gradual
declin
cell
chang
highli
correl
predict
mri
outcom
describ
mechan
nk
cell
may
mediat
peripher
toler
vivo
data
reveal
intrigu
pathway
manipul
cytokin
circuitri
find
import
implic
treatment
autoimmun
diseas
transplant
reject
toward
modif
tumor
immun
immunomodulatori
effect
simvastatin
relapsingremit
multipl
sclerosi
markovicples
b
x
b
giri
c
sujkowski
singh
c
univers
north
carolina
chapel
hill
usa
b
yale
univers
new
usa
c
medic
univers
south
carolina
charleston
usa
object
studi
immunomodulatori
therapeut
potenti
simvastatin
cn
penetr
hmgcoa
reductas
inhibitor
relapsingremit
multipl
sclerosi
rr
ms
result
statin
exhibit
dosedepend
antiprolif
effect
activ
peripher
blood
mononuclear
cell
pbmc
simvastatin
decreas
ifngammainduc
express
mhc
class
ii
dr
monocyt
addit
effect
antigen
present
simvastatin
decreas
surfac
express
activ
marker
memori
narv
subset
marker
chemokin
receptor
effector
lymphocyt
describ
effect
revers
mevalon
product
hmgcoa
reductas
confirm
effect
lymphocyt
activ
specif
hmgcoa
reductas
inhibit
treatment
simvastatin
induc
shift
cytokin
product
measur
significantli
decreas
ifngamma
tnfalpha
secret
increas
product
follow
vitro
pbmc
stimul
analysi
reveal
consist
decreas
express
tbet
transcript
factor
regul
cell
differenti
gene
array
subsequ
use
order
captur
treatmentinduc
chang
express
multipl
cytokin
chemokin
gene
identifi
signific
increas
decreas
tnfbeta
gene
express
simvastatintr
cultur
find
confirm
rtpcr
conclus
due
multipl
immunomodulatori
mechan
action
statin
repres
promis
treatment
ms
chronic
inflammatori
cn
diseas
multipl
sclerosi
chronic
inflammatori
disord
central
nervou
system
cn
autoaggress
tcell
drive
inflamm
lead
focal
myelin
destruct
loss
oligodendrocyt
acut
axon
transect
monoclon
antibodi
induc
prolong
tcell
lymphopenia
campath
treatment
reduct
relaps
rate
initi
improv
disabl
assess
edss
score
may
repres
releas
conduct
block
due
residu
inflamm
howev
continu
improv
disabl
month
although
mani
possibl
explan
hypothesis
immun
cell
regener
secret
growth
factor
promot
neuron
surviv
repair
shown
patient
pbmc
secret
neurotroph
factor
exvivo
respons
variou
stimuli
pbmccondit
medium
support
surviv
neuron
deriv
rat
embryon
cortic
month
posttreat
found
increas
ciliari
neurotroph
factor
cntf
factor
recent
shown
enhanc
myelin
format
addit
found
dramat
reduct
insulinlik
growth
secret
mediat
protect
fasinduc
cell
death
process
essenti
immun
system
homeostasi
clear
activ
cell
find
suggest
campath
immunomodul
may
part
due
apoptot
elimin
activ
cell
increas
evid
indic
epsteinbarr
viru
ebv
role
pathogenesi
mani
autoimmun
diseas
includ
multipl
sclerosi
ms
propos
new
hypothesi
chronic
autoimmun
diseas
occur
individu
genet
suscept
effect
bcell
infect
ebv
result
increas
frequenc
ebvinfect
autoreact
b
cell
produc
autoantibodi
also
inhibit
activationinduc
apoptosi
autoreact
cell
target
organ
trend
immunol
studi
aim
determin
whether
ms
patient
increas
frequenc
ebvinfect
immort
autoreact
b
cell
lead
develop
ms
use
realtim
pcr
measur
ebv
dna
load
peripher
blood
mononuclear
cell
pbmc
elisa
myelin
opsonizationforphagocytosi
assay
measur
antimyelin
antibodi
addit
detect
ebv
dna
pbmc
ms
patient
found
compar
healthi
subject
patient
neurolog
diseas
ms
patient
higher
level
circul
antibodi
two
overlap
peptid
myelin
proteolipid
protein
plp
name
increas
level
opson
antimyelin
antibodi
one
ms
patient
high
circul
level
opson
antimyelin
antibodi
sever
progress
spinal
cord
involv
refractori
intraven
methylprednisolon
glatiram
acet
improv
follow
b
cell
deplet
rituximab
primari
progress
multipl
sclerosi
convert
relaps
remit
multipl
sclerosi
intens
immunosuppress
therapi
ej
vokaer
bron
b
toungouz
goldman
pital
erasm
brussel
belgium
b
pital
bordet
brussel
belgium
primari
progress
multipl
sclerosi
ppm
devast
form
ms
result
progress
handicap
without
remiss
less
frequent
relapsingremit
ms
rrm
studi
suggest
may
repres
total
separ
diseas
provid
evid
convers
ppm
rrm
patient
intens
immunosuppress
patient
born
suffer
ms
sinc
clinic
diagnosi
ppm
confirm
nuclear
magnet
reson
evok
potenti
lumbar
punctur
find
aggress
evolut
despit
corticoid
azathioprin
cyclophosphamid
therapi
result
sever
handicap
develop
decemb
patient
becam
wheelchair
depend
peripher
blood
stem
cell
mobil
harvest
highli
purifi
februari
march
patient
receiv
mgkg
cyclophosphamid
follow
autograft
rescu
success
haematolog
recoveri
handicap
progress
recess
stabil
end
patient
abl
walk
alon
howev
patient
experienc
two
relaps
optic
neuriti
left
arm
neuropath
pain
relaps
follow
partial
remiss
month
confirm
nuclear
magnet
reson
ophthalmolog
find
case
prove
ppm
may
convert
rrm
intens
immunosuppress
suggest
ppm
rrm
separ
entiti
distinct
express
common
immunolog
disord
identif
novel
lead
compound
modul
pathogen
immun
respons
multipl
sclerosi
massa
r
campanelli
uccelli
b
v
meli
c
p
lanza
c
r
billetta
c
martini
albani
e
ircc
matteo
hospit
pavia
itali
b
univers
genoa
genoa
itali
c
androclu
therapeut
san
diego
usa
ircc
g
gaslini
institut
genoa
itali
e
univers
california
san
diego
usa
immun
respons
bacteri
heat
shock
protein
hsp
may
play
role
autoimmun
appli
comput
algorithm
identif
panhladr
binder
motif
defin
two
set
peptid
bacteri
hsp
escherichia
coli
dnaj
may
function
relev
cell
epitop
multipl
sclerosi
ms
pandrpeptid
test
control
peptid
pbmc
ms
individu
stimul
individu
proband
control
peptid
found
peptid
e
coli
dnaj
abl
induc
increas
express
cell
prolifer
compar
control
peptid
addit
peptid
induc
increas
intracellular
product
ifngamma
tnfalpha
stimul
pbmc
peptid
elicit
bulk
cultur
produc
intracellular
ifngamma
significantli
higher
percentag
ifngamma
produc
cell
also
found
follow
incub
deriv
peptid
control
peptid
thu
hspderiv
peptid
capabl
induc
proinflammatori
regulatori
respons
ms
subject
result
suggest
respons
hsp
peptid
may
play
modul
role
cn
autoimmun
may
exploit
tailor
immunomodulatori
compound
treatment
ms
multipl
sclerosi
inflammatori
demyelin
diseas
central
nervou
system
caus
autoimmun
attack
direct
cn
myelin
antigen
cell
form
minor
compon
circul
peripher
lymphocyt
pool
also
home
site
inflamm
includ
brain
report
vitro
activ
human
cell
nonpeptid
ligand
rapidli
induc
product
ifngamma
high
amount
ifngamma
produc
rapidli
cell
bacteri
infect
advers
effect
develop
intracellular
pathogen
hand
gammadelta
cell
may
contribut
immunopatholog
associ
chronic
inflammatori
autoimmun
disord
high
sustain
releas
inflammatori
cytokin
chemokin
evalu
gammadelta
cell
respons
pyrenilpyrophosph
antigen
without
compound
triazol
class
molecul
healthi
ms
individu
result
show
significantli
inhibit
prolifer
cytokin
product
gammadeltat
cell
furthermor
effici
interfer
antigen
specif
cell
activ
conclud
repres
novel
immunomodulatori
agent
treatment
cell
mediat
autoimmun
diseas
multipl
sclerosi
cellmedi
action
selfantigen
implic
varieti
autoimmun
diseas
cell
activ
depend
two
signal
cell
receptor
tcr
engag
costimul
costimul
therefor
potenti
target
treat
autoimmun
diseas
rheumatoid
arthriti
multipl
sclerosi
previous
shown
seri
small
compound
discov
avidex
bind
exclus
nanomolar
affin
spr
technolog
block
interact
time
resolv
fluoresc
reson
energi
transfer
assay
current
studi
demonstr
effect
compound
rang
cellular
assay
use
transform
cell
primari
human
cell
compound
inhibit
cytokin
releas
jurkat
cell
primari
cell
interferongamma
tumour
necrosi
factoralpha
submicromolar
rang
cell
activ
therefor
reduc
presenc
molecul
bound
compound
repres
promis
lead
develop
novel
autoimmun
therapi
influenc
estriol
therapi
inflammatori
respons
brain
endotheli
cell
tight
junction
molecul
multipl
sclerosi
iv
korzh
fedotova
vd
nemtsova
kharkov
medic
univers
kharkov
ukrain
protect
effect
pregnanc
put
autoimmun
diseas
multipl
sclerosi
rheumatoid
arthriti
associ
immun
shift
pregnanc
hormon
estriol
increas
pregnanc
shown
amelior
experiment
autoimmun
encephalomyel
collageninduc
arthriti
elucid
mechan
endotheli
cell
ec
dysfunct
cn
inflammatori
respons
benefici
effect
oral
estriol
therapi
multipl
sclerosi
ms
analyz
effect
individu
combin
solubl
inflammatori
mediat
intracellular
local
ec
tight
junctionassoci
molecul
zonula
human
brain
ec
cytoplasm
major
cell
control
ec
cultur
clear
local
peripher
near
site
cell
contact
associ
submembran
cytoplasm
filament
induc
revers
timeand
concentrationdepend
transloc
random
distribut
within
ec
cytoplasm
retract
ec
border
low
concentr
effect
accompani
less
promin
submembran
filament
evid
cytotox
increas
cell
death
alter
amount
tumor
necrosi
factorbeta
induc
similar
alter
estriol
cotreat
either
cytokin
increas
h
effect
wherea
estriol
therapi
revers
h
induc
effect
control
white
matter
sampl
ec
cytoplasm
clear
locat
cell
border
inflammatori
demyelin
lesion
ec
diffus
indic
alter
induc
vitro
mimic
activ
ms
lesion
find
suggest
ms
patient
estriol
treatment
may
counteract
inflammatori
mediat
effect
cn
ec
tight
junction
molecul
therebi
preserv
ec
barrier
function
type
interferon
ifnbeta
appear
critic
trigger
immunoregulatori
mechan
lie
interfac
innat
adapt
immun
therapeut
effect
ifnbeta
could
due
restor
immunoregulatori
mechan
defect
multipl
sclerosi
ms
patient
regulatori
nkt
pathway
aim
analyz
nkt
cell
defect
patient
affect
ms
test
whether
treatment
improv
immunoregulatori
nkt
cell
function
design
nkt
cell
percentag
peripher
blood
lymphocyt
pbl
secret
cytokin
ifngamma
tgfbeta
nkt
cell
stimul
model
antigen
agalactosylceramid
measur
rr
ms
patient
treatment
individu
affect
neurolog
diseas
healthi
subject
use
control
result
preliminari
data
show
percentag
nkt
cell
reduc
ms
patient
prior
treatment
compar
control
patient
percentag
nkt
cell
pbl
increas
treatment
moreov
increas
secret
cytokin
nkt
cell
ms
patient
without
shift
nkt
cell
cytokin
profil
inflammatori
toward
protect
type
neutral
antibodi
higher
affin
interferonbeta
nonneutr
antibodi
p
tripp
c
gneiss
f
deisenhamm
innsbruck
medic
univers
dept
neurolog
innsbruck
austria
background
patient
multipl
sclerosi
receiv
recombin
interferonbeta
ifnbeta
may
develop
bind
antibodi
bab
ifnbeta
two
type
bab
distinguish
neutral
nab
nonneutr
antibodi
nnab
nab
associ
greater
bab
titer
nnab
suggest
quantit
influenc
nab
develop
correl
nab
bab
weak
evid
ifnbeta
neutral
also
depend
qualit
compon
studi
affin
nab
vs
nnab
investig
method
thirtyeight
serum
sampl
bab
ms
patient
receiv
includ
studi
sampl
nabposit
nabneg
rel
affin
valu
rav
ifnbeta
antibodi
determin
use
affin
assay
describ
earlier
j
neuroimmunol
determin
rav
base
upon
disrupt
interact
antibodi
antigen
use
increas
concentr
sodium
isothiocyan
result
rav
significantli
higher
nabposit
nabneg
serum
sampl
amount
antibodi
measur
optic
densiti
differ
group
vs
signific
correl
observ
rav
bab
nab
titer
conclus
exclus
confound
factor
result
indic
nab
higher
affin
ifnbeta
nnab
evalu
function
disabl
multipl
sclerosi
patient
interferon
beta
treatment
lisak
z
trkanjec
v
demarin
sestr
milosrdnic
univers
hospit
zagreb
croatia
introduct
fifteen
patient
femal
male
remittingrelaps
multipl
sclerosi
rrm
treat
interferon
beta
univers
depart
neurolog
ten
patient
treat
interferon
beta
miu
three
time
weekli
five
interferon
beta
miu
everi
day
method
use
expand
disabl
statu
scale
edss
evalu
function
disabl
rrm
patient
averag
edss
score
record
interferon
beta
therapi
month
initi
interferon
beta
therapi
result
interferon
beta
group
averag
edss
score
therapi
month
therapi
decreas
interferon
beta
group
averag
edss
score
treatment
month
therapi
statist
signific
differ
interferon
beta
group
interferon
beta
group
month
therapi
averag
edss
score
slightli
smaller
month
treatment
group
differ
statist
signific
interferon
beta
group
interferon
beta
group
conclus
result
favor
interferon
beta
therapi
small
group
rrm
patient
followup
requir
obtain
data
function
statu
interferon
beta
treatment
longer
period
time
ifnbeta
shown
effect
treatment
multipl
sclerosi
ms
howev
patient
fail
respond
fulli
biolog
activ
ifnbeta
exert
ifn
receptor
compos
two
subunit
defici
one
subunit
may
lead
loss
interferon
activ
evalu
differ
express
ms
patient
treat
differ
ifnbeta
molecul
quantifi
mrna
realtim
rtpcr
peripher
blood
mononuclear
cell
clinic
diseas
activ
base
annual
relaps
rate
edss
total
ms
patient
treat
betaferon
avonex
rebif
without
treatment
includ
result
analys
comparison
healthi
control
group
nonparametr
test
show
signific
decreas
patient
treat
ifnbeta
compar
patient
without
treatment
healthi
control
express
differ
express
patient
treatment
use
found
decreas
express
ms
patient
compar
healthi
control
also
decreas
express
observ
treat
ms
patient
compar
nontreat
ms
patient
natur
occur
regulatori
cell
crossroad
neuroimmun
interact
j
kipni
cardon
h
avidan
mordechay
l
gil
schwartz
weizmann
institut
scienc
revohot
israel
cn
injuri
activ
autoimmun
cell
accumul
site
injuri
cell
believ
mediat
process
secondari
degener
neural
tissu
group
recent
show
autoimmun
cell
benefici
protect
effect
neuron
protect
nondamag
vulner
death
neuron
degener
autoimmun
cell
kept
peripheri
tight
control
natur
occur
regulatori
cell
mechan
underli
abil
evok
autoimmun
respons
cn
injuri
without
develop
autoimmun
diseas
larg
unknown
studi
show
certain
neurotransmitt
increas
cn
injuri
preferenti
act
natur
occur
regulatori
cell
specif
receptor
express
cell
allevi
inhibitori
activ
neurotransmitt
also
affect
adhes
migrat
cell
mild
manner
name
elimin
rather
weaken
function
effect
suppress
mediat
reduc
express
reduc
product
tgfbeta
howev
adhes
migrat
reduc
decreas
express
specif
receptor
adhes
molecul
chemokin
effect
multipl
function
regulatori
cell
involv
depend
pathway
high
sensit
regulatori
cell
neurotransmitt
might
repres
bmiss
linkq
immun
nervou
system
interact
bfine
tuningq
level
regulatori
cell
neurotransmitt
could
promis
therapi
autoimmun
neurodegen
disord
human
treg
cell
express
highest
level
cell
effici
suppressor
cell
activ
sinc
treg
cell
believ
control
autoreact
experi
perform
determin
whether
treg
cell
isol
peripher
blood
patient
multipl
sclerosi
exhibit
alter
frequenc
function
compar
healthi
control
differ
frequenc
cell
patient
control
treg
cell
isol
patient
ms
significantli
less
suppress
furthermor
treg
cell
ms
patient
less
abl
suppress
respond
cell
allogen
healthi
control
treg
cell
isol
healthi
control
could
strongli
inhibit
respond
cell
isol
ms
patient
function
analysi
nonactiv
cell
express
high
level
demonstr
even
greater
function
dispar
patient
control
furthermor
two
subset
within
treg
popul
differ
hladr
express
exhibit
strike
tempor
differ
suppress
regul
cytokin
indic
subset
treg
may
function
differ
mechan
skew
toward
respons
import
implic
mani
autoimmun
diseas
investig
expand
treg
subset
isol
patient
ms
central
role
cell
inflammatori
reaction
central
nervou
system
cn
well
document
much
less
known
cell
found
within
intact
organ
particular
contribut
cell
infiltr
lymphocyt
pool
preferenti
target
site
within
cn
respons
environment
cue
provid
neurodegener
larg
undefin
address
point
use
lewi
rat
model
organ
studi
cell
intact
degen
spinal
cord
intact
spinal
cord
cell
preferenti
locat
cn
gray
matter
cell
numer
lymphocyt
case
degener
cell
increas
number
preferenti
infiltr
affect
cn
area
effect
pronounc
cell
subset
collect
data
provid
evid
clear
cellular
compartment
bia
immun
cell
infiltr
immun
respons
degener
within
cn
learn
whether
cell
recruit
site
neurodegener
repres
singl
multipl
cell
clone
current
perform
cell
receptor
analysi
combin
spectratyp
singl
cell
pcr
laser
microdissect
cell
immunohistochemistri
activ
differenti
regul
autoreact
cell
respons
cn
threshold
autoimmun
within
cn
cs
anglen
c
ploix
carson
scripp
research
institut
la
jolla
ca
usa
defin
cn
regul
autoreact
cell
respons
use
transgen
mice
express
hemagglutinin
ha
exclus
cn
astrocyt
gfapha
mice
exclus
pancreat
beta
cell
insha
mice
insha
mice
also
express
haspecif
tcr
develop
spontan
autoimmun
diabet
wherea
gfapha
mice
coexpress
either
haspecif
tcr
develop
cn
autoimmun
similarli
transfer
haspecif
cell
lymphopen
insha
mice
led
autoimmun
diabet
fail
caus
cn
autoimmun
gfapha
mice
transgen
mice
express
ha
cn
pancrea
gfaphaxinsha
mice
encount
cnsexpress
antigen
led
clonal
divers
haspecif
cell
decreas
diabet
incid
infrequ
cn
inflamm
contrast
cotransf
haspecif
cell
trigger
diabet
modest
sign
clinic
atax
diseas
gfaphaxinsha
mice
autoreact
cell
also
differenti
respond
adjuv
challeng
coadministr
pertussi
toxin
pt
haspecif
cell
trigger
rapid
lethal
cn
inflamm
gfapha
mice
coadministr
pt
haspecif
cell
fail
produc
cn
diseas
result
suggest
regul
autoreact
cell
respons
tissuespecif
cn
activ
exert
differenti
regul
versu
cell
paradox
role
apc
induct
intraven
toler
experiment
autoimmun
encephalomyel
gx
zhang
b
gran
yu
li
e
ventura
rostami
thoma
jefferson
univers
philadelphia
pa
usa
apc
base
phenotyp
consid
import
determin
differenti
defin
whether
immunoregulatori
function
cell
induct
antoantigenspecif
toler
mediat
via
apc
intraven
iv
toler
experiment
autoimmun
encephalomyel
eae
induc
administ
myelin
oligodendrocyt
glycoprotein
mog
cell
mogiv
pbsiv
mice
purifi
analyz
function
vitro
vivo
cocultur
purifi
apc
cell
show
cell
apc
play
predomin
role
iv
toler
induct
vivo
apc
mogiv
mice
induc
nonspecif
respons
narv
mice
less
effect
suppress
clinic
eae
apc
pbsiv
mice
increas
level
receptor
mrna
express
found
apc
mogiv
mice
conclud
induct
iv
toler
cell
phenomenon
apc
toler
inde
immunostimulatori
upon
system
exposur
autoantigen
block
apc
activ
therefor
would
enhanc
effect
toler
induct
block
potenti
revers
toler
prevent
treat
eae
use
retrovir
transduc
gfp
label
cell
follow
fate
encephalitogen
effector
cell
clinic
phase
eae
learn
mass
pathogen
effector
cell
invad
deepli
cn
use
lifeimag
techniqu
follow
green
autoreact
mbp
specif
cell
within
brain
parenchyma
mani
cell
cruis
unexpect
speed
bmotil
typeq
seemingli
undirect
fashion
cell
howev
attach
begin
toss
around
central
object
bstationari
typeq
specul
motil
cell
search
brain
autoantigen
stationari
cell
found
autoantigen
arrest
reflect
present
recognit
antigen
sever
observ
support
interpret
first
cell
recogn
brain
antigen
ovalbumin
specif
cell
move
almost
exclus
motil
fashion
second
motil
pattern
correl
local
reactiv
level
well
pathogen
potenti
transfer
effector
cell
thu
cell
high
pathogen
potenti
mbp
specif
display
rel
high
proport
stationari
cell
cell
low
pathogen
potenti
eg
specif
brain
autoantigen
show
significantli
lower
proport
stationari
cell
tightli
correl
situ
activ
assess
cell
receptor
downmodul
upmodul
activ
marker
proinflammatori
cytokin
chemokin
impair
function
regulatori
cell
patient
multipl
sclerosi
j
haa
vetter
l
milkova
viehfver
hug
c
falk
b
e
suripay
c
b
fritz
p
krammer
c
b
wildemann
depart
neurolog
univers
heidelberg
heidelberg
germani
b
gsfinstitut
molecular
immunolog
munich
germani
c
dkfz
heidelberg
germani
multipl
sclerosi
ms
chronic
inflammatori
disord
central
nervou
system
cn
sinc
activ
circul
selfreact
cell
specif
myelin
compon
consid
import
diseas
initi
event
effect
immunoregul
peripher
cell
may
critic
prevent
autoimmun
within
cn
immunoregulatori
cell
phenotyp
treg
suppress
cell
function
protect
rodent
organspecif
autoimmun
precis
role
treg
human
autoimmun
unclear
assess
preval
suppressor
function
treg
isol
peripher
blood
patient
clinic
activ
relapsingremit
ms
healthi
control
use
flow
cytometri
gene
express
analysi
vitro
prolifer
assay
demonstr
suppress
potenc
patientderiv
treg
impair
inhibitori
effect
allogen
polyclon
cell
prolif
respons
well
antigen
specif
cell
prolifer
induc
myelin
oligodendrocyt
glycoprotein
significantli
reduc
compar
treg
control
number
cell
surfac
phenotyp
treg
alter
differ
composit
activ
state
respond
cell
observ
result
suggest
impair
inhibitori
effect
treg
autoreact
cell
clone
might
involv
pathogenesi
ms
identif
novel
natur
regulatori
cell
subset
analysi
mechan
regul
e
xystraki
dejean
bernard
saoudi
inserm
toulous
franc
normal
immun
system
contain
bprofessionalq
natur
regulatori
cell
control
physiolog
well
patholog
immun
although
suppress
function
histor
attribut
cell
current
report
natur
regulatori
cell
focu
cell
present
studi
identifi
new
subset
natur
regulatori
cell
normal
healthi
anim
subset
express
low
level
surfac
produc
mainli
cytokin
upon
vitro
stimul
cytotox
allogen
target
cocultur
experi
vitro
stimul
allogen
accessori
cell
subset
suppress
prolifer
differenti
autolog
cell
cytokin
produc
cell
regulatori
subset
mediat
suppress
cellcel
contact
secret
suppress
cytokin
regulatori
activ
cell
also
demonstr
vivo
rat
model
graftversu
host
diseas
collect
data
demonstr
first
time
freshli
isol
rat
cell
contain
cell
regulatori
properti
result
enlarg
gener
figur
cell
mediat
regul
role
cell
subset
regul
central
nervou
system
autoimmun
investig
monoclon
antibodi
use
treatment
multipl
sclerosi
ms
induc
persist
lymphopenia
remiss
autoimmun
diseas
activ
lymphocyt
repopul
third
patient
develop
autoimmun
thyroid
diseas
interact
lymphocyt
mhc
class
ii
self
antigen
complex
cytokin
critic
mainten
cell
number
divers
assess
impact
campath
homeostat
mechan
possibl
involv
subsequ
develop
grave
diseas
demonstr
greater
prolifer
unstimul
lymphocyt
untreat
patient
suggest
increas
homeostat
prolifer
hp
howev
serum
level
equival
patient
control
lymphopenia
induc
signific
increas
serum
level
remain
month
increas
percentag
unstimul
lymphocyt
patient
year
follow
treatment
prolifer
left
day
cultur
result
mimick
use
peripher
blood
mononuclear
cell
control
variabl
deplet
ex
vivo
lymphocyt
suggest
involv
lymphopeniadriven
hp
prolifer
prevent
interact
tcr
mhc
self
peptid
block
conclus
ms
patient
respond
lymphopaenia
appropri
variat
respons
patient
differenti
effect
variou
cell
subset
may
predispos
develop
new
autoimmun
phenomenon
also
evid
hp
may
exagger
patient
ms
perhap
suggest
mechan
autoimmun
may
aris
autoimmun
inflamm
central
nervou
system
cn
occur
multipl
sclerosi
ms
self
reactiv
immun
respons
compartment
oligoclon
expans
b
cell
observ
probabl
equival
expans
occur
cell
subpopul
ongo
antigen
stimul
order
assess
whether
clonal
composit
ex
vivo
unstimul
cerebrospin
fluid
csf
tcell
might
relat
pathogen
potenti
molecular
analysi
tcell
receptor
tcr
vh
transcript
function
rearrang
gene
global
comparison
complementaritydetermin
region
length
distribut
carri
ex
vivo
contemporarili
unstimul
csf
cell
pbmc
method
consist
twostep
multiplex
rtpcr
allow
expans
whole
tcr
vh
gene
repertoir
cell
indic
sensit
enough
evalu
csf
cell
skew
usag
tcrvh
chain
segment
marker
antigendriven
expans
expans
allow
identif
separ
monoclon
ab
magnet
microbead
csf
tcell
subpopul
enrich
ag
specif
cell
allow
gener
high
frequenc
cn
agspecif
cell
clone
bpathogen
relevantq
tcell
csf
examin
character
phenotyp
function
properti
preliminari
find
suggest
strategi
adopt
power
method
sensit
accur
detect
character
relev
tcell
cn
inflamm
multipl
sclerosi
brainderiv
cdna
express
librari
allow
identif
novel
autoantigen
csfinfiltr
lymphocyt
dm
park
sospedra
x
wang
j
quandt
c
rain
b
hf
mcfarland
r
martin
nation
institut
health
bethesda
usa
b
albert
einstein
colleg
medicin
new
york
ny
usa
cell
believ
play
central
role
pathogenesi
multipl
sclerosi
ms
although
extens
research
aim
character
myelinreact
cell
remain
unknown
whether
myelin
compon
princip
target
autoimmun
respons
ms
therefor
tri
identifi
msrelat
autoantigen
unbias
geneticbas
approach
determin
target
cerebrospin
fluid
csf
infiltr
cell
clone
tcc
ms
plaqu
tissuederiv
cdna
clone
express
system
design
human
leukocyt
antigen
hla
class
iirestrict
antigen
present
peripher
blood
deriv
myelinbas
protein
mbp
specif
tcc
serv
control
three
csfderiv
tcc
isol
ms
patient
exacerb
character
detail
respect
hlarestrict
phenotyp
csfderiv
tcc
vivo
clonal
expand
shown
complementar
determin
region
spectratyp
mbpspecif
clone
recogn
mbp
plaquederiv
librari
confirm
technic
feasibl
approach
csfderiv
clonal
expand
tcc
recogn
array
interest
target
find
support
data
gener
posit
scan
synthet
peptid
combinatori
librari
data
indic
like
diseaserelev
csfinfiltr
cell
recogn
much
broader
rang
antigen
within
ms
brain
tissu
previous
anticip
put
mechan
statin
multipl
sclerosispreferenti
inhibit
activ
lymphocyt
neuhau
stuve
jj
archelo
b
hp
hartung
heinrich
hein
univers
germani
b
karl
franzen
univers
graz
austria
object
investig
effect
statin
human
b
lymphocyt
background
recent
demonstr
statin
coenzym
hmgcoa
reductas
inhibitor
immunomodulatori
properti
amelior
diseas
sever
experiment
allerg
encephalomyel
evid
emerg
statin
reduc
mri
diseas
activ
marker
ms
patient
method
mitogenactiv
antigenspecif
narv
peripher
blood
leukocyt
obtain
patient
relapsingremit
ms
healthi
donor
treat
variou
statin
prolif
respons
presenc
surfac
marker
includ
activ
marker
adhes
molecul
evalu
result
statin
reduc
prolif
activ
mitogenactiv
antigenstimul
cell
dosedepend
manner
simvastatin
potent
follow
lovastatin
mevastatin
prolifer
b
cell
affect
mark
alter
surfac
marker
express
activ
cell
decreas
ratio
cell
follow
statintreat
phenotyp
activ
cell
approach
nonactiv
cell
conclus
result
support
preval
hypothesi
regard
mechan
action
statin
intermedi
cholesterol
biosynthesi
pathway
downstream
hmgcoa
promot
isoprenyl
ie
posttransl
lipid
attach
intracellular
protein
regul
activ
lymphocyt
activ
autoreact
encephalitogen
cell
may
affect
statin
treatment
ms
patient
frequenc
regulatori
cell
increas
csf
blood
ms
patient
u
feger
c
luther
b
schreiner
melm
e
tolosa
h
wiendl
depart
neurolog
univers
germani
regulatori
cell
contribut
mainten
peripher
toler
activ
suppress
control
reactiv
potenti
harm
selfreact
cell
prevent
autoimmun
diseas
multipl
sclerosi
ms
inflammatori
autoimmun
diseas
thought
mediat
cell
recogn
myelin
protein
peptid
address
question
regulatori
cell
involv
immunopathogenesi
ms
measur
frequenc
regulatori
cell
flow
cytometri
blood
csf
ms
patient
comparison
healthi
donor
patient
nonautoimmun
neurolog
diseas
agreement
studi
observ
differ
amount
blood
circul
high
cell
patient
either
chronic
remittingrelaps
ms
comparison
normal
donor
contrast
higher
frequenc
regulatori
cell
found
csf
ms
patient
csf
patient
neurolog
disord
select
elev
csf
compart
ms
patient
therefor
suggest
role
regulatori
cell
develop
autoimmun
cn
demyelin
patholog
relev
degener
foreign
self
antigen
recognit
myelinspecif
cell
receptor
ja
quandt
j
huh
park
c
pinilla
b
k
ito
c
r
martin
nation
institut
health
bethesda
usa
b
torrey
pine
institut
molecular
studi
san
diego
usa
c
univers
medicin
dentistri
new
jersey
piscataway
usa
degener
antigen
recognit
cell
may
contribut
significantli
autoimmun
activ
autoreact
cell
via
molecular
mimicri
subsequ
develop
diseas
two
unbias
approach
use
demonstr
degener
antigen
recognit
clone
recogn
immunodomin
myelin
basic
protein
mbp
epitop
restrict
multipl
sclerosi
ms
associ
hla
allel
screen
posit
scan
combinatori
peptid
librari
pscl
ms
brain
cdna
express
librari
specif
cell
clone
identifi
numer
infectiousforeign
protein
well
ubiquit
autoantigen
ligand
pscl
studi
predict
sever
bacteri
viral
epitop
well
myelinassoci
protein
molecular
mimic
prolifer
cytokin
studi
confirm
plp
mog
mbp
epitop
previous
describ
hla
immunodomin
epitop
well
other
ligand
cell
receptor
tcr
reactiv
conserv
human
tcrhla
transgen
mous
share
tcr
studi
current
underway
test
patholog
relev
mimic
vivo
togeth
studi
emphas
highli
degener
antigen
recognit
autoreact
cell
implic
ms
describ
import
mean
identifi
bnovelq
antigen
relev
ms
pathogenesi
suppress
regulatori
cell
possibl
mechan
promot
eae
king
bm
segal
univers
rochest
rochest
usa
famili
monokin
play
critic
role
differenti
lymphocyt
effector
cell
previous
demonstr
monokin
also
critic
develop
relapsingremit
experiment
autoimmun
encephalomyel
eae
murin
model
multipl
sclerosi
mediat
myelinspecif
cell
current
studi
investig
effect
regulatori
cell
treg
thymusderiv
subpopul
cell
immunosuppress
properti
adopt
transfer
treg
prevent
eae
myelinsensit
wildtyp
mice
mice
bear
cell
receptor
transgen
specif
myelin
basic
protein
show
treg
express
subunit
receptor
chain
furthermor
recombin
directli
revers
tregmedi
suppress
effector
cell
prolifer
vitro
endogen
treg
appear
infiltr
cn
peak
eae
persist
high
level
remiss
indic
upregul
tregspecif
transcript
factor
spinal
cord
sensit
mice
conclud
one
mechan
promot
eae
might
inactiv
endogen
popul
treg
furthermor
treg
spontan
infiltr
cn
eae
suggest
might
particip
trigger
remiss
regul
cytokin
balanc
inhibit
nuclear
factor
kappa
b
nf
kappa
b
activ
cannabinoid
encephalitogen
cell
garciamerino
p
gonzalez
arriaga
sanchez
puerta
de
hierro
univers
hospit
madrid
spain
cannabinoid
report
downregul
product
helper
associ
cytokin
includ
interferongamma
ifngamma
tumor
necrosi
factoralpha
increas
product
associ
cytokin
experiment
autoimmun
encephalomyel
eae
lewi
rat
prototyp
cellmedi
diseas
unknown
whether
report
effect
cannabinoid
th
profil
relev
eae
encephalitogen
cell
line
deriv
lewi
rat
inocul
guinea
pig
mbp
cultur
presenc
synthet
cannabinoid
r
win
analyz
flow
cytometri
facscantm
detect
intracellular
cytokin
compar
control
encephalitogen
cell
cannabinoid
reduc
ifn
gamma
product
increas
concentr
suggest
shift
toward
profil
take
account
crucial
role
play
nuclear
factorkappa
b
nfkappa
b
control
key
gene
involv
activ
differenti
autoreact
cell
vivo
also
investig
possibl
effect
cannabinoid
activ
nuclear
factor
use
construct
contain
nfkappa
b
bind
sequenc
observ
r
win
decreas
markedli
promot
activ
coordin
effect
suggest
potenti
role
cannabinoid
autoimmun
diseas
notch
receptor
ligand
deltajag
famili
downstream
signal
mediat
form
highli
conserv
function
pathway
play
central
role
cellular
differenti
prolifer
event
notch
signal
characteris
ligandinduc
proteolyt
cleavag
event
releas
notch
intracellular
domain
transloc
nucleu
bind
convert
repressor
transcript
activ
although
transcript
regul
via
remain
bestcharacteris
outcom
notch
signal
altern
pathway
also
propos
show
notch
signal
via
delta
promot
dosedepend
inhibit
murin
tcell
effector
cytokin
product
ifngamma
tnfalpha
upregul
use
gammasecretas
inhibitor
block
notch
cleavag
show
cytokin
upregul
contrast
deltamedi
cytokin
inhibit
occur
rapidli
involv
differ
cleavageindepend
signal
mechan
activ
associ
differenti
cell
inhibit
develop
acquisit
share
profil
effect
occur
even
condit
promot
differenti
notch
signal
may
therefor
provid
uniqu
therapeut
approach
treatment
autoimmun
disord
multipl
sclerosi
target
jakstat
pathway
nuclear
receptor
agonist
treatment
cellmedi
autoimmun
diseas
jj
bright
g
muthian
hp
raikwar
r
johnson
c
johnson
vanderbilt
univers
medic
center
nashvil
tn
usa
experiment
allerg
encephalomyel
eae
cellmedi
autoimmun
diseas
model
multipl
sclerosi
proinflammatori
cytokin
play
crucial
role
differenti
neural
antigenspecif
cell
pathogenesi
eaem
signal
receptor
induc
activ
jakstat
pathway
cell
target
disrupt
pathway
inhibit
differenti
studi
test
hypothesi
jakstat
pathway
novel
therapeut
target
treatment
cellmedi
autoimmun
diseas
nuclear
receptor
agonist
found
vivo
treatment
specif
agonist
nuclear
receptor
ppargamma
vitamin
receptor
estrogen
receptor
amelior
clinic
patholog
symptom
eae
sjlj
mice
treatment
neural
antigenspecif
cell
nuclear
receptor
agonist
ciglitazon
vitamin
estrogen
quercetin
inhibit
antigeninduc
cell
prolifer
ifngamma
product
nuclear
receptor
agonist
also
inhibit
cell
prolifer
differenti
block
tyrosin
phosphoryl
activ
protein
cell
result
suggest
nuclear
receptor
agonist
modul
jakstat
signal
pathway
cell
use
treatment
ms
cell
mediat
autoimmun
diseas
comput
model
lymphocyt
behavior
inflam
brain
venul
use
stochast
picalculu
p
lecca
c
priami
c
laudanna
b
g
constantin
b
univers
trento
trento
itali
b
univers
verona
verona
itali
object
studi
use
new
mathemat
languag
integr
quantit
qualit
biolog
data
creat
predict
comput
model
lymphocyt
recruit
brain
venul
method
intravit
microscopi
perform
inflam
brain
microcircul
stochast
extens
picalculu
ion
base
notion
name
use
model
simul
biolog
data
result
integr
interact
requir
effici
roll
autoreact
lymphocyt
giproteinlink
signal
interact
led
lymphocyt
arrest
result
togeth
quantif
hemodynam
paramet
adhes
molecul
densiti
allow
us
model
biolog
data
set
concurr
process
creat
comput
model
base
stochast
process
algebra
mobil
system
abl
simul
process
involv
lymphocyt
recruit
inflam
brain
microvessel
moreov
show
model
predict
percentag
roll
lymphocyt
relat
hemodynam
paramet
vessel
diamet
reproduc
function
exponenti
behavior
vivo
result
conclus
usag
mathemat
languag
may
increas
abil
predict
thu
pharmacolog
manipul
complex
key
phenomena
pathogenesi
autoimmun
diseas
visualis
cell
activ
situ
nervou
system
kr
william
ek
mathey
flugel
b
c
linington
depart
medicin
therapeut
institut
medic
scienc
univers
aberdeen
foresterhil
aberdeen
scotland
uk
b
depart
neuroimmunolog
max
planck
institut
neurobiolog
martinsri
munich
germani
recent
studi
use
central
nervou
system
antigen
cn
specif
cell
line
engin
express
green
fluoresc
protein
gfp
demonstr
cell
activ
crucial
determin
diseas
sever
adopt
transfer
experiment
autoimmun
encephalomyel
differ
activ
level
infiltr
cell
antigen
specif
determin
abil
recruit
macrophag
explain
cell
line
weakli
pathogen
other
strongli
pathogen
myelin
basic
protein
howev
littl
known
reactiv
cell
cn
particular
occur
take
place
cell
type
act
antigen
present
cell
answer
question
develop
retrovir
construct
tag
gfp
compon
cell
receptor
tcr
recruit
immun
synaps
form
cell
stimul
antigenpres
cell
demonstr
antigenspecif
stimul
transduc
cell
vitro
result
transloc
cell
surfac
colocalis
compon
tcr
complex
immun
synaps
form
adjac
class
ii
mhc
express
surfac
antigen
present
cell
analysi
autoantigenspecif
cell
adopt
transfer
reveal
immun
synaps
visualis
cn
enabl
identif
antigenpres
cell
experiment
autoimmun
diseas
model
vip
induc
tolerogen
differenti
immun
cell
j
leceta
c
martinez
mg
juarranz
c
abad
arranz
f
rosignoli
garcia
rp
gomariz
departamento
de
celular
facultad
de
universidad
complutens
madrid
spain
vasoact
intestin
peptid
vip
neuropeptid
modul
immun
cellular
signal
mediat
g
proteincoupl
receptor
immun
cell
potent
antiinflammatori
factor
induc
differenti
toward
respons
sever
autoimmun
diseas
present
imbal
respons
preval
vip
protect
effect
murin
experiment
model
collagen
type
ii
cii
induc
arthriti
cia
autoimmun
process
similar
human
rheumatoid
arthriti
aim
studi
determin
express
cytokin
chemokin
receptor
joint
arthrit
mice
treat
vip
well
check
immun
respons
cii
cell
treat
mice
gene
express
cytokin
chemokin
receptor
perform
use
mousetarget
dna
microarray
prolif
respons
secret
cytokin
cultur
synovi
spleen
cell
stimul
cii
use
studi
immun
respons
cytokin
express
joint
cia
mice
howev
vip
reduc
express
differ
cytokin
affect
select
express
cytokin
littl
affect
local
express
mediat
vip
treatment
indic
shift
cellular
infiltr
favour
home
matur
dendrit
cell
cell
naiv
cell
cell
vip
treatment
inhibit
prolifer
cii
stimul
cell
conclus
vip
bias
immun
respons
toward
regulatori
reactiv
